BR122017028637B1 - heteroarylpiperidine and -piperazine derivatives as fungicides and composition for controlling harmful phytopathogenic fungi comprising them and use thereof, method for controlling harmful phytopathogenic fungi as well as process for producing compositions for controlling harmful phytopathogenic fungi - Google Patents

Abstract

heteroarylpiperidine and -piperazine derivatives of formula (i) (i) wherein a, x, y, 11, 12, g, q, p, r 1, r 2 and r 10 are each as defined in the description, and salts, metal complexes and n-oxides of the compounds of formula (i), and their use to control harmful phytopathogenic fungi, and processes for preparing the compounds of formula (i)

Description

Invention Patent Descriptive Report for: HETEROARYLPIPERIDINE DERIVATIVES AND -PIPERAZINE AS FUNGICIDES AND COMPOSITION TO CONTROL HARMFUL PHYTOPHOGENIC FUNGI UNDERSTANDING AND USE OF THE SAME, METHODS TO CONTROL HYPEROPHYGENIC HARMFUL PROTECTIVE HYDROPROPYGENIC HARMFUL PROPERTIES FOR HARMFUL HARMFUL PROPERTIES FOR HARMFUL, HARMFUL, HARMFUL AND HARMFUL PROPERTIES.

Divided from BR1120130032456, deposited on 10/08/2011 [001] The invention relates to derivatives of heteroarylpiperidine and -piperazine, to agrochemically active salts thereof, to their use and to methods and compositions to control harmful pathogenic fungi in and / or on plants or inside and / or outside plant seeds, processes to produce such treated compositions and seeds, and their use to control harmful pathogenic fungi in agriculture, horticulture and forestry, in animal health, in the protection of materials and in the domestic and hygiene sector. The present invention also relates to a process for preparing heteroarylpiperidine and -piperazine derivatives.

[002] It is already known that particular heterocyclic substituted thiazoles can be used as crop protection fungal compositions (see WO

07/014290, WO 08/013925, WO 08/013622, WO 08/091594, WO 08/091580, WO

09/055514, WO 09/094407, WO 09/094445, WO 09/132785, WO 10/037479, WO

10/065579, WO 11/018401, WO 11/018415, WO 11/076510, WO 11/076699). However, in particular at relatively low application rates, the fungicidal activity of these compounds is not always sufficient.

[003] Since the ecological and economic demands made on modern crop protection compositions are constantly increasing, for example, with respect to activity spectrum, toxicity, selectivity, application rate, waste formation and favorable manufacturing, and can in addition to having problems, for example, with resistance, there is a constant goal of developing new crop protection compositions, especially fungicides that have advantages over known compositions in at least some areas.

[004] It has now been found that, surprisingly, the present heteroarylpiperidine and -piperazine derivatives reach at least some aspects of the objects mentioned and are suitable for use as crop protection compositions, especially as fungicides.

Petition 870190021920, of 03/07/2019, p. 5/172

2/160 [005] The invention provides compounds of formula (I)

(I) in which the radicals are defined, each, as follows:

A is phenyl which can contain up to five substituents, where the substituents are selected, each independently from Z ^A-1 , or

A is an optionally substituted unsubstituted or substituted 5- or 6-membered heteroaryl that can contain up to four substituents, where the substituents on the carbon are selected, each independently from Z ^A-2 and the substituents on the nitrogen are selected, each independently from ^a-Z 3,

Z ^A-1 are the same or different and are each independently hydrogen, halogen, hydroxyl, thiol, nitro, cyano, -C (= O) H, -C (= O) OH, alkyl, alkenyl, alkynyl, haloalkyl, haloalquenila, haloalquinila, cycloalkyl, cycloalkenyl, halocicloalquila, halocicloalquenila, hydroxyalkyl, cianoalquila, formilalquila, alkoxyalkyl, haloalcoxialquila, cicloalcoxialquila, alquiniloxialquila, alquiltioalquila, alquilsulfinilalquila, alkylaminoalkyl, haloalquilaminoalquila, cicloalquilaminoalquila, dialkylaminoalkyl, alquilcarbonilalquila, alquilsulfonilalquila, alquilcicloalquila, alquilcicloalquenila alkoxy, alquilcicloalquilalquila, halocycloalkoxy, alkylthio, haloalkylthio, cycloalkylthio, alkynylthio, alkenyloxy, alkynyloxy, haloalkoxy, haloalkenyloxy, haloalkynyloxy, cycloalkoxy, alkoxyalkoxy, cycloalkylalkoxy, alkylcarbonyloxy, haloalquilcarboniloxi, alkylcarbonylamino, alkylsulfonylamino, cycloalkylalkyl, alcoxialcoxialquila, cicloalquilaminocarbonila , Cycloalkylcarbonyloxy, cycloalkylcarbonylamino haloalquilsulfonilamino, halocicloalquilalquila, alkylaminocarbonyloxy, cicloalquilalcoxicarbonila, cycloalkylamino, alkoxycarbonylamino, phenylsulfonylamino, cicloalquilcicloalquila, alquilcarbonilalcoxi, alquilsulfinila, haloalquilsulfinila, alquilsulfonila, haloalquilsulfonila, cicloalquilsulfonila, alkylcarbonyl, haloalquilcarbonila, cicloalquilcarbonila, alkoxycarbonyl, cicloalcoxicarbonila, trialquilsilila, -SF 5, phenyl, -C (= O) NR3R4 or -NR3R4,

Petition 870190021920, of 03/07/2019, p. 6/172

3/160

Z ^A-2 and R ^G1 are the same or different and are each independently hydrogen, halogen, hydroxyl, thiol, nitro, cyano, -C (= O) H, -C (= O) OH, alkyl, alkenyl , alkynyl, haloalkyl, haloalquenila, haloalquinila, cycloalkyl halocicloalquila, hydroxyalkyl, formilalquila, alkoxyalkyl, alquilcarbonilalquila, alquilcicloalquila, alkoxy, alquilcicloalquilalquila, alkylthio, haloalkylthio, alkynylthio, alkenyloxy, alkynyloxy, haloalkoxy, alkoxyalkoxy, alkylcarbonyloxy, haloalquilcarboniloxi, cycloalkylcarbonylamino, alkylsulfonylamino, haloalquilsulfonilamino , phenylsulfonylamino, cycloalkylalkyl, halocicloalquilalquila, cicloalquilcicloalquila, alkoxycarbonyloxy, alquilcarboniltio, alquilsulfinila, haloalquilsulfinila, alquilsulfonila, haloalquilsulfonila, alkylcarbonyl, haloalquilcarbonila, alkoxycarbonyl, alquilamionocarboniloxi, C (= O) NR ³ R 4 or -NR ³ R 4,

Z ^A-3 , R ^G2 and Z ² are the same or different and are each independently hydrogen, -C (= O) H, -C (= O) NR ³ R ⁴ , alkyl, alkenyl, alkynyl, haloalkyl , haloalkenyl, haloalkynyl, cycloalkyl, halocycloalkyl, alkylcycloalkyl, cycloalkylalkyl, alkoxyalkyl, alkylsulfonyl, haloalkylsulfonyl, cycloalkylsulfonyl, phenylsulfonyl, alkylcarbonyl, haloalkylcarbonyl, alkoxycarbonyl, alkoxyalkyl, alkoxycarbonyl

R ³ and R ⁴ are the same or different and are each independently hydrogen, alkyl, alkenyl, alkynyl, haloalkyl, cycloalkyl, benzyl or phenyl,

L ¹ is NR ^L12 or C (R ^L11 ) 2,

R ^L11 are the same or different and are each independently hydrogen, halogen, hydroxyl, cyano, -C (= O) H, -C (= O) OH, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, haloalkynyl, alkoxyalkyl, alquiltioalquila, alkylaminoalkyl, dialkylaminoalkyl, alkoxy, alkylthio, haloalkylthio, haloalkoxy, alkylcarbonyloxy, alkylcarbonylamino, alquilcarboniltio, alquilsulfonila, haloalquilsulfonila, alkylcarbonyl, haloalquilcarbonila, alkoxycarbonyl, trialkylsilyloxy, -NR ³ R 4 or -C (= O) NR ³ R 4, or the two radicals R ^L11 , together with the carbon atom to which they are attached, form a cyclopropyl ring, or the two radicals R ^L11 are = CH2, = COR ³ , = NOR ³ or = CHN (R9) 2,

R ^L12 is hydrogen, -C (= O) H, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl,

Petition 870190021920, of 03/07/2019, p. 7/172

4/160 haloalkynyl, cycloalkyl, halocycloalkyl, alkylcycloalkyl, cycloalkylalkyl, cycloalkylaminocarbonyl, haloalkylaminocarbonyl, alkylsulfonyl, haloalkylsulfonyl, cycloalkylsulfonyl, alkylcarbonyl, haloalkyl, alkylcarbonyl, alkylcarbonyl, alkylcarbonyl, alkoxycarbonyl, alkoxycarbonyl

R9 is alkyl, alkenyl, alkynyl, haloalkyl, cycloalkyl, benzyl or phenyl,

Y is sulfur or oxygen,

X is carbon or nitrogen,

R2 is hydrogen, alkyl, alkenyl, haloalkyl, alkoxy, halogen, cyano or hydroxyl,

R ¹⁰ is oxo, alkyl, alkenyl, haloalkyl, alkoxy, halogen, cyano or hydroxyl, p is 0 to 2,

G is an unsubstituted or substituted 5-membered heteroaryl, where the substituents on carbon are selected, each independently from R ^G1 and the substituents on nitrogen are selected, each independently, from R ^G2 ,

Q is saturated or partially or completely unsaturated, unsubstituted or substituted 5-membered heterocyclyl, where one or more substituents are

R ⁵ the same or different and are selected, each independently from R ⁵ , is the same or different and is independently: linked to the carbon of the 5-membered heterocyclyl of Q:

hydrogen, oxo, halogen, cyano, hydroxyl, nitro, -CHO, -C (= O) OH, -C (= O) NH2, -C (= O) NR3R ⁴ , -NR3R ⁴ , alkyl, alkenyl, alkynyl, haloalkyl, haloalquenila, haloalquinila, cycloalkyl halocicloalquila, alquilcicloalquila, cycloalkylalkyl, cicloalquilcicloalquila, halocicloalquilalquila, alquilcicloalquilalquila, cycloalkenyl, halocicloalquenila, alkoxyalkyl, haloalcoxialquila, cicloalcoxialquila, alcoxialcoxialquila, alquiltioalquila, formilalquila, alquilcarbonilalquila, alquilsulfinilalquila, alquilsulfonilalquila, alkylaminoalkyl, cicloalquilaminoalquila, cicloalquilcarbonila, cicloalquilalcoxicarbonila, haloalkoxy, cycloalkoxy, dialkylaminoalkyl, alkylcarbonyl, alkoxycarbonyl, cycloalkylaminocarbonyl, halocycloalkoxy, haloalkylaminoalkyl, haloalkylcarbonyl, cycloalkoxycarbonyl, hydroxyalkyl, alkoxy, cycloalkylalkoxy, alkenyl

Petition 870190021920, of 03/07/2019, p. 8/172

5/160 haloalkenyloxy, alkynyloxy, haloalkynyloxy, alkoxyalkoxy, alkylcarbonyloxy, haloalquilcarboniloxi, cycloalkylcarbonyloxy, alquilcarbonilalcoxi, alkylthio, haloalkylthio, cycloalkylthio, alquilsulfinila, haloalquilsulfinila, alquilsulfonila, haloalquilsulfonila, cicloalquilsulfonila, trialquilsilila, alkylsulfonylamino, haloalquilsulfonilamino, heterocyclyl attached to the 5-membered nitrogen Q:

hydrogen, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, haloalkynyl, cycloalkyl, halocycloalkyl, alkylcycloalkyl, cycloalkylalkyl, phenyl, benzyl, alkylsulfonyl, -C (= O) H, alkoxycarbonyl or alkylcarbonyl,

L ² is

L ² -4 =

L ² -7 =

R ²⁷

R ²⁷ _R 27 i

i _R 27

S. j _R 27

L ² -10 => 21, L2-2 = ^H , L ² -5 =

27 (O) _m

R ²⁷ _R 27, L ² -8 =, 24

R

R □ ² 3, 27 R

N

> 27 i

N

R ²⁴

R ²⁷

R ²⁵

R ²³ _R 24

R ²⁷ i

, L ² -3 =, L ² -6 =

The .27

R ²⁷

R ·

O, L ² -11

L ² -12 = _R 27

O. . N _R 24

R ²⁰

R ²⁷ > 27

O _R 24 _R 27

R ²⁴ _R 27 .-. 26 / ^χ _26

L2-9 = ^RR or

R ²⁷ R ²⁷

O

R ²⁴

R ²⁴

O where the link identified by i is linked directly to Q, and where the link identified by j is linked directly to R ¹ , m is 0 to 2, n is 0 to 4,

R ²⁰ is halogen or hydroxyl,

R ²¹ is the same or different and is independently alkyl, haloalkyl, alkoxy, haloalkoxy, alkenyl, haloalkenyl, alkynyl, haloalkynyl, alkenyloxy,

Petition 870190021920, of 03/07/2019, p. 9/172

6/160 haloalkenyloxy, alkynyloxy, haloalkynyloxy, or alkylcarbonyloxy,

R ²² is hydroxyl, halogen, alkoxy, haloalkoxy, alkenyl, haloalkenyl, alkynyl, haloalkynyl, alkenyloxy, haloalkenyloxy, alkynyloxy, haloalkynyloxy, alkylcarbonyloxy or cycloalkyl,

R ²³ is hydrogen, -C (= O) H, alkyl, alkenyl, alkynyl, alkoxyalkyl, alkylsulfonyl, haloalkylsulfonyl, alkylcarbonyl, haloalkylcarbonyl, alkoxycarbonyl, haloalkoxycarbonyl, cyclopropyl, benzyl or phenylsulfonyl,

R ²⁴ is the same or different and is independently hydrogen, cyano, alkyl, cycloalkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl, phenyl or benzyl,

R ²⁵ is the same or different and is independently fluorine, bromine, chlorine,

R ²⁶ is hydrogen, hydroxyl, pyridinyl, alkyl, haloalkyl or alkoxy,

R ²⁷ is the same or different and is, in each case, independently hydrogen, alkyl, alkoxy, alkenyloxy or alkynyloxy, with the proviso that L ² can contain no more than two different R ^27s of hydrogen,

R ¹ is a phenyl, benzyl or naphthalenyl optionally mono- or polysubstituted identically or differently by Z ¹ , or an optionally benzofused heteroaryl, unsubstituted or substituted by 5 or 6 members, where the carbon substituents are selected, each, independently of from Z ¹ and the substituents on nitrogen are selected, each independently from Z ² , or

R ¹ is an 8-membered, non-aromatic (saturated or partially saturated) carbocyclic ring, a 5-, 6- or 7-membered non-aromatic heterocyclyl radical or an 8 to 11-membered heterocyclic or carbocyclic bicyclic ring, where the substituents on carbon are selected, each independently from oxo, uncle or Z ¹ and the substituents on nitrogen are selected, each independently from Z ² ,

Z ¹ are each hydrogen, halogen, hydroxyl, thiol, nitro, cyano, -C (= O) H, C (= O) OH, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, haloalkynyl, cycloalkyl, cycloalkenyl, halocycloalkyl, halocycloalkenyl, hydroxyalkyl, alkoxyalkyl, haloalkoxyalkyl, cycloalkoxyalkyl, alkylthioalkyl, alkylsulfinylalkyl, alkylaminoalkyl, haloalkylaminoalkyl,

Petition 870190021920, of 03/07/2019, p. 10/172

7/160 alcoxicarbonilalquila, alquilcicloalquilalquila, alkenyloxy, alkynyloxy, alkoxyalkoxy, cicloalquilaminoalquila, dialkylaminoalkyl, alquilsulfonilalquila, alquilcicloalquila, alkoxy, halocycloalkoxy, alkylthio, haloalkylthio, alkynylthio, haloalkoxy, haloalkenyloxy, haloalkynyloxy, cycloalkoxy, cycloalkylalkoxy, alkylcarbonyloxy, haloalquilcarboniloxi, cycloalkylcarbonyloxy, halocicloalquilcarboniloxi, alkylcarbonylamino , haloalquilsulfonilamino, halocicloalquilalquila, alquilcarbonilalcoxi, alkylsulfonyloxy, haloalquilsulfoniloxi, phenylsulfonyloxy, haloalquilcarbonilamino, phenylsulfonylamino, cicloalquilcicloalquila, cicloalquilcarbonila, alkylsulfonylamino, cycloalkylalkyl, alcoxialcoxialquila, cycloalkylthio, cicloalquilaminocarbonila, cicloalquilalcoxicarbonila, alkenylthio, alquilcarboniltio, alquilsulfinila, haloalquilsulfinila, alquilsulfonila, haloalquilsulfonila, cicloalquilsulfonila, alkylcarbonyl, haloalquilcarbonila , alkoxycarbonyl, haloalkoxycarboni la, cicloalcoxicarbonila, trialquilsilila, trialkylsilyloxy, -SF 5, cycloalkylalkylamino, dialquilaminotiocarbonila, alkoxycarbonylamino, alcoxialquilaminocarbonila, haloalcoxiamino, cicloalquilalquilaminoalquila, dialkylaminocarbonylamino, alcoxihaloalcoxi, alkylthiocarbonyloxy, haloalcoxialcoxi, dialquilaminosulfonila, alcoxihaloalquila, alquilaminosulfonila, dialcoxialquila, haloalcoxihaloalquila, -NHC (= O) H, halocicloalqueniloxialquila , alquiltiocarbonila, alcoxialquenila, -SO2 NHCN, -NHCN, haloalquilsulfonilaminocarbonila, alquilaminotiocarbonilamino, alquilaminotiocarbonila, alquilaminocarbonilalquilamino, alcoxialquinila, halodialquilaminoalquila, cianoalquila, alcoxialquilcarbonila, alkoxycarbonylalkoxy, alkoxyamino, alcoxialcoxicarbonila, cicloalqueniloxialquila, dialquilaminotiocarbonilamino, alquilsulfonilaminocarbonila, haloalcoxihaloalcoxi, halocicloalcoxialquila, -C (= O) NHCN , -N = C (R9) 2, -NR3R4, C (= O) NR3R4, -C (= N-OR ⁷ ) R8 or -L3Z3,

R ⁷ is hydrogen, alkyl, haloalkyl, benzyl or Z3,

R8 is hydrogen, alkyl, haloalkyl, cycloalkylalkyl, cycloalkyl, alkylcycloalkyl, haloalkylcycloalkyl, alkoxyalkyl, haloalkoxyalkyl, benzyl or phenyl,

L3 is a direct bond, -CH2-, -C (= O) -, sulfur, oxygen, -C (= O) O-, -C (= O) NH-, OC (= O) - or -NHC ( = O) -,

Z ³ is a phenyl radical or a 5- or 6-membered heteroaryl radical that can

Petition 870190021920, of 03/07/2019, p. 11/172

8/160 contain up to three substituents, where the substituents are selected, each independently from the following list:

carbon substituents: halogen, cyano, nitro, hydroxyl, amino, -SH, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, haloalkynyl, cycloalkyl, halocycloalkyl, alkoxyalkyl, alkylcarbonyl, haloalkylcarbonyl, alkoxyalkoxy, alkoxyalkoxy, alkoxyalkoxy, alkoxyalkoxy, alkoxyalkoxy , alkynyloxy, alkoxyalkoxy, alkylthio, haloalkylthio, alkylsulfinyl, haloalkylsulfinyl, alkylsulfonyl, haloalkylsulfonyl, trisylylalkyl or phenyl, substituents on nitrogen: hydrogen, -C (= O) H, alkyl, alkylen, alkyl, halo, alkyl, halo, alkyl, halo, alkyl , alkylcycloalkyl, cycloalkylalkyl, alkoxyalkyl, alkylsulfonyl, haloalkylsulfonyl, cycloalkylsulfonyl, phenylsulfonyl, alkylcarbonyl, haloalkylcarbonyl, alkoxycarbonyl, haloalkoxycarbonyl, cycloalkoxycarbonyl compounds and of the N (O4) compounds (I).

[006] The invention also deals with the use of the compounds of formula (I) as fungicides.

[007] The inventive heteroarylpiperidine and -piperazine derivatives of formula (I) and the salts, metal complexes and N-oxides thereof are very suitable for controlling harmful pathogenic fungi. The inventive compounds mentioned above exhibit, in particular, potent fungicidal activity and can be used in crop protection, in the domestic and hygiene sectors and in the protection of materials.

[008] The compounds of formula (I) can be present in pure form or as mixtures of different possible isomeric forms, especially of stereoisomers, such as E- and Z-, -treo and erythro, as well as optical isomers, such as atropisomers or R and S isomers, and, if appropriate, also of tautomers. Both E and Z isomers are claimed, since they are the thromus and erythro isomers, as well as the optical isomers, any mixtures of these isomers, and also the possible tautomeric forms.

[009] The radical definitions of the inventive compounds of formula (I) have preferred, more preferred and even more preferred definitions:

A is preferably phenyl which can contain up to two substituents, where the substituents are selected, each, independently from the following list:

Petition 870190021920, of 03/07/2019, p. 12/172

9/160 halogen, cyano, hydroxyl, -NR ³ R ⁴ , -C (= O) NR ³ R ⁴ , nitro, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C3-C8- cycloalkyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C2-C6-haloalkynyl, C3-C6-halocycloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C1-C4-alkenyloxy, C1-C4-alkynyl C1-C4-alkylthio,

C1-C4-alkylsulfonyl, C1-C4-haloalkylthio, C1-C4-haloalkylsulfonyl,

C1-C4-alkoxy-C1-C6-alkyl, hydroxyl-C1-C4-alkyl, C1-C6-alkylcarbonyl,

C1-C6-alkoxycarbonyl, C1-C6-alkylcarbonyloxy or -C (= O) H, or

A is preferably a heteroaromatic radical selected from the following group: furan-2-yl, furan-3-yl, thiophen-2-yl, thiophen-3-yl, isoxazol-3-yl, isoxazol4-yl, isoxazol-5 -yl, pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, oxazol-2-yl, oxazol-4yl, oxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazole -5-yl, isothiazol-3-yl, isothiazol-4yl, isothiazol-5-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, imidazol-1-yl, imidazol-2-yl , imidazol-4-yl, 1,2,3-triazol-1-yl, 1,2,4-triazol-1-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin -3-yl, pyridazin-4-yl, pyrazin-2-yl, pyrazin-3yl, pyrimidin-2-yl, pyrimidin-4-yl or pyrimidin-5-yl which can contain up to two substituents, where the substituents are selected , each, independently from the following list, substituents on carbon:

halogen, cyano, hydroxyl, nitro, -NR ³ R ⁴ , C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C3-C6-cycloalkyl, C1-C6-haloalkyl, C2-C6-haloalkenyl,

C2-C6-haloalkynyl, C3-C6-halocycloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-haloalkylthio,

C1-C4-haloalkylsulfonyl, C1-C4-alkoxy-C1-C4-alkyl, hydroxyl-C1-C4-alkyl,

C1-C6-alkylcarbonyl, C1-C6-alkoxycarbonyl, C1-C6-alkylcarbonyloxy or phenyl, substituents on nitrogen:

C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl,

C2-C6-haloalkenyl, C2-C6-haloalkynyl, C3-C10-cycloalkyl-C1-C6-alkyl, C1-C6-haloalkylcarbonyl, phenyl, benzyl, C1-C4-alkylsulfonyl, C1-C4haloalkylsulfonyl, phenylsulfonyl, O) H, or C1-C6-alkylcarbonyl,

A is most preferably phenyl which can contain up to two substituents, where the substituents are selected, each, independently from the following list:

fluorine, bromine, iodine, chlorine, cyano, nitro, methyl, ethyl, propyl, 1-methylethyl, 1,1dimethylethyl, chlorofluoromethyl, dichloromethyl, dichlorofluoromethyl, difluoromethyl,

Petition 870190021920, of 03/07/2019, p. 13/172

10/160 trichloromethyl, trifluoromethyl, cyclopropyl, ethoxy, 1-methylethoxy, propoxy, methoxy, trifluoromethoxy, difluoromethoxy, 1-methylethylthio, methylthio, ethylthio, propylthio, difluoromethylthio or trifluoromethylthio, or

A is most preferably a heteroaromatic radical selected from the following group: furan-2-yl, furan-3-yl, thiophen-2-yl, thiophen-3-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, thiazol-2-yl, thiazole- 4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, imidazole-

1-yl, imidazol-2-yl, imidazol-4-yl, 1,2,3-triazol-1-yl, 1,2,4-triazol-1-yl, pyridin-

2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl or pyrimidin-5-yl, which may contain up to two substituents, where the substituents are the same or different and are selected, each independently from the following list:

substituents on carbon:

fluorine, chlorine, bromine, iodine, cyano, nitro, methyl, ethyl, propyl, 1-methylethyl, 1,1dimethylethyl, chlorofluoromethyl, dichloromethyl, dichlorofluoromethyl, difluoromethyl, trichloromethyl, trifluoromethyl, cyclopropyl, ethoxy, 1-methylethoxy, propyl trifluoromethoxy, difluoromethoxy, 1-methylethylthio, methylthio, ethylthio, propylthio, difluoromethylthio, trifluoromethylthio or phenyl, substituents on nitrogen:

methyl, ethyl, propyl, 1-methylethyl, methylsulfonyl, trifluoromethylsulfonyl, methylcarbonyl, trifluoromethylcarbonyl, chloromethylcarbonyl, 2,2-trifluoroethyl, 2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2-chloro-2-difluoroethyl or 2-chloro-2fluoroethyl.

A is even more preferably pyrazol-1-yl which can contain up to two substituents, where the substituents are selected, each, independently from the following list:

methyl, ethyl, propyl, 1-methylethyl, chlorine, bromine, fluorine, monofluoromethyl, difluoromethyl or trifluoromethyl, or

A is even more preferably phenyl which can contain up to two substituents, where the substituents are selected, each, independently from the following list:

methyl, ethyl, iodine, chlorine, bromine, fluorine, methoxy, ethoxy, difluoromethyl or trifluoromethyl.

Petition 870190021920, of 03/07/2019, p. 14/172

11/160

R ³ and R ⁴ are preferably the same or different and are each independently hydrogen, C1-C6-alkyl, C2-C6-alkenyl,

C2-C6-alkynyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, benzyl or phenyl, and more preferably methyl, ethyl, propyl, 1-methylethyl, butyl or 1,1-dimethylethyl,

L ¹ is preferably C (R ^L11 ) 2 (especially CHR ^L11 ) or NR ^L12 and more preferably CH2,

R ^L11 is preferably hydrogen, methyl, ethyl or cyclopropyl, or the two radicals R ^L11 , together with the carbon atom to which they are attached, form a cyclopropyl ring, or the two radicals R ^L11 are = CHN (R9) 2,

R ^L11 is more preferably hydrogen or methyl,

R ^L12 is preferably hydrogen, C1-C4-alkyl, C1-C4-haloalkyl, C3-C8cycloalkyl, C1-C4-alkylsulfonyl, C1-C4-alkoxycarbonyl, and more preferably hydrogen or methyl, and even more preferably hydrogen,

R9 is preferably the same or different and is independently C1-C6-alkyl,

C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, benzyl or phenyl, and more preferably hydrogen, methyl, ethyl, propyl, 1-methylethyl, butyl or 1,1-dimethylethyl ,

Y is preferably oxygen or sulfur and more preferably oxygen,

X is carbon or nitrogen and preferably carbon,

R ² is preferably hydrogen, C1-C4-alkyl, C1-C4-alkenyl, C1-C4-haloalkyl,

C1-C4-alkoxy, halogen, cyano or hydroxyl, and more preferably hydrogen, fluorine, chlorine, bromine or hydroxyl, and even more preferably hydrogen or fluorine,

R ¹⁰ is preferably oxo, C1-C4-alkyl, C1-C4-alkenyl, C1-C4-haloalkyl,

C1-C4-alkoxy, halogen, cyano or hydroxyl, and more preferably fluorine, chlorine, bromine or hydroxyl, and even more preferably fluorine, p is preferably 0 to 1, and more preferably 0,

G is preferably

Petition 870190021920, of 03/07/2019, p. 15/172

12/160

G ¹⁰ =

, G ¹¹ =

where the link identified by v is linked directly to X and where the link identified by w is linked directly to Q,

G is more preferably G ¹ , G ² or G3, and even more preferably G ¹ ,

R ^G1 is preferably hydrogen or halogen and more preferably hydrogen,

Q is preferably

# #

# ^R \

Q ⁶ =, 5 *

, Q7 =, 5 *

, Q8 =, 5 *

, Q9 = * ·, Q ¹⁰ =

Q ¹¹

^R \ ^ N, #

Q ¹² = _Q 16 ₌

Q ¹³ =

_Q 31 ₌

Petition 870190021920, of 03/07/2019, p. 16/172

13/160

Q ³⁶ =

Q ⁴¹ =

where the link identified by is linked directly to G and, at the same time, the link identified by # directly to L2, or where the link identified by * is linked directly to L2 and, at the same time, the link identified by # is linked directly to G, it is more preferably

Q ²⁴ -1

Q ¹¹ -1

where the link identified by x is linked directly to G, and where the link identified by y is linked directly to L ² , it is especially preferably

or Q ¹¹ -1 =

o where the link identified by x is linked directly to G, and where the link identified by y is linked directly to L ² ,

R5 is preferably the same or different and is independently linked to the carbon of the 5-membered heterocyclyl of Q: hydrogen, cyano, -NR ³ R ⁴ , C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1 -C6-haloalkyl, C2-C6-haloalkenyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl,

Petition 870190021920, of 03/07/2019, p. 17/172

14/160

Cs-Cs-halocycloalkyl, C3-C8-halocycloalkyl, C1-C4-alkyl-C3-C8-cycloalkyl, C3-C8-cycloalkyl-Ci-C4-alkyl, C1-C4-alkoxy-C1-C4-alkyl, Cs- Cs-cycloalkoxyCi-C4-alkyl, C1-C4-alkoxy-C1-C4-alkoxy-C1-C4-alkyl, C1-C4-alkylthioC1-C4-alkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, Cs- Cs-cycloalkoxy,

Cs-Cs-halocycloalkoxy, Cs-Cs-cycloalkyl-C1 -C4-alkoxy, C2-C6-alkenyloxy,

C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C6-alkoxyCi -C4-alkoxy, C1-C6-alkylcarbonyloxy, Ci -C6-haloalkylcarbonyloxy,

C3-C8-cycloalkylcarbonyloxy, C1-C6-alkylcarbonyl-C1-C6-alkoxy, C1-C6-alkylthio,

Ci -C6-haloalkylthio, C3-C8-cycloalkylthio, linked to the nitrogen of the 5-membered heterocyclyl of Q:

hydrogen, -C (= O) H, C1-C3-alkyl, C1-C6-alkylcarbonyl,

C1-C6-alkoxycarbonyl or benzyl,

R ⁵ is most preferably hydrogen, cyano, methyl, trifluoromethyl, difluoromethyl or methoxymethyl,

R ⁵ is even more preferably hydrogen,

L ² is preferably L ² -1, L ² -2, L ² -3, L ² -4, L ² -5, L ² -6, L ² -7, L ² -8 or L ² -9, m is preferably 0 or 2, n is preferably 0 to 2, and more preferably 0 or 1,

R ²⁰ is preferably halogen or hydroxyl, more preferably hydroxyl, chlorine, fluorine,

R ²¹ is the same or different and is independently preferably C1-C4-alkyl,

C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-alkoxy,

C1-C4-haloalkoxy, C2-C4-alkenyloxy C2-C4-haloalkenyloxy, C2-C4-alkynyloxy,

C2-C4-haloalkynyloxy, C1-C4-alkylcarbonyloxy, and more preferably methyl, ethyl, ethylenyl, ethynyl, trifluoromethyl, difluoromethyl, methylcarbonyloxy, ethylcarbonyloxy, methoxy, ethoxy, propoxy, 1-methylethoxyoxy, 2-propyleneoxy, 2-propyleneoxy, 2 ,

R ²² is preferably hydroxyl, halogen, C1-C4-alkoxy, C1-C4-haloalkoxy,

C2-C4-alkenyloxy C2-C4-haloalkenyloxy, C2-C4-alkynyloxy,

C2-C4-haloalkynyloxy, C1-C4-alkylcarbonyloxy, C3-C6-cycloalkyl and more preferably hydroxyl, chlorine, fluorine, bromine, iodine, methoxy, ethoxy, propoxy, 1methylethoxy, butoxy, trifluoromethyl, difluoroxy, methylcarbonyl, methylcarbonyl, methylcarbonyl, methyl ethenyloxy, 2-propenyloxy, 2-propynyloxy or trifluoromethoxy,

R ^2s is preferably C1-C4-alkyl, C1-C4-alkylcarbonyl, C1-C4-alkoxy

Petition 870190021920, of 03/07/2019, p. 18/172

15/160

C1-C4-alkyl, C1-C4-alkoxycarbonyl, -C (= O) H, benzyl, phenylsulfonyl, C1-C4alkylsulfonyl, C1-C4-haloalkylsulfonyl, hydrogen, and more preferably hydrogen, methyl, ethyl, propyl, 1-methylethyl , methylcarbonyl, ethylcarbonyl, 1,1dimethylethyloxycarbonyl, -C (= O) H, phenylsulfonyl, methylsulfonyl, trifluoromethylsulfonyl or benzyl,

R ²⁴ is the same or different and is independently preferably hydrogen,

C1-C4-alkyl or C1-C4-haloalkyl, and more preferably hydrogen,

R ²⁵ is preferably fluorine,

R ²⁶ is the same or different and is independently preferably preferably C1-C2-alkyl or C1-C2-alkoxy, and more preferably methyl, ethyl, methoxy or ethoxy,

R ²⁷ is the same or different and is independently preferably hydrogen,

C1-C4-alkyl, C1-C4-alkoxy, and more preferably hydrogen,

R ¹ is preferably unsubstituted or substituted C5-C6-cycloalkenyl, C3-C8cycloalkyl, where the substituents are each selected independently from Z ^1-1 , and more preferably cyclopentenyl, cyclohexenyl, cyclopentyl, cyclohexyl or cycloheptyl, each one of which may contain up to two substituents, where the substituents are selected, each independently from the following list: methyl, ethyl, methoxy, ethoxy, trifluoromethoxy, ethynyl, 2-propenyloxy, 2-propynyloxy, methylcarbonyloxy, ethylcarbonyloxy, trifluoroalkylcarbonyloxyalkylcarbonyloxy , methylthio, ethylthio or trifluoromethylthio and even more preferably cyclopent-2-en-1-yl, cyclopent-3-en-1-yl, cyclohex1-en-1-yl, cyclohex-2-en-1-yl, cyclohex- 3-en-1-yl, cyclopentyl, or cyclohexyl, or

R ¹ is preferably unsubstituted or substituted phenyl, where the substituents are selected, each independently from Z ^1-2 and more preferably phenyl which can contain up to three substituents, where the substituents are selected, each independently from from the following list: fluorine, chlorine, bromine, iodine, cyan, nitro, hydroxyl, amino, uncle, (C = O) H, methyl, ethyl, propyl, 1-methylethyl, butyl, 1,1-dimethylethyl, 1,2dimethylethyl , ethenyl, ethynyl, trifluoromethyl, difluoromethyl, trichloromethyl, dichloromethyl, cyclopropyl, methoxy, ethoxy, propoxy, 1-methylethoxy, 1,1-dimethylethoxy, methylcarbonyl, ethylcarbonyl, trifluoromethylcarbonyl, methoxycarbonyl, methoxycarbonyl, methoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, methoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, methoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl. , 1-ethenyloxy, 2-propenyloxy, 2-propynyloxy, methylcarbonyloxy,

Petition 870190021920, of 03/07/2019, p. 19/172

16/160 trifluoroalkylcarbonyloxy, chloromethylcarbonyloxy, methylcarbonylamino, trifluoroalkylcarbonylamino, chloromethylcarbonylamino, methylthio, ethylthio, methylsulfinyl, methylsulfonyl, methylsulfonyloxy, trifluorosulfonyl-methyl-, (= N-OCH2CH3) H, -C (= N-OH) CH3, -C (= N-OCH3) CH3, -C (= N-OCH2CH3) CH3 or trimethylsilyloxy, even more preferably phenyl which can contain up to three substituents , where the substituents are selected, each independently from the following list: fluorine, chlorine, bromine, iodine, cyano, amino, hydroxyl, - (C = O) H, methyl, ethyl, propyl, 1-methylethyl, ethylene , ethynyl, trifluoromethyl, difluoromethyl, methoxy, ethoxy, methylcarbonyl, trifluoromethylcarbonyl, methoxycarbonyl, ethoxycarbonyl, 1-ethenyloxy, 2propenyloxy, 2-propenyloxy, 2-propynyloxy, methylcarbonyloxy, methylcarbonyloxy, methylcarbonyloxy, triloxycarbonyl uorosulfonyloxy, methylsulfonylamino, trifluoromethylsulfonylamino, -C (= N-OH) H, -C (= N-OCH3) H, -C (= N-OCH2CH3) H, C (= N-OH) CH3, -C (= N -OCH3) CH3, -C (= N-OCH2CH3) CH3 or trimethylsilyloxy, or

R ¹ is preferably unsubstituted or substituted, naphthalen-1-yl, naphthalen-2-yl,

1,2,3,4-tetrahydronaphthalen-1-yl, 1,2,3,4-tetrahydronaphthalen-2-yl, 5,6,7,8-tetrahydronaphthalen-1-yl, 5,6,7,8- tetrahydronaphthalen-2-yl, decalin-1-yl, decalin2-yl, 1H-inden-1-yl, 2,3-dihydro-1H-inden-1-yl, 1H-inden-2-yl, 1H-inden- 3-yl, 1H-inden-4-yl, 1H-inden-5-yl, 1H-inden-6-yl, 1H-inden-7-yl, indan-1-yl, indan-2-yl, indan- 3-yl, indan-4-yl or indan-5-yl, where the substituents are selected, each independently from Z ¹³ and more preferably where the substituents are selected, each independently from the following list: methyl, methoxy, cyano, fluorine, chlorine, bromine, iodine, where, in the most preferred variant, a maximum of three substituents are present and even more preferably no substituent is present, or

R ¹ is preferably an unsubstituted or substituted 5- or 6-membered heteroaryl radical, where the substituents on the carbon are selected, each independently from Z ^1-4 , and the substituents on the nitrogen are selected, each, independently from from Z ² , and is most preferably furan-2-yl, furan-3-yl, thiophen-2-yl, thiophen-3-yl, isoxazol-3yl, isoxazol-4-yl, isoxazol-5-yl, pyrrole -1-yl, pyrrol-2-yl, pyrrol-3-yl, oxazol-2-yl,

Petition 870190021920, of 03/07/2019, p. 20/172

17/160 oxazol-4-yl, oxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl , pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, imidazole-

1-yl, imidazol-2-yl, imidazol-4-yl, 1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl,

1.3.4- oxadiazol-2-yl, 1,2,4-thiadiazole-3-yl, 1,2,4-thiadiazole-5-yl, 1,3,4-thiadiazole-

2-yl, 1,2,3-triazol-1-yl, 1,2,3-triazol-2-yl, 1,2,3-triazol-4-yl, 1,2,4-triazole-1- ila,

1.2.4- triazol-3-yl, 1,2,4-triazol-4-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4- ila, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl or pyrazin-2-yl, each of which may contain up to two substituents, where the substituents are selected, each independently from the next list:

carbon substituents: fluorine, chlorine, bromine, iodine, cyan, nitro, hydroxyl, amino, uncle, (C = O) H, methyl, ethyl, propyl, 1-methylethyl, butyl, 1,1-dimethylethyl, 1,2dimethylethyl , ethenyl, ethynyl, trifluoromethyl, difluoromethyl, trichloromethyl, dichloromethyl, cyclopropyl, methoxy, ethoxy, propoxy, 1-methylethoxy, 1,1-dimethylethoxy, methylcarbonyl, ethylcarbonyl, trifluoromethylcarbonyl, methoxycarbonyl, methoxycarbonyl, methoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, methoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, methoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl, ethoxycarbonyl. , 1-ethenyloxy, 2-propenyloxy, 2-propynyloxy, methylcarbonyloxy, trifluoroalquilcarboniloxi, clorometilcarboniloxi, methylcarbonylamino, trifluoroalquilcarbonilamino, clorometilcarbonilamino, methylthio, ethylthio, metilsulfinila, methylsulfonyl, methylsulfonyloxy, trifluorosulfoniloxi, methylsulfonylamino or trifluorometilsulfonilamino substituents on nitrogen: methyl, ethyl, propyl, -C (= O) H, methylcarbonyl, trifluoromethylcarbonyl, chloromethylcarbonyl, methylsulfonyl, trifluoromethylsulfonyl, phenylsulfonyl, phenyl or 2-propynyl, where even more preferably no substituent is present in nitrogen, or

R ¹ is preferably 5- or 6-membered unsubstituted or substituted benzofused heteroaryl, where the substituents on the carbon are selected, each independently from Z ^1-5 , and the substituents on the nitrogen are selected, each, independently from of Z ² , and more preferably indole-1-yl, indole-2-yl, indole-3-yl, indole-4-yl, indole-5-yl, indole-6-yl, indole-7-yl, benzimidazole -1-yl, benzimidazol-2-yl, benzimidazol-4yl, benzimidazol-5-yl, indazol-1-yl, indazol-3-yl, indazol-4-yl, indazol-5-yl, indazol-6-yl , indazol-7-yl, indazol-2-yl, 1-benzofuran-2-yl, 1-benzofuran-3

Petition 870190021920, of 03/07/2019, p. 21/172

18/160 ila, 1-benzofuran-4-yl, 1-benzofuran-5-yl, 1-benzofuran-6-yl, 1-benzofuran-7ila, 1-benzothiophen-2-yl, 1-benzothiophen-3-yl , 1-benzothiophen-4-yl, 1-benzothiophen-5-yl, 1-benzothiophen-6-yl, 1-benzothiophen-7-yl, 1,3-benzothiazol-2-yl, 1,3benzothiazole-4-yl, 1 , 3-benzothiazol-5-yl, 1,3-benzothiazol-6-yl, 1,3-benzothiazol7-yl, 1,3-benzoxazol-2-yl, 1,3-benzoxazol-4-yl, 1,3 -benzoxazol-5-yl, 1,3benzoxazol-6-yl, 1,3-benzoxazol-7-yl, quinolin-2-yl, quinolin-3-yl, quinolin-4yl, quinolin-5-yl, quinolin-6 -yl, quinolin-7-yl, quinolin-8-yl, isoquinolin-1-yl, isoquinolin-3-yl, isoquinolin-4-yl, isoquinolin-5-yl, isoquinolin-6-yl, isoquinolin-7-yl or isoquinolin-8-yl, each of which may contain up to two substituents, where the substituents are selected, each, independently from the following list:

carbon substituents: fluorine, chlorine, bromine, iodine, methyl, methoxy, 2-propynyloxy, 2propenyloxy, nitrogen substituents: methyl, ethyl, propyl, -C (= O) H, methylcarbonyl, trifluoromethylcarbonyl, chloromethylcarbonyl, methylsulfonyl, trifluoromethyl, trifluoromethyl phenylsulfonyl, phenyl or 2-propynyl, and even more preferably no substituent is present on the benzofused heteroaryl radicals, or

R ¹ is preferably unsubstituted or substituted C5-C15-heterocyclyl, where the substituents on the carbon are selected each independently from Z ^1-6 and the substituents on the nitrogen are each selected independently from Z ² and more preferably piperidin-1-yl, piperidin-2-yl, piperidin-3-yl, piperidin-4-yl, piperazin-1-yl, piperazin-2-yl, piperazin-3-yl, morpholin-1-yl , morpholin-2-yl, morpholin-3-yl, tetrahydropyran-2-yl, tetrahydropyran-3-yl, tetrahydropyran-4-yl, 1,2,3,4-tetrahydroquinolin-1-yl,

1,2,3,4-tetrahydroisoquinolin-2-yl, 1,2,3,4-tetrahydroquinoxalin-1-yl, indolin-1-yl, isoindolin-2-yl, decahidroquinolin-1-ila or decahidroisoquinolin-2-yl , each of which may contain up to two substituents, where the substituents are selected, each independently from the following list:

carbon substituents: fluorine, chlorine, bromine, iodine, methyl, methoxy, 2-propynyloxy, 2propenyloxy, nitrogen substituents: methyl, ethyl, propyl, -C (= O) H, methylcarbonyl, trifluoromethylcarbonyl, chloromethylcarbonyl, methylsulfonyl, trifluoromethyl phenylsulfonyl, phenyl or 2-propynyl, and even more preferably no substituent is present on the heterocyclyl radicals,

Petition 870190021920, of 03/07/2019, p. 22/172

19/160

Z ^1-1 are the same or different and are each independently cyano, halogen, -C (= O) H, C1-C6-alkyl, C1-C6-haloalkyl, C3-C6-cycloalkyl, C2-C6- alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, hydroxyl, oxo, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy,

C2-C6-alkynyloxy, C1-C6-alkylcarbonyloxy, C1-C6-haloalkylcarbonyloxy,

C1-C6-alkylthio or C1-C6-haloalkylthio,

Z ^1-2 are the same or different and are each independently halogen, cyan, hydroxyl, uncle, nitro, -C (= O) H, -COOH, -C (= O) NR ³ R4, -NR3R4, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl,

C2-C6-haloalkenyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl,

C3-C8-halocycloalkyl, C3-C8-cycloalkenyl, C3-C8-halocycloalkenyl,

C1 -C6-alkoxy-C1 -C6-alkyl, C1 -C6-alkylcarbonyl, C1 -C6-haloalkylcarbonyl,

C3-C8-cycloalkylcarbonyl, C1-C6-alkoxycarbonyl, C3-C8-cycloalkoxycarbonyl, C3-C8-cycloalkylaminocarbonyl, Ci -C6-alkoxy, Ci -C6-haloalkoxy,

C3-C8-cycloalkoxy, C3-C8-halocycloalkoxy, C2-C6-alkenyloxy,

C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C4-alkoxyCi -C4-alkoxy, C1-C6-alkylcarbonyloxy, Ci -C6-haloalkylcarbonyloxy,

C3-C8-cycloalkylcarbonyloxy, C1-C6-alkylcarbonyl-C1-C4-alkoxy, C1-C6-alkylthio, C1-C6-haloalkylthio, C3-C6-cycloalkylthio, C1-C6-alkylsulfonyl,

C1-C6-haloalkylsulfonyl, C3-C8-cycloalkylsulfonyl, C1-C6-alkylsulfonyloxy, C1-C6-haloalkylsulfonyloxy, phenylsulfonyloxy, C1-C6-alkylsulfonylamino,

C1-C6-haloalkylsulfonylamino, tri (C1-C4) alkylsilyl, tri (C1-C4) alkylsilyloxy or C (= N-OR7) R ⁸ ,

Z ^1-3 and Z ^1-5 are the same or different and are each independently halogen, cyan, nitro, -C (= O) H, -NR ³ R ⁴ , -C (= O) NR ³ R ⁴ , C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl,

C2-C6-haloalkynyl, C1-C4-alkoxy-C1-C4-alkyl, C1-C6-alkylcarbonyl,

C1-C6-alkoxycarbonyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C1-C6-alkylcarbonyloxy, C1-C6-alkylcarbonylthio, C1-C4-alkylthio, C1-C4-haloalkylthio,

C1-C4-alkylsulfonyl, C1-C4-haloalkylsulfonyl,

Z ^1-4 are the same or different and are each independently halogen, cyan, hydroxyl, uncle, nitro, -C (= O) H, -C (= O) OH, -C (= O) NR ³ R ⁴ , -NR ³ R ⁴ , C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl,

C2-C6-haloalkenyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl,

Petition 870190021920, of 03/07/2019, p. 23/172

20/160

Cs-Cs-halocycloalkyl, Cs-Cs-cycloalkenyl, Cs-Cs-halocycloalkenyl,

C1 -C6-alkoxy-C1 -C6-alkyl, C1 -C6-alkylcarbonyl, C1 -C6-haloalkylcarbonyl, Cs-Cs-cycloalkylcarbonyl, C1-C6-alkoxycarbonyl, Cs-Cs-cycloalkoxycarbonyl, C3-C10-cycloalkylaminocarbonyl, C1- C6-alkoxy, C1-C6-haloalkoxy,

Cs-Cs-cycloalkoxy, Cs-Cs-halocycloalkoxy, C2-C6-alkenyloxy,

C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C4-alkoxyCi -C4-alkoxy, C1-C6-alkylcarbonyloxy, Ci -C6-haloalkylcarbonyloxy,

Cs-Cs-cycloalkylcarbonyloxy, C1-C6-alkylcarbonyl-C1-C4-alkoxy, C1-C6-alkylthio, C1-C6-haloalkylthio, C3-C6-cycloalkylthio, C1-C6-alkylsulfonyl,

C1-C6-haloalkylsulfonyl, Cs-Cs-cycloalkylsulfonyl, C1-C6-alkylsulfonyloxy, C1-C6-haloalkylsulfonyloxy, phenylsulfonyloxy, C1-C6-alkylsulfonylamino or

C1-C6-haloalkylsulfonylamino,

Z ^1-6 are the same or different and are each independently cyan, halogen, -C (= O) H, -C (= O) NR ³ R ⁴ , phenyl, C1-C6-alkyl, C1-C6 -haloalkyl, Cs-C6-cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl,

C2-C6-haloalkynyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy,

C2-C6-alkynyloxy, C1-C6-alkylthio, -NR ^s R ⁴ , C1-C6-alkylcarbonyl,

C1-C6-alkoxycarbonyl, C1-C6-alkylcarbonyloxy or C1-C6-haloalkylthio,

Z ² are the same or different and are each independently preferably hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C2-C6 -haloalkynyl, C1-C4-alkoxyC1-C4-alkyl, phenyl, benzyl, C1-C4-haloalkylsulfonyl, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, phenylsulfonyl, C1-C4-alkylsulfonyl, -C (O) , or C1-Cs-alkylcarbonyl,

R7 is preferably hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, benzyl or Z ^3-1 , more preferably hydrogen, methyl or ethyl,

R ⁸ is preferably hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, Cs-Cs-cycloalkylC1-C4-alkyl, Cs-Cs-cycloalkyl, C1-C4-alkyl-Cs-Cs-cycloalkyl, C1-C4haloalkyl- Cs-Cs-cycloalkyl, C1-C4-alkoxy-C1-C4-alkyl, C1-C4-haloalkoxy-C1C4-alkyl, benzyl or phenyl,

L ³ is preferably a direct bond, -CH2-, sulfur, oxygen, -C (= O) O-, C (= O) NH-, -OC (= O) - or -NHC (= O) -, more preferably a direct link,

Z ^3-1 is preferably a phenyl radical or a 5- or 6-membered heteroaryl radical that can contain up to two substituents, where the substituents are

Petition 870190021920, of 03/07/2019, p. 24/172

21/160 selected, each independently from the following list: substituents on carbon:

halogen, cyano, nitro, hydroxyl, amino, -SH, C1-C4-alkyl, C2-C4-alkenyl, C2C4-alkynyl, C1-C4-haloalkyl, C2-C4-haloalkenyl, C2-C4-haloalkynyl, C1-C4alkoxyalkyl , C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C1-C6alkoxycarbonyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C6-alkenyloxy, C2-C6alkynyloxy, C1-C4-alkylthio, C1 , C1-C4-alkylsulfonyl, C1-C4haloalkylsulfonyl or C1-C4-alkylamino, di (C1-C4-alkyl) amino, substituents on nitrogen: C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1 -C6-haloalkyl, C2-C6-haloalkenyl, C2-C6-haloalkynyl, C1-C4-alkoxyC1-C4-alkyl, phenyl, benzyl, C1-C4-haloalkylsulfonyl, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxy , C1-C4-alkylsulfonyl, -C (= O) H, or C1 -C3-alkylcarbonyl.

[0010] The heteroarylpiperidine and -piperazine derivatives useful according to the invention are defined in general terms by formula (I). The radical definitions of the radicals above and specified below in formula (I) apply to the final products of formula (I), and also equally to all intermediates (see also below under Process and intermediary clarifications).

[0011] The definitions of radical and elucidations listed above and below, in general terms or in areas of preference, can be combined with each other as desired, that is, including combinations between particular areas and areas of preference. They apply both to final products and correspondingly to precursors and intermediates. In addition, individual definitions may not apply.

[0012] Preference is given to those compounds of formula (I) in which each of the radicals has the preferred definitions mentioned above.

[0013] Particular preference is given to those compounds of formula (I) in which each of the radicals has the most preferred definitions mentioned above.

[0014] Very particular preference is given to those compounds of formula (I) in which each of the radicals has the even more preferred definitions mentioned above.

[0015] Preference is also given to compounds of formula (I) where A is

3,5-bis (difluoromethyl) -1H-pyrazol-1-yl, and agrochemical active salts, metal complexes and N-oxides thereof.

Petition 870190021920, of 03/07/2019, p. 25/172

22/160 [0016] Preference is also given to compounds of formula (I) where A is

2.5- dichlorophenyl, and agrochemically active salts, metal complexes and N-oxides thereof.

[0017] Preference is also given to compounds of formula (I) where A is

2.5- bis (difluoromethyl) phenyl, and agrochemically active salts, metal complexes and Noxides thereof.

[0018] Preference is also given to compounds of the formula (I) in which A is 5methyl-3- (trifluoromethyl) -1H-pyrazol-1-yl, and agrochemically active salts, metal complexes and N-oxides thereof.

[0019] Preference is also given to compounds of formula (I) where A is

2.5- dimethylphenyl, and agrochemically active salts, metal complexes and N-oxides thereof.

[0020] Preference is also given to compounds of the formula (I) in which A is 2-methoxy-5-methylphenyl, and agrochemically active salts, metal complexes and N-oxides thereof.

[0021] Preference is also given to compounds of the formula (I) in which A is 5 chloro-2-methylphenyl, and agro-chemically active salts, metal complexes and N-oxides thereof.

[0022] Preference is also given to compounds of formula (I) where A is 3 (difluoromethyl) -5-methyl-1 H-pyrazol-1-yl.

[0023] Preference is also given to compounds of the formula (I) in which A is 3isopropyl-5- (trifluoromethyl) -1 H-pyrazol-1-yl.

[0024] Preference is also given to compounds of the formula (I) in which L ¹ is CH2-, and agrochemically active salts, metal complexes and N-oxides thereof.

[0025] Preference is also given to compounds of the formula (I) in which L ¹ is NH-, and agro-chemically active salts, metal complexes and N-oxides thereof.

[0026] Preference is also given to compounds of the formula (I) in which Y is sulfur, and agrochemical active salts, metal complexes and N-oxides thereof.

[0027] Preference is also given to compounds of the formula (I) in which Y is oxygen, and agrochemical active salts, metal complexes and N-oxides thereof.

[0028] Preference is also given to compounds of formula (I) where X is carbon, and agrochemical active salts, metal complexes and N-oxides of

Petition 870190021920, of 03/07/2019, p. 26/172

23/160 same.

[0029] Preference is also given to compounds of the formula (I) in which R ² is hydrogen or fluorine, and agro-chemically active salts, metal complexes and N-oxides thereof.

[0030] Preference is also given to compounds of the formula (I) in which G is G ¹ , and agro-chemically active salts, metal complexes and N-oxides thereof.

[0031] Preference is also given to compounds of the formula (I) in which Q is Q ²⁴ -3, and agrochemically active salts, metal complexes and N-oxides thereof.

[0032] Preference is also given to compounds of the formula (I) in which Q is Q11-1, and agro-chemically active salts, metal complexes and N-oxides thereof.

[0033] Preference is also given to compounds of the formula (I) in which R ^G1 is hydrogen, and agro-chemically active salts, metal complexes and N-oxides thereof.

[0034] Preference is also given to compounds of the formula (I) in which R ⁵ is hydrogen, and agrochemical active salts, metal complexes and N-oxides thereof.

[0035] Preference is also given to compounds of the formula (I) in which L ² is CH2O-, and agrochemically active salts, metal complexes and N-oxides thereof.

[0036] Preference is also given to compounds of the formula (I) in which L ² is CH2S-, and agrochemical active salts, metal complexes and N-oxides thereof.

[0037] Preference is also given to compounds of the formula (I) in which L ² is C (CH3) 2-, and agro-chemically active salts, metal complexes and N-oxides thereof.

[0038] Preference is also given to compounds of the formula (I) in which L ² is CH2S (O) 2-, and agro-chemically active salts, metal complexes and N-oxides thereof.

[0039] Preference is also given to compounds of the formula (I) in which L ² is CH2 (OCH3) -, and agro-chemically active salts, metal complexes and N-oxides thereof.

[0040] Preference is also given to compounds of the formula (I) in which L ² is Si (CH3) 2-, and agro-chemically active salts, metal complexes and N-oxides thereof.

Petition 870190021920, of 03/07/2019, p. 27/172

24/160 [0041] Preference is also given to compounds of the formula (I) in which L ² is CH2CH2 (C = O) -, and agrochemically active salts, metal complexes and N-oxides thereof.

[0042] Preference is also given to compounds of the formula (I) in which L ² is CF2-, and agrochemically active salts, metal complexes and N-oxides thereof.

[0043] Preference is also given to compounds of the formula (I) in which L ² is CHF-, and agro-chemically active salts, metal complexes and N-oxides thereof.

[0044] Preference is also given to compounds of the formula (I) in which L ² is CH (OH) -, and agro-chemically active salts, metal complexes and N-oxides thereof.

[0045] Preference is also given to compounds of the formula (I) in which L ² is CH2N (CH3) 2-, and agrochemically active salts, metal complexes and N-oxides thereof.

[0046] Preference is also given to compounds of the formula (I) in which L ² is C (CH3) OH-, and agrochemically active salts, metal complexes and N-oxides thereof.

[0047] Preference is also given to compounds of the formula (I) in which L ² is C (CF3) OH-, and agrochemically active salts, metal complexes and N-oxides thereof.

[0048] Preference is also given to compounds of the formula (I) in which R ¹ is phenyl, and agrochemical active salts, metal complexes and N-oxides thereof.

[0049] Preference is also given to compounds of the formula (I) in which R ¹ is 2acetylphenyl, and agrochemically active salts, metal complexes and N-oxides thereof.

[0050] Preference is also given to compounds of formula (I) where R ¹ is

2.6- difluorophenyl, and agrochemically active salts, metal complexes and N-oxides thereof.

[0051] Preference is also given to compounds of formula (I) where R ¹ is

2.6- dibromophenyl, and agrochemically active salts, metal complexes and N-oxides thereof.

[0052] Preference is also given to compounds of the formula (I) in which R ¹ is 2methoxyphenyl, and agro-chemically active salts, metal complexes and N-oxides thereof.

[0053] Preference is also given to compounds of formula (I) where R ¹ is 2

Petition 870190021920, of 03/07/2019, p. 28/172

25/160 methylphenyl, and agrochemically active salts, metal complexes and N-oxides thereof.

[0054] Preference is also given to compounds of the formula (I) in which R ¹ is 2-fluorophenyl, and agrochemically active salts, metal complexes and N-oxides thereof.

[0055] Preference is also given to compounds of formula (I) where R ¹ is

2,6-dichlorophenyl, and agrochemically active salts, metal complexes and N-oxides thereof.

[0056] Preference is also given to compounds of the formula (I) in which R ¹ is 2-chloro-6-fluorophenyl, and agrochemically active salts, metal complexes and N-oxides thereof.

[0057] Preference is also given to compounds of the formula (I) in which R ¹ is thiophen-2-yl, and agrochemically active salts, metal complexes and N-oxides thereof.

[0058] Preference is also given to compounds of the formula (I) in which R ¹ is 2 [(E / Z) - (methoxyimino) methyl] phenyl, and agrochemically active salts, metal complexes and N-oxides thereof.

[0059] Preference is also given to compounds of the formula (I) in which R ¹ is 2-chlorophenyl, and agro-chemically active salts, metal complexes and N-oxides thereof.

[0060] Preference is also given to compounds of the formula (I) in which R ¹ is 2bromophenyl, and agro-chemically active salts, metal complexes and N-oxides thereof.

[0061] Preference is also given to compounds of the formula (I) in which R ¹ is 2 [(E / Z) - (hydroxyimino) methyl] phenyl, and agrochemically active salts, metal complexes and N-oxides thereof.

[0062] Preference is also given to compounds of formula (I) in which R ¹ is 2formyl-6-methoxyphenyl, and agrochemically active salts, metal complexes and Noxides thereof.

[0063] Preference is also given to compounds of the formula (I) in which R ¹ is 2formylphenyl, and agro-chemically active salts, metal complexes and N-oxides thereof.

[0064] Preference is also given to compounds of the formula (I) in which R ¹ is 2bromo-6-fluorophenyl, and agrochemically active salts, metal complexes and N

Petition 870190021920, of 03/07/2019, p. 29/172

26/160 oxides thereof.

[0065] The radical definitions specified above can be combined with each other as desired. In addition, individual definitions may not apply.

[0066] According to the type of substituents defined above, the compounds of the formula (I) have acidic or basic properties and can form salts, possibly also internal salts or adducts, with inorganic or organic acids or with bases or with metal ions. If the compounds of formula (I) carry amino, alkylamino or other groups that induce basic properties, these compounds can be reacted with acids to give salts, or are obtained directly as salts by synthesis. If the compounds of formula (I) carry hydroxyl, carboxyl or other groups that induce acidic properties, these compounds can be reacted with bases to give salts. Suitable bases are, for example, hydroxides, carbonates, hydrogen carbonates of alkali metals and alkaline earth metals, especially those of sodium, potassium, magnesium and calcium, and also ammonia, primary, secondary and tertiary amines that have C1-C4-alkyl groups, mono-, die trialcanolamines of C1-C4-alkanols, choline and chlorocholine.

[0067] The salts thus obtained have similarly fungicidal properties.

[0068] Examples of inorganic acids are hydrohalic acids, such as hydrogen fluoride, hydrogen chloride, hydrogen bromide and hydrogen iodide, sulfuric acid, phosphoric acid and nitric acid, and acid salts, such as NaHSO4 and KHSO4. Useful organic acids include, for example, formic acid, carbonic acid and alkanoic acids, such as acetic acid, trifluoroacetic acid, trichloroacetic acid and propionic acid, as well as glycolic acid, thiocyanic acid, lactic acid, succinic acid, citric acid, benzoic acid , cinnamic acid, oxalic acid, saturated or mono- or di-unsaturated C6-C20 fatty acids, alkyl sulfuric monoesters, alkyl sulfonic acids (sulfonic acids that have straight or branched chain alkyl radicals that have 1 to 20 carbon atoms), aryl sulfonic acids or acids arildisulfonic (aromatic radicals, such as phenyl and naphthyl, which carry one or two sulfonic acid groups), alkylphosphonic acids (acidic phosphonic acids that have straight or branched chain alkyl radicals that have 1 to 20 carbon atoms), arylphosphonic acids or acids arildiphosphonic (aromatic radicals, such as phenyl and naphthyl, which for one or two radicals of phosphonic acid), where the

Petition 870190021920, of 03/07/2019, p. 30/172

27/160 alkyl and aryl radicals may carry additional substituents, for example, ptoluenesulfonic acid, salicylic acid, p-aminosalicylic acid, 2-phenoxybenzoic acid, 2-acetoxybenzoic acid, etc.

[0069] Useful metal ions are especially the ions of the elements of the second main group, especially calcium and magnesium, of the third and fourth main groups, especially aluminum, tin and lead, and also of the first to eighth transition groups, especially chromium, manganese , iron, cobalt, nickel, copper, zinc and others. Particular preference is given to the metal ions of the elements of the fourth period. Here, metals can be present in the various valences they can assume.

[0070] Optionally substituted groups can be mono- or polysubstituted, where the substituents in the case of polysubstitutions can be identical or different.

[0071] Collective terms have been used in the definitions of the symbols given in the formulas above which are generally representative of the following substituents:

[0072] Halogen: fluorine, chlorine, bromine and iodine and preferably fluorine, chlorine, bromine and more preferably fluorine, chlorine.

[0073] Alkyl: saturated, straight or branched chain hydrocarbyl radicals having 1 to 8, preferably 1 to 6 and more preferably 1 to 3 carbon atoms, for example (but not limited to) C1-C6-alkyl such such as methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, pentyl, 1methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl , 1,1dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2 , 3dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methylpropyl. This definition also applies to alkyl as part of a compound substituent, for example, cycloalkylalkyl, hydroxyalkyl etc., unless defined elsewhere in this document such as, for example, alkylthio, alkylsulfinyl, alkylsulfonyl, haloalkyl or haloalkylthio. When the alkyl is at the end of a compound substituent, as, for example, in alkylcycloalkyl, the part of the compound substituent at the beginning, for example, cycloalkyl, may be mono- or polysubstituted, identically or different and in each case independently, by alkyl. O

Petition 870190021920, of 03/07/2019, p. 31/172

28/160 same also applies to compound substituents in which other radicals, for example, alkenyl, alkynyl, hydroxyl, halogen, formyl, etc. are at the end.

[0074] Alkenyl: unsaturated, straight or branched chain hydrocarbyl radicals having 2 to 8, preferably 2 to 6, carbon atoms and a double bond in any position, for example (but not limited to) C2-C6 -alkenyl, such as ethylene, 1-propenyl, 2-propenyl, 1-methylethyl, 1-butenyl, 2-butenyl, 3butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2 -propenyl, 2-methyl-2propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl -2-butenyl, 2-methyl-2-butenyl, 3-methyl-2 butenyl, propenyl, propenyl, pentenyl, pentenyl, pentenyl, pentenyl, butenyl,

1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-21,2-dimethyl-1-propenyl, 1,2-dimethyl-2-propenyl, 1-ethyl-1-propenyl, 1-ethyl-2-

1- hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl,

2- methyl-1-pentenyl,

2-methyl-2-pentenyl,

2-methyl-3-pentenyl,

2-methyl-4-pentenyl,

1,1-dimethyl-3-butenyl, 1,2-dimethyl-1-butenyl, 1,2-dimethyl-2-butenyl, 1,23-methyl-1-pentenyl,

3-methyl-2-pentenyl,

3-methyl-3-pentenyl,

3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1,1-dimethyl-24-methyl-1-pentenyl,

4-methyl-2-pentenyl,

4-methyl-3-pentenyl,

1-methyl-11-methyl-21-methyl-31-methyl-4-dimethyl-3-butenyl, 1,3-dimethyl-1-butenyl, 1,3-dimethyl-2-butenyl, 1,3-dimethyl-3- butenyl,

2,2-dimethyl-3-butenyl, 2,3-dimethyl-1-butenyl, 2,3-dimethyl-2-butenyl, 2,3-dimethyl-3butenyl, 3,3-dimethyl-1-butenyl, 3, 3-dimethyl-2-butenyl, 1-ethyl-1-butenyl, 1-ethyl-2butenyl, 1-ethyl-3-butenyl, 2-ethyl-1-butenyl, 2-ethyl-2-butenyl, 2-ethyl- 3-butenyl, 1,1,2-trimethyl-2-propenyl, 1-ethyl-1-methyl-2-propenyl, 1-ethyl-2-methyl-1-propenyl and 1-ethyl-2methyl-2-propenyl. This definition also applies to alkenyl as part of a compound substituent, for example, haloalkenyl, etc., unless defined elsewhere in this document.

[0075] Alquinyl: straight or branched chain hydrocarbyl groups having 2 to 8, preferably 2 to 6, carbon atoms and a triple bond in any position, for example (but not limited to) C2-C6-alkynyl, such as ethynyl, 1propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl- 2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2hexinyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3-pentynyl, 1methyl-4-pentynyl, 2-methyl-3-pentynyl, 2-methyl-4-pentynyl, 3-methyl-1-pentynyl, 3-methyl-4pentinyl, 4-methyl-1-pentinyl, 4-methyl-2-pentynyl, 1,1-dimethyl-2-butynyl, 1,1-dimethyl-3

Petition 870190021920, of 03/07/2019, p. 32/172

29/160 butynyl, 1,2-dimethyl-3-butynyl, 2,2-dimethyl-3-butynyl, 3,3-dimethyl-1-butynyl, 1-ethyl-2-butynyl, 1-ethyl-3-butynyl, 2 -ethyl-3-butynyl and 1-ethyl-1-methyl-2-propynyl. This definition also applies to alkynyl as part of a compound substituent, for example, haloalkynyl, etc., unless defined elsewhere in this document.

[0076] Alkoxy: saturated alkoxy radicals, straight or branched chain having 1 to 8, preferably 1 to 6 and more preferably 1 to 3 carbon atoms, for example (but not limited to) C1-C6-alkoxy, such such as methoxy, ethoxy, propoxy, 1methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1-dimethylethoxy, pentoxy, 1methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy , 1dimethylpropoxy, 1,2-dimethylpropoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy,

2.3- dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy,

1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy and 1-ethyl-2-methylpropoxy. This definition also applies to alkoxy as part of a compound substituent, for example, haloalkoxy, alkynylalkoxy, etc., unless defined elsewhere in this document.

[0077] Alkylthio: saturated, straight chain or branched alkylthio radicals having 1 to 8, preferably 1 to 6 and more preferably 1 to 3 carbon atoms, for example (but not limited to) C1-C6-alkylthio, such as methylthio, ethylthio, propylthio, 1-methylethylthio, butylthio, 1-methylpropylthio, 2-methylpropylthio, 1,1-dimethylethylthio, pentylthio, 1-methylbutylthio, 2-methylbutylthio, 3-methylbutylthio, 2,2-dimethylpropylthio, 1ethylpropylthio, hexylthio, 1,1-dimethylpropylthio, 1,2-dimethylpropylthio, 1-methylpentylthio, 2-methylpentylthio, 3-methylpentylthio, 4-methylpentylthio, 1,1-dimethylbutylthio, 1,2-dimethylbutylthio,

1.3-dimethylbutylthio, 2,2-dimethylbutylthio, 2,3-dimethylbutylthio, 3,3-dimethylbutylthio, 1-ethylbutylthio, 2-ethylbutylthio, 1,1,2-trimethylpropylthio, 1,2,2-trimethylpropylthio, 1-ethyl- 1-methylpropylthio and 1-ethyl2-methylpropylthio. This definition also applies to alkylthio as part of a compound substituent, for example, haloalkylthio etc., unless defined elsewhere in this document.

[0078] Alkoxycarbonyl: an alkoxy group having 1 to 6, preferably 1 to 3, carbon atoms (as mentioned above) which is attached to the main structure via a carbonyl group (-CO-). This definition also applies to alkoxycarbonyl as part of a compound substituent, for example, cycloalkylalkoxycarbonyl etc., unless defined elsewhere in this document.

[0079] Alkylsulfinyl: saturated alkylsulfinyl radicals, straight chain or

Petition 870190021920, of 03/07/2019, p. 33/172

Branched 30/160 having 1 to 8, preferably 1 to 6 and more preferably 1 to 3 carbon atoms, for example, (but not limited to) C1-C6-alkylsulfinyl, such as methylsulfinyl, ethylsulfinyl, propylsulfinyl, 1-methylethylsulfinyl , butylsulfinyl, 1methylpropylsulfinyl, 2-methylpropylsulfinyl, 1,1-dimethylethylsulfinyl, pentylsulfinyl, 1methylbutylsulfinyl, 2-methylbutylsulfinyl, 3-methylbutylsulfinyl, 2,2-dimethylpropylsulfinyl, dimethylsulfinyl, methylpropylsulfinyl, methylpropylsulfinyl , 2-methylpentylsulfinyl, 3-methylpentylsulfinyl, 4-methylpentylsulfinyl,

1,1-dimethylbutylsulfinyl, 1,2-dimethylbutylsulfinyl, 1,3-dimethylbutylsulfinyl, 2,2dimethylbutylsulfinyl, 2,3-dimethylbutylsulfinyl, 3,3-dimethylbutylsulfinyl, 1-ethylbutylsulfinyl,

2-ethylbutylsulfinyl, 1,1,2-trimethylpropylsulfinyl, 1,2,2-trimethylpropylsulfinyl, 1-ethyl-1methylpropylsulfinyl and 1-ethyl-2-methylpropylsulfinyl. This definition also applies to alkylsulfinyl as part of a compound substituent, for example, haloalkylsulfinyl etc., unless defined elsewhere in this document.

[0080] Alkylsulfonyl: saturated, straight-chain or branched alkylsulfonyl radicals having 1 to 8, preferably 1 to 6 and more preferably 1 to 3 carbon atoms, for example (but not limited to) C1-C6-alkylsulfonyl, such as methylsulfonyl, ethylsulfonyl, propylsulfonyl, 1-methylethylsulfonyl, butylsulfonyl, 1-methylpropylsulfonyl, 2-methylpropylsulfonyl, 1,1-dimethylethylsulfonyl, pentylsulfonyl, 1 methylbutylsulfonyl, 2-methylbutylsulfonyl, 3-methylbutyl, 3-methylbutyl

1-ethylpropylsulfonyl, hexylsulfonyl, 1,1-dimethylpropylsulfonyl, 1,2-dimethylpropylsulfonyl,

1-methylpentylsulfonyl, methylpentylsulfonyl, dimethylbutylsulfonyl,

2-methylpentylsulfonyl,

1.1 - dimethylbutylsulfonyl,

2.2- dimethylbutylsulfonyl,

3-methylpentylsulfonyl,

1.2- dimethylbutylsulfonyl,

2.3- dimethylbutylsulfonyl,

41,33,3dimethylbutylsulfonyl, 1-ethylbutylsulfonyl, 2-ethylbutylsulfonyl, 1, 1,2-trimethylpropylsulfonyl,

1,2,2-trimethylpropylsulfonyl, 1-ethyl-1-methylpropylsulfonyl and 1-ethyl-2-methylpropylsulfonyl. This definition also applies to alkylsulfonyl as part of a compound substituent, for example, alkylsulfonylalkyl etc., unless defined elsewhere in this document.

[0081] Cycloalkyl: monocyclic saturated hydrocarbyl groups having 3 to 10, preferably 3 to 8 and more preferably 3 to 6 carbon ring members, e.g. (but not limited to) cyclopropyl, cyclopentyl and cyclohexyl. This definition also applies to cycloalkyl as part of a compound substituent, for example, cycloalkylalkyl etc., unless defined elsewhere in this document.

Petition 870190021920, of 03/07/2019, p. 34/172

31/160 [0082] Cycloalkenyl: monocyclic, partially unsaturated hydrocarbyl groups having 3 to 10, preferably 3 to 8 and more preferably 3 to 6 carbon ring members, for example (but not limited to) cyclopropenyl, cyclopentenyl and cyclohexenyl. This definition also applies to cycloalkenyl as part of a compound substituent, for example, cycloalkenylalkyl etc., unless defined elsewhere in this document.

[0083] Cycloalkoxy: saturated monocyclic cycloalkyloxy radicals having 3 to 10, preferably 3 to 8 and more preferably 3 to 6 carbon ring members, for example (but not limited to) cyclopropyloxy, cyclopentyloxy and cyclohexyloxy. This definition also applies to cycloalkoxy as part of a compound substituent, for example, cycloalkoxyalkyl etc., unless defined elsewhere in this document.

[0084] Haloalkyl: straight or branched chain alkyl groups having 1 to 8, preferably 1 to 6 and more preferably 1 to 3 carbon atoms (as specified above), where some or all of the hydrogen atoms in these groups can be substituted by halogen atoms as specified above, for example (but not limited to) C1-C3-haloalkyl, such as chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, chlorodifluoromethyl, chlorodifluoromethyl, chlorodifluoromethyl 1-bromoethyl, 1fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichlorethyl, pentafluoroethyl and

1,1,1-trifluoroprop-2-yl. This definition also applies to haloalkyl as part of a compound substituent, for example, haloalkylaminoalkyl etc., unless defined elsewhere in this document.

[0085] Haloalkenyl and haloalkynyl are defined analogously to haloalkyl, except that, instead of alkyl groups, alkenyl and alkynyl groups are present as part of the substituent.

[0086] Haloalkoxy: straight or branched chain alkoxy groups having 1 to 8, preferably 1 to 6 and more preferably 1 to 3 carbon atoms (as specified above), where some or all of the hydrogen atoms in these groups can be substituted by halogen atoms as specified above, for example (but not limited to) C1-C3-haloalkoxy, such as chloromethoxy, bromomethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorofluoromethoxy, dichlorofluoromethoxy, chlorofluoromethoxy, chloro

Petition 870190021920, of 03/07/2019, p. 35/172

32/160 bromoethoxy, 1-fluoroethoxy, 2-fluoroethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2 -fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy and 1,1,1-trifluoroprop-2-oxy. This definition also applies to haloalkoxy as part of a compound substituent, for example, haloalkoxyalkyl etc., unless defined elsewhere in this document.

[0087] Haloalkylthio: straight or branched chain alkylthio groups having 1 to 8, preferably 1 to 6 and more preferably 1 to 3 carbon atoms (as specified above), where some or all of the hydrogen atoms in these groups can be substituted by halogen atoms as specified above, for example (but not limited to) C1-C3-haloalkylthio, such as chloromethylthio, bromomethylthio, dichloromethylthio, trichloromethylthio, fluoromethylthio, difluoromethylthio, trifluoromethylthio, chlorofluoromethylthio, dichlorofluoroethyl, chlorofluoromethyl , 1-fluoroethylthio, 2-fluoroethylthio, 2,2-difluoroethylthio, 2,2,2trifluoroethylthio, 2-chloro-2-fluoroethylthio, 2-chloro-2,2-difluoroethylthio, 2,2-dichloro-2fluoroethylthio, 2,2 , 2-trichloroethylthio, pentafluoroethylthio and 1,1,1-trifluoroprop-2-ylthio. This definition also applies to haloalkylthio as part of a compound substituent, for example, haloalkylthioalkyl etc., unless defined elsewhere in this document.

[0088] Heteroaryl: a 5- or 6-membered completely unsaturated monocyclic ring system containing one to four heteroatoms of the oxygen, nitrogen and sulfur group; if the ring contains a plurality of oxygen atoms, it will not be directly adjacent;

[0089] 5-membered heteroaryl: containing one to four nitrogen atoms or one to three nitrogen atoms and one sulfur or oxygen atom: groups of 5-membered heteroaryl which, in addition to carbon atoms, can contain one to four nitrogen atoms or one to three nitrogen atoms and a sulfur or oxygen atom as ring members, for example, (but are not limited to) 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2- pyrrolyl, 3-pyrrolyl, 3-isoxazolyl,

4-isoxazolyl, 5-isoxazolyl, 3-isothiazolyl, 4-isothiazolyl, 5-isothiazolyl, 3-pyrazolyl, 4 pyrazolyl, 5-pyrazolyl, 2-oxazolyl, 4-oxazolyl, 5-oxazolyl, 2-thiazolyl, 4-thiazolyl 5 thiazolyl, 2-imidazolyl, 4-imidazolyl, 1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl, 1,2,4 thiadiazol-3-yl, 1,2,4- thiadiazol-5-yl, 1,2,4-triazol-3-yl, 1,3,4-oxadiazol-2-yl, 1,3,4thiadiazol-2-yl and 1,3,4-triazole-2- ila;

[0090] 5-membered heteroaryl that contains one to four atoms of

Petition 870190021920, of 03/07/2019, p. 36/172

33/160 nitrogen and is bonded via nitrogen or benzofused 5-membered heteroaryl which contains one to three nitrogen atoms and is linked via nitrogen: groups of 5-membered heteroaryl which, in addition to carbon atoms, can contain one to four atoms nitrogen or one to three nitrogen atoms as ring members and where two adjacent carbon ring members or a nitrogen and an adjacent carbon ring member can be bridged by a buta-1,3-diene-1 group , 4-diyl in which one or two carbon atoms can be replaced by nitrogen atoms, where these rings are attached to the skeleton via one of the nitrogen ring members, for example, (but are not limited to) 1pyrrolyl, 1- pyrazolyl, 1,2,4-triazol-1-yl, 1-imidazolyl, 1,2,3-triazol-1-yl and 1,3,4-triazol1-yl;

[0091] 6-membered heteroaryl containing one to four nitrogen atoms: 6-membered heteroaryl groups that, in addition to carbon atoms, may contain one to three or one to four nitrogen atoms as ring members, for example, ( but are not limited to) 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 3-pyridazinyl, 4-pyridazinyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl, 2-pyrazinyl, 1,3,5-triazin-2- ila, 1,2,4-triazin-3-yl and 1,2,4,5-tetrazin-3-yl;

[0092] Benzo-fused 5-membered heteroaryl containing one to three nitrogen atoms or a nitrogen atom and an oxygen or sulfur atom :, for example, (but are not limited to) indole-1-yl, indole-2 -yl, indol-3-yl, indol-4-yl, indol-5-yl, indol-6-yl, indol-7-yl, benzimidazol-1-yl, benzimidazol-2-yl, benzimidazol-4-yl , benzimidazol-5-yl, indazol-1-yl, indazol-3-yl, indazol-4-yl, indazol-5-yl, benzofuran-3-yl, benzofuran-7-yl, benzothiophen-5-yl, benzothiazole -4-yl, indazol-6-yl, indazol-7-yl, indazol-2-yl,

1-benzofuran-5-yl,

1-benzothiophen-3-yl,

1-benzothiophen-7-yl, 1,3-benzothiazol-2-yl,

1-benzofuran-2-yl,

1-benzofuran-6-yl,

1-benzothiophen-4-yl,

1111,31-benzofuran-4-yl,

1-benzothiophen-2-yl,

1-benzothiophen-6-yl,

1,3-benzothiazol-5-yl, 1,3-benzothiazol-6-yl, 1,3-benzothiazol-7-yl,

1,3-benzoxazol-2-yl, 1,3-benzoxazol-4-yl, 1,3-benzoxazol-5-yl, 1,3-benzoxazol-6-yl and 1,3-benzoxazol-7-yl, [0093] Benzo-fused 6-membered heteroaryl containing one to three nitrogen atoms: for example, (but not limited to) quinolin-2-yl, quinolin-3-yl, quinolin-4-yl, quinolin-5 -yl, quinolin-6-yl, quinolin-7-yl, quinolin-8-yl, isoquinolin-1-yl, isoquinolin-3-yl, isoquinolin-4-yl, isoquinolin-5-yl, isoquinolin-6-yl , isoquinolin-7-ila and isoquinolin-8-ila

Petition 870190021920, of 03/07/2019, p. 37/172

34/160 [0094] This definition also applies to heteroaryl as part of a compound substituent, for example, heteroarylalkyl etc., unless defined elsewhere in this document.

[0095] Heterocyclyl: a saturated or partially unsaturated heterocycle of three to fifteen members, preferably one of three to nine members, which contains one to four heteroatoms of the oxygen, nitrogen and sulfur group: mono-, bi- or tricyclic heterocycles that contain , in addition to carbon ring members, one to three nitrogen atoms and / or an oxygen or sulfur atom or one or two oxygen and / or sulfur atoms; if the ring contains a plurality of oxygen atoms, it will not be directly adjacent; e.g. (but not limited to), oxiranyl, aziridinyl, 2-tetrahydrofuranyl, 3-tetrahydrofuranyl, 2-tetrahydrothienyl, 3tetrahydrothienyl, 2-pyrrolidinyl, 3-pyrrolidinyl, 3-isoxazolidinyl, 4-isoxazolidinyl, 3-isoxazolidinyl, 3 4-isothiazolidinyl, 5-isothiazolidinyl, 3-pyrazolidinyl, 4-pyrazolidinyl, 5-pyrazolidinyl, 2-oxazolidinyl, 4-oxazolidinyl, 5-oxazolidinyl, 2-thiazolidinyl, 4-thiazolidinyl, 5-thiazolidinyl, 2-imidazolidinyl, 4-imidazolidinyl 2,4oxadiazolidin-3-yl, 1,2,4-oxadiazolidin-5-yl, 1,2,4-thiadiazolidin-3-yl, 1,2,4 thiadiazolidin-5-yl, 1,2,4-triazolidin- 3-yl, 1,3,4-oxadiazolidin-2-yl, 1,3,4-thiadiazolidin-2yl, 1,3,4-triazolidin-2-yl, 2,3-dihydrofur-2-yl, 2, 3-dihydrofur-3-yl, 2,4-dihydrofur-2-yl,

2,4-dihydrofur-3-yl, 2,3-dihydrothien-2-yl, 2,3-dihydrothien-3-yl, 2,4-dihydrothien-2-yl, 2,4dihydrotien-3-yl, 2- pyrrolin-2-yl, 2-pyrrolin-3-yl, 3-pyrrolin-2-yl, 3-pyrrolin-3-yl, 2isoxazolin-3-yl, 3-isoxazolin-3-yl, 4-isoxazolin-3- ila, 2-isoxazolin-4-yl, 3-isoxazolin4-yl, 4-isoxazolin-4-yl, 2-isoxazolin-5-yl, 3-isoxazolin-5-yl, 4-isoxazolin-5-yl, 2isothiazolin- 3-yl, 3-isothiazolin-3-yl, 4-isothiazolin-3-yl, 2-isothiazolin-4-yl, 3-isothiazolin4-yl, 4-isothiazolin-4-yl, 2-isothiazolin-5-yl, 3-isothiazolin-5-yl, 4-isothiazolin-5-yl, 2,3-dihydropyrazol-1-yl, 2,3-dihydropyrazol-2-yl, 2,3-dihydropyrazol-3-yl, 2,3-dihydropyrazol4- ila, 2,3-dihydropyrazol-5-yl, 3,4-dihydropyrazol-1-yl, 3,4-dihydropyrazol-3-yl, 3,4 dihydropyrazol-4-yl, 3,4-dihydropyrazol-5-yl, 4,5-dihydropyrazol-1-yl, 4,5-dihydropyrazole-

3-yl, 4,5-dihydropyrazol-4-yl, 4,5-dihydropyrazol-5-yl, 2,3-dihydrooxazol-2-yl, 2,3dihydrooxazol-3-yl, 2,3-dihydrooxazol-4- ila, 2,3-dihydrooxazol-5-yl, 3,4-dihydrooxazol2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 3,4-dihydrooxazol-5-yl, 3,4dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 2-piperidinyl, 3piperidinyl, 4-piperidinyl, 1,3-dioxan-5-yl, 2- tetrahydropyranyl, 4-tetrahydropyranyl, 2tetrahydrothienyl, 3-hexahydropyridazinyl, 4-hexahydropyridazinyl, 2hexahydropyrimidinyl, 4-hexahydropyrimidinyl, 5-hexahydropyrimidinyl, 2-piperazinyl,

Petition 870190021920, of 03/07/2019, p. 38/172

35/160

1,3,5-hexahydrotriazin-2-yl and 1,2,4-hexahydrotriazin-3-yl. This definition also applies to heterocyclyl as part of a compound substituent, for example, heterocyclylalkyl etc., unless defined elsewhere in this document.

[0096] Leaving group: the leaving group Sn1 or Sn2, for example, chlorine, bromine, iodine, alkylsulfonates (-OSO2-alkyl, for example, -OSO2CH3, -OSO2CF3) or arylsulfonates (-OSO2-aryl, for example , -OSO2Ph, -OSO2PhMe);

[0097] Not included are combinations that are contrary to the laws of nature and that the technician in the subject, therefore would exclude based on his expert knowledge. Ring structures that have three or more adjacent oxygen atoms, for example, are excluded.

[0098] Elucidation of the preparation processes and intermediates [0099] The heteroarylpiperidine and -piperazine derivatives of the formula (I) can be prepared by several means. First of all, the possible processes are shown schematically below. Unless otherwise indicated, the specified radicals are each as defined above.

[00100] The processes according to the invention to prepare the compounds of formula (I) are optionally carried out using one or more reaction aids.

[00101] Useful reaction aids include, if required, inorganic or organic bases or acid acceptors. These preferably include alkali metal or alkaline earth metal acetates, amides, carbonates, hydrogen carbonates, hydrides, hydroxides or alkoxides, for example, sodium acetate, potassium acetate or calcium acetate, lithium amide, sodium amide, potassium amide or calcium amide, sodium carbonate, potassium carbonate or calcium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or calcium hydrogen carbonate, lithium hydride, sodium hydride, potassium hydride or calcium hydride, lithium hydroxide, hydroxide sodium, potassium hydroxide or calcium hydroxide, sodium methoxide, ethoxide, n- or i-propoxide, n-, i-, s- or t-butoxide or potassium methoxide, ethoxide, n- or i-propoxide, n-, i-, s- or tbutoxide; and also basic organic nitrogen compounds, for example, trimethylamine, triethylamine, tripropylamine, tributylamine, ethyldiisopropylamine, N, Ndimethylcyclohexylamine, dicyclohexylamine, ethyldicyclohexylamine, N, N-dimethyl-aniline, N, N-dimethylbenzylamine, pyridine, 2-methydine-2-pyridine 3-methyl-, 4-methyl-, 2,4-dimethyl-, 2,6-dimethyl-,

Petition 870190021920, of 03/07/2019, p. 39/172

36/160

3,4-dimethyl- and 3,5-dimethylpyridine, 5-ethyl-2-methylpyridine, 4-dimethylaminopyridine, Nmethylpiperidine, 1,4-diazabicyclo [2.2.2] octane (DABCO), 1,5-diazabicyclo [4.3. 0] non-5eno (DBN), or 1,8-diazabicyclo [5.4.0] undec-7-ene (DBU).

[00102] The processes according to the invention are optionally carried out using one or more diluents. Useful diluents include virtually all inert organic solvents. These preferably include optionally halogenated aliphatic and aromatic hydrocarbons, such as pentane, hexane, heptane, cyclohexane, petroleum ether, benzene, ligroin, benzene, toluene, xylene, methylene chloride, ethylene chloride, chloroform, carbon tetrachloride, chlorobenzene and the -dichlorobenzene, ethers such as diethyl ether and dibutyl ether, glycol dimethyl ether and diglycol dimethyl ether, tetrahydrofuran and dioxane, ketones, such as acetone, methyl ethyl ketone, methyl isopropyl ketone and methyl isobutyl ketone, esters, and such as acetates ethyl acetate, nitriles, for example, acetonitrile and propionitrile, amides, for example, dimethylformamide, dimethylacetamide and Nmethylpyrrolidone, and also dimethyl sulfoxide, tetramethylenesulfone and hexamethylphosphoramide and DMPU.

[00103] The reaction temperatures in the process according to the invention can be varied within a relatively wide range. In general, working temperatures are between 0 ° C and 250 ° C, preferably temperatures between 10 ° C and 185 ° C.

[00104] The reaction time varies according to the reaction scale and the reaction temperature, but it is usually between a few minutes and 48 hours.

[00105] The processes according to the invention are generally carried out under standard pressure. However, it is also possible to work under high or reduced pressure.

[00106] For the performance of the processes according to the invention, the starting materials required in each case are generally used in approximately equimolar amounts. However, it is also possible to use one of the components used in each case in a relatively large excess.

[00107] Process A

Scheme 1: Process A

Petition 870190021920, of 03/07/2019, p. 40/172

37/160

R ² W ^1o -L ² -R ¹ R ² y _N y. _GV v -! ** !!> —- y _N -i. _{G. Q} .j _R '

AL H ⁷ one or more steps aL VL / ⁽ Ά (r '% (XXIV) (I)

W ⁹ and W ¹⁰ are functional groups suitable for the formation of the desired heterocycle [00108] In general, it is possible to prepare compounds of formula (I) from corresponding compounds (XXIII) and (XXIV) with suitable functional groups W9 and W10 ( I) (see Scheme 1, process A). Possible functional groups for W9 and W10 are, for example, aldehydes, ketones, esters, carboxylic acids, amides, thioamides, nitriles, alcohols, thiols, hydrazines, oximes, amidines, amide oximes, olefins, acetylenes, halides, alkyl halides , methanesulfonates, trifluoromethanesulfonates, boronic acids, boronates etc., which can form the desired Q heterocycle under suitable reaction conditions. There are numerous methods in the literature for preparing heterocycles (see WO 2008/013622; Comprehensive Heterocyclic Chemistry Vol. 4-6, editors: AR Katritzky and CW Rees, Pergamon Press, New York, 1984; Comprehensive Heterocyclic Chemistry II, Vol. 2-4, editors: AR Katritzky, CW Rees and EF Scriven, Pergamon Press, New York, 1996; The Chemistry of Heterocyclic Compounds, editor: EC Tailor, Wiley, New York; Rodd's Chemistry of Carbon Compounds, Vol. 2-4 , Elsevier, New York; Synthesis, 1982, 6, 508-509;

Tetrahedron, 2000, 56, 1057-1094; and literature cited therein).

[00110] A particular means of preparing compounds of the formula (le) from corresponding compounds (III) by reaction with the compounds (Ila) or (Hb) is shown in Scheme 2.

[00111] Alkenes and alkynes (Ila) and (lib) are commercially available or

Petition 870190021920, of 03/07/2019, p. 41/172

38/160 can be prepared from commercially available precursors by the methods described in the literature (Figure 1 and Scheme 2).

Figure 1 (IIb-1) (IIa-1)

Y ² = O, S, NR ²³ , Si (R ²⁶ ) 2 k = 1-5.

[00112] The alkene (IIa-2) is prepared, for example, from the corresponding ketone (IIc) by fluorination with sulfur (diethylamino) sulfur (DAST) or bis (2-methoxyethyl) amino sulfur trifluoride (Deoxofluor) (see, for example, Advances in Organic Synthesis, 2006, 2, 291-326, Singh, RP, Meshri, DT, Shreeve, JM, Bentham Science Publishers Ltd; Singh, RP, Shreeve, JM Synthesis 2002, 17, 2561- 2578; Chang, Y., Tewari, A., Adi, A., Bae, C. Tetrahedron 2008, 64, 98379842; and literature cited therein). The alkene (IIa-3), (IIa-4) or (IIa-5) can also be prepared by acetalization, reducing amination, nucleophilic addition or reduction (see Scheme 3). Alkenes (IIa-6) and (IIa-7) can be prepared from compounds (IIa-5) by halogenation and thionation (see, for example, for acetalization: Meskens, FAJ Synthesis 1981, 501; for reductive amination: Nugent, TC, El-Shazly, M. Adv. Sinth. Catal. 2010, 352, 753-819; Margaretha, P. Science de Synthesis 2008, Vol. 40, 65-89, Georg Tieme Verlag; for nucleophilic addition, reduction , halogenation and thionation: Smith, MB, March J. March's Advanced Organic Chemistry, 6th ^to 2007, Wiley-Interscience; WO 2006/11761 A1; Shandala, MY, Khalil, SM; Al-Dabbagh, M. S Tetrahedron 1984, 40, 1195-8; Yang, X .; Mague, JT; Li, CJ Org. Chem. 2001, 66, 739-747; and literature cited therein).

Layout 3

Petition 870190021920, of 03/07/2019, p. 42/172

39/160

η = 0, 1,2, 3, or 4,

R ^y = alkyl, haloalkyl, alkylcarbonyl

R ^x = alkyl, haloalkyl, alkenyl, alkynyl,

W ¹³ = halogen, toluenesulfonyloxy, methylsulfonyloxy.

[00113] Additional reactions with compounds (lla-4), (lla-5) and (lla-7) can be carried out. For example, substitution reaction with electrophilic reagents (XXII) can give compounds (lla-9) (Scheme 4). There are numerous methods in the literature for the preparation of amines, thioalcohols and alcohols (see Smith. Μ. B., March J. March's Advanced Organic Chemistry, 6th ^to Ed. 2007, Wiley-Interscience; Matsuda, H., Ando, S. , Mohkawa, T., Kataoka, S., Yoshikawa, M. Bioorg. Med. Chem. Lett. 2005, 15, 1949-1953; US 2005/0234040 A1; Masquelin, T. Obrecht, D. Tetrahedron Lett. 1994 , 35, 9387-90; Bondzic, BP, Eilbracht, P. Org. Lett. 2008, 10, 3433-3436; Bondzic, BP, Farwick, A., Liebich, J., Eilbracht, Pv Org. Biomol. Chem. 2008, 6, 3723-3731; and literature cited in them).

Layout 4

H r ^q _r 5 _γ 3 QR ^Q _r 5 γ3

R ⁵ vVpi < ^χχιι > ΜΑ γζ V-Jn R --------------------- * -] K base R (lla-8) (lla-9)

W ¹³ = halogen, toluenesulfonyloxy, methylsulfonyloxy,

Y ³ = O, S, NR ²³ , and

R ^Q = C1-C4-alkyl, C1-C4-haloalkyl, C3-C4-alkenyl, C3-C4-haloalkenyl,

C3-C4-alkynyl, C3-C4-haloalkynyl, C2-C4-alkylcarbonyl [00114] Similar to the process shown in Scheme 2, the

Petition 870190021920, of 03/07/2019, p. 43/172

40/160 compounds of the formula (llb) are prepared.

[00115] A compound of the general formula (le) is obtained from an alkene of the general formula (Ha) or an alkaline of the formula (Hb) and compound (III) by a cycloaddition reaction (see, for example, WO 08 / 013622 and Synthesis, 1987, 11, 998-1001).

[00116] Process B is carried out in the presence of an adequate base. Preferred bases are tertiary amines (e.g., triethylamine), and alkali metal or alkaline earth metal carbonates, hydrogen carbonates and phosphates.

[00117] Process B is preferably carried out using one or more diluents. In the performance of process B, inert organic solvents are a preferred option (for example, toluene and hexane). Water is similarly a possible solvent. Alternatively, process B can be carried out in excess of the alkene (Ha) or the alkaline (Hb).

[00118] The initial preparation is carried out by custom methods. If necessary, the compounds are purified by recrystallization, distillation or chromatography, or they can optionally also be used in the next step without prior purification.

[00120] A means of preparing the intermediate (HI) from the compound (IV) is shown in Scheme 5 (Process C).

[00121] A compound of the general formula (III) is obtained by condensing an aldehyde of the formula (IV) with hydroxylamine and subsequent chlorination (see, for example, WO 05/0040159, WO 08/013622 and Synthesis, 1987, 11, 9981001).

[00122] In process C, aldehyde (IV) and hydroxylamine are first reacted (Scheme 5, step (a)). The corresponding oxime is subsequently chlorinated in the presence of a suitable chlorinating agent. Preferred chlorination reagents are N-chlorosuccinimide, HCIO and chlorine. After step (a) of process C, the mixture of

Petition 870190021920, of 03/07/2019, p. 44/172

41/160 reaction can be prepared initially by custom methods or then converted directly to step (b).

[00123] Process C is preferably carried out using one or more diluents. In step (a) of process C according to the invention, preference is given to using protic solvents, for example, ethanol, as the solvent. After the formation of the corresponding oxime from the compound (VI), the reaction mixture is diluted in step (b) with an additional solvent, for example, tetrahydrofuran, and then aqueous sodium hypochlorite is added. Chlorination can similarly be performed with the help of N-chlorosuccinimide in DMF.

[00124] Initial preparation is carried out by custom methods. If necessary, the compounds are purified by recrystallization or chromatography, or they can optionally also be used in the next step without prior purification.

[00125] Process D

Figure 6: Process D r ^ n / Xr '__________ γ R ^2N pÇ ^L >

Y,, is VR 'Y! ç | AK h _c ^s one or more steps Vf ·,] χ.β

AL 'V ^A ' ^L 'X (R ¹ % | V) | l) [00126] A particular means of preparing compounds of formula (le) from corresponding compounds (V) is shown in Scheme 6 (process D) . Process D is performed in a similar way to process B (in Schemes 3 and 4).

[00128] A particular means of preparing intermediate (V) from compound (III) with compounds (llc-1) or (lld) is shown in Scheme 7 (process E). Process E is performed in a similar way to process B (Scheme

Petition 870190021920, of 03/07/2019, p. 45/172

42/160

2).

[00129] Process F

Scheme 8: Process F, O ^

R ^{2 N} a ^ L 5

X-G

W ¹

H

YR ¹ .O ^ x 2 r ^2N 3Í ^y ' ^r

A (R ¹⁰ ) p (VI) base (R ¹⁰ ) p (VII) (If)

W ¹ is chlorine, bromine, iodine, toluenesulfonyloxy, Y ² is O, S, NR ²³ .

[00130] A particular means of preparing compounds of formula (Se) from corresponding compounds (VII) with compounds (VI) is shown in

Scheme 8 (process F).

[00131] In the presence of an organic or inorganic base, for example, K2CO3 or Cs2CO3, the compounds of the formula (Se) are prepared from corresponding compounds (VII) with the compounds (VI). The reaction temperature for the substitution can be varied within a relatively wide range, and it is possible to use different inert solvents, for example, DMF, CH3CN and acetone. The presence of a cocatalyst can also be useful for the reaction, for example, potassium iodide or tetrabutylammonium iodide (see, for example, Mao, J., Yuan, H., Wang, Y. et al Biorg. Med. Chem. Lett. 2010, 20, 1263-1268; Mirzae, YR, Tabrizi, SB, Edjlali, L. Acta Chim. Slov. 2008, 55, 554-561; Huang Q. et al J. Med. Chem. 2009, 52 , 6757-6767; WO 2006/114272 and literature cited therein).

[00132] Substituted compounds of formula (VI) are commercially available or can be prepared by methods known from the literature from commercially available precursors.

[00133] Process G

Figure 9: Process G xg (R ¹⁰ ) p

OH

2N

, r ² ^? ^w

XG (III) (IIf) (R ¹⁰ ) p

Petition 870190021920, of 03/07/2019, p. 46/172

43/160

W ¹ is chlorine, bromine, iodine, toluenesulfonyloxy.

[00134] A particular means of preparing intermediate (VII) from corresponding compounds (III) with compounds (He) or (llf) is shown in Scheme 9 (process G). Alkenes (He) and alkynes (llf) are commercially available or can be prepared from commercially available precursors by the methods described in the literature (for example, from allyl alcohols or propargyl alcohols, or from nucleophilic vinyl addition products or acetylenyl nucleophiles in ketones or aldehydes; (see, for example, Smith. Μ. B., March J. March's Advanced Organic Chemistry, 6 ^to Ed. 2007, Wiley-lnterscience; for nucleophilic addition of vinyl or acetylenyl nucleophiles: Palin , R. et al Bioorg. Med. Chem. Lett. 2005, 15, 589-593; Kanady, JS, Nguyen, JD, Ziller, JW, Vanderwal, CDJ Org. Chem. 2009, 74, 2175-2178; for halogenation : Yamakoshi, S., Hayashi, N., Suzuki, T., Nakada, M. Tetrahedron Lett. 2009, 50, 5372-5375; Niggemann, M., Jelonek, A., Biber, N., Wuchrer, M. , Plietker, BJ Org. Chem. 2008, 73, 70287036; Forbeck, EM, Evans, CD, Gilleran, JA, Li, P., Joullie, Madeleine MJ Am. Chem. Soc. 2007, 129, 14463-14469; Gichinga , M., Striegler, S. Tetrahedron 2009, 65, 4917-492; and literature cited therein). Process G is performed in a similar way to process B (Scheme 2).

[00135] Process H

Figure 10: Process H

Y

A-L

(XXVI) w ¹¹ —QLR ¹ (XXV) one or more steps

W ¹¹ and W ¹² are functional groups suitable for the formation of the desired heterocycle.

[00136] In general, it is possible to prepare the compounds of formula (I) from corresponding compounds (XXVI) and (XXV) with suitable functional groups W ¹¹ and W ¹² , (I) (see Scheme 10, process H). Possible functional groups for W ¹¹ and

W ¹² are, for example, aldehydes, ketones, esters, carboxylic acids, amides, thioamides, nitriles, alcohols, thiols, hydrazines, oximes, amidines, amide oximes, olefins, acetylenes, halides, alkyl halides, methanesulfonates, trifluoromethanesulfonates, acids boric acid, boronates etc. They can form the desired 5-membered G-heterocycle under suitable reaction conditions. exist

Petition 870190021920, of 03/07/2019, p. 47/172

44/160 numerous methods in the literature for preparing heterocycles (see WO 2008/013622; Comprehensive Heterocyclic Chemistry Vol. 4-6, editors: AR Katritzky and CW Rees, Pergamon Press, New York, 1984; Comprehensive Heterocyclic Chemistry II, Vol. 2-4, editors: AR Katritzky, CW Rees and EF Scriven, Pergamon Press, New York, 1996; The Chemistry of Heterocyclic Compounds, editor: EC Tailor, Wiley, New York; Rodd's Chemistry of Carbon Compounds, Vol. 2 -4, Elsevier, New York; and literature cited therein).

[00137] Process I

Petition 870190021920, of 03/07/2019, p. 48/172

45/160

[00138] A particular means of synthesizing compounds of formula (le) from compounds (IX) with compounds (VIII) is shown in Scheme 11 (process I).

[00139] Thiocarboxamides (IX) are obtainable by methods known from the literature, for example, by thionization of the corresponding commercially available carboxamide using, for example, Lawesson's reagent (document W02008 / 013622, Org. Sinth. Vol. 7, 1990 , 372).

[00140] oc-Halo ketones or corresponding equivalents (for example, toluenesulfonyloxy) are also obtainable by methods known from the literature (for example, see document W02008 / 013622), (Scheme 12).

[00141] Thiazoles (le) are obtained by a synthesis of thiazole Hantzsch from thiocarboxamides (IX) and ochalo ketones or corresponding equivalents (VIII) (see, for example, Comprehensive Heterocyclic Chemistry, Pergamon Press, 1984; vol. 6, pages 235-363, Comprehensive Heterocyclic Chemistry II, Pergamon Press, 1996; vol. 3, pages 373-474 and references cited therein, and WO

Petition 870190021920, of 03/07/2019, p. 49/172

46/160

07/014290).

[00142] Process I is preferably carried out using one or more diluents. In the performance of process I, inert organic solvents are a preferred option (for example, Ν, Ν-dimethylformamide and ethanol).

[00143] If appropriate, an auxiliary base is used, for example, triethylamine.

[00144] If necessary, the compounds are purified by recrystallization or chromatography, or they can optionally also be used in the next step without prior purification.

[00146] The amines (Ia) obtained in the performance of process J according to the invention (Scheme 13) can be converted by methods described in the literature to the corresponding thioamides (Ib) (for example, Bioorganic & Medicinal Chemistry Letters, 2009, 19 (2), 462-468). This involves reacting the compounds of formula (Ia) typically with phosphorous pentasulfide or 2,4-bis (4-methoxyphenyl) -1,3ditia-2,4-diphosphetus 2,4-disulfide (Lawesson's reagent).

[00147] Process J according to the invention is preferably carried out using one or more diluents. Preferred solvents are toluene, tetrahydrofuran and 1,2-dimethoxyethane.

[00148] After the reaction has ended, the compounds (Ib) are separated from the reaction mixture by one of the usual separation techniques. If necessary, the compounds are purified by recrystallization or chromatography.

Petition 870190021920, of 03/07/2019, p. 50/172

47/160 [00150] A means of preparing compounds of formula (Ia) from corresponding compounds (XIII) with compounds (XXII) is shown in Scheme 14 (process K).

[00151] The compounds (XXII) are either commercially available or can be prepared by processes described in the literature (see, for example, WO 2008/013622 and WO 2008/013925).

[00152] A compound of the general formula (Ia) can be synthesized in a manner analogous to methods described in the literature (see, for example, WO 2007/147336), by a coupling reaction of a compound with the corresponding general formula ( XIII) with a substrate of the general formula (XXII) where W ⁴ is chlorine, optionally in the presence of an acid / base scavenger.

[00153] At least one equivalent of an acid scavenger / a base (eg, Hünig base, triethylamine or commercially available polymeric acid scavengers) is used, relative to the starting material of the general formula (XIII). If the starting material is a salt, at least two equivalents of the acid scavenger are required.

[00154] Alternatively, a compound of formula (Ia) can also be synthesized from the corresponding compound of formula (XIII) with a substrate of formula (XXII) where W ⁴ is hydroxyl in the presence of a coupling agent, in a similar manner to methods described in the literature (for example, Tetrahedron 2005, 61, 10827-10852, and references cited therein).

[00155] Suitable coupling reagents are, for example, peptide coupling reagents, for example, N- (3-dimethylaminopropyl) -N'-ethylcarbodiimide mixed with 4-dimethylaminopyridine, N- (3-dimethylaminopropyl) -N'- ethylcarbodiimide mixed with 1-hydroxybenzotriazole, bromotripyrrolidinophosphonium hexafluorophosphate, O- (7-azabenzotriazol-1-yl) -N, N, N ', N'-tetramethyluronium hexafluorophosphate, etc.

[00156] After the reaction has ended, the compounds (Ia) are separated from the reaction mixture by one of the usual separation techniques. If necessary, the compounds are purified by recrystallization or chromatography.

[00157] Process L

Scheme 15: Process L

Petition 870190021920, of 03/07/2019, p. 51/172

48/160 o ^R ah

1J-N XGQ-L2R ¹ (XXXIV) w ¹¹ ^ ψ _base * (R ¹⁰ ) p (XXXIII)

O

THE

XGQLR ¹

R ² (R ¹⁰ ) p (Ia)

W ¹⁴ = OSO2CH3, OSO2C6H4CH3, I, Br or Cl,

In A ¹ -H, hydrogen is joined via a nitrogen atom.

[00158] A means of preparing compounds of the formula (Ig) from corresponding compounds (XXXIII) with the compounds (XXXIV) is shown in

Scheme 15 (process L).

[00159] Starting materials, α-haloacetamide or the equivalent leaving group (XXXIII), can be prepared using methods described in the literature from compounds (XXXV), (XVIIe) (Figure 2) or from (XIII) (see, for example, mesylation: Organic Letters, 2003, 2539-2541; tosylation: JP60156601; halogenation: Australian Journal of Chemistry, 1983, 2095-2110;). Typically, the compounds of the formula (XXXIII, W ¹⁴ = chlorine) are prepared from an amide of the formula (XIII) and chloroacetyl chloride. Compounds (XXXV) in (Figure 2) are prepared in a manner analogous to process K with glycolic acid or (XIII) hydroxyacetyl chloride (see, for example, document

WO2007103187, WO document

Letters, 2007, 6326-6329).

2006117521, Bioorganic & Medicinal Chemistry

Figure 2

O / \ ^R

N, XGQ-L2R HO ^ (R ¹⁰ ) p (XXXV)

R ²

XG ^ LR ¹ (R ¹⁰ ) p (XVIIe) [00160] At least one equivalent of a base (for example, sodium hydride, potassium carbonate) is used in relation to the starting material of the general formula (XXXIV).

[00161] After the reaction has ended, the compounds (Ig) are separated from the reaction mixture by one of the usual separation techniques. If necessary, the compounds are purified by recrystallization or chromatography, or can, if desired, also be used in the next step without prior purification.

[00162] Process M

Petition 870190021920, of 03/07/2019, p. 52/172

49/160

[00163] A means of preparing compounds of the formula (lc) from corresponding compounds (XIII) with the compounds (XIV) is shown in Scheme 16 (process M).

[00164] A compound with the general formula (Ic) can be synthesized in a manner analogous to the methods described in the literature (see, for example, WO

2009/055514), by a coupling reaction of a compound with the corresponding general formula (XIII) with a substrate of the general formula (XIV), optionally in the presence of an acid / base scavenger, for example, triethylamine, 1,8 -diazabicycle [5.4.0] undec-7-eno or Hünig's base.

[00165] After the reaction has ended, the compounds (Ic) are separated from the reaction mixture by one of the usual separation techniques. If necessary, the compounds are purified by recrystallization or chromatography.

[00166] Process N

AND. Figure 17: Process N □ ^Ξ Y XGQ- W ψ <R '% (XVa) or (XVb) HY -S ² LR ^{1 A} V _a . _n '®V ^G ' ^Q ' ^{L? R} ' (xvi '1¾ | ld)

W ⁵ is chlorine or imidazole-1-yl.

[00167] A means of preparing compounds of the formula (Id) from corresponding compounds (XVa) or (XVb) (see Figure 3) with the compounds (XVI) is shown in Scheme 17 (process N).

Figure 3

5-n ^ xgqlr ¹

Cl 4 ⁷ (R ¹ % (XVa)

VnT ^ XGQLR ¹ rN ψ

M (r ¹ % (XVb) [00168] The starting materials, carbamoyl and thiocarbamoyl chlorides from

Petition 870190021920, of 03/07/2019, p. 53/172

50/160 formula (XVa, W ⁵ = chlorine), can be prepared using methods described in the literature from compounds (XIII) (see, for example, Tetrahedron, 2008, 7605; Journal of Organic Chemistry, 2004, 3787 ; Journal of Organic Chemistry, 1983, 4750; European Journal of Organic Chemistry, 2006, 1177). Typically, the compounds of the formula (XVa, W ⁵ = chlorine) are prepared from amines of the formula (XIII) and phosgene, thiophosgene or their equivalents.

[00169] Alternative starting materials, carbamoyl- and thiocarbamoylimidazoles of the formula (XVb, W ⁵ = imidazol-1-yl), can be prepared using methods described in the literature (see, for example, Tetrahedron Letters, 2008, 5279 ; Tetrahedron, 2005, 7153). Typically, the compounds of the formula (XVb, W5 = imidazole-1-yl) are prepared from amines of the formula (XIII) and 1, Tcarbonildiimidazole or 1,1'-thiocarbonyldimidazole.

[00170] Process N is optionally carried out in the presence of a suitable acid acceptor.

[00171] The compounds (Id) obtained in the performance of the N process according to the invention may alternatively in some cases also be obtained without using an acid acceptor, such as the corresponding acid chlorides [(Id) -HCI]. If required, compounds (Id) are released by customary methods.

[00172] After the reaction has ended, the compounds (Id) are separated from the reaction mixture by one of the usual separation techniques. If necessary, the compounds are purified by recrystallization or chromatography.

[00173] Process O

R ²

Scheme 18: Process O

Disunity of the protecting group

R ²

W-N

X-G-Q-L-R / \ | 9

H-N, X-G-Q-L-R / p (XIII) (XVII)

V ^ is acetyl, C1-4 alkoxycarbonyl, benzyl or benzyloxycarbonyl.

[00174] A means of preparing compounds of the formula (XIII) from corresponding compounds (XVII) is shown in Scheme 18 (process O).

[00175] A compound of the formula (XVII) is converted to a compound of the formula (XIII) by suitable methods to remove protective groups described in the literature (Protective Groups in Organic Synthesis', Third Edition; 494-653, and the

Petition 870190021920, of 03/07/2019, p. 54/172

51/160 literature cited therein).

[00176] Ferc-Butoxycarbonyl and benzyloxycarbonyl protecting groups can be removed in an acidic medium (for example, with hydrochloric acid or trifluoroacetic acid). Protective acetyl groups can be removed under basic conditions (for example, with potassium carbonate or cesium carbonate). Benzyl protecting groups can be removed hydrogenolytically with hydrogen in the presence of a catalyst (eg, palladium on activated carbon).

[00177] After the reaction has ended, the compounds (XIII) are separated from the reaction mixture by one of the usual separation techniques. If necessary, the compounds are purified by recrystallization or chromatography, or can, if desired, also be used in the next step without prior purification. It is also possible to isolate the compound of the general formula (XIII) as a salt, for example, as a salt of hydrochloric acid or trifluoroacetic acid.

[00178] Process P

Figure 19: Process P

R ² W ¹¹ —QL ² -R ¹

Γ-J ₁₂ (XXV) _and / —J ₂ ,

W ⁵ -N XW -------------- * - W - N. XGQLR one or more steps vL / $ °) _P ixxvni _{| XV) I)} ννθέ acetyl, C1-4 alkoxycarbonyl, benzyl or benzyloxycarbonyl, W ¹¹ and W ¹² are functional groups suitable for the formation of the desired heterocycle.

[00179] In general, it is possible to prepare the intermediate (XVII) from corresponding compounds (XXVII) with compounds (XXV). Process P (Scheme 19) is performed in a similar way to process H (Scheme 10).

Petition 870190021920, of 03/07/2019, p. 55/172

52/160

W ⁶ is acetyl, C1-4 alkoxycarbonyl, benzyl or benzyloxycarbonyl.

[00181] Another means of preparing the intermediate of the formula (XVIIf) from corresponding compounds (XXI) is shown in Scheme 20 (process Q). The compounds (XXI) are commercially available or can be prepared by processes described in the literature (see, for example, WO 2008/013622 and WO 2007/014290). Process Q is performed in a similar way to process I (Scheme 11).

[00182] Process R

Scheme 21: Process R

(XXIX)

HG ^to -QL ² -R ¹ (XXX) base

(XVI Ib)

G ^a : The piperidine radical is joined by a nitrogen atom or carbon atom, W ⁶ is acetyl, C1-C4-alkoxycarbonyl, benzyl or benzyloxycarbonyl, W ⁷ is bromine, iodine, methylsulfonyloxy or trifluoromethylsulfonyloxy.

[00183] A compound with the general formula (XVIIb) can be synthesized in a manner analogous to the methods described in the literature by a coupling reaction of a compound with the corresponding general formula (XXIX) with a substrate of the general formula (XXX), optionally in the presence of a base (Scheme 21, process R). (See, for example, for nucleophilic substitutions:

WO 2008/104077; WO 2006/084015 (pyrazoles with Nsubstitution); for Zn / Pd coupling: WO 2008/147831, WO 2006/106423 (pyridine), Shakespeare, W. C. et al Chem. Biol. Drug Design 2008, 71, 97-105 (pyrimidine derivatives), Pasternak, A. et al Bioorg. Med. Chem. Lett. 2008, 18, 994-998 (diazines); Coleridge, B. M .; Bello, C. S .; Leitner, A.

Tetrahedron Lett. 2009, 50, 4475-4477; Bach, T., Heuser, S. Angew. Chem. Int.

Ed. 2001, 40, 3184-3185 (thiazole)).

[00184] For nucleophilic substitutions, at least one equivalent of a base (for example, sodium hydride, potassium carbonate) is used in relation to the starting material of the general formula (XXIX).

[00185] After the reaction has ended, the compounds (XVIIb) are separated from the reaction mixture by one of the usual separation techniques. If

Petition 870190021920, of 03/07/2019, p. 56/172

53/160 necessary, the compounds are purified by recrystallization or chromatography, or can, if desired, be used in the next step also without prior purification.

[00186] Process S

Scheme 22: Process S

w — GQLR ¹ WN, NH ( ^R ”) p (XXXII) w-nVn-g-q-l-r (Hp base (XXXI) (XVIIc)

G ^b : The piperazine ring is joined by a carbon atom, W ⁶ is acetyl, C1-4 alkoxycarbonyl, benzyl or benzyloxycarbonyl, W ⁸ is bromine, iodine, methylsulfonyloxy or trifluoromethylsulfonyloxy.

[00187] A compound with the general formula (XVIIc) can be synthesized in a manner analogous to the methods described in the literature (see, for example, for nucleophilic substitutions: Li, CS, Belair, L., Guay, J. et al Bioorg. Med. Chem. Lett. 2009, 19, 5214-5217; document W02008 / 062276; for copper couplings: Yeh, VSC; Wiedeman, PE Tetrahedron Lett. 2006, 47, 6011-6016; for palladium couplings: document W02008 / 157500) by a coupling reaction of a compound with the corresponding general formula (XXXI) with a substrate of the general formula (XXXII), optionally in the presence of a base (Scheme 22, process S).

[00188] For nucleophilic substitutions, at least one equivalent of a base (for example, sodium hydride, potassium carbonate) is used in relation to the starting material of the general formula (XXXI).

[00189] After the reaction has ended, the compounds (XVIIc) are separated from the reaction mixture by one of the usual separation techniques. If necessary, the compounds are purified by recrystallization or chromatography, or can, if desired, also be used in the next step without prior purification.

[00190] Process T

Scheme 23: Process T

Petition 870190021920, of 03/07/2019, p. 57/172

54/160

R ² W ¹⁰ —L —R ¹ R

I (XXIII) I

V / -N X-GW ^S -------------- _W - _N ^/ ~ XGQLR ¹

V-r one or more steps \ / n>) (XXVIII) (XVII)

V ^ isacetyl, C1-4 alkoxycarbonyl, benzyl or benzyloxycarbonyl,

V ^ and W ¹⁰ are functional groups suitable for the formation of the desired heterocycle.

[00191] In general, it is possible to prepare the intermediate (XVII) from the corresponding compounds (XXVIII) and (XXIII). Process T is performed in a similar way to process A (Scheme 1).

[00193] A particular means of preparing the intermediate (XVIIa) from corresponding compounds (XVIII) is shown in Scheme 24 (process U). The starting materials of formula (XVIII) can be prepared using methods described in the literature (see, for example, document WO 2008/013622), and process U is carried out in a manner similar to process B (Scheme 2).

[00194] Process V

Scheme 25: Process V

Petition 870190021920, of 03/07/2019, p. 58/172

55/160

[00195] Another particular means of preparing the intermediate (XVIIa) from corresponding compounds (XVIII) is shown in Scheme 25 (process V). O

Process V is performed in a similar way to process E (Scheme 7) and process D (Scheme 6).

[00196] Process W

Figure 26: Process W

wN xg (R ¹ % (XVIId)

W ¹ is chlorine, bromine, iodine, toluenesulfonyloxy,

V ^ is acetyl, Ci-C4-alkoxycarbonyl, benzyloxycarbonyl or benzyl, Y ² is O, S, NR ^23.

[00197] Another particular means of preparing the intermediate of the formula (XVIId) from corresponding compounds (XVIII) is shown in Scheme 26 (process W). Process l / l / is carried out in a similar way to process G (Scheme

9) and process F (Scheme 8).

Petition 870190021920, of 03/07/2019, p. 59/172

56/160

[00198] Process X

Scheme 27 ·. Process X b 1 ^a ) Disunity of the

W ⁶ —NX <3 Protector group (rW) b) ⁹ coupling reaction (AA)

W ¹ is chlorine, bromine, iodine toluenesulfonyloxy,

W ⁶ is acetyl, C1 -C4-alkoxycarbonyl, benzyl or benzyloxycarbonyl, [00199] Another particular means of preparing the intermediate of formula (VII) from corresponding compounds (XX) is shown in Scheme 27 (process X). Process X is performed analogously to process O (Scheme 18, step one) and then process K (Scheme 14), process M (Scheme 16) or process N (Scheme 17, step b).

[00200] Process Y

Scheme 28: Process Y

R ² _(! ^ 1. 2 1 R ² (HO), BQl — r ^ i '' 4 «/ 1 o 1

w — N X-G- OR I sr I --------- * W — N X-G-Q-L-R

T (R ¹ °) _p (XXXVII) R ² ₆ WN XGB (OH) ₂ ÍR ² ) p (XXXIX) (XXXVI) \ iy Pd catalyst ΓΠη. (R ¹ % (XVII) 2 1 1 or J er 1 — Q — L — R íxxxviin Pd catalyst

ννθό acetyl, C1-4 alkoxycarbonyl, benzyl or benzyloxycarbonyl.

[00201] A compound of the general formula (XVII) can be prepared from compounds (XXXVII) or (XXXIX) by palladium-catalyzed coupling reactions, for example, the Suzuki reaction (Angew. Chem. Int. Ed. Engl., 1998, 27, 2046; A. Syn. Commun., 1981, 11.7, 513) (see Scheme 28, process Y).

[00202] The solvents used can be all the usual solvents that are inert under the reaction conditions, and the reactions can be carried out in mixtures of two or more of these solvents. Preferred solvents are N, Ndimethylformamide, dichloromethane, DMSO and tetrahydrofuran.

[00203] The reaction can be conducted in the presence of the following additives: phosphines, for example, 2-dicyclohexylphosphinobiphenyl, desiccants, for example, 4 A molecular sieve, and suitable bases, for example, triethylamine, pyridine, carbonate

Petition 870190021920, of 03/07/2019, p. 60/172

57/160 sodium, sodium ethoxide or potassium phosphate.

[00204] It is possible to use numerous copper (ll) catalysts, palladium (O) catalysts or commercially available palladium (ll) catalysts, but preference is given to using copper (ll) acetate, tetrakistriphenylphosphinapalladium in the reaction (O), 1,1-bis (diphenylphosphino) ferrocene] dichloropalladium (ll), or palladium acetate (ll). The amount of catalyst spent is at least 1% to an excess, depending on the starting compound (XXXVII) or (XXXIX).

[00205] After the reaction has ended, the compounds (XVII) are separated from the reaction mixture by one of the usual separation techniques. If necessary, the compounds are purified by recrystallization, distillation or chromatography, or they can optionally also be used in the next step without prior purification.

[00206] It is recognized that some reagents and reaction conditions, described above for the preparation of compounds of formula (I), may not be compatible with particular functionalities present in the intermediate compounds. In these cases, the introduction of protection / deprotection sequences or mutual conversions of functional groups in the synthesis helps to obtain the desired products. The use and selection of protective groups is obvious to the technician on the subject of chemical synthesis (see, for example, Protective Groups in Organic Synthesis', Third Edition; 494-653, and literature cited therein). The person skilled in the art will recognize that it may be necessary in some cases, after the introduction of a given reagent as shown in an individual scheme, to carry out additional routine synthesis steps that are not specifically described, in order to complete the synthesis of compounds from the formula (I). The person skilled in the art will similarly recognize that it may be necessary to perform a combination of the steps illustrated in the schemes above in a sequence other than the sequence shown specifically, in order to prepare the compounds of formula (I).

[00207] New compounds are those of the formula (Villa)

(Villa) and salts thereof, where the symbols W ² , L ² and R ¹ have the general, preferred, most preferred, even more preferred definitions specified above.

Petition 870190021920, of 03/07/2019, p. 61/172

58/160 [00208] New compounds are those of the formula (XVIIa),

R2 1

Λ ^ R5 ^R

WN, XG (R ¹⁰ ) p (XVIIa) for example, (XVIIa-1),

N% l ² -r '

N ^ X ^

W-N

S (XVIIa-1) and salts, metal complexes and N-oxides thereof, where the symbols W ⁶ , X, G, L ² , p, R ¹ , R ² , R ⁵ and R ¹⁰ have general definitions , preferred, more preferred, even more preferred specified above.

[00209] New compounds are those of the formula (XXXIII),

O ^R w1 ^ V <- ^G - ^Q - ^L2 - ^R1 for example, (XXXIII-1), ⁽ R ¹⁰⁾ p (XXXIII)

(XXXIII-1) and salts thereof, where the symbols W ¹⁴ , X, L ² , R ¹ , R ² , R ¹⁰ , Q, p and G have the general, preferred, most preferred, even more preferred definitions specified above .

[00210] New compounds are those of formula (XIIIa),

R ¹

HN, XG (R ¹⁰ ) p (XIIIa) for example, (XIIIa-1),

Petition 870190021920, of 03/07/2019, p. 62/172

59/160

(XIIIa-1) and salts, metal complexes and N-oxides thereof, where the symbols X, L ² , p, G, R ¹ , R ² , R ⁵ and R ¹⁰ have the most preferred general definitions, more preferred, even more preferred, specified above.

[00211] The invention also addresses the non-medical use of the inventive heteroarylpiperidine and -piperazine derivatives of formula (I) for the control of unwanted microorganisms.

[00212] The invention further provides a composition for controlling unwanted microorganisms, comprising at least one heteroarylpiperidine and -piperazine derivative according to the present invention.

[00213] The invention also relates to a method for controlling unwanted microorganisms, characterized in that the inventive heteroarylpiperidine and -piperazine derivatives are applied to the microorganisms and / or in their habitat.

[00214] The invention also relates to the seed that has been treated with at least one inventive heteroarylpiperidine and -piperazine derivative.

[00215] The invention finally provides a method for protecting the seed against unwanted microorganisms using the seed treated with at least one heteroarylpiperidine and -piperazine derivative according to the present invention.

[00216] The inventive substances have potent microbial activity and can be used for the control of unwanted microorganisms, such as fungi and bacteria, in crop protection and material protection.

[00217] The inventive heteroarylpiperidine and -piperazine derivatives of formula (I) have very good fungicidal properties and can be used in crop protection, for example, for the control of Plasmodioforomycetes, Oomycetes, Quitridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes .

[00218] Bactericides can be used in crop protection, for example, for the control of Pseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceae and Streptomycetaceae.

[00219] The inventive fungicidal compositions can be used for the cure or protective control of phytopathogenic fungi. The invention therefore also

Petition 870190021920, of 03/07/2019, p. 63/172

60/160 refers to curative and protective methods to control phytopathogenic fungi by using the inventive active ingredients or compositions, which are applied to the seed, the plant or plant parts, the fruit or the soil in which the plants grow.

[00220] The inventive compositions for controlling phytopathogenic fungi in crop protection comprise an effective, but not phytotoxic, amount of the inventive active ingredients. An effective, but non-phytotoxic amount means an amount of the inventive composition that is sufficient to satisfactorily control fungal disease from the plant or to eradicate fungal disease completely, while at the same time not causing any significant symptoms of phytotoxicity. In general, this application rate can vary within a relatively wide range. It depends on several factors, for example, the fungus to be controlled, the plant, the climatic conditions and the ingredients of the compositions according to the invention.

[00221] All plants and plant parts can be treated according to the invention. Plants are here understood to mean all plants and plant populations such as desired and unwanted wild plants or agricultural plants (including naturally occurring agricultural plants). Agricultural plants can be plants that can be obtained through conventional breeding and optimization methods or through genetic engineering and biotechnological methods or combinations of these methods, including transgenic plants and including plant varieties that are protectable or not protectable through variety protection rights. Plant parts are to be understood as meaning all plant parts and organs above and below the ground, such as bud, flower, leaf and root, examples that can be mentioned being leaves, needles, stems, stems, flowers, bodies fruit, fruits, seeds, roots, tubers and rhizomes. Plant parts also include harvested plants and material for vegetative and generative propagation, for example, seedlings, tubers, rhizomes, cuttings and seeds.

[00222] Plants that can be treated according to the invention include the following: cotton, flax, vine, fruit, vegetables, such as Rosaceae sp. (for example, pommel fruits, such as apples and pears, but also stone fruits, such as apricots, cherries, almonds and peaches and soft fruits, such as strawberries), Ribesioidae sp., Juglandaceae sp., Betulaceae sp., Anacardiaceae sp. ., Fagaceae sp., Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp., Musaceae sp. (for example, banana trees and banana plantations), Rubiaceae sp. (e.g. coffee),

Petition 870190021920, of 03/07/2019, p. 64/172

61/160

Theaceae sp., Sterculiceae sp., Rutaceae sp. (for example, lemons, oranges and pomelot); Solanaceae sp. (for example, tomatoes), Liliaceae sp., Asteraceae sp. (for example, lettuce), Umbelliferae sp., Cruciferae sp., Chenopodiaceae sp., Cucurbitaceae sp. (for example, cucumbers), Alliaceae sp. (for example, leeks, onions), Papilionaceae sp. (for example, peas); larger cultivation plants such as Gramineae sp. (for example, maize, peat, cereals such as wheat, rye, rice, barley, oats, millet and triticale), Asteraceae sp. (e.g., sunflower), Brassicaceae sp. (for example, white cabbage, red cabbage, broccoli, cauliflower, brussels sprouts, Chinese chard, kohlrabi, radishes, and also rapeseed oil, mustard, horseradish and watercress), Fabacae sp. (for example, beans, peanuts), Papilionaceae sp. (for example, soybeans), Solanaceae sp. (for example, potatoes), Chenopodiaceae sp. (eg sweet beet, fodder beet, Swiss chard, beet root) useful and ornamental plants in gardens and forests, and genetically modified types of each of these plants.

[00223] Non-limiting examples of pathogens of fungal diseases that can be treated according to the invention include:

[00224] Diseases caused by powdery mildew pathogens, such as, for example, Blumeria species, such as, for example, Blumeria graminis; Podosphaera species, such as Podosphaera leucotricha; Sphaerotheca species, such as, for example, Sphaerotheca fuliginea; Uncinula species, such as, for example, Uncinula necator;

[00225] Diseases caused by pathogens of rust diseases, such as, for example, Gymnosporangium species, such as, for example, Gymnosporangium sabinae; Hemileia species, such as, for example, Hemileia vastatrix; Phakopsora species, such as, for example, Phakopsora pachyrhizi and Phakopsora meibomiae; Puccinia species, such as, for example, Puccinia recondita, Puccinia graminis or Puccinia striiformis; species of Uromyces, for example, Uromyces appendiculatus;

[00226] Diseases caused by pathogenic agents from the group of Oomycetes, such as, for example, species of Albugo, for example, Albugo candida; Bremia species, for example, Bremia lactucae; Peronospora species, for example, Peronospora pisi or P. brassicae; Phytoftora species, for example, Phytoftora infestans; Plasmopara species, for example, Plasmopara viticola; species of Pseudoperonospora, for example, Pseudoperonospora humuli or Pseudoperonospora cubensis; Pythium species,

Petition 870190021920, of 03/07/2019, p. 65/172

62/160 for example, Pythium ultimum;

[00227] Leaf spot diseases and leaf wilt diseases caused, for example, by Alternaria species, such as, for example, Alternaria solani; Cercospora species, such as, for example, Cercospora beticola; species of Cladiosporum, such as, for example, Cladiosporium cucumerinum; Cochliobolus species, such as, for example, Cochliobolus sativus (form of conidia: Drechslera, Sin: Helminthosporium); Colletotrichum species, such as, for example, Colletotrichum lindemuthanium; Cycloconium species, such as, for example, Cycloconium oleaginum; Diaporthe species, such as, for example, Diaporthe citri; Elsinoe species, such as, for example, Elsinoe fawcettii; Gloeosporium species, such as, for example, Gloeosporium laeticolor; Glomerella species, such as, for example, Glomerella cingulata; Guignardia species, such as, for example, Guignardia bidwelli; Leptosphaeria species, such as, for example, Leptosphaeria maculans; species of

Magnaporthe, such as, for example, Magnaporthe grisea; species of

Microdochium, such as, for example, Microdochium nivale; species of

Mycosphaerella, such as, for example, Mycosphaerella graminicola, Mycosphaerella arachidicola or Mycosphaerella fijiensis; Phaeosphaeria species, such as, for example, Phaeosphaeria nodorum; Pyrenophora species, such as, for example, Pyrenophora teres or Pyrenophora tritici repentis; Ramularia species, such as, for example, Ramularia collo-Cygni or Ramularia areola; Rhynchosporium species, such as, for example, Rhynchosporium secalis; Septoria species, such as, for example, Septoria apii or Septoria lycopersici; species of Stagonospora, for example, Stagonospora nodorum species of Typhula, such as, for example, Typhula incarnata; Venturia species, such as, for example, Venturia inaequalis;

[00228] Root and stem diseases caused, for example, by species of Corticium, such as, for example, Corticium graminearum; Fusarium species, such as, for example, Fusarium oxysporum, Gaeumannomyces species, such as, for example, Gaeumannomyces graminis; Plasmodiophora, species of for example, Plasmodiophora brassicae; Rhizoctonia species, for example, Rhizoctonia solani; Sarocladium species, for example, Sarocladium oryzae; Sclerotium species, for example, Sclerotium oryzae; Tapesia species, for example, Tapesia acuformis; Thielaviopsis species, for example, Thielaviopsis

Petition 870190021920, of 03/07/2019, p. 66/172

63/160 basicola;

[00229] Auricula and panicle diseases (including ears of corn), caused, for example, by Alternaria species, such as, for example, Alternaria spp. Aspergillus species, such as, for example, Aspergillus flavus; Cladosporium species, such as, for example, Cladosporium Cladosporium; species of Claviceps, such as, for example, Claviceps purpurea, Fusarium species, such as, for example, Fusarium culmorum; Gibberella species, such as, for example, Gibberella zeae; Monographella species, such as, for example, Monographella nivalis; Septoria species, for example, Septoria nodorum;

[00230] Diseases caused by fungi, such as soot, for example, species of Sphacelotheca, such as, for example, Sphacelotheca reiliana; Tilletia species, such as, for example, Tilletia caries, Tilletia controversa; Urocystis species, such as, for example, Urocystis occulta; Ustilago species, such as, for example, Ustilago nuda;

[00231] Fruit rot caused, for example, by Aspergillus species, such as, for example, Aspergillus flavus; Botrytis species, such as, for example, Botrytis cinerea; Penicillium species, such as, for example, Penicillium expansum and P. purpurogenum; Sclerotinia species, such as, for example, Sclerotinia sclerotiorum; Verticilium species, such as, for example, Verticilium alboatrum;

[00232] Diseases of rot and wilt transmitted through seed and soil, and also seedling diseases, caused, for example, by species of Alternaria, for example, Alternaria brassicicola; Aphanomyces species, for example, Aphanomyces euteiches; Ascochyta species, for example, Ascochyta lentis; Aspergillus species, for example, Aspergillus flavus; Cladosporium species, for example, Cladosporium herbarum; species of Cochliobolus, for example, Cochliobolus sativus (form of conidia: Drechslera, Bipolaris Sin: Helminthosporium); Colletotrichum species, for example, Colletotrichum coccodes; Fusarium species, for example, Fusarium culmorum; Gibberella species, for example, Gibberella zeae; Macrophomina species, for example, Macrophomina phaseolina; Microdochium species, for example, Microdochium nivale; Monographella species, for example, Monographella nivalis; Penicillium species, for example, Penicillium expansum; Phoma species, for example, Phoma lingam; Phomopsis species, for example,

Petition 870190021920, of 03/07/2019, p. 67/172

64/160

Phomopsisoyae; Phytoftora species, for example, Phytoftora cactorum; Pirenophora species, for example, Pirenophora graminaa; Piricularia species, for example, Piricularia oryzae; Pythium species, for example, Pythium ultimum; Rhizoctonia species, for example, Rhizoctonia solani; Rhizopus species, for example, Rhizopus oryzae; Sclerotium species, for example, Sclerotium rolfsii; Septoria species, for example, Septoria nodorum; Typhula species, for example, Typhula incarnata; Verticillium species, for example, Verticillium dahliae;

[00233] Cancerous, gall and witches' broom diseases caused, for example, by species of Nectria, such as, for example, Nectria galligena;

[00234] Withering diseases caused, for example, by Monilinia species, such as, for example, Monilinia laxa;

[00235] Deformations of leaves, flowers and fruits caused, for example, by species of Exobasidium, for example, Exobasidium vexans; Taphrina species, for example, Taphrina deformans;

[00236] Degenerative diseases of woody plants caused, for example, by species of Esca, such as, for example, Phaeomoniella chlamydospora and Phaeoacremonium aleophilum or Fomitiporia mediterranea; Ganoderma species, for example, Ganoderma boninense;

[00237] Diseases of flowers and seeds caused, for example, by Botrytis species, such as, for example, Botrytis cinerea;

[00238] Diseases of plant tubers caused, for example, by Rhizoctonia species, such as, for example, Rhizoctonia solani; Helminthosporium species, such as, for example, Helminthosporium solani;

[00239] Diseases caused by bacterial pathogens, such as, for example, Xanthomonas species, such as, for example, Xanthomonas campestris pv. oryzae; Pseudomonas species, such as, for example, Pseudomonas syringae pv. lachrymans; Erwinia species, such as, for example, Erwinia amylovora.

[00240] Preference is given to control the following diseases of soybeans:

[00241] Fungal diseases on leaves, stems, pods and seeds caused, for example, by leaf spot by alternaria (Alternaria spec. Atrans

Petition 870190021920, of 03/07/2019, p. 68/172

65/160 tenuissima), anthracnose (Colletotrichum gloeosporoides dematium var. Truncatum), brown spot (Septoria glycines), spot and leaf rust by cercospora (Cercospora kikuchii), leaf rust by choanephora (Choanephora infundibulifera), trispor. leaf spot by dactuliophora (Dactuliophora glycines), downy mildew (Peronospora manshurica), rust by drechslera (Drechslera glycini), frog's eye spot (Cercospora sojina), leaf spot by leptosphaerulina (Leptosphaerulina phifolia) by leaf trifoli (Phyllostictaoyaecola), pod and stem rust (Phomopsis soye), oid (Microsphaera diffusa), leaf spot by pyrenochaeta (Pyrenochaeta glycines), shoot rust, foliage and net by rhizoctonia (Rhizoctonia solani), rust ( Phakopsora pachyrhizi), scar (Sphaceloma glycines), leaf rust by stemphylium (Stemphylium botryosum), target spot (Corynespora cassiicola).

[00242] Fungal diseases in the roots at the base of the stem caused, for example, by Root black rot (Calonectria crotalariae), coal rot (Macrophomina phaseolina), rust or wilting, root rot, and pod and collar rot fusarium (Fusarium oxisporum, Fusarium orthoceras, Fusarium semitectum, Fusarium equiseti), root rot by mycoleptodiscus (Mycoleptodiscus terrestris), neocosmospora (Neocosmospora vasinfecta), pod and stem rust (Diaporthe phaseolorum), stem cancer (Diaporthe phaseolorum), stem cancer (Diaporthe phaseolorum). caulivora), phytophthora rot (Phytophthora megasperma), brown stem rot (Phialophora gregata), pythium rot (Pythium aphanidermatum, Pythium irregulare, Pythium debaryanum, Pythium myriotylum, Pythium ultimum, root decay), by rhizoctonia (Rhizoctonia solani), stem deterioration by sclerotinia (Sclerotinia sclerotiorum), rust by sclerotinia southe rn (Sclerotinia rolfsii), root rot by thielaviopsis (Thielaviopsis basicola).

[00243] The inventive active ingredients also have very good fortifying action on plants. They may therefore be suitable for mobilizing the plant's own defense against attack by undesirable microorganisms.

[00244] Substances that fortify plants (resistance inducers) are understood to mean, in the present context, those substances that are capable of stimulating the plant defense system in such a way that the treated plants, when subsequently inoculated with undesirable microorganisms, develop a high degree of resistance to these microorganisms.

Petition 870190021920, of 03/07/2019, p. 69/172

66/160 [00245] In the present case, undesirable microorganisms are understood to mean phytopathogenic fungi and bacteria. The inventive substances can thus be used to protect plants against attack by the pathogens mentioned above, for a certain period of time after treatment. The period for which protection is provided generally extends over 1 to 10 days, preferably 1 to 7 days, after treatment of the plants with the active compounds.

[00246] The fact that the active ingredients are well tolerated by plants in the concentrations required to control plant diseases allows treatment of parts of plants above the ground, of propagating material and seeds, and of the soil.

[00247] The inventive active ingredients can be used particularly successfully to control diseases in viticulture and potatoes, fruit and plant growth, for example, against fungus oidios, Oomycetes, for example, species of Ftoftora, Plasmopara, Pseudoperonospora and Pythium .

[00248] The inventive active ingredients are also suitable for increasing crop yields. In addition, they have reduced toxicity and are well tolerated by plants.

[00249] In some cases, the inventive compounds may, at particular concentrations or rates of application, also be used as herbicides, phytoprotectors, growth regulators or agents to improve the properties of the plant, or as microbicides, for example, as fungicides, antimycotics, bactericides, viricides (including compositions against viroids) or as compositions against MLO (Organisms similar to mycoplasma) and RLO (Organisms similar to Rickettsia). If appropriate, they can also be used as intermediates or precursors for the synthesis of other active compounds.

[00250] The inventive active ingredients, when they are well tolerated by plants, have favorable homeothermic toxicity and are well tolerated by the environment, are suitable to protect plants and plant organs, to increase harvest yields, to improve the quality of the material harvested in agriculture, horticulture, animal husbandry, forests, gardens and factory halls, the protection of stored products and materials, and the hygiene sector. They can preferably be used as

Petition 870190021920, of 03/07/2019, p. 70/172

67/160 harvest. They are active against resistant sensitive species and against all or some of the stages of development.

[00251] The inventive treatment of plants and plant parts with active ingredients or compositions is carried out directly or through action on the respective environment, habitat or storage space, by the usual treatment methods, such as, for example, immersion, spraying, atomization, irrigation, evaporation, dusting, misting, launching, foaming, painting, spreading, wetting (imbibition), drip irrigation and, in the case of propagating material, especially in the case of seeds, also by dry seed treatment , wet seed treatment, suspension treatment, encrustation, by coating with one or more layers, etc. It is also possible to apply the active compounds using the ultra low volume method, or inject the preparation of active compounds or the active compound itself into the soil.

[00252] The inventive active ingredients or compositions can also be used in the protection of materials, to protect industrial materials from attack and destruction by unwanted microorganisms, for example, fungi.

[00253] It is understood that industrial materials in the present context mean inanimate materials that have been prepared for use in industry. For example, industrial materials that are intended to be protected by active compounds according to the invention from microbial alteration or destruction can be adhesives, glue, cardboard and wallpaper, fabrics, carpets, leather, wood, paints and articles plastic, cooling lubricants and other materials that can be infected with, or destroyed by, microorganisms. The range of materials to be protected also includes parts of production plants and buildings, for example, cooling water circuits, which can be harmed by the proliferation of microorganisms. Industrial materials within the scope of the present invention preferably include adhesives, glues, paper and board, leather, wood, paints, cooling lubricants and heat transfer fluids, particularly preferably wood. Inventive active ingredients or compositions can prevent adverse effects such as rotting, deterioration, discoloration, decolorization, or the formation of fungi.

[00254] The inventive method for the control of unwanted fungi can also be used for the protection of storage goods. Here, storage goods are to be understood as meaning natural substances of

Petition 870190021920, of 03/07/2019, p. 71/172

68/160 vegetable or animal origin, or products derived from its transformation, of natural origin, for which long-term protection is desired. Storage goods of plant origin, such as, for example, plants or parts of plants, such as leaves, stems, tubers, seeds, fruits, cereals, can be protected recently harvested or after processing by (pre) drying, moistening, crushing, grinding, pressing or roasting. Storage goods also include wood, both unprocessed, such as construction timber, electricity poles and barriers, as well as in the form of finished products, such as furniture. Storage goods of animal origin are, for example, furs, hides, skins and hair. The inventive active ingredients according to the invention can avoid disadvantageous effects, such as decomposition, deterioration, discoloration, or mold formation.

[00255] Microorganisms capable of degrading or modifying industrial materials include, for example, bacteria, fungi, yeasts, algae and slime organisms. The inventive active ingredients preferably act against fungi, especially molds, wood destroying fungi and wood discoloration (Basidiomycetes), and against slime and algae organisms. Examples include microorganisms of the following genera: Alternaria, such as Alternaria tenuis; Aspergillus, such as Aspergillus niger, Chaetomium, such as Chaetomium globosum, Coniophora, such as Coniophora puetana, Lentinus, such as Lentinus tigrinus, Penicillium, such as Penicillium glaucum; Polyporus, such as Polyporus versicolor, Aureobasidium, such as Aureobasidium pullulans; Sclerophoma, such as Sclerophoma pityophila, Trichoderma, such as Trichoderma viride; Escherichia, such as Escherichia coli; Pseudomonas, such as Pseudomonas aeruginosa; Staphylococcus, such as Staphylococcus aureus.

[00256] The present invention also relates to a composition for controlling unwanted microorganisms, comprising at least one of the inventive heteroarylpiperidine and -piperazine derivatives. These are preferably fungicidal compositions which comprise agriculturally suitable auxiliaries, solvents, carriers, surfactants or extension agents.

[00257] According to the invention, a carrier is a natural or synthetic organic or inorganic substance with which the active ingredients are mixed or combined for better applicability, in particular for application to plants or parts of plants or the seed. The carrier,

Petition 870190021920, of 03/07/2019, p. 72/172

69/160 which may be solid or liquid, is generally inert and should be suitable for use in agriculture.

[00258] Useful solid carriers include: for example, ammonia salts and rock flours, such as kaolin, clays, talc, chalk, quartz, atapulgite, montmorillonite or diatomaceous earth, and synthetic rock flours, such as finely silica split, alumina and silicates; Useful solid carriers for granules include: for example, crushed and fractionated natural rocks, such as calcite, marble, pumice, sepiolite, dolomite, as well as synthetic granules of inorganic and organic flours, and granules of organic materials, such as sawdust, coconut husks, corn cobs and tobacco stalks; Useful emulsifiers and / or foams include: for example, nonionic and anionic emulsifiers, such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, for example, alkylaryl polyglycol ethers, alkylsulfonates, alkyl sulfates, arylsulfonates and also protein hydrolysates; Suitable dispersants are non-ionic and / or ionic substances, for example, from the alcohol-POE and / or -POP ether classes, acid and / or POP POE esters, alkylaryl and / or POP POE ethers, fatty adducts and / or POP POE, derivatives of POE- and / or POP-polyol, POE- and / or POPsorbitan or-sugar adducts, alkyl or aryl sulfates, alkyl- or arylsulfonates and alkyl or aryl phosphates or the corresponding PO- adducts ether. In addition, suitable oligo- or polymers, for example, those derived from vinyl monomers, acrylic acid, EO and / or PO alone or in combination with, for example, (poly) alcohols or (poly) amines. It is also possible to use lignin and its derivatives of sulfonic acid, modified and unmodified celluloses, aromatic and / or aliphatic sulfonic acids and their adducts with formaldehyde.

[00259] The active ingredients can be converted into the usual formulations, such as solutions, emulsions, moisturizing powders, water-based suspensions in oil, powders, dust, pastes, soluble powders, soluble granules, granules for diffusion, concentrating suspensions, natural products impregnated with active compound, synthetic substances impregnated with active compound, fertilizers and also microencapsulations in polymeric substances.

[00260] The active ingredients can be applied as such, in the form of their formulations or the forms of use prepared from them, such as ready-to-use solutions, emulsions, water or oil based suspensions, powders, wetting powders, pastes, soluble powders, dust, soluble granules, granules

Petition 870190021920, of 03/07/2019, p. 73/172

70/160 for diffusion, suspoemulsion concentrates, natural products impregnated with active ingredient, synthetic substances impregnated with active ingredient, fertilizers and also microencapsulations in polymeric substances. The application is achieved in a usual way, for example, by immersion, spraying, atomization, irrigation, evaporation, dusting, nebulization, launching, foaming, painting, spreading, etc. It is also possible to apply the active ingredients using the ultra low volume method, or inject the preparation of active compounds or the active compound itself into the soil. It is also possible to treat the seed of plants.

[00261] The mentioned formulations can be prepared in a manner known per se, for example, by mixing the active compounds with at least one usual diluent, solvent or diluent, emulsifier, dispersant and / or binder or fixing agent, wettable agent , repellent agent, if appropriate, UV drying and stabilizers and, if appropriate, dyes and pigments, defoamers, preservatives, secondary thickeners, adhesives, gibberellins and also other processing aids.

[00262] The present invention includes not only formulations that are already ready for use but can be applied with an apparatus suitable for the plant or seed, but also commercial concentrates that have to be diluted with water before use.

[00263] The inventive active ingredients can be present as such or in their (commercial) formulations and in the forms of use prepared from these formulations as a mixture with other active compounds (known), such as insecticides, insecticidal baits, sterilizers, bactericides, acaricides, nematicides, fungicides, growth regulators, herbicides, fertilizers, phytoprotectors and / or semiochemicals.

[00264] The auxiliaries used may be those substances that are suitable for imparting to the composition itself and / or to preparations derived therefrom (for example spray liquors, seed treatment) particular properties such as certain technical properties and / or also biological properties private individuals. Typical auxiliaries include: extension agents, solvents and carriers.

[00265] Suitable extension agents are, for example, water, organic polar and non-polar chemical liquids, for example, from classes of

Petition 870190021920, of 03/07/2019, p. 74/172

71/160 aromatic and non-aromatic hydrocarbons (such as paraffins, alkylbenzenes, alkylnaphthalenes, chlorobenzenes), alcohols and polyols (which can optionally also be substituted, etherified and / or esterified), ketones (such as acetone, cyclohexanone), esters (including fats and oils) and (poly) ethers, amines, amides, lactams (such as N-alkylpyrrolidones) and unsubstituted and substituted lactones, sulfones and sulfoxides (such as dimethyl sulfoxide).

[00266] Suitable liquefied gas extension agents or carriers are liquids that are gaseous at room temperature and under atmospheric pressure, for example, aerosol propellants, such as halogenated hydrocarbons, as well as butane, propane, nitrogen and carbon dioxide.

[00267] In formulations, it is possible to use adhesion promoters, such as carboxymethylcellulose, natural and synthetic polymers in the form of powders, granules or trellises, such as arabic gum, polyvinyl alcohol and polyvinyl acetate, or else natural phospholipids, such as cephalins and synthetic lecithins and phospholipids. Additional additives can be mineral and vegetable oils.

[00268] If the extension agent used is water, it is also possible to use, for example, organic solvents as auxiliary solvents. Essentially, suitable liquid solvents are: aromatic compounds, such as xylene, toluene or alkylnaphthalenes, chlorinated aliphatic hydrocarbons, aromatic and chlorinated compounds, such as chlorobenzenes, chloroethylenes or dichloromethane, aliphatic hydrocarbons, such as cyclohexane or paraffins, for example, fractions of mineral oils, minerals and vegetable oils, alcohols, such as butanol or glycol and their ethers and esters, ketones, such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents, such as dimethyl and dimethylformamide sulfoxide , and also water.

[00269] The inventive compositions may additionally comprise other components, such as, for example, surfactants. Suitable surfactants are emulsifiers and / or foams, dispersants or wettable agents with ionic or non-ionic properties, or mixtures of these surfactants. Examples of these are polyacrylic acid salts, lignosulfonic acid salts, phenolsulfonic acid or naphthalenesulfonic acid salts, polycondensates of ethylene oxide with fatty alcohols or with fatty acids or with fatty amines, substituted phenols (preferably alkylphenols or arylphenols) , salts of sulfosuccinic esters, derived from taurine (preferably alkyl taurates),

Petition 870190021920, of 03/07/2019, p. 75/172

72/160 phosphoric esters of polyethoxylated alcohols or phenols, polyol fatty acid esters, and those derived from compounds containing sulphates, sulphonates and phosphates, for example, alkylaryl polyglycol ethers, alkyl sulphonates, alkyl sulphates, aryl sulphonates, protein hydrolysates, lignosulphite and methylcellulose waste liquors. The presence of a surfactant is necessary if one of the active compounds and / or one of the inert carriers is insoluble in water and where the application takes place in water. The proportion of surface active substances is between 5 and 40 percent by weight of the composition according to the invention.

[00270] It is possible to use dyes such as inorganic pigments, for example, iron oxide, titanium oxide and Prussian blue and organic dyes, such as alizarin dyes, azo dyes and phthalocyanine metal pigments, and trace nutrients, such such as iron, manganese, boron, copper, cobalt, molybdenum and zinc salts.

[00271] Additional additives can be perfumes, mineral or vegetable oils, optionally modified, waxes and nutrients (including trace nutrients), such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.

[00272] Additional components can be stabilizers, such as low temperature stabilizers, preservatives, antioxidants, light stabilizers or other agents that improve chemical and / or physical stability.

[00273] If appropriate, it is also possible that other additional components are present, for example, protective colloids, binding agents, adhesives, thickeners, thixotropic substances, penetrating agents, stabilizers, sequestering agents, complex forming agents. In general, the active compounds can be combined with any solid or liquid additive normally used for formulation purposes.

[00274] The formulations generally contain between 0.05 and 99% by weight, 0.01 and 98% by weight, preferably between 0.1 and 95% by weight, more preferably between 0.5 and 90% of active ingredient, even more preferably between 10 and 70 weight percent.

[00275] The formulations described above can be used in an inventive method to control unwanted microorganisms, in which the inventive heteroarylpiperidine and -piperazine derivatives are applied to the microorganisms and / or in their habitat.

[00276] The inventive active ingredients can also be used,

Petition 870190021920, of 03/07/2019, p. 76/172

73/160 as such or in formulations thereof, in a mixture with known fungicides, bactericides, acaricides, nematicides or insecticides, in order to expand, for example, the spectrum of activity or to prevent the development of resistance.

[00277] Useful mixing partners include, for example, fungicides, insecticides, acaricides, nematicides or even bactericidal known (see also Pesticide Manual, 14th ed.).

[00278] A mixture with other known active ingredients, such as herbicides, or with fertilizers and growth regulators, phytoprotectors and / or semi-chemicals is also possible.

[00279] The application is achieved in a usual manner appropriate to the forms of use.

[00280] The invention further comprises a method for treating seeds.

[00281] A further aspect of the present invention relates in particular to the seed treated with at least one of the inventive heteroarylpiperidine and -piperazine derivatives. The inventive seeds are used in methods for protecting seeds from harmful pathogenic fungi. In these methods, seed treated with at least one inventive active ingredient is used.

[00282] The inventive active ingredients or compositions are also suitable for treating seed. A large part of the damage caused to agricultural plants by harmful organisms is triggered by the infection of the seeds during storage or after sowing, and during and after the germination of the plants. This stage is particularly critical since the roots and buds of the growing plant are particularly sensitive, and even only minor damage can result in the death of the plant. There is therefore a great interest in protecting seeds and plants from germination using appropriate compositions.

[00283] The control of phytopathogenic fungi by treating plant seed has been known for a long time and is the subject of continuous improvement. However, seed treatment provides a number of problems that cannot always be satisfactorily solved. For example, it is desirable to develop methods to protect the seed and plant from germination that it dispenses with, or at least

Petition 870190021920, of 03/07/2019, p. 77/172

74/160 less significantly reduce the additional application of crop protection agents after planting or after plant emergence. In addition, it is desirable to optimize the amount of active compound used in such a way as to provide optimum protection for the seed and germination plant from attack by phytopathogenic fungi, but without damaging the plant itself by the active compound used. In particular, seed treatment methods must also take into account the intrinsic fungicidal properties of transgenic plants, in order to guarantee optimum protection of the seeds and the germination plant, with a minimum of crop protection agents being employed.

[00284] The present invention, therefore, also relates to a method for the protection of seeds and plants against germination attack by animal pests and / or phytopathogenic fungi by treating the seed with an inventive composition. The invention relates in a similar way to the use of inventive compositions for seed treatment to protect the seed and the germinating plant against phytopathogenic fungi. In addition, the invention relates to seeds treated with a composition according to the invention for protection against phytopathogenic fungi.

[00285] Animal pests and / or phytopathogenic fungi that damage post-emergence plants are controlled primarily by treating the soil and exposed parts of plants with crop protection agents. Due to concerns about the possible impact of pesticide compositions on the environment and the health of humans and animals, efforts are being made to reduce the amount of active compounds applied.

[00286] One of the advantages of the present invention is that the particular systemic properties of the active compounds and compositions according to the invention mean that the treatment of the seeds with these active compounds and compositions not only protects the seed itself, but also the resulting plants after emergence, from phytopathogenic fungi. In this sense, immediate treatment of the crop at the time of sowing, or shortly thereafter, can be dispensed with.

[00287] It is similarly considered to be advantageous that the active compounds or compositions according to the invention can be used, in particular also for the transgenic seed of the growing plant, where from these seeds it is able to express a protein that acts against pests. Because of the treatment of such seeds with the active compounds or compositions according to

Petition 870190021920, of 03/07/2019, p. 78/172

75/160 the invention, merely with the expression of, for example, the insecticidal protein, certain pests can be controlled. Surprisingly, another synergistic effect can be seen in this case, which also increases the effectiveness for protection against pest attack.

[00288] The inventive compositions are suitable for protecting seeds of a plant variety that is used in agriculture, greenhouse, forests or horticulture and viticulture. More particularly, the seed is that of cereals (such as wheat, barley, rye, triticale, millet and oats), maize, cotton, soybeans, rice, potatoes, sunflower, beans, coffee, beets (for example, beets and beets forage), peanuts, rapeseed, poppy, olives, coconut, cocoa, sugar cane, tobacco, vegetables (such as tomatoes, cucumbers, onions and lettuce), grass and ornamental plants (see also here below). Of particular importance is the treatment of cereal seeds (such as wheat, barley, rye, triticale and oats), corn and rice.

[00289] As also described below, the treatment of transgenic seeds with the inventive active ingredients or compositions is of particular importance. This refers to plant seeds that contain at least one heterologous gene, which allows the expression of a polypeptide or protein with insecticidal properties. The heterologous gene in transgenic seeds may originate, for example, from microorganisms of the species Bacillus, Rhizobium, Pseudomonas, Serratia, Trichoderma, Clavibacter, Glomus or Gliocladium. This heterologous gene originates preferably from Bacillus sp., In which case the gene product is effective against the European corn borer and / or the western corn root larva. The heterologous gene most preferably originates from Bacillus thuringiensis.

[00290] In the context of the present invention, the inventive composition is applied to the seed separately or in a suitable formulation. Preferably, the seed is treated in a state where it is stable enough to avoid damage during treatment. In general, the seed can be treated at any point in time between harvest and sowing. The seed usually used was separated from the plant and free of ears, husks, stems, coatings, hair or the flesh of the fruits. Thus, it is possible to use, for example, the seed that has been harvested, cleaned and dried to a moisture content of less than 15% by weight. Alternatively, it is also possible to use seeds that, after drying, were treated, for example, with water and then dried again.

[00291] When treating the seed, care must be taken generally in which the

Petition 870190021920, of 03/07/2019, p. 79/172

76/160 amount of the inventive composition applied to the seed and / or the amount of other additives is chosen in such a way that the germination of the seed is not affected, or that the resulting plant is not damaged. Account should be taken, particularly in the case of active compounds that may have phytotoxic effects at specific application rates.

[00292] The inventive compositions can be applied directly, that is, without containing any other additional component and without diluting. In general, it is preferable to apply the compositions to the seed in the form of an appropriate formulation. Formulations and methods suitable for seed treatment are known to a person skilled in the art and are described, for example, in the following documents: US 4,272,417, US 4,245,432, US 4,808,430, US 5,876,739, US 2003 / 0176428, WO 2002/080675, WO 2002/028186.

[00293] The active ingredients useful according to the invention can be converted into the usual seed coating formulations, such as solutions, emulsions, suspensions, powders, foams, pastes or other seed coating compositions, as well as ULV formulations.

[00294] These formulations are prepared in a known manner by mixing the active compounds with the usual additives, such as, for example, usual diluents and solvents or diluents, dyes, wettable agents, dispersants, emulsifiers, defoamers, preservatives, thickeners, adhesives , secondary gibberellins, and also water.

[00295] Useful dyes that can be present in seed treatment formulations, which can be used according to the invention are all dyes that are usual for such purposes. It is possible to use any pigments, which are poorly soluble in water, but also dyes, which are soluble in water, can be used. Examples of dyes that can be mentioned are dyes that are known by the names of rhodamine B, CI Pigmento Vermelho 112 and C.I. Solvente Vermelho 1.

[00296] Useful wetting agents that can be present in seed treatment formulations, which can be used according to the invention, are all substances that promote wetting and that are conventionally used in the formulation of active agrochemical compounds. Preference is given to using alkylnaphthalenesulfonates, such as diisopropyl- or diisobutylnaphthalenesulfonates.

[00297] Useful dispersants and / or emulsifiers that may be

Petition 870190021920, of 03/07/2019, p. 80/172

77/160 present in the seed treatment formulations that can be used according to the invention are all nonionic, anionic and cationic dispersants conventionally used for the formulation of active agrochemicals. Preference is given to nonionic or anionic dispersants or mixtures of nonionic or anionic dispersants. Suitable non-ionic dispersants that can be mentioned are, in particular, the ethylene oxide / propylene oxide block polymers, alkylphenol polyglycol ethers and tristrrylphenol polyglycol ethers, and the phosphate or sulfate derivatives thereof. Suitable anionic dispersants are called lignosulfonates, salts of polyacrylic acids and arylsulfonate / formaldehyde condensates.

[00298] Defoamers that can be present in seed treatment formulations that can be used according to the invention are all foam inhibiting substances conventionally used for the formulation of active agrochemicals. Silicone defoaming agents and magnesium stearate can be used preferably.

[00299] Preservatives that can be present in seed treatment formulations that can be used according to the invention are all substances that can be used for such purposes in agrochemical compositions. Dichlorophene and hemiformal benzyl alcohol can be mentioned by way of example.

[00300] Secondary thickeners that can be present in seed treatment formulations that can be used according to the invention are all substances that can be used for such purposes in agrochemical compositions. Cellulose derivatives, derivatives of acrylic acid, xanthan, modified clays and finely divided silica are preferred.

[00301] The adhesives that may be present in seed treatment formulations that can be used according to the invention are all the usual binding agents that can be used in the treatment of seed products. Preferred examples include polyvinylpyrrolidone, polyvinyl alcohol acetate, and tylose.

[00302] The gibberellins which can be present in the seed treatment formulations which can be used according to the invention are preferably A1 = gibberellins, A3 (= gibberellic acid), A4 and A7; gibberellic acid is especially preferably used. Gibberellins are known (cf. R. Wegler

Petition 870190021920, of 03/07/2019, p. 81/172

78/160

Chemie der Planzenschutz und Schãdlingsbekãmpfungsmittel, vol. 2, Springer Verlag, 1970, p 401-412).

[00303] Useful seed treatment formulations according to the invention can be used to treat a wide variety of different types of seeds, including the seed of transgenic plants, directly or after previous dilution with water. For example, concentrates or preparations obtainable from them by diluting with water can be used to treat cereal seed, such as wheat, barley, rye, oats, and triticale, and also corn seed, rice , canola, peas, beans, cotton, sunflowers, and beets, or even a wide variety of different vegetable seeds. Seed treatment formulations useful according to the invention, or diluted preparations thereof, can also be used to treat seed of transgenic plants. In this case, additional synergistic effects can also occur in interaction with substances formed by expression.

[00304] For seed treatment with the useful seed treatment formulations according to the invention or the preparations prepared therefrom by adding water, all the usual useful mixing units for seed treatment are Useful. Specifically, the procedure in seed treatment is to place the seed in a mixer, add the particular desired amount of seed treatment formulations, as such or after previous dilution with water, and mix everything until the formulation is evenly distributed in the seed. If appropriate, this is followed by a drying operation.

[00305] The application rate of the useful seed treatment formulations according to the invention can be varied within a relatively wide range. It is guided by the particular content of the active ingredients in the formulations and by the seed. Application rates of active ingredient combination are generally between 0.001 and 50 g per kilogram of seed, preferably between 0.01 and 15 g per kilogram of seed.

[00306] In addition, the inventive compounds of formula (I) also have good antimycotic activity. They have a very broad spectrum of antimycotic activity, particularly against dermatophytes and yeasts, molds and diphasic fungi (for example, against Candida species, such as Candida albicans, Candida

Petition 870190021920, of 03/07/2019, p. 82/172

79/160 glabrata) and Epidermophyton floccosum, Aspergillus species, such as Aspergillus niger and Aspergillus fumigatus, Trichophyton species such as Trichophyton mentagrophytes, Microsporon species such as Microsporon canis and audouinii. The list of these fungi in no way limits the covered mycotic spectrum, and is merely illustrative.

[00307] The inventive active ingredients of formula (I) can therefore be used in both medical and non-medical applications.

[00308] The active ingredients can be used as such, in the form of their formulations or the forms of use prepared from them, such as ready-to-use solutions, suspensions, wetting powders, pastes, soluble powders, dust and granules. The application is achieved in a usual way, for example, by immersion, spraying, atomization, launching, dusting, foaming, spreading, etc. It is also possible to apply the active ingredients using the ultra-low volume method, or inject the active ingredient preparation or the active ingredient itself into the soil. It is also possible to treat the seed of plants.

[00309] When using the inventive active ingredients as fungicides, application rates can be varied within a relatively wide range, depending on the type of application. The application rate of the inventive active ingredients is • for the treatment of plant parts, for example, leaves: from 0.1 to 10,000 g / ha, preferably from 10 to 1000 g / ha, more preferably from 50 to 300 g / ha (in the case of irrigation or drip application, it is still possible to reduce the application rate, especially when inert substrates such as rock or perlite wool are used);

• in the case of seed treatment: from 2 to 200 g per 100 kg of seed, preferably from 3 to 150 g per 100 kg of seed, more preferably from 2.5 to 25 g per 100 kg of seed, even more preferably from 2.5 to 12.5 g per 100 kg of seed;

• in the case of soil treatment: from 0.1 to 10,000 g / ha, preferably from 1 to 5000 g / ha.

[00310] These application rates are for example only and are not by way of limitation, for the purposes of the invention.

[00311] Inventive active ingredients are used in the veterinary sector

Petition 870190021920, of 03/07/2019, p. 83/172

80/160 and in animal husbandry in a manner known as enteral administration in the form of, for example, tablets, capsules, potions, baths, granules, pastes, boluses, the direct feeding process, in the form of suppositories, by parenteral administration , such as, for example, by injection (intramuscular, subcutaneous, intravenous, intraperitoneal and the like), implants, by nasal administration, by dermal use in the form, for example, of immersion or bathing, spraying, pouring on and spotting on, washing and powder spray, and also with the help of molded articles that contain the active compound, such as collars, ear markers, tail markers, end bands, halters, marking devices and the like.

[00312] When used for poultry, poultry, domestic animals and the like, the active compounds of the formula (I) can be used as formulations (for example powders, emulsions, fluids) comprising the active compounds in an amount of from 1 up to 80% by weight, directly or after 100 to 10,000 times dilution, or can be used as a chemical bath.

[00313] Ready-to-use compositions may also optionally comprise other insecticides and also optionally one or more fungicides.

[00314] With respect to additional mixing partners, reference is made to the insecticides and fungicides mentioned above.

[00315] At the same time the compounds according to the invention can be used to protect objects that are in contact with salt water or brackish water, such as hulls, screens, nets, buildings, mooring and signaling systems, against dirt.

[00316] Furthermore, the compounds according to the invention can be used alone or in combinations with other active compounds as anti-dust compositions.

[00317] The inventive treatment method can be used for the treatment of genetically modified organisms (GMOs), for example, plants or seeds. Genetically modified plants (or transgenic plants) are plants in which a heterologous gene has been integrated into the genome in a stable manner. The term “heterologous gene” essentially means a gene that is supplied or collected outside the plant and when introduced into the nuclear, chloroplastic or mitochondrial genome, resulting in a new plant transformed or agronomically

Petition 870190021920, of 03/07/2019, p. 84/172

81/160 improved or other properties by expressing the protein or polypeptide of interest or by regulating or silencing other genes that are present in the plant (using, for example, antisense technology, cosupressure technology or RNAi technology). interference] A heterologous gene that is located in the genome is also called a transgene A transgene that is defined by its particular location in the plant genome is called a transgenic transformation or event.

[00318] Depending on the plant species or plant varieties, their location and growing conditions (land, climate, vegetation period, diet), the treatment according to the invention can also result in superadditive (synergistic) effects. Possible are, for example, the following effects that exceed the effects to be expected: reduced application rates and / or broadening of the activity spectrum and / or an increase in the activity of the active compounds and compositions that can be used according to the invention, better plant growth, increased tolerance to high and low temperatures, increased tolerance to drought or flood or soil salt content, increased flowering performance, ease of harvest, accelerated ripening, higher crop yields, bigger fruits, bigger plant height, greener leaves, early flowering, higher quality and a higher nutritional value of the harvested products, higher concentration of sugar in the fruits, better storage stability, and / or processing of the harvested products.

[00319] At certain application rates, inventive active ingredient combinations can also have a strengthening effect on plants. They are therefore suitable to mobilize the plant's defense system against the attack of phytopathogenic fungi and / or unwanted microorganisms and / or viruses. This may be one of the reasons for the increased activity of inventive combinations, for example, against fungi. Plant-strengthening substances (resistance inducers) should be understood, in the present context, also as those substances or combinations of substances that are capable of stimulating the defense system of plants so that, when subsequently inoculated with unwanted phytopathogenic fungi, the treated plants have a substantial degree of resistance to these unwanted phytopathogenic fungi and / or microorganisms and / or viruses. In the present case, phytopathogenic fungi and / or viruses and / or unwanted microorganisms, fungi, bacteria and viruses should be understood

Petition 870190021920, of 03/07/2019, p. 85/172

82/160 phytopathogens. Thus, the substances according to the invention can be used to protect plants against attack by the pathogens mentioned above, for a certain period of time after treatment. The period within which protection is carried out extends from 1 to 10 days, preferably 1 to 7 days, after the treatment of the plants with the active compounds.

[00320] The plants and varieties of plants that are preferably treated according to the invention include all plants that have the genetic material that confers particularly advantageous characteristics, useful to those plants (even if this is obtained by means of cultivation and / or biotechnology ).

[00321] The plants and varieties of plants that are also preferably treated according to the invention are resistant to one or more factors of biotic stress, that is, said plants have an improved defense against animal and microbial pests, such as nematodes, insects, mites , phytopathogenic fungi, bacteria, viruses and / or viroids.

[00322] Plants and plant varieties that can similarly be treated according to the invention are those plants that are resistant to one or more abiotic stressors. Abiotic stress conditions may include, for example, drought, cold and heat conditions, osmotic stress, flooding, increased soil salinity, increased exposure to minerals, ozone conditions, conditions of strong light conditions, limited availability of nutrients from nitrogen, limited availability of phosphorus nutrients or shade restriction.

[00323] Plants and plant varieties that can similarly be treated according to the invention are those plants that are characterized by high yield properties. High yield means that plants can be the result of, for example, plant physiology, improved growth and development, such as water use efficiency, water retention efficiency, improved nitrogen use, increased carbon assimilation, photosynthesis improved, improved germination efficiency and accelerated maturation. Yield can also be affected by improved plant architecture (under stress and non-stress conditions), including early flowering, flowering control for hybrid seed production, seed vigor, plant size, number and distance of internodes, growth of roots, seed size, fruit size, pod size, pod or number of ears,

Petition 870190021920, of 03/07/2019, p. 86/172

83/160 number of seeds per pod or ear, seed mass, improved seed filling, reduced seed dispersion, reduced pod dehiscence and resistance to housing. Other yield characteristics include seed composition, such as carbohydrate content, protein content, oil content and composition, nutritional value, reduction in anti-nutritional compounds, improved processing and better storage stability.

[00324] The plants that can be treated according to the invention are hybrid plants that already express the characteristics of heterosis, or hybrid effect, which generally results in greater yield, vigor, health and resistance, in relation to biotic and stress factors abiotics. Such plants are typically produced by crossing an inborn male sterile relative (the female relative) with another inborn male fertile line (male relative). Hybrid seed is usually harvested from sterile male plants and sold to producers. Sterile male plants may occasionally (for example, in maize) be produced by threshing (ie, the mechanical removal of male reproductive organs or male flowers) but, more typically, male sterility is the result of genetic determinants in the plant's genome . In this case, and especially when the seed is the desired product to be harvested from hybrid plants, it is typically useful to ensure that male fertility in hybrid plants, which contain the genetic determinants responsible for male sterility, is completely restored. This can be accomplished by ensuring that male relatives have the appropriate fertility restoring genes, capable of restoring male fertility in hybrid plants that contain the genetic determinants responsible for male sterility. The genetic determinants for male sterility may be located in the cytoplasm. Examples of cytoplasmic male sterility (CMS) have, for example, been described for Brassica species. However, genetic determinants for male sterility may also be located in the nuclear genome. Sterile male plants can also be obtained by plant biotechnology methods, such as genetic engineering. Particularly useful means of obtaining sterile male plants are described in WO 89/10396, in which, for example, a ribonuclease, such as barnase, is selectively expressed in the layers of cells in the stamens. Fertility can then be restored by

Petition 870190021920, of 03/07/2019, p. 87/172

84/160 expression in the cell layers of a ribonuclease inhibitor, such as barstar.

[00325] The plants or varieties of plants (obtained by methods of plant biotechnology, such as genetic engineering) that can be treated according to the invention are plants tolerant to herbicides, i.e. plants that become tolerant to one or more herbicides given. Such plants can be obtained, either by genetic transformation, or by selecting plants containing a mutation, conferring such tolerance to the herbicide.

[00326] Herbicide-tolerant plants are, for example, glyphosate-tolerant plants, that is, plants that become tolerant to the glyphosate herbicide or salts thereof. For example, glyphosate-tolerant plants can be obtained by transforming the plant with a gene encoding the enzyme 5-enolpyruvylshiquimato3-phosphate synthase (EPSPS). Examples of such EPSPS genes are the AroA gene (CT7 mutant) of the Salmonella typhimurium bacterium, the CP4 gene of the bacterium Agrobacterium sp., The genes encoding EPSPS from petunia, an EPSPS from tomatoes, or an EPSPS from Eleusina. It can also be a mutated EPSPS. Glyphosate-tolerant plants can also be obtained by expressing a gene that encodes a glyphosate oxidoreductase enzyme. Glyphosate-tolerant plants can also be obtained by expressing a gene that encodes a glyphosate acetyltransferase enzyme. Glyphosate tolerant plants can also be obtained by selecting plants that contain the aforementioned naturally occurring gene mutations.

[00327] The other herbicide-resistant plants are plants, for example, that have been made tolerant to herbicides that inhibit the enzyme glutamine synthase, such as bialafos, phosphinothricin or glufosinate. Such plants can be obtained by the expression of a detoxifying enzyme of the herbicide or a mutant of the enzyme glutamine synthase, which is resistant to inhibition. Such an effective detoxifying enzyme is, for example, an enzyme encoding a phosphinothricin acetyltransferase (such as, a bar protein or pat of Streptomyces species). Plants that express an exogenous phosphinothricin acetyltransferase have been described.

[00328] The other herbicide tolerant plants are also plants that have been made tolerant to herbicides by inhibiting the enzyme hydroxyphenylpyruvate dioxigenase (HPPD). Hydroxyphenylpyruvate dioxigenase are enzymes that catalyze the

Petition 870190021920, of 03/07/2019, p. 88/172

85/160 reaction where para - hydroxyphenylpyruvate (HPP) is transformed into homogentisate. Plants tolerant to HPPD inhibitors can be transformed by encoding a naturally occurring HPPD-resistant enzyme, or a gene encoding a mutated HPPD enzyme. Tolerance to HPPD inhibitors can also be obtained by transforming plants with genes that encode certain enzymes allowing the formation of homogentisate, despite the inhibition of the native HPPD enzyme by the HPPD inhibitor. Plant tolerance to HPPD inhibitors can also be improved by transforming plants with a gene encoding a prefenate dehydrogenase enzyme, in addition to a gene encoding an HPPD tolerant enzyme.

[00329] Other herbicide resistant plants are plants that have been made tolerant to acetolactate synthase (ALS) inhibitors. ALS inhibitors include, for example, sulfonylurea, imidazolinone, triazolopyrimidines, pyrimidinyloxy (thio) benzoates and / or sulfonylaminocarbonyltriazolinone herbicides. Different mutations in the ALS enzyme (also known as acetohydroxy acid synthase AHAS) are known to confer tolerance to different herbicides and groups of herbicides. The production of sulfonylurea tolerant plants and imidazolinone tolerant plants have been described in international patent application WO 1996/033270. Other sulfonylurea tolerant plants and imidazolinone tolerant plants have also been described, for example, in WO 2007/024782.

[00330] Other plants tolerant to sulfonylurea and / or imidazolinone can be obtained by induced mutagenesis, through selection in cell cultures in the presence of the herbicide or by creating mutation.

[00331] The plants or varieties of plants (obtained by methods of plant biotechnology. Such as genetic engineering) that can also be treated according to the invention are transgenic plants resistant to insects, ie plants that become resistant to attack certain target insects. Such plants can be obtained by genetic transformation, or by selecting plants containing a mutation conferring such resistance to the insect.

[00332] In the present context, the term insect resistant transgenic plant includes any plant containing at least one transgene constituting a coding sequence, which encodes:

1) an insecticidal crystalline protein from Bacillus thuringiensis or an insecticidal part of it, such as the insecticidal crystalline proteins, listed online at:

Petition 870190021920, of 03/07/2019, p. 89/172

86/160 http://wwwJifesci.sussex.ac.uk/Home/Neil Crickmore / Bt /, or insecticidal portions thereof, for example, Cry proteins of the classes CrylAb, CrylAc, Cry1F, Cry2Ab, Cry3Ae or Cry3Bb or insecticidal portions the same; or

2) a crystalline protein from Bacillus thuringiensis or a portion thereof, which is insecticidal in the presence of a second crystalline protein from Bacillus thuringiensis or a portion thereof, such as binary toxin made with the crystalline proteins Cy34 and Cy35; or

3) a hybrid insecticidal protein comprising parts of two different crystalline insecticidal proteins from Bacillus thuringiensis, such as a protein hybrid from (1) above or a protein hybrid from (2) above, for example, the Cry1A.1O5 protein produced by MON98034 corn event (WO 2007/027777); or

4) a protein from any of points (1) to (3) mentioned above where some, particularly 1 to 10, amino acids have been replaced by another amino acid to obtain greater insecticidal activity for some target insect species, and / or to expand the scale of target insect species affected, and / or because of changes induced by coding DNA during cloning or transformation, such as the Cry3Bb1 protein in the MON863 or MON88017 corn events, or the Cry3A protein in the MIR corn event 604;

5) an insecticidal protein secreted from Bacillus thuringiensis or

Bacillus cereus, or an insecticidal part of it, such as vegetable insecticidal proteins (VIP) listed under:

http://www.lifesci.sussex.ac.uk/Home/Neil_Crickmore/Bt/vip.html, for example, proteins of the VIP3Aa class; or

6) a protein secreted from Bacillus thuringiensis or Bacillus cereus that is insecticidal in the presence of a second protein secreted from Bacillus thuringiensis or B. cereus, such as the binary toxin made from the VIP1A and VIP2A proteins; or

7) an insecticidal hybrid protein comprising parts of different proteins secreted from Bacillus thuringiensis or Bacillus cereus, such as, a protein hybrid in (1) above or a protein hybrid in (2) above; or

8) a protein from any of the points (1) to (3) mentioned above some, particularly 1 to 10, amino acids have been replaced by another amino acid to obtain greater insecticidal activity for some target insect species, and

Petition 870190021920, of 03/07/2019, p. 90/172

87/160 / or to expand the scale of affected target insect species, and / or because of changes induced by encoding DNA during cloning or transformation (while still encoding an insecticidal protein), such as the VIP3Aa protein in the event of COT 102 cotton.

[00333] Naturally, transgenic insect-resistant plants, as used here, also include any plant constituting a combination of genes encoding the proteins of any of the classes above 1 to 8. In one embodiment, an insect-resistant plant contains more than a transgene encoding a protein of any of the classes above 1 to 8, to expand the range of affected target insect species, or to delay the development of insect resistance to plants, using different insecticidal proteins for the same target insect species , but presenting a different mode of action, such as binding to different binding receptor sites in the insect.

[00334] Plants or plant cultivars (obtained by plant biotechnology methods, such as genetic engineering) that can also be treated according to the invention, are tolerant to abiotic stress factors. Such plants can be obtained by genetic transformation, or by selecting plants containing a mutation conferring such resistance to stress. Particularly useful stress-tolerant plants include the following:

The. plants containing a transgene capable of reducing the expression and / or activity of the poly (ADP-ribose) polymerase (PARP) gene in plant cells or plants;

B. plants with tolerance to stress resulting from transgenesis, capable of reducing the expression and / or activity of the PARG coding genes of plants or plant cells;

ç. plants containing a stress tolerance-enhancing transgene encoding a plant functional enzyme from the nicotinamide adenine dinucleotide reuse route, including nicotinamidase, nicotinate phosphoribosyltransferase, nicotinic mononucleotide adenyltransferase, nicotinamide dinotinamide, nicotinamide

[00335] Plants or plant varieties (obtained by methods of plant biotechnology, such as genetic engineering), which in the same way

Petition 870190021920, of 03/07/2019, p. 91/172

88/160 can be treated according to the invention, show an altered quantity, quality and / or storage stability of the harvested product and / or altered properties of the specific ingredients of the harvested product, for example:

1) Transgenic plants that synthesize a modified starch that is altered with respect to its physicochemical traits, in particular the amylose content or the amylose-amylopectin rate, the degree of branching, the average chain length, the distribution of side chains, viscosity behavior, gel resistance, grain size and / or grain morphology of starch compared to starch synthesized in the wild type of plant cells or plants, such that this modified starch is more suitable for certain applications.

2) Transgenic plants that synthesize polymers of carbohydrate other than starch or that synthesize polymers of carbohydrate other than starch with altered properties compared to wild type plants without genetic modification. Examples are plants that produce polifructose, especially of the inulin or levan type, plants that produce alpha-1,4-glucan branches, plants that produce alpha-1,6 branched alpha-1,4-glucans, and plants that produce alternan.

3) Transgenic plants that produce hyaluronic acid.

Plants or plant cultivars (which are obtained by plant biotechnology methods, such as genetic engineering), which in the same way can be treated according to the invention, are plants, such as cotton plants, with altered fiber characteristics . Such plants can be obtained by genetic transformation, or by selecting plants containing a mutation conferring such altered characteristics of the fiber and includes:

a) plants, such as cotton plants, which contain an altered form of the cellulose synthase genes;

b) plants, such as cotton plants, which contain an altered form of homologous nucleic acids rsw2 or rsw3;

c) plants, such as cotton plants with increased sucrose phosphate synthase expression;

d) plants, such as cotton plants with increased sucrose synthase expression;

e) plants, such as cotton plants, in which the connection time

Petition 870190021920, of 03/07/2019, p. 92/172

89/160 plasmodesmal at the base of the fiber cell is altered, for example, through selective regulation of the fiber by β-1,3-glucanase;

f) plants, such as cotton plants that have fibers with altered reactivity, for example, through the expression of the N-acetylglucosamine transferase gene including the nodC and chitin synthase genes.

[00336] Plants or plant varieties (which can be obtained by plant biotechnology methods, such as genetic engineering) that can also be treated according to the invention, are plants such as rapeseed or Brassica-related plants, with characteristics changed in oil profile. Such plants can be obtained by genetic transformation or by selecting plants containing a mutation, which confers such altered oil characteristics, and includes:

a) plants, such as rapeseed plants, that produce the oil having a high oleic acid content;

b) plants, such as rapeseed plants, that produce the oil having a low oleic acid content;

c) plants, such as rapeseed plants, that produce the oil having the low level of saturated fatty acids.

[00337] Particularly useful transgenic plants that can be treated according to the invention are plants that comprise one or more genes that encode one or more toxins, the transgenic plants that are sold under the following trademarks: YIELD GARD® (for example, corn, cotton, soybeans), KnockOut® (for example, corn), BiteGard® (for example, corn), Bt-Xtra® (for example, corn), StarLink® (for example, corn), Bollgard® ( cotton), Nucotn® (cotton), Nucotn 33B ^® (cotton), NatureGard ^® (for example maize), Protecta ^{® ®} and NewLeaf (potato). Examples of herbicide-tolerant plants that can be mentioned are maize varieties, cotton varieties and soybean varieties that are sold under the registered trade names: Roundup Ready ^® (tolerance to glyphosate, eg maize, cotton, grains of soy), Liberty Link ^® (tolerance to phosphinothricin, for example, rapeseed), IMI ^® (tolerance to imidazolinone) and SCS ^® (tolerance to sulfonylurea, for example, corn). The herbicide resistant plants (plants produced in a conventional manner for herbicide tolerance) that can be mentioned include the varieties sold under the name Clearfield ^® (for example, maize).

[00338] Particularly useful transgenic plants that can be

Petition 870190021920, of 03/07/2019, p. 93/172

90/160 treated according to the invention are plants containing transformation events, or a combination of transformation events, which are listed, for example, in the databases of various national or regional regulatory agencies (see, for example, http : //gmoinfo.jrc.it/gmp browse.aspx and http://www.agbios.com/dbase.php).

[00339] The listed plants can be treated according to the invention in a particularly advantageous manner with the compounds of the general formula (I) and / or mixtures of active ingredient according to the invention. The preferred ranges indicated above for the active ingredients or mixtures also apply to the treatment of these plants. Particular emphasis is placed on the treatment of plants with the compounds or mixtures specifically mentioned in this text.

[00340] The inventive active ingredients or compositions can thus be used to protect plants against attack by the mentioned pathogens for a specified period of time after treatment. The period in which protection is provided is generally 1 to 28 days, preferably 1 to 14 days, most preferably 1 to 10 days, most preferably 1 to 7 days after treatment of the plants with the active compounds , or up to 200 days after seed treatment.

[00341] The preparation and use of the inventive active ingredients of formula (I) are illustrated by the following examples. However, the invention is not limited to these examples.

[00342] General notes: Unless otherwise indicated, all chromatographic separation and purification steps are carried out on silica gel and using a solvent gradient of 0: 100 ethyl acetate / cyclohexane to 100: 0 acetate ethyl / cyclohexane.

Preparation of compounds of the formula (I-15)

Step 1

Tert-butyl 4- (4-bromo-1,3-thiazol-2-yl) -4-hydroxypiperidine-1-carboxylate [00343] To a solution of 2,4-dibromo-1,3-thiazole (8, 8 g) in dichloromethane (180 ml) was added dropwise, at -78 ° C under argon, n-butyllithium (1.6 M in tetrahydrofuran, 25 ml). The reaction mixture was stirred at -78 ° C for 20 minutes and then tert-butyl 4-oxopiperidine-1-carboxylate was added. The mixture was stirred at room temperature for 30 minutes. The reaction mixture was subsequently mixed with saturated ammonium chloride solution at -30 ° C and

Petition 870190021920, of 03/07/2019, p. 94/172

91/160 the aqueous phase was removed. After the aqueous phase was extracted with dichloromethane, the combined organic phases were dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by means of chromatography. This gave tert-butyl 4- (4-bromo-1,3-thiazol-2-yl) -4-hydroxypiperidine-1-carboxylate (15.3 g).

Step 2

Tert-butyl 4- (4-bromo-1,3-thiazol-2-yl) -4-fluoropiperidine-1-carboxylate [00344] 4- (4-bromo-1,3-thiazol-2-yl) - Tercbutyl 4-hydroxypiperidine-1-carboxylate (17.7 g) was initially loaded under argon at 0 ° C in dichloromethane in a PE flask, and diethylamino sulfur trifluoride (DAST) (7.08 ml) was added dropwise . The cooling has been removed. After stirring overnight, saturated aqueous sodium hydrogen carbonate solution was added and the mixture was extracted with dichloromethane. The organic extracts were dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by means of chromatography. This gave tert-butyl 4- (4-bromo-1,3-thiazol-2-yl) -4-fluoropiperidine-1-carboxylate (18.0 g).

Step 3

Tert-butyl 4-fluoro-4- (4-formyl-1,3-thiazol-2-yl) piperidine-1-carboxylate [00345] To a solution of 4- (4-bromo-1,3-thiazol- 2-yl) -4-fluoropiperidine-1 tert-butyl carboxylate (245 mg) in dichloromethane (5 ml) was added dropwise at -78 ° C, n-butyllithium (1.6 M in tetrahydrofuran, 0, 42 ml). After 20 min, N, Ndimethylformamide (0.16 ml) was added dropwise. After stirring at -78 ° C for 30 minutes, a saturated ammonium chloride solution was added, and the mixture was extracted with dichloromethane. The organic extracts were dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by means of chromatography. This gave tert-butyl 4-fluoro-4- (4-formyl-1,3-thiazol-2-yl) piperidine-1-carboxylate (75 mg).

Step 4 tert-Butyl 4-fluoro-4- {4 - [(E / Z) - (hydroxyimino) methyl] -1,3-thiazol-2-yl} piperidine-1-carboxylate (XVIII-1) [00346 ] To a solution of tert-butyl 4-fluoro-4- (4-formyl-1,3-thiazol-2-yl) piperidine-1-carboxylate (3.49 g) in ethanol (50 ml) was added dropwise hydroxylamine (50% in water, 0.81 ml) at room temperature. The reaction mixture was stirred at 60 ° C for 1 hour, then the solvent was removed under reduced pressure.

Petition 870190021920, of 03/07/2019, p. 95/172

92/160

This gave tert-butyl 4-fluoro-4- {4 - [(E / Z) - (hydroxyimino) methyl] -1,3-thiazol-2-yl} piperidine-1-carboxylate (3.49 g).

Step 5 4-fluoro-4- (4- {5- [methoxy (phenyl) methyl] -4,5-dihydro-1,2-oxazol-3-yl} -1,3-thiazol-2yl) piperidine-1 tert-butyl carboxylate (XVIIa-1) [00347] To a solution of 4-fluoro-4- {4 - [(E / Z) - (hydroxyimino) methyl] -1,3thiazol-2-yl} piperidine- Tert-butyl 1-carboxylate (200 mg) and (1-methoxyprop-2-en-1yl) benzene (99 mg) in ethyl acetate (3 ml) were added at room temperature with potassium hydrogen carbonate (304 mg) and N-chlorosuccinimide (97 mg), and then a drop of water. After stirring at reflux overnight, ethyl acetate and water were added to the reaction mixture, which was extracted with ethyl acetate. The organic extracts were dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by means of chromatography. This gave 4-fluoro-4- (4 {5- [methoxy (phenyl) methyl] -4,5-dihydro-1,2-oxazol-3-yl} -1,3-thiazol-2-yl) piperidine- 1 tert-butyl carboxylate (150 mg).

Step 6

4-fluoro-4- (4- {5- [methoxy (phenyl) methyl] -4,5-dihydro-1,2-oxazol-3-yl} -1,3thiazol-2-yl) piperidinium chloride (XIII -1) [00348] To a solution of 4-fluoro-4- (4- {5- [methoxy (phenyl) methyl] -4,5-dihydro1,2-oxazol-3-yl} -1,3-thiazole -2-yl) tert-butyl piperidine-1-carboxylate (150 mg) was added dropwise, at 0 ° C, a 4 molar solution of hydrogen chloride in

1.4- dioxane. The reaction mixture was stirred at 0 ° C and then gradually warmed up to room temperature. After stirring overnight, the excess solvent and hydrogen chloride were removed. This gave 4-fluoro-4- (4- {5 [methoxy (phenyl) methyl] -4,5-dihydro-1,2-oxazol-3-yl} -1,3-thiazol-2-yl) piperidinium (150 mg). Step 7

2- [3,5-Bis (difluoromethyl) -1 H-pyrazol-1-yl] -1 - [4-fluoro-4- (4- {5- [methoxy (phenyl) methyl] -

4.5- dihydro-1,2-oxazol-3-yl} -1,3-thiazol-2-yl) piperidin-1-yl] ethanone (I-15) [00349] To a suspension of 4-fluoro-chloride 4- (4- {5 [methoxy (phenyl) methyl] -4,5-dihydro-1,2-oxazol-3-yl} -1,3-thiazol-2-yl) piperidinium (153 mg) in dichloromethane ( 2 ml) and triethylamine (0.05 ml) were added, at room temperature, bis-3,5- (difluoromethyl) -1H-pyrazol-1-yl] acetic acid (70 mg), 4-dimethylaminopyridine (4 mg) and 1 -ethyl-3- (3'-dimethylaminopropyl) carbodiimide (65 mg). The mixture was stirred at room temperature for 2 hours, and water was then added.

Petition 870190021920, of 03/07/2019, p. 96/172

93/160

The aqueous phase was removed and extracted with ethyl acetate. The combined organic phases were dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by means of chromatography. This gave 2- [3,5-bis (difluoromethyl) 1 H-pyrazol-1-yl] -1 - [4-fluoro-4- (4- {5- [methoxy (phenyl) methyl] -4,5- dihydro-1,2-oxazol-3-yl} -1,3thiazol-2-yl) piperidin-1-yl] ethanone (30 mg).

Preparation of compounds of the formula (I-9)

Step 1

4- [tert-Butyl 4- [4- (5-benzoyl-4,5-dihydro-1,2-oxazol-3-yl) -1,3-thiazol-2-yl] piperidine-1-carboxylate (XIX-1 ) Tert-butyl [{hydroxyimino) methyl] -1,3-thiazol-2-yl} piperidine-1-carboxylate (1.0 g) was reacted in a manner analogous to I- 15 (step 5) with 1-phenylprop-2-en-1-one (637 mg). This gave tert-butyl 4- [4- (5-benzoyl-4,5-dihydro-1,2-oxazol-3-yl) 1,3-thiazol-2-yl] piperidine-1-carboxylate (1, 12 g).

Step 2 4- (4- {5- [difluoro (phenyl) methyl] -4,5-dihydro-1,2-oxazol-3-yl} -1,3-thiazol-2-yl) piperidine-

Tert-butyl 1-carboxylate (XVIIa-2) [00351] 4- [4- (5-benzoyl-4,5-dihydro-1,2-oxazol-3-yl) -1,3-thiazol-2- il] tert-butyl piperidine-1 carboxylate (2.0 g) was initially charged under argon at room temperature in dichloromethane (20 ml) in a PE flask, and sulfur (diethylamino) trifluoride (DAST) (1.50 ml) was added dropwise. After stirring at reflux at temperature overnight, a saturated aqueous sodium hydrogen carbonate solution was added and the mixture was extracted with dichloromethane. The organic extracts were dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by means of chromatography. This gave 4- (4- {5 [difluoro (phenyl) methyl] -4,5-dihydro-1,2-oxazol-3-yl} -1,3-thiazol-2-yl) piperidine-1-carboxylate tert-butyl (1.8 g).

Step 3 4- (4- {5- [Difluoro (phenyl) methyl] -4,5-dihydro-1,2-oxazol-3-yl} -1,3-thiazol-2yl) piperidinium chloride (XIII-2 ) [00352] 4- (4- {5- [difluoro (phenyl) methyl] -4,5-dihydro-1,2-oxazol-3-yl} -1,3-thiazol-2yl) piperidine-1-carboxylate tert-butyl (1.8 g) was reacted in a similar way to I-15 (step 6). This gave 4- (4- {5- [difluoro (phenyl) methyl] -4,5-dihydro-1,2-oxazol-

3-yl} -1,3-thiazol-2-yl) piperidinium (1.7 g).

Step 4

Petition 870190021920, of 03/07/2019, p. 97/172

94/160

2- [3,5-Bis (difluoromethyl) -1 H-pyrazol-1 - [4- (4- {5- [difluoro (phenyl) methyl] -4,5dihydro-1,2-oxazol-3-yl} -1,3-thiazol-2-yl) piperidin-1-yl] ethanone (I-9) [00353] To a chloride suspension of 4- (4- {5- [difluoro (phenyl) methyl] -4, 5dihydro-1,2-oxazol-3-yl} -1,3-thiazol-2-yl) piperidinium (407 mg) in dichloromethane (4 ml) and triethylamine (0.43 ml) were added, at room temperature, acid bis-3,5 (difluoromethyl) -1H-pyrazol-1-yl] acetic (230 mg) and benzotriazole-1yl-oxitripyrrolidinophosphonium hexafluorophosphate (570 mg). The mixture was stirred at room temperature for 2 hours, and water was then added. The aqueous phase was removed and extracted with ethyl acetate. The combined organic phases were dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by means of chromatography. This gave 2- [3,5-bis (difluoromethyl) -1H-pyrazol-1-yl] -1- [4- (4- {5 [difluoro (phenyl) methyl] -4,5-dihydro-1,2 -oxazol-3-yl} -1,3-thiazol-2-yl) piperidin-1-yl] ethanone (455 mg).

Preparation of compounds of the formula (I-31)

2- [3,5-Bis (difluoromethyl) -1 H-pyrazol-1-yl] -1 - [4- (4- {5- [difluoro (phenyl) methyl] -4,5dihydro-1,2-oxazole -3-yl} -1,3-thiazol-2-yl) piperidin-1-yl] ethanothione (I-31) [00354] To a solution of 2- [3,5-bis (difluoromethyl) -1H-pyrazole -1-yl] -1- [4 (4- {5- [difluoro (phenyl) methyl] -4,5-dihydro-1,2-oxazol-3-yl} -1,3-thiazol-2-yl ) piperidin-1 yl] ethanone (455 mg) in toluene (10 ml) was added at room temperature, 2,4bis- (4-methoxyphenyl) -1,3,2,4-dithiadiphosphetane 2,4-disulfide (reagent Lawesson's) (213 mg). The mixture was stirred at 70 ° C for 2 hours, and then water was added. The aqueous phase was removed and extracted with ethyl acetate. The combined organic phases were dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by means of chromatography. This gave 2- [3,5-bis (difluoromethyl) 1 H-pyrazol-1-yl] -1 - [4- (4- {5- [difluoro (phenyl) methyl] -4,5-dihydro-1, 2-oxazol-3-yl} -1,3-thiazol-2yl) piperidin-1-yl] ethanothione (350 mg).

Preparation of compounds of the formula (I-16) N- [2,5-Bis (difluoromethyl) phenyl] -4- (4- {5- [difluoro (phenyl) methyl] -4,5-dihydro-1,2oxazole- 3-yl} -1,3-thiazol-2-yl) piperidine-1-carboxamide (I-16) [00355] To a chloride suspension of 4- (4- {5- [difluoro (phenyl) methyl] - 4,5dihydro-1,2-oxazol-3-yl} -1,3-thiazol-2-yl) piperidinium (411 mg) in dichloromethane (5 ml) and triethylamine (0.16 ml) were added at room temperature , 1,4bis (difluoromethyl) -2-isocyanatobenzene (225 mg) and a drop of 1.8 diazabicyclo [5.4.0] undec-7-ene (DBU). The mixture was stirred at room temperature

Petition 870190021920, of 03/07/2019, p. 98/172

95/160 for 2 hours, and saturated ammonium chloride solution was then added. The aqueous phase was removed and extracted with ethyl acetate. The combined organic phases were dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by means of chromatography. This gave N- [2,5-bis (difluoromethyl) phenyl] -4- (4- {5 [difluoro (phenyl) methyl] -4,5-dihydro-1,2-oxazol-3-yl} -1, 3-thiazol-2-yl) piperidine-1 carboxamide (388 mg).

Preparation of compounds of the formula (I-2)

Step 1

4- {4- [5- (phenoxymethyl) -4,5-dihydro-1,2-oxazol-3-yl] -1,3-thiazol-2-yl} piperidine-1 tert-butyl carboxylate (XVIIa- 3) [00356] To a solution of tert-butyl 4- {4 - [(E / Z) - (hydroxyimino) methyl] -1,3-thiazol-2yl} piperidine-1-carboxylate (3.2 g) and allyl phenyl ether (2.21 g) in ethyl acetate (80 ml) were added, at room temperature, potassium hydrogen carbonate (5.65 g) and N-chlorosuccinimide (2.34 g), and then a drop of Water. After stirring at reflux overnight, water was added to the reaction mixture, which was extracted with ethyl acetate. The organic extracts were dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by means of chromatography. This gave tert-butyl 4- {4- [5- (phenoxymethyl) -4,5-dihydro-1,2-oxazol-3-yl] -1,3-thiazol-2yl} piperidine-1-carboxylate (2 , 34 g).

Step 2

2- [3,5-Bis (difluoromethyl) -1 H-pyrazol-1-yl] -1 - (4- {4- [5- (phenoxymethyl) -4,5-dihydro-1,2oxazol-3-yl ] -1,3-thiazol-2-yl} piperidin-1-yl) ethanone (I-2) [00357] To a solution of 4- {4- [5- (phenoxymethyl) -4,5-dihydro-1 , 2-oxazol-3yl] -1,3-thiazol-2-yl} tert-butyl piperidine-1-carboxylate (4.27 g) in dichloromethane (20 ml) was added dropwise at 0 ° C, a 4 molar solution of hydrogen chloride in 1,4-dioxane. The reaction mixture was stirred at 0 ° C and then gradually warmed up to room temperature. After stirring for 5 hours, the excess solvent and hydrogen chloride were removed. The residue was redissolved in dichloromethane (50 ml) (solution A).

[00358] At the same time, a solution of 3,5-bis (difluoromethyl) 1H-pyrazol-1-yl] acetic acid (2.89 g) in dichloromethane (30 ml) was added, at room temperature, a drop of N, N-dimethylformamide, and oxalyl chloride (3.74

g) was added dropwise. After stirring at room temperature for 5 hours, the solvent was removed and the residue was redissolved in dichloromethane (20 ml)

Petition 870190021920, of 03/07/2019, p. 99/172

96/160 (solution B).

[00359] Diisopropylethylamine (3.77 ml) was added to solution A at room temperature. After 15 minutes, solution B was added dropwise. After stirring at room temperature overnight, water was added to the reaction mixture, which was extracted with ethyl acetate. The organic extracts were dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by means of chromatography. This gave 2- [3,5-bis (difluoromethyl) -1H-pyrazol-1yl] -1 - (4- {4- [5- (phenoxymethyl) -4,5-dihydro-1,2-oxazol-3- yl] -1,3-thiazol-2-yl} piperidin-1 yl) ethanone (3.81 g).

Preparation of compounds of the formula (I-43)

Step 1

4- tert-butyl 4- {4- [5- (bromomethyl) -4,5-dihydro-1,2-oxazol-3-yl] -1,3-thiazol-2-yl} piperidine-1 carboxylate (XX- 1) [00360] To a solution of tert-butyl 4- {4 - [(E / Z) - (hydroxyimino) methyl] -1,3-thiazol-2yl} piperidine-1-carboxylate (250 mg) and bromide of allyl (107 mg) in ethyl acetate (10 ml) was added, at room temperature, potassium hydrogen carbonate (402 mg) and N-chlorosuccinimide (129 mg), and then a drop of water. After stirring at reflux overnight, water was added to the reaction mixture, which was extracted with ethyl acetate. The organic extracts were dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by means of chromatography. This gave tert-butyl 4- {4- [5- (bromomethyl) -4,5-dihydro-1,2oxazol-3-yl] -1,3-thiazol-2-yl} piperidine-1-carboxylate (136 mg)

Step 2

2- [3,5-Bis (difluoromethyl) -1 H-pyrazol-1-yl] -1 - (4- {4- [5- (bromomethyl) -4,5-dihydro-1,2oxazol-3-yl ] -1,3-thiazol-2-yl} piperidin-1-yl) ethanone (VII-1) [00361] To a solution of 4- {4- [5- (bromomethyl) -4,5-dihydro-1 , 2-oxazol-3yl] -1,3-thiazol-2-yl} tert-butyl piperidine-1-carboxylate (720 mg) in dichloromethane (5 ml) was added dropwise at 0 ° C a solution to 4 molar of hydrogen chloride in 1,4-dioxane. The reaction mixture was stirred at 0 ° C and then gradually warmed up to room temperature. After stirring for 2 hours, the excess solvent and hydrogen chloride were removed. The residue was redissolved in dichloromethane (30 ml) (solution A).

[00362] At the same time, to a solution of 3,5-bis (difluoromethyl) 1H-pyrazol-1-yl] acetic acid (397 mg) in dichloromethane (10 ml),

Petition 870190021920, of 03/07/2019, p. 100/172

97/160 at room temperature, a drop of N, N-dimethylformamide, and oxalyl chloride (650 mg) was added dropwise. After stirring at room temperature for 2 hours, the solvent was removed and the residue was redissolved in dichloromethane (10 ml) (solution B).

[00363] Diisopropylethylamine (0.66 ml) was added to solution A at room temperature. After 15 minutes, solution B was added dropwise. After stirring at room temperature overnight, water was added to the reaction mixture, which was extracted with ethyl acetate. The organic extracts were dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by means of chromatography. This gave 2- [3,5-bis (difluoromethyl) -1H-pyrazol-1yl] -1 - (4- {4- [5- (bromomethyl) -4,5-dihydro-1,2-oxazol-3- yl] -1,3-thiazol-2-yl} piperidin-1 yl) ethanone (335 mg).

Step 3

2- [3,5-Bis (difluoromethyl) -1 H-pyrazol-1 - [4- (4- {5 - [(2,6-difluorophenoxy) methyl] -4,5dihydro-1,2-oxazol-3 -il} -1,3-thiazol-2-yl) piperidin-1-yl] ethanone (I-43) [00364] To a solution of 2- [3,5-bis (difluoromethyl) -1H-pyrazol-1 -il] -1- (4 {4- [5- (bromomethyl) -4,5-dihydro-1,2-oxazol-3-yl] -1,3-thiazol-2-yl} piperidin-1 -il ) ethanone (55 mg) and 2,6-difluorophenol (13.3 mg) were added tetra-n-butylammonium bromide (33 mg) and sodium hydroxide (13 mg, finely ground). After stirring at reflux for 48 hours, ethyl acetate and hydrochloric acid (pH2) were added to the reaction mixture, which was extracted with ethyl acetate. The organic extracts were dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by means of chromatography. This gave 2- [3,5-bis (difluoromethyl) -1H-pyrazol-1-yl] -1- [4- (4- {5 [(2,6-difluorophenoxy) methyl] -4,5-dihydro- 1,2-oxazol-3-yl} -1,3-thiazol-2-yl) piperidin-1 yl] ethanone. (10 mg)

Examples [00365] The following compounds can be prepared by one or more of the processes mentioned above.

Q —- L— ^y ij

R ¹ (I) [00366] The structural elements G1 and Q24-3 listed in Table 1 are defined as follows:

Petition 870190021920, of 03/07/2019, p. 101/172

98/160

</ ^S \ ^ R ^G1 A \ w G1 = ^X R ^ T (O \ /> = N ^x / 024-3 = ⁷ / y C z ° Q11-1 = ^{x N}

[00367] For all compounds listed in Table 1, p = 0.

[00368] Table 1:

Ex THE L1 Y X (R 2) G R G1 Q R 5 L2 R1 Log P 1-1 3,5bis (difluoromethyl) -1 H-pyrazol-1 yl CH 2 O CH G 1 H Q2 4-3 H CH2O 2,6dichlorophyll 3.7 [a]; 3.66 [b] I-2 3,5bis (difluoromethyl) -1 H-pyrazol-1 yl CH 2 O CH G 1 H Q2 4-3 H CH2O phenyl 3.22 [a] 3.25 [b] Ex THE L1 Y X (R 2) G R G1 Q R 5 L2 R1 Log P I-3 3,5bis (difluoromethyl) -1 H-pyrazol-1 yl CH 2 O CH G 1 H Q2 4-3 H CH2O 2fluorophen il 3.19 [a]; 3.2 [b] I-4 3,5bis (difluoromethyl) -1 H-pyrazol-1 yl CH 2 O CH G 1 H Q2 4-3 H C (CH3 )2 phenyl 3.79 [a] I-5 3,5bis (difluoromethyl) -1 H-pyrazol-1 yl CH 2 O CH G 1 H Q2 4-3 H CHF phenyl 3.23 [a] I-6 3,5bis (difluoromethyl) -1 H-pyrazol-1 yl CH 2 O CH G 1 H Q2 4-3 H CH2C H2C (O ) phenyl 3.16 [a] 3.13 [b]

Petition 870190021920, of 03/07/2019, p. 102/172

99/160

Ex THE L1 Y X (R 2) G R G1 Q R 5 L2 R1 Log P 1-7 3,5bis (difluoromethyl) -1 H-pyrazol-1 yl CH 2 0 CH G 1 H Q2 4-3 H CH2S 02 phenyl 2.65 [a] 2.65 [b] 1-8 3,5bis (difluoromethyl) -1 H-pyrazol-1 yl CH 2 0 CH G 1 H Q2 4-3 H CHOH phenyl 2.53 [a] 1-9 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CH G 1 H Q2 4-3 H CF2 phenyl 3.41 [a] Ι- ΙΟ 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CH G 1 H Q2 4-3 H CH2S phenyl 3.46 [a] 3.51 [b] 1- 11 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CF G 1 H Q2 4-3 H C (CH3 )2 phenyl 4.03 [a] I- 12 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CH G 1 H Q2 4-3 H CH2O 2- acetylpheni I 2.93 [a] 2.89 [b] I- 13 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CH G 1 H Q2 4-3 H CH2O 2- methylphenyl 3.5 [a]; 3.46 [b] I- 14 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CH G 1 H Q2 4-3 H CH2N ( CH3) phenyl 3.47 [a] 3.64 [b]

Petition 870190021920, of 03/07/2019, p. 103/172

100/160

Ex THE L1 Y X (R 2) G R G1 Q R 5 L2 R1 Log P 1- 15 3.5- bis (difluoromethi 1) -1 h-pyrazol-1-yl CH 2 O CF G ¹ H Q ²⁴ -3 H CH (O CH ₃ ) phenyl 3.56 ^[aI I- 16 2.5- bis (difluoromethi l) phenyl NH O CH G ¹ H Q ²⁴ -3 H CF2 phenyl 3.64 ^[aI I- 17 3,5bis (difluoromethyl) -1 H-pyrazol-1 yl CH 2 O CH G ¹ H Q ²⁴ -3 H CHF 2,6difluorophenyl 3.36 ^[a] I- 18 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 s CH G ¹ H Q ²⁴ -3 H CHF 2,6difluorophenyl 3.81 ^ I- 19 5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl CH 2 O CH G ¹ H Q ²⁴ -3 H CHF phenyl 3.3 ^ Ι- ΣΟ 5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl CH 2 O CH G ¹ H Q ²⁴ -3 H CHF 2,6difluorophenyl 3.48 ^ I- 21 2,5-dimethylphenyl NH s CH G ¹ H Q ²⁴ -3 H CF2 phenyl 3.861 ^a ] I- 22 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 O CH G ¹ H Q ²⁴ -3 H CF2 2,6difluorophenyl 3.471 ^a ] I- 23 2,5-dichlorophenyl CH 2 O CH G ¹ H Q ²⁴ -3 H CH2O phenyl 3.89 [ ^a l; 3.82 ^[b] I- 24 2.5- bis (difluoromethi l) phenyl NH O CH G ¹ H Q ²⁴ -3 H CHF phenyl 3.41 [a]

Petition 870190021920, of 03/07/2019, p. 104/172

101/160

Ex THE L1 Y X (R 2) G R G1 Q R 5 L2 R1 Log P 1- 25 5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl CH 2 0 CH G ¹ H Q ²⁴ -3 H CF2 phenyl 3.55 ^[aI 1- 26 3,5bis (difluoromethyl) -1 H-pyrazol-1 yl CH 2 0 CH G ¹ H Q ²⁴ -3 H CH ₂ O 2- methoxy nil 3.01 [a]; 3.03 ^[bI 1- 27 2,5-dimethylphenyl NH s CH G ¹ H Q ²⁴ -3 H CF2 2,6difluorophenyl 3.81 ^[aI 1- 28 5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl CH 2 0 CH G ¹ H Q ²⁴ -3 H CF2 2,6difluorophenyl 3,511 ^a ] 1- 29 2,5-dimethylphenyl CH 2 0 CH G ¹ H Q ²⁴ -3 H CH2O phenyl 3.711 ^a ]; 3.67 ^[b ] 1- 30 2.5- bis (difluoromethi l) phenyl NH 0 CH G ¹ H Q ²⁴ -3 H CHF 2,6difluorophenyl 3.60 ^[a ] 1- 31 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 s CH G ¹ H Q ²⁴ -3 H CF2 phenyl 3.88 ^[a ] I- 32 2,5-dimethylphenyl NH s CH G ¹ H Q ²⁴ -3 H CHF 2,6difluorophenyl 3.80 ^[a ] I- 33 5-chloro-2- methylphenyl NH 0 CH G ¹ H Q ²⁴ -3 H CH2O phenyl 3.541 ^a ]; 3.5 ^[b ] I- 34 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 s CH G ¹ H Q ²⁴ -3 H CH2O phenyl 3.73 ^[a l; 3.66 ^[b l

Petition 870190021920, of 03/07/2019, p. 105/172

102/160

Ex THE L1 Y X (R 2) G R G1 Q R 5 L2 R1 Log P 1- 35 2.5- bis (difluoromethi l) phenyl NH 0 CH G ¹ H Q ²⁴ -3 H CF2 2,6difluorophenyl 3.61 ^[aI 1- 36 3,5bis (difluoromethyl) -1 H-pyrazol-1 yl CH 2 0 CH G ¹ H Q ²⁴ -3 H CH ₂ O 2,6dibromophenyl 3.9 ^[aI ; 3.82 ^ 1- 37 5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl CH 2 0 CH G ¹ H Q ²⁴ -3 H CH2O phenyl 3.27 ^; 3.28 ^ 1- 38 2-methoxy-5- methylphenyl NH 0 CH G ¹ H Q ²⁴ -3 H CH2O phenyl 3.591 ^a ]; 3.55 ^[b ] 1- 39 2,5-dimethylphenyl NH s CH G ¹ H Q ²⁴ -3 H CHF phenyl 3,611 ^a ] 1- 40 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CH G ¹ H Q ²⁴ -3 H Si (CH ₃ ) 2 phenyl 4.011 ^a ]; 3.99 ^[b ] 1- 41 2,5-dimethylphenyl NH 0 CH G ¹ H Q ²⁴ -3 H CH2O phenyl 3.36 ^: 3.28 ^ I- 42 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 s CH G ¹ H Q ²⁴ -3 H CF2 2,6difluorophenyl 3.94 ^ 1 I- 43 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CH G ¹ H Q ²⁴ -3 H CH2O 2,6difluorophenyl 3.3 ^ 3.23 ^ I- 44 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CH G ¹ H Q ¹¹ -1 CH2O phenyl 3,631®]; 3.52 ^[b ]

Petition 870190021920, of 03/07/2019, p. 106/172

103/160

Ex THE L1 Y X (R 2) G R G1 Q R 5 L2 R1 Log P 1- 45 3- (difluoromethyl) 5-methyl-1 Hpyazol-1-yl CH 2 0 CH G ¹ H Q ²⁴ -3 H CH ₂ O 2,6dichlorophyll 3.35 ^; 3.4 [ ^b ] 1- 46 5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl CH 2 0 CH G ¹ H Q ²⁴ -3 H CH2O 2-chloro- 6- fluorophen il 3.541 ^a ]; 3.56 ^ 1 1- 47 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CH G ¹ H Q ²⁴ -3 H C (CH ₃ ) OH 2,6difluorophenyl 3.03 [®l; 2.94 ^ 1 1- 48 3- (difluoromethyl) - 5-methyl-1 Hpirazol-1-yl CH 2 0 CH G ¹ H Q ²⁴ -3 H CH2O 2,6difluorophenyl 3.011®]; 2.93 ^ 1 1- 49 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CH G ¹ H Q ²⁴ -3 H C (CF ₃ ) OH phenyl 3.21®]; 3.13 ^ 1- 50 5-chloro-2- methylphenyl NH 0 CH G ¹ H Q ²⁴ -3 H CH2O 2,6difluorophenyl 3.66 ^[ ®l; 3.54 ^] 1- 51 5-chloro-2- methylphenyl NH 0 CH G ¹ H Q ²⁴ -3 H CH2O 2-chloro- 6- fluorophen il 3.811®]; 3.78 ^] I- 52 3-isopropyl-5 (trifluoromethyl) 1 H-pyrazol-1-yl CH 2 0 CH G ¹ H Q ²⁴ -3 H C (CH ₃ ) OH 2,6difluorophenyl 3.66 ^[ ®]; 3.56 ^]

Petition 870190021920, of 03/07/2019, p. 107/172

104/160

Ex THE L1 Y X (R 2) G R G1 Q R 5 L2 R1 Log P 1- 53 2.5- bis (difluoromethi l) phenyl NH 0 CH G ¹ H Q ²⁴ -3 H C (CH ₃ ) 2 2-chloro- 6- fluorophen il 4.53 [a] _; 4.43 [b] 1- 54 5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl CH 2 0 CH G ¹ H Q ²⁴ -3 H CH ₂ O 2,6difluorophenyl 3.34 ^ 3.32 ^ 1- 55 3,5bis (difluoromethyl) -1 H-pyrazol-1 yl CH 2 0 CH G ¹ H Q ²⁴ -3 H CH ₂ S 2- fluorophen il 3.54 [a] _; 3.47 ^ 1- 56 2,5-dimethylphenyl NH 0 CH G ¹ H Q ²⁴ -3 H CH2O 2,6dichlorophyll 3.89l ^to F 3.9 ^[b] 1- 57 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CH G ¹ H Q ²⁴ -3 H CF2 tiofen-2- il 3.33 ^ 1- 58 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CH G ¹ H Q ²⁴ -3 H CH ₂ S 2,6dichlorophyll 3.99 [ ^a l; 3.96 ^[b] 1- 59 5-chloro-2- methylphenyl NH 0 CH G ¹ H Q ²⁴ -3 H CH2O 2,6dichlorophyll 4.081®]; 4.08 ^ 1 1- 60 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CH G ¹ H Q ²⁴ -3 H CH2O 2 - [(E / Z) (methoxymino) methyl] phenyl 3,391®]; 3.39 ^[b ]

Petition 870190021920, of 03/07/2019, p. 108/172

105/160

Ex THE L1 Y X (R 2) G R G1 Q R 5 L2 R1 Log P 1- 61 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CH G ¹ H Q ²⁴ -3 H CH ₂ S 2- chloropheni I 3.68 ^[al ; 3.7 ^] I- 62 5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl CH 2 0 CH G ¹ H Q ²⁴ -3 H C (CH ₃ ) 2 2,6difluorophenyl 4.09 ^[a] ; 4.15 ^[b l I- 63 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CH G ¹ H Q ²⁴ -3 H CH ₂ S 2- bromofe nil 3.72 ^; 3.71 M I- 64 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CH G ¹ H Q ²⁴ -3 H ch ₂ o 2 - [(E / Z) (hydroxymino) methyl] phenyl 2.62 ^: 2.59 ^[b ] I- 65 5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl CH 2 0 CH G ¹ H Q ²⁴ -3 H CH2O 2,6dichlorophyll 3.9 [ ^a l; 3.81b] I- 66 3,5bis (difluoromethyl) -1 H-pyrazol-1il CH 2 0 CH G ¹ H Q ²⁴ -3 H C (CH ₃ ) 2 2,6difluorophenyl 4.05 [ ^a l; 3.941b] I- 67 5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl CH 2 0 CH G ¹ H Q ²⁴ -3 H C (CH ₃ ) 2 2-chloro- 6- fluorophen il 4,431®]; 4,361b] I- 68 2.5- bis (difluoromethi l) phenyl NH 0 CH G ¹ H Q ²⁴ -3 H C (CH ₃ ) 2 2,6difluorophenyl 4,291®]; 4.04 ^

Petition 870190021920, of 03/07/2019, p. 109/172

106/160

Ex THE L1 Y X (R 2) G R G1 Q R 5 L2 R1 Log P 1- 69 3.5bis (difluoromethi l) -1 H-pyrazole-1- il CH 2 0 CH G ¹ H Q ²⁴ -3 H C (CH ₃ ) 2 2-chloro- 6- fluorophen il 4.32 ^; 4.21 [ ^b ] 1- 70 3.5bis (difluoromethi l) -1 H-pyrazole-1- il CH 2 0 CH G ¹ H Q ²⁴ -3 H CH ₂ S 2- methylphenyl 3.781 ^a ]; 3.75Μ 1- 71 3.5bis (difluoromethi l) -1 H-pyrazole-1- il CH 2 0 CH G ¹ H Q ²⁴ -3 H ch ₂ o 2chloropheni I 3.351 ^a ); 3.31 Μ I- 72 3.5bis (difluoromethi l) -1 H-pyrazole-1- il CH 2 0 CH G ¹ H Q ²⁴ -3 H CH2O 2-formyl- 6- methoxy nil 3.021 ^a !; 2.941b] I- 73 3.5bis (difluoromethi l) -1 H-pyrazole-1- il CH 2 0 CH G ¹ H Q ²⁴ -3 H CH2O 2formilfen il 2.831 ^a ]; 2.83 ^[b] I- 74 3.5bis (difluoromethi l) -1 H-pyrazole-1- il CH 2 0 CH G ¹ H Q ²⁴ -3 H CH2O 2-chloro- 6- fluorophen il 3,441a]; 3.39 ^[b l I- 75 3.5bis (difluoromethi l) -1 H-pyrazole-1- il CH 2 0 CH G ¹ H Q ²⁴ -3 H CH2O 2bromo- 6fluorophenyl 3.67 ^[a] ; 3.65 ^ [00369] The values d and logP were finished according to Directive

EEC 79/831 Annex V.A8 by means of HPLC (High Performance Liquid Chromatography

Performance) using reverse phase (C 18) columns by the following methods:

Petition 870190021920, of 03/07/2019, p. 110/172

107/160 [00370] [a] The determination of LC-MS in the acid range is carried out at pH 2.7 with 0.1% aqueous formic acid and acetonitrile (contains 0.1% formic acid) as eluents ; linear gradient from 10% acetonitrile to 95% acetonitrile.

[00371] [b] The determination of LC-MS in the neutral range is carried out at pH 7.8 using 0.001 molar aqueous ammonium hydrogen carbonate solution and acetonitrile as eluents; linear gradient of 10% acetonitrile to 95% acetonitrile [00372] Calibration was carried out using unbranched alkan-2-ones (which have from 3 to 16 carbon atoms) with known logP values (logP values determined based on retention times using linear interpolation between two successive alkanones).

[00373] The lambda maX values were determined at the maximum of the chromatographic signals using the UV spectra from 200 nm to 400 nm. NMR data from selected examples [00374] NMR peak list method [00375] The 1H NMR data from Examples I-1 to I-43 are indicated in the form of 1H NMR peak lists. For each peak signal, the δ value in ppm and the signal strength in parentheses are listed:

Ex. I-1, solvent: DMSO-de

8.7789 (0.96); 8.0181 (10.19); 7.5119 (9.1); 7.4916 (10.83); 7.3082 (1.65); 7.2169 (3.43); 7.1971 (4.32); 7.1961 (3.93); 7.1761 (5.27); 7.1595 (1.95); 7.0416 (1.79); 7.0235 (4.31); 6.8992 (4.11); 6.8877 (2.32); 5.7476 (5.36); 5.4539 (0.75); 5.412 (2.71); 5.3675 (2.99); 5.325 (0.81); 5.3067 (0.37); 5.1157 (0.4); 5.1032 (0.7); 5.0973 (0.72); 5.0843 (1.01); 5.0753 (1.09); 5.058 (0.72); 5.0462 (0.45); 4,363 (0.86); 4.3302 (0.97); 4.1787 (0.37); 4.1682 (0.55); 4.1524 (4.14); 4.1498 (4.08); 4.1426 (3.51); 4.1368 (3.15); 4.123 (0.38); 4.1104 (0.44); 4.0568 (1.19); 4,039 (3.63); 4.0212 (3.65); 4.0035 (1.41); 3.9866 (0.85); 3.9503 (0.96); 3.6413 (1.12); 3.6136 (1.22); 3,598 (2.09); 3.5705 (1.86); 3.4989 (2.06); 3.48 (2.06); 3.4557 (1.32); 3.4367 (1.32); 3.4161 (0.89); 3.3966 (1.11); 3.3875 (1.58); 3.3776 (1.15); 3.3676 (1.06); 3.359 (1.49); 3.3506 (1.4); 3.2991 (837.78); 3.2776 (5.93); 3.2439 (1.17); 3.0369 (0.71); 2.8735 (0.7); 2.8496 (1.48); 2.8175 (0.66); 2.6733 (1.51); 2.6687 (1.94); 2.6641 (1.4); 2.5928 (0.4); 2.5387 (2.37); 2.5219 (9.51); 2.5085 (118.32); 2.5042 (214.59); 2.4997 (276.14); 2.4953 (189.37); 2.4909 (89.72); 2.3309 (1.45); 2.3263 (1.89); 2.3216 (1.36); 2.1348 (0.9); 2.1032 (1.72); 2.0695 (3.22); 1.9867 (16); 1.8391

Petition 870190021920, of 03/07/2019, p. 111/172

108/160 (0.41); 1.8184 (0.8); 1.7889 (0.74); 1.7558 (0.33); 1.6154 (0.43); 1.5793 (0.83); 1.5592 (0.85); 1.5288 (0.37); 1.3988 (0.71); 1.2351 (0.51); 1.1926 (4.73); 1.1748 (9.4); 1.157 (4.55); 0.7834 (0.49); 0.008 (1.76); -0,0002 (35.77); -0.0084 (1.31) Ex. I-2, solvent: DMSO-de

8.7784 (1.46); 8.4332 (0.32); 8.0177 (13.14); 7.3122 (4.56); 7.293 (5.64); 7.2901 (4.38); 7.2799 (1.11); 7.2721 (4.78); 7.2658 (0.67); 7.1758 (5.2); 7.1598 (2.55); 7.0427 (2.58); 7.0369 (0.73); 7.0238 (5.91); 6.9671 (9.39); 6.9604 (2.61); 6.9504 (7.44); 6.9458 (5.79); 6.9436 (5.22); 6,932 (1.82); 6.8998 (5.29); 6.8879 (2.93);

5.7473 (1.69); 5.4555 (1.04); 5.4119 (3.69); 5.396 (0.77); 5.3693 (3.98); 5.3265 (1.07); 5.0802 (0.58); 5.0674 (0.83); 5.0616 (0.85); 5.0509 (1.14); 5.0478 (1.16); 5.0393 (1.19); 5.0287 (0.86); 5.0207 (0.89); 5.0095 (0.64); 4.3632 (1.17); 4.3321 (1.27); 4.33 (1.24); 4.1518 (0.33); 4.1397 (0.71); 4.1232 (6.29); 4,113 (4.31); 4.1082 (4.2); 4.0955 (0.47); 4.0818 (0.52); 4.0569 (1.29); 4,039 (3.67); 4.0212 (3.78);

4.0035 (1.48); 3.9856 (1.19); 3.9517 (1.3); 3.6073 (1.85); 3.5799 (2.11); 3.564 (2.73); 3.5366 (2.33); 3.4542 (0.42); 3.4458 (0.48); 3.4184 (1.34); 3.3986 (1.5);

3.3897 (2.32); 3.3798 (1.71); 3.3719 (1.41); 3,361 (1.95); 3.3444 (4.05); 3.325 (6.91); 3,3006 (1060.06); 3.2447 (1.16); 2.8741 (0.86); 2.8438 (1.48); 2.8168 (0.85);

2.6734 (1.9); 2.6687 (2.44); 2.6641 (1.88); 2.6597 (0.99); 2.6468 (0.33); 2.6335 (0.32); 2.5387 (2.85); 2,522 (9.76); 2.5086 (140.38); 2.5042 (264.61); 2.4997 (348.18); 2.4953 (240.49); 2.4909 (113.32); 2.3355 (0.84); 2.3311 (1.7); 2.3263 (2.21); 2.3218 (1.56); 2.1455 (1.09); 2.1414 (1.11); 2.1058 (2.18); 2.0693 (3.84); 1.9867 (16); 1.8472 (0.45); 1.8233 (1.05); 1.8153 (1.01); 1.7943 (0.95); 1.7642 (0.41); 1.6218 (0.44); 1.6141 (0.52); 1.583 (1.05); 1.5624 (0.98); 1.553 (0.97); 1.5341 (0.41); 1.4081 (1.71); 1.3985 (2.92); 1.3017 (0.49); 1.2367 (0.57); 1.1926 (4.37); 1.1748 (8.96); 1.157 (4.31); 0.8902 (0.35); 0.0079 (1.2); -0,0002 (27.08); 0.0085 (0.9)

Ex. I-3, solvent: DMSO-de

8.018 (14.6); 7.309 (2.51); 7.2336 (1.85); 7.2297 (2.13); 7.226 (1.76); 7.2221 (1.72); 7.2134 (2.44); 7.2094 (2.88); 7.2047 (4.81); 7.2008 (4.9); 7.1839 (4.61); 7.1799 (5.33); 7.1757 (6.35); 7.1594 (2.91); 7.1469 (2.1); 7.1282 (3.25); 7.1078 (1.56); 7.0424 (2.78); 7.0234 (6.26); 6,989 (1.26); 6.9851 (1.34); 6.9775 (1.43); 6.9731 (1.62); 6.9692 (1.83); 6.9661 (1.78); 6.9584 (1.73); 6.9538 (1.67); 6.9462 (0.99); 6,939 (0.82); 6.9347 (0.88); 6,9002 (5.56); 6.8875 (3.21); 5.7463 (16); 5.4543 (1.15); 5.4118 (4.26); 5.369 (4.19); 5.3272 (1.11); 5.1002 (0.59); 5.0863 (1.03); 5.0819

Petition 870190021920, of 03/07/2019, p. 112/172

109/160 (0.99); 5.0726 (1.44); 5.0677 (1.32); 5.0585 (1.59); 5.0485 (1.02); 5.044 (0.94); 5.0404 (0.95); 5.0302 (0.63); 4.3654 (1.3); 4.3326 (1.37); 4.2343 (0.65); 4.2239 (0.95); 4.2072 (4.86); 4.2007 (5.8); 4.1974 (5.32); 4.1868 (4.21); 4.174 (0.81);

4.1597 (0.8); 4.0392 (0.55); 4.0213 (0.64); 4.0032 (0.49); 3.9854 (1.21); 3.9528 (1.32); 3.6171 (2.01); 3.5896 (2.28); 3.5739 (3.05); 3.5467 (2.58); 3.4279 (0.8);

3.4184 (1.3); 3.4087 (1.15); 3.3997 (1.7); 3.3897 (2.64); 3.3807 (2.08); 3.3579 (5.39); 3.3387 (8.4); 3.3098 (1358.34); 3.2435 (2.19); 3.2218 (1.32); 3.1444 (0.37);

3.1345 (0.34); 2.8759 (0.99); 2.8475 (1.71); 2.8187 (0.97); 2.6739 (1.13); 2.6694 (1.5); 2.6649 (1.12); 2.6604 (0.61); 2.5394 (2.36); 2.5224 (6.94); 2.5091 (85.13);

2.5048 (157.27); 2.5004 (204.86); 2,496 (145.08); 2.4916 (71.76); 2.3924 (0.35); 2.336 (0.7); 2.3317 (1.18); 2.327 (1.5); 2.3225 (1.15); 2.3182 (0.66); 2.1408 (1.26);

2.1051 (2.51); 2.0846 (1.2); 2.0691 (3.78); 1.9867 (2.4); 1.8544 (0.5); 1.8453 (0.55); 1.8217 (1.1); 1.8154 (1.16); 1.7931 (1.06); 1.7847 (0.99); 1.7641 (0.48); 1.6129 (0.54); 1.5913 (1.08); 1.5831 (1.12); 1.5601 (1.06); 1.5521 (1.01); 1.5306 (0.45);

1.5208 (0.39); 1.3984 (0.5); 1.2365 (0.43); 1.1927 (0.68); 1.1749 (1.31); 1.1571 (0.65); 0.8903 (0.34); 0.0079 (0.59); -0,0002 (11.53); -0.0085 (0.53)

Ex. I-4, solvent: DMSO-de

7.8948 (11.69); 7.4657 (3.19); 7.4625 (4.18); 7.4443 (5.4); 7.4422 (4.93); 7.3519 (3.15); 7.3471 (1.2); 7.3333 (5.39); 7.3133 (3.22); 7.3003 (1.95); 7.2342 (1.99);

7.216 (2.9); 7.2006 (0.78); 7.1978 (1.14); 7.167 (4.23); 7.1563 (2.09); 7.0338 (2.09); 7.0203 (4.86); 6.8962 (3.9); 6.8844 (2.46); 5.7465 (7.98); 5.4414 (0.77); 5.3991 (2.88); 5.356 (2.84); 5.3139 (0.79); 4.9693 (1.71); 4.9472 (2.2); 4.9414 (2.04);

4.9192 (1.76); 4.35 (0.86); 4.3178 (0.89); 4.057 (0.58); 4.0392 (1.67); 4.0214 (1.69); 4.0036 (0.6); 3.9638 (0.79); 3.93 (0.89); 3.3758 (0.6); 3.3674 (0.96); 3.3573 (0.85);

3.3777 (1.32); 3.3383 (2.18); 3.3062 (607.62); 3.2816 (4.07); 3.2528 (2.1); 3.3271 (2.83); 3.209 (2.17); 2.9596 (1.83); 2.9375 (1.74); 2.9156 (1.44); 2.8936 (1.43);

2.8409 (0.64); 2.8131 (1.06); 2.7833 (0.6); 2.6737 (0.56); 2.6692 (0.7); 2.6646 (0.54); 2.5392 (0.93); 2.5224 (2.18); 2.5177 (3.43); 2.50 (39.04); 2.5046 (75.34);

2.5001 (100.62); 2.4957 (69.15); 2.4912 (32.6); 2.3314 (0.52); 2.3268 (0.67); 2.3223 (0.47); 2.0991 (0.78); 2.069 (2.9); 2.0307 (0.87); 1.9867 (7.51); 1.7791 (0.69);

1.7494 (0.64); 1.5739 (0.32); 1.5429 (0.71); 1.513 (0.66); 1.3399 (16); 1.2731 (15.91); 1.2361 (0.45); 1.2307 (0.44); 1.1927 (2.11); 1.1749 (4.34); 1.1571 (2.09); 0.0002 (1.98)

Petition 870190021920, of 03/07/2019, p. 113/172

110/160

Ex. I-5, solvent: DMSO-de

8.7779 (0.36); 8.0112 (16); 8,0008 (2.37); 7.5131 (0.47); 7.4949 (0.98); 7.4838 (1.49); 7.4786 (2.4); 7.4585 (12.69); 7.442 (7.85); 7.4227 (3.62); 7.4138 (2.68); 7.409 (2.95); 7.401 (1.78); 7.3924 (2.63); 7.3836 (0.72); 7.3803 (0.73); 7.3759 (0.84); 7.3069 (2.88); 7.1737 (6.44); 7.1597 (3.25); 7.1523 (0.9); 7.0404 (3.14); 7.0237 (7.34); 7.0161 (1.52); 6.8994 (6.62); 6.8879 (4.11); 6.8803 (0.87); 5.8553 (2.32); 5.8454 (2.32); 5.777 (5.71); 5.7374 (2.32); 5.7275 (2.41); 5.6879 (0.32); 5.5853 (0.32); 5.5699 (0.34); 5.451 (1.28); 5.4083 (4.72); 5.3653 (4.58); 5.3227 (1.38); 5.217 (1.94); 5.1711 (0.68); 5.1609 (0.73); 5.152 (0.89); 5.1426 (1.39); 5.1335 (0.8); 5.1243 (0.84); 5.1192 (0.93); 5.1144 (0.95); 5.1099 (0.81); 5.1004 (0.92); 5.0912 (1.3); 5.0818 (0.72); 5.0727 (0.74); 5.063 (0.63); 4.5906 (0.52);

4.3598 (1.4); 4.3273 (1.47); 3.9779 (1.29); 3.9444 (1.4); 3.7205 (0.34); 3.7153 (0.34); 3.7096 (0.92); 3.7055 (0.75); 3.6981 (1.17); 3,696 (1.24); 3.6812 (1.37); 3.6791 (1.09); 3.6717 (0.78); 3.6682 (0.94); 3.6621 (0.39); 3.6568 (0.34); 3.5224 (0.68); 3.5053 (1.5); 3,498 (2.16); 3.4879 (1.22); 3.4743 (1.41); 3.4701 (1.54); 3.4639 (1.37); 3.4544 (3.17); 3.4269 (2.83); 3.4103 (0.69); 3.394 (4.02); 3.3752 (4.64); 3.3618 (1.64); 3.351 (2.34); 3.3426 (1.48); 3.3318 (2.7); 3.3018 (604.73); 3.263 (2.65); 3.2332 (1.3); 3.15 (0.53); 3.1309 (0.46); 3.1067 (0.4); 3.0871 (0.34); 2.8628 (0.96); 2.8319 (1.73); 2.8051 (0.94); 2.6779 (0.39); 2.6734 (0.8); 2.6688 (1.08); 2.6643 (0.79); 2.6596 (0.39); 2.5388 (1.24); 2.5221 (3.17); 2.5173 (4.97); 2.5087 (61.05); 2.5043 (118.37); 2.4998 (158.05); 2.4954 (110.05); 2.4909 (52.81);

2.3358 (0.49); 2.3311 (0.87); 2.3265 (1.16); 2.3219 (0.87); 2.3173 (0.45); 2.1242 (1.26); 2.0888 (2.62); 2.0691 (1.82); 2.0564 (1.47); 1.9866 (0.33); 1.9407 (0.5);

1.9241 (0.83); 1.9077 (0.68); 1.8296 (0.73); 1.8104 (1.54); 1.7952 (1.61); 1.7782 (1.53); 1.7484 (0.51); 1.5966 (0.52); 1.5758 (1.05); 1.5673 (1.17); 1.5451 (1.07); 1.5368 (1.08); 1.5164 (0.48); 1.5064 (0.44); 1.4065 (1.23); 1.3983 (1.77); 1.2362 (0.49); 1.1083 (0.33); 1.0909 (0.63); 1.0733 (0.33); 0.008 (0.7); -0,0002 (18.53); 0.0085 (0.73)

Ex. I-6, solvent: DMSO-de

7.9948 (5.21); 7.9771 (6.01); 7.9736 (4.77); 7.9474 (11.68); 7.6622 (1.19); 7.659 (0.77); 7.6438 (3.02); 7.6392 (1.1); 7.6285 (1.47); 7.6254 (2.25); 7.6221 (1.27);

7.5544 (4.18); 7.5349 (6.04); 7.5165 (2.74); 7.3091 (1.94); 7.1756 (4.37); 7.1597 (2.13); 7.0425 (2.19); 7.0237 (4.84); 6,9003 (4.31); 6.8879 (2.42); 5.7467 (16);

5.4536 (0.89); 5.4105 (3.21); 5.3676 (3.19); 5.3254 (0.86); 4.7927 (0.51); 4.7764

Petition 870190021920, of 03/07/2019, p. 114/172

111/160 (0.94); 4.7674 (0.73); 4.7579 (1.26); 4.7521 (1.17); 4.7405 (0.73); 4.7332 (1); 4.7151 (0.43); 4.3659 (1.04); 4.3316 (1.12); 3.9855 (0.99); 3.9482 (1.11); 3.5676 (0.71); 3.5614 (0.38); 3.537 (1.8); 3.511 (2.08); 3.4943 (2.58); 3.4685 (2.19); 3.4081 (1.6); 3.3879 (2.12); 3.3791 (2.87); 3,369 (2.71); 3.3066 (1246.75); 3.2408 (1.38); 3.1894 (3.26); 3.7772 (3.6); 3.1722 (4.94); 3.1577 (3.08); 3.153 (3.57); 3.1348 (1.79); 3.1552 (1.73); 2.8708 (0.74); 2.8417 (1.32); 2.8131 (0.78); 2.6942 (0.44); 2.6737 (1.38); 2.6691 (1.85); 2.6645 (1.38); 2.6259 (0.39); 2,579 (0.7); 2.5392 (3.68); 2.5222 (9.49); 2.50 (106.46); 2.5046 (194.2); 2.5001 (250.65); 2.4957 (174.09); 2.4913 (83.35); 2.3314 (1.22); 2.3269 (1.65); 2.3222 (1.19); 2.1317 (1); 2.0976 (1.89); 2.0692 (2); 2.0497 (0.76); 2.0143 (0.37); 1.9998 (1.13); 1.9916 (1.11); 1.9824 (2.09); 1.9766 (2.09); 1.9634 (2.31); 1.9468 (1.03); 1.9396 (1); 1.8468 (0.35); 1.8383 (0.39); 1.8086 (0.86); 1.7849 (0.82); 1.6082 (0.39); 1.5872 (0.82); 1.5798 (0.84);

1.5581 (0.8); 1.5281 (0.35); 1.2365 (0.52); -0,0002 (3.32)

Ex. I-7, solvent: DMSO-de

7.9748 (10.13); 7.9587 (3.46); 7.9559 (4.09); 7,943 (1.43); 7,938 (5.32); 7.9346 (3.96); 7.7961 (0.56); 7.7934 (0.94); 7.7903 (0.61); 7.7801 (0.78); 7,775 (2.5); 7.77 (0.92); 7.7595 (1.27); 7.7563 (2.06); 7.7531 (1.09); 7.6979 (3.47); 7.6941 (1.64);

7.6812 (2.95); 7.6782 (4.96); 7.664 (0.96); 7.6599 (2); 7.3064 (1.46); 7.1731 (3.48); 7.1587 (1.69); 7.0399 (1.71); 7.0227 (4.01); 6.8989 (3.26); 6.8868 (1.99); 5.4503 (0.66); 5.4074 (2.49); 5.3643 (2.45); 5.3216 (0.68); 5.0161 (0.36); 5,0002 (0.78);

4.9889 (0.59); 4.9827 (1); 4.9742 (0.97); 4.9563 (0.83); 4.9401 (0.35); 4.3529 (0.77); 4.32 (0.78); 4.0566 (1.21); 4.0388 (3.55); 4.0211 (3.55); 4.0033 (1.29); 3.9732 (0.7); 3.9405 (0.79); 3.878 (0.53); 3.862 (0.56); 3.8417 (2.78); 3.8286 (3.34); 3.8257 (3.32); 3.8143 (2.66); 3.7924 (0.56); 3.7778 (0.48); 3.6418 (1.21); 3.6151 (1.42); 3.5985 (1.79); 3.572 (1.49); 3.407 (0.51); 3.398 (0.81); 3.3786 (0.96); 3.3688 (1.52); 3.3604 (1.12); 3.351 (1.08); 3.3409 (1.53); 3.3171 (5.32); 3.2965 (828.91); 3.2746 (5); 3.2564 (2.6); 3.2319 (0.74); 2.8643 (0.56); 2.8366 (0.97); 2.8067 (0.59); 2.6775 (1.02); 2,673 (1.98); 2.6684 (2.62); 2.6638 (1.94); 2.6591 (0.99); 2.5385 (3.43); 2.5217 (10.36); 2.5169 (16.24); 2.5083 (147.02); 2.5038 (275.75); 2.4993 (362.1); 2.4949 (247.06); 2.4904 (115.63); 2.3352 (0.97); 2.3307 (1.87); 2.3261 (2.47); 2.3215 (1.75); 2.3169 (0.84); 2.1126 (0.66); 2.082 (1.39); 2.0695 (3); 2.0492 (0.86); 2.0391 (1.09); 1.9866 (16); 1.9072 (0.42); 1.823 (0.35); 1.7918 (0.66); 1.7697 (0.59); 1.5549 (0.62); 1.535 (0.58); 1.2364 (0.7); 1.1925 (4.7); 1.1747 (9.31); 1.1569 (4.59); 0.008 (2.61); -0,0002 (63.6); -0.0085 (2.11)

Petition 870190021920, of 03/07/2019, p. 115/172

112/160

Ex. I-8, solvent: DMSO-de

7.9579 (3.77); 7.9086 (16); 7.4331 (5.22); 7.4154 (7.99); 7.3777 (1.39); 7.3732 (0.66); 7.3597 (6.08); 7.3418 (8.65); 7.3229 (4.35); 7.3043 (3.02); 7.2854 (2.23);

7.282 (3.2); 7.2786 (1.92); 7.2696 (1.97); 7.264 (3.9); 7.2581 (1.12); 7.2492 (1.12); 7.2458 (1.28); 7.1709 (6.49); 7.1582 (3.33); 7.0377 (3.2); 7.0221 (7.39); 7.0162 (1.07); 6.8978 (6.85); 6.8863 (3.96); 5.7467 (12.05); 5.7383 (0.96); 5.7268 (0.81);

5.651 (2.28); 5.6388 (2.22); 5.4469 (1.21); 5.4041 (4.42); 5.361 (4.23); 5.3189 (1.25); 5.2164 (0.98); 4.8728 (1.17); 4.859 (1.29); 4.8521 (1.67); 4.8458 (1.36);

4.838 (1.74); 4.8317 (1.76); 4.8248 (1.26); 4.8184 (0.6); 4.8109 (1.61); 4.7991 (0.49); 4.7916 (0.48); 4.7731 (0.43); 4.7632 (0.57); 4.7514 (0.84); 4.7404 (0.36);

4.6652 (1.76); 4.6528 (2.67); 4.6407 (1.57); 4.3539 (1.4); 4.3207 (1.42); 4.0567 (0.39); 4.039 (1.23); 4.0213 (1.23); 4.0033 (0.52); 3.9706 (1.28); 3.9379 (1.42);

3.5053 (0.65); 3.4885 (0.4); 3.4113 (0.63); 3,392 (1.06); 3.3815 (1.27); 3.3681 (1.59); 3.3632 (1.71); 3.3527 (2.57); 3.3441 (2.09); 3.3032 (915.47); 3.2697 (4.08);

3.254 (5.65); 3.2266 (3.86); 3.1879 (0.63); 3.1689 (0.34); 3.1478 (2.97); 3.1267 (2.96); 3.1047 (1.92); 3.0837 (1.79); 2.8545 (0.99); 2.8267 (1.6); 2.7973 (0.94);

2.6782 (0.6); 2.6733 (1.19); 2.6688 (1.61); 2.6643 (1.2); 2.6595 (0.56); 2.5542 (0.33); 2.5388 (2.11); 2,522 (5.65); 2.5172 (8.99); 2.5086 (94.87); 2.5042 (180.06);

2.4997 (237.82); 2.4953 (161.9); 2.4908 (75.43); 2.4273 (0.35); 2.3358 (0.64); 2,331 (1.27); 2.3264 (1.68); 2.3218 (1.24); 2.1052 (1.45); 2.0759 (2.54); 2.069 (3.09);

2.047 (1.37); 1.9865 (5.52); 1.9234 (0.45); 1.9076 (1.04); 1.823 (0.6); 1.8135 (0.95); 1.7937 (1.45); 1.7848 (1.28); 1.7631 (1.09); 1.7562 (1.03); 1.7334 (0.44); 1.5813 (0.68); 1.5496 (1.18); 1.5276 (0.96); 1.4971 (0.4); 1.399 (0.33); 1.2369 (0.52);

1.1925 (1.54); 1.1747 (3.13); 1.157 (1.53); 0.008 (1.16); -0,0002 (30.07); -0.0085 (0.94)

Petition 870190021920, of 03/07/2019, p. 116/172

113/160

Ex. I-9, solvent: DMSO-de

8.0673 (16); 8.0335 (0.47); 7.6238 (3.09); 7.6196 (3.66); 7.6064 (4.82); 7.6001 (5.56); 7.5834 (0.44); 7.5773 (0.53); 7.5575 (2.22); 7.5457 (9.82); 7.5294 (4.28); 7.5221 (1.24); 7.507 (0.66); 7.3063 (2.61); 7.191 (0.34); 7.173 (5.94); 7.1592 (2.99);

7.0547 (0.6); 7.0397 (2.95); 7.0232 (6.92); 6.9172 (0.39); 6.8996 (5.69); 6.8873 (3.45); 5.7468 (8.71); 5.4503 (1.46); 5.4353 (0.75); 5.4224 (1.12); 5.4067 (5.06); 5.391 (1.24); 5.3651 (4.35); 5.346 (0.69); 5.3226 (1.1); 4.5924 (0.35); 4.3582 (1.25);

4.3267 (1.31); 3.9766 (1.17); 3.9441 (1.28); 3.7153 (0.34); 3.709 (0.69); 3.7021 (2); 3.6985 (1.07); 3.6961 (0.9); 3.6814 (0.91); 3.6792 (0.84); 3.6733 (2.37); 3.6686 (0.85); 3.6576 (3.19); 3.6291 (2.58); 3.5677 (0.47); 3.5118 (0.4); 3.4981 (0.65);

3.4866 (3.17); 3.4705 (3.01); 3.4526 (0.49); 3.4421 (2.18); 3.4261 (2.19); 3.4107 (0.78); 3.4014 (1.21); 3.3915 (1.04); 3.3818 (1.55); 3.3728 (2.31); 3.3633 (1.63);

3.3534 (1.41); 3.3438 (1.89); 3.3058 (797.64); 3.2847 (4.81); 3.2617 (1.87); 3.2324 (0.85); 2.8619 (0.88); 2.8498 (0.46); 2.8347 (1.56); 2.8049 (0.89); 2.6782 (0.41);

2.6738 (0.81); 2.6691 (1.09); 2.6646 (0.78); 2.5392 (1.63); 2.5224 (4.11); 2.5177 (6.46); 2.5091 (60.47); 2.5047 (113.02); 2.5002 (147.94); 2.4957 (99.66); 2.4913 (45.49); 2.3315 (0.74); 2.3269 (0.97); 2.3224 (0.67); 2.1254 (1.06); 2.0917 (2.24); 2.0692 (1.38); 2.0578 (1.21); 1.9867 (0.66); 1.8275 (0.46); 1.8071 (1); 1.7992 (1);

1.7769 (0.94); 1.7464 (0.38); 1.6013 (0.38); 1.5933 (0.45); 1.5749 (0.96); 1.5651 (0.98); 1.5438 (0.95); 1.5342 (0.83); 1.5134 (0.37); 1.3982 (0.39); 1.237 (0.33);

1.1749 (0.45); 0.008 (0.79); -0,0002 (19.93); -0.0085 (0.6)

Petition 870190021920, of 03/07/2019, p. 117/172

114/160

Ex. I-10, solvent: DMSO-de

8.7783 (1.32); 7.9848 (16); 7.4231 (4.67); 7.4198 (6.3); 7.4148 (2.02); 7.4018 (8.93); 7.3997 (8.43); 7.3507 (5.5); 7.346 (1.88); 7.3322 (8.79); 7.3164 (2.4); 7.3123 (5.44);

7.2397 (1.92); 7.2366 (3.1); 7.2334 (1.72); 7.2228 (1.65); 7.2183 (4.21); 7.203 (1.05); 7.2001 (1.67); 7.1762 (6.25); 7.1606 (3.15); 7.1492 (0.46); 7.0429 (3.06); 7.0245 (6.92); 6,9006 (6.35); 6.8886 (3.63); 5.7472 (10.81); 5.4546 (1.18); 5.4113 (4.45); 5.3685 (4.82); 5.3266 (1.31); 5.307 (0.59); 4.8733 (0.58); 4.8571 (1.57);

4.8413 (1.73); 4.8311 (1.81); 4.8161 (1.63); 4.7992 (0.71); 4.3599 (1.39); 4.3296 (1.44); 4.039 (0.55); 4.0212 (0.42); 3.9817 (1.39); 3.9472 (1.51); 3,581 (2.32);

3.5549 (2.63); 3.5379 (3.39); 3.5117 (2.92); 3.4319 (0.41); 3.4068 (1.29); 3.3972 (1.13); 3.3876 (1.69); 3.3784 (2.56); 3.3683 (1.83); 3.3594 (1.72); 3.3499 (2.28);

3.3372 (4.07); 3.3226 (7.22); 3,3004 (1081.4); 3.2896 (11.86); 3.2543 (3.75); 3.2395 (5.77); 3.2236 (4.22); 3.2055 (2.26); 3.1893 (2.08); 3.0369 (1.13); 2.8711 (1.07);

2.849 (2.13); 2.8422 (1.88); 2.8131 (1.05); 2.6778 (0.97); 2.6732 (1.78); 2.6688 (2.43); 2.6643 (1.77); 2.5388 (2.46); 2,522 (8.87); 2.5086 (135.1); 2.5042 (255.37); 2.4998 (336.11); 2.4954 (233.23); 2,491 (110.97); 2,331 (1.72); 2.3265 (2.3); 2.3218 (1.58); 2.1325 (1.32); 2.0956 (2.61); 2.0693 (2); 2.0611 (1.49); 1.9866 (1.89); 1.8407 (0.52); 1.8355 (0.59); 1.8128 (1.14); 1.8068 (1.19); 1.7823 (1.18); 1,776 (1.08);

1.7542 (0.44); 1.7432 (0.43); 1.6133 (0.51); 1.6029 (0.6); 1,581 (1.18); 1.5729 (1.15); 1.5515 (1.11); 1.521 (0.45); 1.51 (0.42); 1.2363 (0.45); 1.1927 (0.52); 1.1748 (1); 1.1571 (0.49); -0,0002 (15.5)

Petition 870190021920, of 03/07/2019, p. 118/172

115/160

Ex. I-12, solvent: DMSO-de

8.0094 (5.02); 7.5797 (1.05); 7.5753 (1.3); 7.5605 (1.23); 7.5558 (1.56); 7.5496 (0.57); 7.5357 (0.93); 7.533 (1.01); 7.5286 (0.77); 7.5149 (0.84); 7.5103 (0.62);

7.3082 (0.8); 7.1973 (1.42); 7.1753 (2.88); 7.1592 (0.9); 7.0589 (0.91); 7.0567 (0.89); 7.0406 (2.09); 7.0228 (2.41); 6.8997 (1.8); 6.8872 (1.03); 5.4548 (0.4); 5.413 (1.34); 5.3683 (1.34); 5.3264 (0.38); 5.1469 (0.51); 5.1334 (0.58); 5.1153 (0.32);

4.3631 (0.45); 4.3316 (0.53); 4.3194 (0.72); 4.3105 (0.53); 4.2926 (1.14); 4.2836 (1.06); 4.2658 (1.07); 4.2525 (1.04); 4.2392 (0.51); 4.2558 (0.45); 4.0568 (0.71);

4.039 (2.03); 4.0212 (2.05); 4.0032 (0.77); 3.9835 (0.43); 3.961 (0.37); 3.951 (0.47); 3.6559 (0.65); 3.6282 (0.73); 3.6128 (1.02); 3.5848 (0.84); 3.4224 (1.36); 3.404 (1.47); 3.3917 (1.06); 3.3792 (1.34); 3.3611 (1.51); 3.3013 (476.96); 3.2467 (0.64); 2.8796 (0.67); 2.8678 (0.51); 2.8508 (0.56); 2.82 (0.33); 2.6734 (0.83); 2.6689 (1.07); 2.6643 (0.79); 2.6095 (0.34); 2.5388 (1.84); 2.5219 (5.94); 2.5086 (63.99); 2.5043 (114.23); 2.4998 (145.47); 2.4954 (99.54); 2,491 (47.06); 2.4509 (16);

2.3311 (0.74); 2.3264 (0.99); 2.3218 (0.67); 2.14 (0.39); 2.1054 (0.8); 2.0694 (0.5); 1.9867 (8.88); 1.8231 (0.36); 1.8119 (0.36); 1.7914 (0.36); 1.5926 (0.35); 1.5834 (0.38); 1.5632 (0.36); 1.5547 (0.35); 1.1926 (2.49); 1.1748 (5.05); 1.157 (2.44); 0.0079 (0.56); -0,0002 (11.07); -0.0085 (0.42)

Ex. I-13, solvent: DMSO-de

8.0118 (8.81); 7.3082 (1.51); 7.1748 (3.46); 7.1583 (2.4); 7.1373 (1.94); 7.1231 (2.51); 7.1054 (2.06); 7.0416 (1.74); 7.0225 (3.77); 6.9441 (2.54); 6.9248 (2.21);

6.8997 (3.36); 6.8865 (1.95); 6.8612 (1.49); 6.8426 (2.4); 6.8245 (1.12); 5.7463 (10.1); 5.4555 (0.72); 5.412 (2.58); 5.3675 (2.48); 5.3254 (0.74); 5.0994 (0.43); 5.0825 (0.67); 5.0727 (0.92); 5.06 (1.04); 5.0509 (0.64); 5.0426 (0.62); 5.029 (0.71); 4.3643 (0.8); 4.3288 (0.85); 4.1569 (0.9); 4.1482 (0.98); 4.1298 (2.25); 4.1211 (2.1); 4.1028 (2.2); 4.0903 (2.14); 4.076 (0.9); 4.0638 (0.92); 3.9829 (0.8); 3.9516 (0.85);

3.6102 (1.27); 3.5827 (1.38); 3.5675 (2.06); 3.54 (1.73); 3.4719 (0.38); 3.4194 (1.24); 3.4073 (2.83); 3.4009 (1.86); 3.3901 (3.8); 3.3638 (3.81); 3.3467 (5.47);

3.3095 (1099.49); 3.2454 (1.43); 2.8775 (0.64); 2.851 (1.03); 2.819 (0.6); 2.6951 (0.34); 2.6738 (1.1); 2.6692 (1.43); 2.6648 (1.09); 2.5393 (2.63); 2.5091 (83.19);

2.5048 (152.23); 2.5003 (196.93); 2.4959 (138.75); 2.4916 (67.78); 2.4342 (0.37); 2.4274 (0.36); 2.3314 (1.04); 2.3269 (1.33); 2.3224 (0.96); 2.2521 (0.94); 2.1282 (0.76); 2.1028 (1.57); 2.069 (1.54); 2.0486 (16); 1.8137 (0.7); 1.79 (0.64); 1.6108 (0.35); 1.583 (0.68); 1.56 (0.67); 1.2364 (0.38); -0,0002 (1.69)

Petition 870190021920, of 03/07/2019, p. 119/172

116/160

Ex. I-14, solvent: CD3CN

7.5913 (6.28); 7.2623 (12.81); 7.2542 (0.36); 7.2501 (2.47); 7.2475 (2.49); 7.2389 (0.69); 7.2354 (2.02); 6.9715 (1.06); 6.8797 (2.25); 6,788 (1.14); 6.7625 (4.16);

6.7607 (3.61); 6.7548 (1.23); 6.747 (2.69); 6.7415 (2.2); 6.7294 (0.85); 6.6713 (2.65); 6.5799 (1.28); 5.3017 (13.63); 5.1586 (2.57); 5.1469 (2.57); 5.1196 (0.32);

5.0547 (0.57); 5.0509 (0.36); 5.0461 (0.49); 5.0416 (0.7); 5.0373 (0.69); 5.0328 (0.52); 5.028 (0.38); 5.0242 (0.62); 4,588 (0.5); 4.5659 (0.52); 3.922 (0.48); 3.8985 (0.51); 3.5991 (3.75); 3.5898 (3.89); 3.4854 (1.03); 3,468 (1.08); 3.4572 (1.34);

3.4398 (1.22); 3.3537 (0.51); 3.3476 (0.57); 3.3418 (0.67); 3.3351 (1.03); 3.3286 (1); 3.3243 (0.87); 3.3166 (0.61); 3.3097 (0.37); 3.3063 (0.47); 3.3018 (0.38); 3.2217 (1.33); 3.2086 (1.31); 3.1935 (1.1); 3.1804 (1.09); 3.0639 (16); 3.0568 (0.58); 2.9359 (0.35); 2.9159 (0.61); 2.8955 (0.36); 2.2792 (0.43); 2.259 (0.5); 2.2004 (0.44);

2.1747 (0.69); 1.8991 (0.86); 1.8856 (0.92); 1.882 (0.44); 1.8765 (0.45); 1.8606 (0.44); 1.8555 (0.44); 1.8344 (0.39); 1.8147 (0.5); 1.808 (0.55); 1.7928 (0.55);

1.7863 (0.52); 1.7736 (0.36); 1.7665 (0.36); 1.2531 (0.82); 0.0052 (0.38); -0,0002 (13.69); -0.0057 (0.45)

Ex. I-15, solvent: DMSO-de

8.6125 (0.43); 8.4815 (0.4); 8.1857 (0.45); 8.1796 (5.87); 8.1262 (2.3); 7.8855 (1.12); 7.8776 (1.89); 7.8711 (1.65); 7.8511 (4.04); 7.8431 (2.38); 7.4285 (0.63);

7.4082 (4.86); 7.3968 (7.52); 7.3942 (7.05); 7.3902 (5.82); 7.3744 (1.23); 7.3628 (0.62); 7.3545 (1.14); 7.3503 (1.16); 7.3411 (1.22); 7.3333 (1.23); 7.3241 (0.67);

7.3174 (1.93); 7.3093 (0.73); 7.1842 (3.18); 7.1759 (1.24); 7.1671 (1.33); 7.1623 (1.56); 7.0511 (1.62); 7.0427 (0.67); 7.0312 (2.94); 7.0262 (3.17); 6,911 (4.79);

6.8954 (1.42); 6.8904 (1.52); 5.7457 (15.25); 5.5303 (0.5); 5.5157 (0.4); 5.5093 (0.56); 5.4901 (1.21); 5.466 (1.57); 5.4166 (2.89); 5.3741 (0.94); 4.9239 (0.36);

4.8679 (0.47); 4.8551 (0.51); 4.8482 (0.56); 4.8408 (0.72); 4.8356 (0.6); 4.8281 (0.73); 4.8212 (0.51); 4.8086 (0.48); 4.4144 (1.75); 4.4017 (1.64); 4.3381 (1); 4.3217 (0.96); 4.2794 (0.55); 4.2399 (0.84); 4.2004 (0.49); 3.9117 (0.9); 3.5678 (0.53);

3.5097 (0.58); 3.4988 (0.59); 3.4803 (0.98); 3.4604 (1); 3.4407 (0.9); 3.4167 (1.39);

3.3963 (1.47); 3.3865 (1); 3.3614 (1.17); 3.3138 (787.45); 3.2785 (0.64); 3.2698 (0.36); 3.2113 (16); 3.181 (0.51); 3.1693 (7.55); 3.1505 (0.34); 3.1399 (0.35); 3.1165 (0.74); 3.0872 (0.9); 3.0794 (0.93); 3.0559 (0.5); 2.6744 (0.46); 2.6697 (0.64);

2.6652 (0.48); 2.5397 (1.12); 2.5231 (1.95); 2.5183 (2.97); 2.5097 (35.11); 2.5053 (68.02); 2.5007 (90.85); 2.4963 (61.93); 2.4918 (28.84); 2.4616 (0.42); 2.4343

Petition 870190021920, of 03/07/2019, p. 120/172

117/160 (0.42); 2.4081 (0.33); 2.3699 (0.39); 2.3367 (0.64); 2.3322 (0.82); 2.3274 (0.88);

2.3227 (0.68); 2.3185 (0.47); 2.2355 (0.67); 2.2033 (1.21); 2.1742 (2.11); 2.1497 (1.24); 2.1155 (0.42); 2.0973 (0.38); 2.0783 (0.35); 2.0688 (0.71)

Ex. I-16, solvent: DMSO-de

8.6106 (6.92); 8.0668 (16); 7.7227 (0.38); 7.7034 (3.86); 7.6833 (4.57); 7.6258 (4.01); 7.6216 (4.72); 7.6084 (6.05); 7.6022 (6.7); 7.5858 (0.7); 7.5781 (0.83);

7.5728 (0.83); 7.5456 (12.63); 7.5329 (9.9); 7.5069 (0.95); 7.485 (3.76); 7.465 (3.04); 7.2205 (3); 7.2134 (2.43); 7.0814 (6.6); 7.0756 (5.45); 6.9422 (3.48); 6,938 (2.87); 5.7471 (10.76); 5.4521 (0.56); 5.4361 (0.7); 5.4241 (1.09); 5.4088 (1.17);

5.4018 (1); 5.3977 (1.03); 5.3917 (1.19); 5.376 (1.13); 5.3635 (0.7); 5.3472 (0.57); 4.1729 (3.64); 4.1395 (3.76); 4.0574 (0.52); 4.0397 (1.42); 4.0218 (1.42); 4.0041 (0.51); 3.7064 (2.25); 3.6776 (2.47); 3.6618 (3.55); 3.6332 (2.98); 3.5681 (0.56);

3.4936 (3.34); 3.4775 (3.4); 3.4491 (2.45); 3.4331 (2.37); 3.355 (1.85); 3.3067 (282.1); 3.0619 (2.49); 3.0326 (4.52); 3.0035 (2.46); 2.6742 (0.4); 2.6696 (0.52);

2.6652 (0.4); 2.5394 (1.28); 2.5092 (31.19); 2.50 (54.68); 2.5006 (68.48); 2.4963 (47.2); 2.332 (0.33); 2.3272 (0.46); 2.3226 (0.35); 2.1042 (2.9); 2.0982 (3); 2.0697 (4.01); 1.9871 (5.92); 1.7193 (1.05); 1.713 (1.17); 1.689 (2.62); 1.6825 (2.69);

1.6595 (2.52); 1.6303 (0.91); 1.1929 (1.61); 1.1751 (3.22); 1.1573 (1.53); -0,0002 (6.37)

Ex. I-18, solvent: DMSO-de

8.8065 (0.37); 8.1082 (7.01); 8.0642 (2.58); 7.6069 (0.45); 7.5951 (0.73); 7.5818 (0.87); 7.5703 (0.59); 7.2965 (0.96); 7.2889 (0.42); 7.2636 (0.58); 7.2487 (1.09);

7.2394 (1.57); 7.2348 (0.78); 7.2253 (2.8); 7.2082 (2.59); 7.2005 (0.96); 7.1773 (0.35); 7.1302 (1.16); 7.1249 (0.54); 7.1197 (1.2); 7.1121 (0.48); 7.0398 (2.82);

7.0346 (1.04); 7.028 (0.47); 6.9495 (1.32); 6.9443 (0.5); 6.9131 (3.05); 6.9007 (0.39); 5.888 (0.95); 5.8755 (0.99); 5.8659 (0.35); 5.8528 (0.35); 5.8136 (0.96);

5.8011 (1.02); 5.7888 (0.33); 5.7757 (0.38); 5.7617 (16); 5.6067 (0.43); 5.578 (2.82);

5.5701 (3.19); 5.5604 (1.49); 5.5419 (0.41); 5.4185 (0.84); 5.3285 (0.75); 5.3162 (0.57); 5.3061 (0.73); 5.2435 (0.36); 5.2386 (0.44); 5.2273 (0.65); 5.2156 (0.42);

5.2107 (0.37); 4.4699 (0.55); 4.4486 (0.73); 4.0344 (0.91); 4.0226 (0.91); 3.8026 (0.43); 3.7902 (0.34); 3.7487 (0.69); 3.7311 (0.76); 3.7198 (1.24); 3.7023 (1.08);

3.6813 (0.37); 3.6396 (1.04); 3.6293 (1.06); 3.6108 (0.69); 3.6005 (0.68); 3.5881 (0.63); 3.5826 (0.8); 3.5748 (0.46); 3.5632 (1.95); 3.5562 (0.88); 3.5441 (1.41);

3.5376 (1.07); 3.5301 (0.32); 3.5247 (0.36); 3.5195 (0.55); 3.3795 (0.77); 3.3488

Petition 870190021920, of 03/07/2019, p. 121/172

118/160 (43.09); 3,3201 (0.53); 2.6152 (0.34); 2.5245 (0.65); 2.5214 (0.81); 2.5183 (0.79); 2.5094 (18.14); 2.5065 (39.22); 2.5034 (53.9); 2.5004 (39.02); 2.4974 (17.97); 2.3876 (0.34); 2.211 (0.92); 2.2039 (0.84); 2.1887 (1.31); 2.0413 (0.4); 1.9903 (4.08); 1.9214 (0.55); 1.9105 (1.44); 1.8986 (0.73); 1.8721 (0.32); 1.7405 (0.54); 1.7203 (0.62); 1.6954 (0.33); 1.1865 (1.11); 1.1746 (2.17); 1.1628 (1.1); -0,0002 (9.35)

Ex. I-19, solvent: DMSO-de

8.0092 (7.59); 7,999 (1.95); 7.5135 (0.5); 7.4955 (0.98); 7.4836 (1.02); 7.4787 (1.51); 7.4585 (6.94); 7.4415 (4.39); 7.4221 (2.14); 7.4135 (1.62); 7.4086 (1.72);

7.4007 (1.06); 7.3921 (1.49); 7.3832 (0.47); 7.3797 (0.46); 7.3755 (0.49); 6.4914 (4.78); 5.8548 (1.23); 5.8449 (1.22); 5.7368 (1.2); 5.7271 (1.26); 5.3421 (0.86);

5.2994 (2.74); 5.2467 (2.55); 5.2036 (0.99); 5.1702 (0.45); 5.1602 (0.52); 5.1516 (0.58); 5.142 (0.84); 5.133 (0.49); 5.1233 (0.53); 5.119 (0.6); 5.1137 (0.62); 5.1092 (0.57); 5.0997 (1.63); 5.0907 (0.79); 5.0815 (0.43); 5.0722 (0.4); 5.0623 (0.35);

4.3825 (0.84); 4.3495 (0.92); 4.0572 (0.87); 4.0394 (2.6); 4.0216 (2.65); 4.0037 (1.08); 3.9867 (0.82); 3.9527 (0.88); 3.6998 (0.38); 3.6963 (0.41); 3.6818 (0.41);

3.5678 (1.07); 3.5321 (0.35); 3.5154 (0.73); 3.5055 (0.51); 3.4898 (1.12); 3.475 (0.6); 3.4706 (0.85); 3.4649 (0.59); 3.4547 (1.7); 3.4273 (1.63); 3.3947 (2.46);

3.3757 (2.66); 3.3659 (1.75); 3.3514 (1.92); 3.3113 (116.41); 3.2633 (1.52); 3.2329 (0.79); 3.1512 (0.43); 3.1318 (0.39); 2.8629 (0.59); 2.8328 (1.04); 2.8049 (0.57);

2.8001 (0.56); 2.5393 (0.58); 2.5223 (1.32); 2.50 (16.52); 2.5048 (30.02); 2.5003 (38.56); 2,496 (27.04); 2.4918 (13.33); 2.2155 (3.97); 2.2094 (16); 2.1943 (1.86);

2.1231 (0.85); 2.0907 (1.7); 2.0688 (0.99); 1.9867 (11.23); 1.9229 (0.47); 1.9081 (0.46); 1.8299 (0.4); 1.8232 (0.38); 1.8116 (0.96); 1.7944 (0.84); 1.7768 (0.89);

1.7522 (0.33); 1.555 (0.33); 1.5723 (0.62); 1.5645 (0.72); 1.5429 (0.63); 1.5336 (0.68); 1.398 (0.36); 1.1927 (3.06); 1.1749 (6.08); 1.1571 (2.97); -0,0002 (1.99) Ex. I-20, solvent: DMSO-de

8.0774 (8.72); 7.5961 (0.77); 7.5783 (1.07); 7.5753 (1.08); 7.5579 (0.78); 7.2359 (2.04); 7.2147 (3.56); 7.1933 (1.66); 6.4936 (4.25); 5.9037 (1.2); 5.8853 (1.27);

5.7919 (1.19); 5.7734 (1.26); 5.7461 (2.03); 5.3481 (0.79); 5.3053 (2.42); 5.2506 (2.73); 5.2212 (0.98); 5.2077 (1.14); 5.0984 (1.35); 4.3902 (0.71); 4.3556 (0.77); 4.057 (0.64); 4.0393 (1.89); 4.0215 (1.92); 4.0037 (1.1); 3.9951 (0.73); 3.9605 (0.79); 3.7563 (0.81); 3.73 (0.85); 3.7125 (1.73); 3.6865 (1.55); 3.6391 (1.48); 3.6232 (1.47); 3.5953 (0.8); 3.5794 (0.77); 3.568 (0.42); 3.5321 (0.56); 3.5153 (0.9);

Petition 870190021920, of 03/07/2019, p. 122/172

119/160

3.4981 (0.6); 3.4187 (0.96); 3.4091 (0.86); 3.3991 (1.21); 3.3896 (1.76); 3.3803 (1.44); 3.3611 (2.06); 3,314 (823.15); 3.2454 (0.73); 2.8749 (0.5); 2.8472 (0.87);

2.8171 (0.49); 2.6745 (0.6); 2.6699 (0.8); 2.6652 (0.6); 2.5398 (1.27); 2.5229 (3.35); 2.5097 (46.25); 2.5053 (86.72); 2.5008 (113.85); 2.4964 (78.37); 2.4919 (37.11);

2.3321 (0.56); 2.3275 (0.73); 2.3229 (0.53); 2.2128 (16); 2.1964 (0.97); 2.1997 (0.68); 2.1091 (1.46); 2.0787 (0.84); 2.0692 (0.91); 1.9869 (8.1); 1.9233 (0.5);

1.9081 (0.91); 1.8284 (0.69); 1.8192 (0.65); 1.8124 (0.68); 1.7953 (1.02); 1,778 (0.45); 1.6149 (0.37); 1.5794 (0.63); 1.5573 (0.57); 1.1929 (2.25); 1.1751 (4.55);

1.1573 (2.25); -0,0002 (3.63)

Ex. I-21, solvent: DMSO-de

9.0409 (2.65); 8.068 (6.88); 7.6266 (1.65); 7.6225 (1.95); 7.6093 (2.53); 7.603 (2.87); 7.579 (0.33); 7.5469 (5.02); 7.5307 (2.23); 7.5234 (0.63); 7.5081 (0.34);

7.0898 (1.84); 7.0706 (2.38); 6.9585 (1.6); 6.9391 (1.22); 6.8671 (2.64); 5.4248 (0.45); 5.409 (0.5); 5.3982 (0.44); 5.392 (0.51); 5.3764 (0.5); 4.7973 (1.43); 4.7644 (1.47); 4.0571 (1.25); 4.0393 (3.72); 4.0215 (3.75); 4.0037 (1.27); 3.7079 (0.93);

3.6792 (1.04); 3.6634 (1.49); 3.6349 (1.28); 3.5677 (0.94); 3.4934 (1.45); 3.4772 (1.51); 3.4491 (0.47); 3.4577 (0.63); 3.4488 (1.4); 3.4398 (0.83); 3.4326 (1.66);

3.4203 (0.68); 3.4117 (0.51); 3.4017 (0.62); 3.3924 (0.41); 3.3629 (0.36); 3.3061 (168.87); 3.2656 (2.26); 3.3266 (1.16); 2.539 (0.7); 2.5087 (17.42); 2.5045 (31.21);

2.5001 (39.62); 2.4958 (27.56); 2.2544 (10.98); 2.1146 (12.12); 2.0847 (1.53); 1.9868 (16); 1.7601 (0.46); 1.7514 (0.52); 1.7229 (1.17); 1.6978 (1.11); 1.6695 (0.41); 1.6623 (0.34); 1.1927 (4.4); 1.1749 (8.74); 1.1571 (4.25); -0,0002 (3.25)

Petition 870190021920, of 03/07/2019, p. 123/172

120/160

Ex. I-22, solvent: DMSO-de

8.7773 (0.37); 8.1319 (5.01); 7.7175 (0.44); 7.7129 (0.45); 7.6971 (0.76); 7.6807 (0.46); 7.6761 (0.44); 7.3167 (1.41); 7.3086 (1.24); 7.2931 (1.73); 7.2702 (1.05);

7.1753 (2.18); 7.1598 (1.07); 7.0421 (1.09); 7.0238 (2.35); 7.016 (0.43); 6,9002 (2.39); 6,888 (1.27); 5.7465 (16); 5.4541 (0.46); 5.4113 (1.79); 5.369 (1.98); 5.3475 (0.33); 5.3276 (0.51); 5.217 (0.75); 4.3657 (0.53); 4.3325 (0.54); 3.9848 (0.52);

3.9508 (0.56); 3.8142 (0.61); 3.7855 (0.68); 3.7693 (0.96); 3.7409 (0.85); 3.7096 (0.41); 3.7059 (0.35); 3.6965 (0.53); 3.6819 (0.55); 3.6724 (0.35); 3.6687 (0.4);

3.5993 (1.01); 3.585 (1.01); 3.5546 (0.75); 3.5405 (0.72); 3.5234 (0.39); 3.5058 (0.65); 3.499 (0.51); 3.4882 (0.6); 3.4764 (0.6); 3.4646 (0.54); 3.4207 (0.59); 3.4107 (0.52); 3.4007 (0.7); 3.3912 (1.01); 3.3817 (0.78); 3.3707 (0.69); 3.3625 (0.93);

3.3524 (0.94); 3.3067 (225.38); 3.2838 (2.97); 3.2411 (0.43); 2.8706 (0.39); 2.8417 (0.65); 2.8127 (0.36); 2.6697 (0.35); 2.5396 (0.78); 2.5093 (20.82); 2.5051 (36.76);

2.5006 (46.42); 2.4963 (32.28); 2.1991 (0.51); 2.1049 (1); 2.0695 (0.77); 1,987 (0.7); 1.8132 (0.65); 1.7945 (0.65); 1.5889 (0.41); 1.5812 (0.44); 1.5587 (0.4); 1.5514 (0.4); 1.1752 (0.37); -0,0002 (1.67)

Ex. I-23, solvent: DMSO-de

9.8983 (0.54); 8.7716 (0.39); 8.6417 (0.48); 8.0108 (16); 7.4632 (6.45); 7.4416 (15.56); 7.4349 (8.11); 7.3627 (5.42); 7.3562 (4.62); 7.3414 (3.68); 7.3349 (3.3);

7.3126 (4.9); 7.2933 (7.2); 7.2906 (5.75); 7.2802 (1.67); 7.2725 (5.97); 7.2665 (0.96); 6.9982 (0.36); 6.9672 (11.48); 6.9604 (3.73); 6.9507 (9.22); 6.9459 (7.58);

6.9436 (7.04); 6.9349 (2.35); 6.9325 (2.45); 5.7458 (12.3); 5.0801 (0.72); 5.0664 (1.17); 5.0616 (1.09); 5.0512 (1.5); 5.0477 (1.56); 5.039 (1.67); 5.0283 (1.1); 5.0204 (1.13); 5.0092 (0.71); 4.4347 (1.44); 4.404 (1.51); 4.1506 (0.53); 4.1396 (0.94);

4.1225 (8.17); 4,113 (6.4); 4.1077 (6.75); 4.0808 (1.4); 4.0667 (1.61); 4.0571 (1.83); 4.0392 (2.3); 4.0214 (2.19); 4.0036 (0.8); 3.9219 (0.79); 3.8822 (6.31); 3.8638 (6.24); 3.8235 (0.78); 3.6056 (2.28); 3.5782 (2.61); 3.5624 (3.42); 3.5351 (2.96);

3.4192 (1.4); 3.4101 (2.06); 3.4002 (1.97); 3.3912 (2.73); 3.3816 (3.98); 3.3719 (3.79); 3.3425 (12.82); 3.3146 (1762.05); 3.2816 (10.18); 3.253 (2.92); 2.8407 (1.12); 2.8121 (1.86); 2.7827 (1.08); 2.6954 (0.49); 2.6742 (1.25); 2.6698 (1.63);

2.6653 (1.27); 2.5398 (4.13); 2.5228 (8.11); 2.5095 (91.71); 2.5052 (168.54); 2.5007 (219.29); 2.4963 (156.07); 2.4919 (77.43); 2.4192 (0.46); 2.3367 (0.74); 2.3321 (1.25); 2.3274 (1.59); 2.3228 (1.17); 2.3184 (0.68); 2.3777 (1.43); 2.1016 (2.25); 2.069 (3); 1.9868 (9.07); 1.9082 (0.68); 1.8581 (0.43); 1.8537 (0.42); 1.841 (0.43);

Petition 870190021920, of 03/07/2019, p. 124/172

121/160

1.8367 (0.43); 1.7746 (0.61); 1.7515 (1.25); 1.7454 (1.32); 1.7214 (1.19); 1.7143 (1.16); 1.6932 (0.52); 1.5872 (0.64); 1.5667 (1.21); 1.5557 (1.26); 1.5352 (1.17);

1.5285 (1.11); 1.5055 (0.51); 1.2367 (0.68); 1.2169 (0.49); 1.1992 (0.88); 1.1928 (2.64); 1.1812 (0.69); 1,175 (5.05); 1.1572 (2.5); -0,0002 (10.01)

Ex. I-24, solvent: DMSO-de

8.6102 (3.25); 8.0095 (7.64); 7.9989 (1.98); 7.7027 (2.05); 7.6823 (2.42); 7.5339 (3.15); 7.5142 (0.77); 7.496 (1.33); 7.4811 (3.25); 7.4602 (7.87); 7.4419 (4.43);

7.4228 (2.15); 7.4137 (1.6); 7.409 (1.73); 7.4037 (1.01); 7.3925 (1.51); 7.3832 (0.46); 7.3797 (0.44); 7.3755 (0.49); 7.2203 (1.7); 7.2133 (1.32); 7.081 (3.6); 7.0756 (2.77); 6.9419 (1.9); 5.8563 (1.24); 5.8465 (1.2); 5.7384 (1.21); 5.7286 (1.24);

5.7055 (0.32); 5.1706 (0.42); 5.1604 (0.48); 5.1516 (0.53); 5.142 (0.82); 5.1331 (0.48); 5.1236 (0.52); 5.119 (0.57); 5.1139 (0.59); 5.1094 (0.51); 5.1001 (0.51);

5.0909 (0.7); 5.0817 (0.39); 5.0727 (0.38); 5.0628 (0.33); 4.1733 (1.97); 4.1396 (2.06); 4.0571 (1.25); 4.0392 (3.7); 4.0215 (3.73); 4.0037 (1.33); 3.5677 (1.55);

3.5013 (0.82); 3.4742 (0.92); 3.4578 (1.76); 3.4304 (1.67); 3.4003 (1.96); 3.3926 (0.89); 3.3812 (1.99); 3.3641 (1.12); 3.3566 (1.67); 3.3373 (2.18); 3.3043 (180.29);

3.1567 (0.35); 3.3669 (0.34); 3.0626 (1.32); 3.0331 (2.39); 3.0044 (1.35); 2.6735 (0.32); 2,669 (0.41); 2.539 (1.02); 2.5087 (23.16); 2.5044 (40.63); 2.5 (51.1); 2.4956 (35.01); 2.4913 (16.57); 2.3265 (0.35); 2.2176 (0.6); 2.0977 (1.71); 2.0693 (1.96);

1.9867 (16); 1.7129 (0.68); 1.6826 (1.57); 1.6584 (1.32); 1.6522 (1.37); 1.63 (0.51); 1.6219 (0.47); 1.398 (1.94); 1.1927 (4.49); 1.1748 (8.9); 1.1571 (4.31); -0,0002 (3.48)

Ex. I-25, solvent: DMSO-d6

8.0662 (7.79); 7.6237 (1.93); 7.6196 (2.28); 7.6064 (2.93); 7.6002 (3.29); 7.5832 (0.34); 7.5774 (0.39); 7.5726 (0.38); 7.5453 (5.81); 7.5289 (2.5); 7.5217 (0.67);

7.5067 (0.36); 6.4913 (4.18); 5.4346 (0.36); 5.4225 (0.55); 5.4072 (0.59); 5.3963 (0.53); 5.3897 (0.6); 5.3741 (0.59); 5.3617 (0.4); 5.3409 (0.8); 5.2978 (2.43); 5.2464 (2.37); 5.204 (0.73); 5.0993 (1.13); 4.3814 (0.75); 4.3479 (0.79); 4.0572 (1.28);

4.0394 (3.75); 4.0216 (3.8); 4.0038 (1.44); 3.9847 (0.76); 3.9511 (0.79); 3.7021 (1.08); 3.6733 (1.19); 3.6575 (1.7); 3.6288 (1.46); 3.5321 (0.41); 3.5153 (0.72);

3.4981 (0.54); 3.4863 (1.71); 3.4702 (1.69); 3.4417 (1.28); 3.4258 (1.31); 3.4051 (0.57); 3.3963 (0.83); 3.3864 (0.76); 3.3766 (1.05); 3.3674 (1.57); 3.3578 (1.28);

3.3067 (213.67); 3.2616 (1.1); 3.2317 (0.53); 2.8614 (0.53); 2.8336 (0.93); 2.8037 (0.53); 2.6693 (0.4); 2.5393 (0.99); 2.50 (22.17); 2.5048 (39.42); 2.5004 (49.88);

Petition 870190021920, of 03/07/2019, p. 125/172

122/160

2.496 (34.5); 2.4919 (16.6); 2.3271 (0.34); 2.2156 (3.78); 2.2092 (15.56); 2.1951 (0.94); 2.1245 (0.72); 2.0963 (1.43); 2.0633 (0.79); 1.9869 (16); 1.923 (0.42); 1.9073 (0.36); 1.8292 (0.35); 1.8239 (0.33); 1.8118 (0.87); 1.8025 (0.67); 1.7949 (0.73);

1.7778 (0.77); 1.572 (0.57); 1.5629 (0.6); 1.5414 (0.56); 1.5329 (0.53); 1.1928 (4.44); 1,175 (8.67); 1.1572 (4.28); -0,0002 (2.03)

Ex. I-26, solvent: DMSO-de

8.0125 (5.61); 7.3094 (0.99); 7.176 (2.23); 7.1598 (1.09); 7.0428 (1.12); 7.0237 (2.5); 7,0093 (1.23); 7.0051 (1.29); 6.99 (1.7); 6.9855 (1.97); 6.9788 (1.09); 6.9635 (1.87); 6,959 (1.96); 6.9439 (0.88); 6.9397 (0.96); 6.9256 (1.67); 6.9214 (1.38);

6.9013 (2.8); 6,893 (1.89); 6,888 (2.42); 6.8739 (1.32); 6.8693 (1.24); 6.8552 (0.48);

6.8507 (0.43); 5.4544 (0.48); 5.4128 (1.71); 5.3692 (1.68); 5.3267 (0.47); 5.0558 (0.44); 5.0516 (0.42); 5.042 (0.6); 5.0282 (0.63); 5.0171 (0.41); 5.0131 (0.39);

4.3647 (0.57); 4.3324 (0.58); 4.1084 (0.44); 4.0921 (2); 4.0859 (2.29); 4.0818 (2.07); 4.0719 (1.71); 4.0594 (0.35); 4.0448 (0.36); 3.9864 (0.54); 3.9506 (0.58); 3.7196 (16); 3.5963 (0.85); 3.5689 (0.98); 3.5533 (1.3); 3.5262 (1.14); 3.4195 (0.69); 3.4094 (0.63); 3.3994 (0.85); 3.3905 (1.25); 3,381 (1.02); 3.3624 (2.32); 3.3438 (2.62);

3.3052 (335.58); 3.2474 (0.63); 2.8903 (1.3); 2.8762 (0.39); 2.8494 (0.67); 2.8183 (0.4); 2.7315 (1); 2.6733 (0.46); 2.6689 (0.59); 2.6651 (0.44); 2.5391 (1.5); 2.5087 (34.08); 2.5045 (60.85); 2.5001 (77.38); 2.4958 (54.01); 2.3311 (0.36); 2.3267 (0.49); 2.3222 (0.36); 2.142 (0.49); 2.108 (1); 2.0692 (8.08); 1.825 (0.41); 1.817 (0.44); 1,794 (0.41); 1.5918 (0.41); 1.5842 (0.45); 1.5618 (0.4); 1.5525 (0.38); 0.008 (0.41); -0,0002 (7.11)

Ex. I-27, solvent: DMSO-d6

9.0457 (2.78); 8.1319 (10.41); 7.7342 (0.33); 7.7182 (0.76); 7.7134 (0.79); 7.6975 (1.39); 7.6818 (0.82); 7.6769 (0.81); 7.6613 (0.36); 7.3176 (2.39); 7.2935 (3.05);

7.2708 (1.93); 7.0908 (2.52); 7.0715 (3.26); 6.9585 (2.13); 6.9391 (1.61); 6.8706 (3.52); 5.7455 (9.76); 5.4138 (0.34); 5.402 (0.42); 5.3871 (0.64); 5.377 (0.54);

5.3626 (0.67); 5.3489 (0.44); 5.3364 (0.34); 4.8049 (1.84); 4.7718 (1.92); 4.0573 (0.96); 4.0395 (2.83); 4.0217 (2.87); 4.0039 (0.96); 3.8192 (1.12); 3.7907 (1.24);

3.7745 (1.8); 3.7461 (1.56); 3.6962 (0.4); 3.6819 (0.38); 3.6048 (1.83); 3.5904 (1.87); 3.5681 (0.75); 3.5602 (1.35); 3.5459 (1.32); 3.4988 (0.42); 3.4869 (0.63);

3.4765 (1.04); 3.4649 (0.82); 3.4584 (0.97); 3.4484 (1.47); 3.4386 (0.95); 3.4296 (0.72); 3.4201 (0.91); 3.4103 (0.63); 3,3148 (596,34); 3.2916 (5.41); 3.2731 (3.05);

3.2442 (1.54); 2.6745 (0.4); 2.6699 (0.54); 2.6653 (0.4); 2.5399 (0.73); 2.5231

Petition 870190021920, of 03/07/2019, p. 126/172

123/160 (2.23); 2.5098 (30.74); 2.5054 (57.48); 2.5009 (75.17); 2.4965 (51.99); 2.4921 (24.84); 2.3322 (0.4); 2.3277 (0.51); 2.3228 (0.39); 2.255 (14.88); 2.1178 (16); 2.0995 (2.1); 2.069 (0.45); 1,987 (12.44); 1.7667 (0.6); 1.7381 (1.52); 1.7093 (1.41); 1.6812 (0.48); 1.193 (3.41); 1.1752 (6.83); 1.1574 (3.33); -0,0002 (3.29)

Ex. I-28, solvent: DMSO-de

8.1299 (8.46); 7.7169 (0.67); 7.7123 (0.65); 7.6962 (1.2); 7.6807 (0.68); 7.6749 (0.68); 7.3164 (2.02); 7.2921 (2.57); 7.2699 (1.6); 6.4922 (4.16); 6.4424 (0.33); 5.7461 (12.32); 5.3978 (0.37); 5.3848 (0.56); 5.372 (0.49); 5.3592 (0.64); 5.344 (1.06); 5.3187 (0.38); 5.3011 (2.41); 5.2486 (2.39); 5.2066 (0.73); 5.0986 (0.47); 4.3855 (0.72); 4.3541 (0.75); 4.0572 (0.61); 4.0394 (1.79); 4.0216 (1.84); 4.0038 (0.97); 3.9911 (0.71); 3.9597 (0.79); 3.8135 (0.98); 3.7847 (1.06); 3.7685 (1.54); 3.7399 (1.33); 3.5977 (1.62); 3.5833 (1.6); 3.5532 (1.2); 3.5389 (1.19); 3.5161 (0.47); 3.4986 (0.36); 3.4146 (1.08); 3.4044 (1.03); 3.3951 (1.39); 3.3856 (1.98); 3.3761 (1.77); 3.3116 (294.6); 3.2397 (0.95); 2.8699 (0.49); 2.8409 (0.88); 2.81 (0.49); 2.6745 (0.52); 2.6697 (0.69); 2.6653 (0.52); 2.5397 (0.99); 2.5229 (3.04); 2.5096 (41.56); 2.5052 (77.43); 2.5008 (101.04); 2.4964 (69.82); 2.492 (33.24);

2.3319 (0.47); 2.3274 (0.64); 2.3232 (0.46); 2.2214 (2.68); 2.2113 (16); 2.1959 (0.62); 2.138 (0.67); 2.109 (1.39); 2.0693 (1.01); 1.9869 (7.6); 1.8259 (0.59); 1.8174 (0.61); 1.7943 (0.71); 1.586 (0.56); 1.5772 (0.57); 1.555 (0.55); 1.5492 (0.52); 1.193 (2.09); 1.1751 (4.15); 1.1574 (2.02); -0,0002 (4.74)

Ex. I-29, solvent: DMSO-d6

9.89 (0.4); 8.7611 (0.88); 8.631 (0.39); 8,0008 (8.78); 7.3113 (2.73); 7.3029 (0.72); 7.2919 (4.02); 7.2798 (0.83); 7.2711 (3.33); 7.2649 (0.53); 7.037 (2.39); 7.018 (3.4); 6.9651 (5.82); 6.9582 (2.13); 6.9495 (4.7); 6.9434 (4.98); 6.9414 (5.57); 6.9344 (3.21); 6.9174 (1.72); 6.8928 (3.54); 5.7468 (4.93); 5.0757 (0.38); 5.0621 (0.68); 5.057 (0.61); 5.0436 (0.86); 5.0347 (0.93); 5.0239 (0.59); 5.0165 (0.64); 5.005 (0.42); 4.4937 (0.81); 4.4611 (0.87); 4.1352 (0.49); 4.1886 (4.85); 4.1084 (3.35); 4.1042 (3.24); 4.0771 (0.35); 4.0567 (0.44); 4.039 (1.14); 4.0212 (1.17); 4.0033 (0.6); 3.9842 (0.85); 3.9508 (0.89); 3.7125 (0.46); 3.6733 (3.39); 3.6545 (3.43); 3.6136 (0.52); 3.5973 (1.34); 3.5699 (1.48); 3.5542 (1.9); 3.5268 (1.65); 3.3739 (1.53); 3.3641 (1.63); 3.354 (2.34); 3.3445 (3.55); 3.3354 (5.77); 3.3045 (806.31); 3.2739 (3.71); 3.2317 (0.97); 3,2008 (1.18); 3.1713 (0.67); 2.8194 (0.63); 2,789 (1.05); 2.76 (0.61); 2.6735 (0.9); 2.6689 (1.2); 2.6645 (0.91); 2.5389 (2.08); 2.5219 (6.03); 2.5086 (66.99); 2.5043 (123.34); 2.4998 (160.5); 2.4954 (113.45); 2.4911

Petition 870190021920, of 03/07/2019, p. 127/172

124/160 (55.69); 2.3312 (0.87); 2.3266 (1.13); 2.3221 (0.83); 2.2293 (16); 2.1477 (15.22); 2.0853 (0.91); 2.0691 (3.21); 2.0498 (1.58); 2.0156 (0.93); 1.9866 (4.77); 1.9077 (0.34); 1.6213 (0.38); 1.5903 (0.97); 1.5592 (1.26); 1.5277 (0.87); 1.236 (0.55); 1.1926 (1.34); 1.1748 (2.61); 1.157 (1.29); 0.0079 (1.09); -0,0002 (20.51); -0.0084 (0.88)

Ex. I-30, solvent: DMSO-de

8.7761 (1.28); 8.6165 (5.41); 8.6062 (2.47); 8.0776 (12.69); 8.0349 (4.7); 7.7031 (3.54); 7.6828 (4.18); 7.615 (0.65); 7.5967 (1.54); 7.5792 (1.95); 7.5586 (1.36);

7.5336 (4.83); 7.4848 (3.66); 7.4648 (3.06); 7.2586 (1.12); 7.2367 (4.98); 7.2156 (8.65); 7.1935 (2.68); 7.0795 (7.18); 7.068 (1.8); 6.9406 (4.08); 6.9308 (0.91);

5.9057 (1.8); 5.8866 (2.4); 5.8658 (0.76); 5.7936 (1.83); 5,775 (2.05); 5,746 (8.02); 5.4744 (0.34); 5.355 (0.53); 5.3237 (0.32); 5.2667 (0.39); 5.2488 (0.74); 5.2412 (0.83); 5.2233 (1.31); 5.2064 (0.87); 5.1996 (0.74); 5.181 (0.35); 4.1804 (2.81);

4.1464 (3.02); 4.0571 (1.26); 4.0393 (3.71); 4.0215 (3.73); 4.0038 (1.32); 3.76 (1.23); 3.7337 (1.36); 3.7162 (2.7); 3.6901 (2.34); 3.6721 (0.4); 3.6628 (0.35);

3.6435 (2.25); 3.6273 (2.28); 3.6 (1.3); 3.5842 (1.26); 3.5775 (0.89); 3.5678 (0.48); 3.5492 (0.85); 3.532 (0.94); 3.5046 (0.95); 3.4739 (0.6); 3.4644 (0.64); 3.4515 (0.6);

3.4419 (0.62); 3.3746 (2.64); 3.3145 (1557.26); 3.2614 (0.79); 3.2262 (0.33); 3.0795 (1.53); 3.074 (1.79); 3.0448 (3.38); 3.0262 (2.35); 3.0169 (2.27); 3.0103 (2.14);

2.9974 (0.99); 2.984 (0.74); 2.9656 (0.53); 2.6744 (1.13); 2.6699 (1.49); 2.6654 (1.13); 2.6608 (0.6); 2.5399 (2.5); 2.523 (6.43); 2.5097 (85.96); 2.5054 (160.56);

2.5009 (209.76); 2.4965 (144.61); 2.4921 (68.47); 2.3321 (1.03); 2.3275 (1.38); 2.323 (0.99); 2.3182 (0.49); 2.2225 (0.58); 2.1229 (2.49); 2.0874 (3.37); 2.0692 (5.14); 1.9869 (16); 1.9083 (1.73); 1.7353 (0.8); 1.7263 (0.95); 1.6962 (2.47); 1.6747 (2.76); 1.6481 (1.56); 1.6227 (0.67); 1.2364 (1.18); 1.1929 (4.5); 1.1751 (8.89); 1.1573 (4.41); 1.1205 (0.32); -0,0002 (4.43)

Ex. I-31, solvent: DMSO-d6

8.0778 (16); 7.6241 (3.81); 7.6201 (4.53); 7.6069 (5.93); 7.6007 (6.72); 7.5843 (0.66); 7.5772 (0.8); 7.5456 (11.72); 7.5293 (5.17); 7.5068 (0.79); 7.3345 (2.68);

7,2014 (5.85); 7.1753 (0.61); 7.1598 (3.01); 7.1504 (0.42); 7.0683 (2.92); 7.0418 (0.44); 7.0238 (7.03); 7.0145 (0.8); 6.8983 (6.52); 6,888 (4.21); 5.6026 (0.52);

5.5586 (10.22); 5.5132 (0.53); 5.4542 (0.54); 5.438 (0.73); 5.4261 (1.12); 5.4095 (2.18); 5.3932 (1.22); 5.3774 (1.21); 5.3653 (0.74); 5.3486 (0.63); 5.3127 (1.67);

5.2792 (1.69); 4.4646 (1.56); 4.4301 (1.65); 4.0573 (1.09); 4.0395 (3.27); 4.0217

Petition 870190021920, of 03/07/2019, p. 128/172

125/160 (3.28); 4.0039 (1.13); 3.801 (0.58); 3.7864 (0.65); 3.7741 (0.35); 3.7063 (2.11); 3.6777 (2.29); 3.6618 (3.19); 3.6332 (2.78); 3.586 (1.44); 3.5766 (1); 3.5562 (3.05); 3.5382 (2.57); 3.5278 (2.6); 3.5098 (1.45); 3.4989 (1.08); 3.4905 (3.44); 3.4744 (3.39); 3,446 (2.53); 3.43 (2.51); 3.3879 (1.85); 3.3566 (3.74); 3.3103 (148.24); 2.6741 (0.48); 2.6695 (0.61); 2.6652 (0.45); 2.5395 (1.36); 2.5225 (3.18); 2.5092 (37.41); 2.5049 (67.29); 2.5005 (85.79); 2.4961 (59.65); 2.4919 (29.05); 2.4509 (0.4); 2.3319 (0.52); 2.3272 (0.62); 2.3229 (0.47); 2.2028 (2.66); 2.1718 (3.05); 2.0692 (0.48); 2.0606 (0.33); 2.0436 (0.5); 2.0256 (0.42); 1.9869 (14.24); 1.9276 (0.95); 1.9052 (1.43); 1.8959 (1.67); 1.8725 (1.31); 1.8429 (0.55); 1.8338 (0.46); 1.7726 (0.57); 1.7624 (0.7); 1.7389 (1.31); 1.7331 (1.4); 1.7094 (1.33); 1.7025 (1.22); 1.6799 (0.57); 1.6703 (0.46); 1.3981 (8.63); 1.2368 (0.33); 1.1928 (3.93); 1,175 (7.64); 1.1572 (3.83); -0,0002 (3.87)

Ex. I-32, solvent: DMSO-de

9.0484 (3.42); 9.0375 (1.56); 8.7766 (0.88); 8.0787 (8.46); 8.0346 (3.42); 7.6174 (0.45); 7.5977 (0.95); 7.5798 (1.25); 7.5593 (0.81); 7.261 (0.85); 7.2383 (3.13); 7.2163 (3.98); 7.1947 (1.66); 7.0919 (2.56); 7.0724 (3.39); 6.9596 (2.64); 6.9402 (1.97); 6.8666 (3.23); 5.9067 (1.14); 5.8877 (1.5); 5.8665 (0.55); 5.7947 (1.14); 5.7761 (1.28); 5.7452 (6.11); 5.3569 (0.36); 5.2422 (0.55); 5.225 (0.83); 5.2078 (0.54); 5.2 (0.47); 4.8049 (1.75); 4.7722 (1.85); 4.0572 (0.79); 4.0394 (2.4); 4.0216 (2.42); 4.0038 (0.82); 3.7623 (0.72); 3.7364 (0.78); 3.7191 (1.63); 3.6929 (1.45); 3.6455 (1.35); 3.6297 (1.36); 3.6021 (0.72); 3.5863 (0.73); 3.5797 (0.54); 3.568 (0.96); 3.5517 (0.48); 3.5353 (0.56); 3.5078 (0.58); 3.49 (0.43); 3.4807 (0.7); 3.4621 (0.88); 3.4525 (1.33); 3.4427 (0.98); 3.4359 (0.83); 3.4254 (1.08); 3.3989 (0.68); 3.3208 (964.66); 3.2857 (3.65); 3.2811 (3.68); 3.2514 (1.96); 3.2309 (0.93); 3.0297 (0.43); 3.0107 (0.43); 2.9852 (0.39); 2.9678 (0.36); 2.6749 (0.48); 2.6702 (0.65); 2.6656 (0.5); 2.5402 (0.9); 2.5233 (2.56); 2.51 (38.44); 2.5056 (72.22); 2.5011 (94.66); 2.4967 (65.78); 2.4923 (31.57); 2.3324 (0.56); 2.3278 (0.72); 2.3232 (0.52); 2.2552 (16); 2,1201 (13.74); 2.107 (7.19); 2.0688 (1.3); 1.9869 (10.72); 1.9085 (0.33); 1.77 (0.62); 1.7404 (1.52); 1.7156 (1.73); 1.6952 (0.98); 1,689 (1.05); 1.6575 (0.51); 1.2363 (0.69); 1.1929 (2.99); 1.1751 (6.03); 1.1573 (3.02); -0,0002 (1.42)

Petition 870190021920, of 03/07/2019, p. 129/172

126/160

Ex. I-33, solvent: DMSO-de

8.7735 (0.39); 8.1276 (3.43); 8.0111 (8.23); 7.3352 (3.24); 7.3296 (3.4); 7.3183 (0.52); 7.3113 (2.55); 7.292 (3.58); 7.289 (3.01); 7.2781 (0.94); 7.2712 (3.09);

7.2648 (0.46); 7.1991 (2.26); 7.1785 (3.06); 7.0836 (2.35); 7.078 (2.21); 7.0633 (1.69); 7.0576 (1.6); 6.9668 (7.11); 6.9496 (5.26); 6.9459 (4.34); 6.9334 (1.11);

6,931 (1.21); 5.7474 (13.56); 5.0789 (0.35); 5.0655 (0.63); 5.0603 (0.58); 5.0497 (0.79); 5.0467 (0.78); 5.0375 (0.86); 5.0271 (0.58); 5.0192 (0.57); 5.0079 (0.37);

4.1734 (1.84); 4.1397 (2.32); 4.1227 (4.54); 4.1226 (3.12); 4.1077 (2.93); 4.095 (0.34); 4.0808 (0.33); 4.0568 (0.43); 4.039 (1.24); 4.0212 (1.24); 4.0034 (0.45);

3.6083 (1.19); 3.5809 (1.34); 3.5651 (1.75); 3.5378 (1.49); 3.3592 (0.95); 3.3456 (2.38); 3.3268 (3.27); 3.2985 (242.68); 3.284 (3.41); 3.2753 (1.76); 3.0429 (1.24);

3.0129 (2.26); 2.9846 (1.25); 2.6734 (0.51); 2.6687 (0.64); 2.6641 (0.5); 2.5386 (1.32); 2.5083 (39.8); 2.50 (71.66); 2.4996 (91.54); 2.4952 (63.53); 2.4908 (30.43);

2.3309 (0.51); 2.3263 (0.63); 2.322 (0.43); 2.1572 (16); 2.0976 (1.58); 2.0695 (2.22); 1.9867 (5.34); 1.7228 (0.54); 1.7125 (0.68); 1.6889 (1.33); 1.6824 (1.51); 1.66 (1.37); 1.6525 (1.31); 1.6306 (0.55); 1.6212 (0.45); 1.1926 (1.48); 1.1748 (2.92);

1.157 (1.42); 0.0077 (0.62); -0,0002 (11.11); -0.0081 (0.46)

Petition 870190021920, of 03/07/2019, p. 130/172

127/160

Ex. I-34, solvent: DMSO-de

8.0282 (16); 7.3359 (2.71); 7.3123 (4.83); 7.2929 (7.15); 7.2902 (5.8); 7.28 (1.6); 7.2721 (5.94); 7.2659 (1); 7.2028 (5.7); 7.1604 (2.96); 7.0698 (2.88); 7.0244 (6.79);

6.9974 (0.44); 6.9666 (11.24); 6.9598 (3.78); 6.9503 (8.94); 6.9453 (7.58); 6.9431 (7.11); 6.9346 (2.41); 6.9321 (2.53); 6.8987 (6.25); 6.8886 (3.79); 5.7468 (14.78); 5.6071 (0.51); 5.5628 (9.63); 5.5169 (0.59); 5.3162 (1.61); 5.2841 (1.66); 5.0825 (0.69); 5.0688 (1.18); 5.0635 (1.07); 5.0534 (1.5); 5.0501 (1.55); 5.0412 (1.68); 5.0304 (1.12); 5.0229 (1.14); 5.0116 (0.72); 4.4711 (1.47); 4.4362 (1.59); 4.1511 (0.46); 4.1401 (0.85); 4.2229 (7.68); 4.1335 (5.68); 4.1081 (5.36); 4.0956 (0.64); 4.0811 (0.62); 4.0568 (0.74); 4.039 (2.13); 4.0212 (2.16); 4.0034 (0.75); 3.6097 (2.66); 3.5988 (1.6); 3.5826 (3.82); 3.5669 (6.18); 3.5554 (2.78); 3.5396 (4.61); 3.5273 (1.62); 3.5173 (0.81); 3.4023 (1.59); 3.3713 (3); 3.3478 (6); 3.3287 (9.44); 3.3051 (1062.1); 3.2417 (0.99); 3.2042 (0.46); 3.1807 (0.36); 2.6778 (0.62); 2.6737 (1.14); 2,669 (1.51); 2.6645 (1.09); 2.5391 (2.45); 2.5221 (7.27); 2.5088 (84.55); 2.5045 (157.29); 2.5 (206.45); 2.4956 (148.03); 2.4912 (74.31); 2.3313 (1.15);

2.3267 (1.5); 2.3221 (1.13); 2.3178 (0.62); 2.2173 (2.66); 2.1859 (3.08); 2.0693 (0.85); 1.9867 (9.37); 1.9501 (0.56); 1.94 (0.69); 1.9079 (1.47); 1.886 (1.28); 1.8579 (0.54); 1.8484 (0.45); 1.7914 (0.56); 1.7828 (0.72); 1.753 (1.39); 1.7298 (1.35);

1.7214 (1.22); 1.7004 (0.56); 1.6918 (0.46); 1.3983 (2.52); 1.2364 (0.54); 1.1927 (2.61); 1.1749 (5.19); 1.1571 (2.56); 0.0079 (1.28); -0,0002 (24.6); -0.0084 (1.16)

Petition 870190021920, of 03/07/2019, p. 131/172

128/160

Ex. I-35, solvent: DMSO-de

8.6138 (5.08); 8.1304 (14.08); 7.733 (0.59); 7,712 (1.36); 7.7031 (3.62); 7.6826 (4.23); 7.6596 (0.51); 7.5345 (4.3); 7.4849 (2.66); 7.4651 (2.2); 7.3163 (3.2); 7.292 (4); 7.2697 (2.53); 7.2194 (2.41); 7.2143 (1.94); 7.0801 (5.54); 7.0767 (4.58); 6.9407 (3.11); 5.7462 (12.57); 5.4264 (0.36); 5.4121 (0.44); 5.3991 (0.54); 5.3852 (0.81);

5.3741 (0.69); 5.3619 (0.88); 5.3477 (0.58); 5.3348 (0.48); 5.3202 (0.37); 4.1786 (2.61); 4.1448 (2.72); 4.0573 (1.24); 4.0395 (3.63); 4.0218 (3.65); 4.004 (1.28);

3.8168 (1.44); 3.7879 (1.63); 3.7719 (2.4); 3.7435 (2.03); 3.6983 (0.33); 3.6818 (0.34); 3.68 (0.32); 3.6036 (2.44); 3.5892 (2.42); 3.5589 (1.76); 3.5447 (1.71);

3.4986 (0.32); 3.4871 (0.33); 3.4757 (0.44); 3.4449 (0.42); 3.4246 (0.37); 3.41 (0.47); 3.3828 (1.11); 3,373 (1.68); 3.363 (1.74); 3.3537 (2.48); 3.3443 (3.99);

3.3112 (792.76); 3.2878 (6.77); 3.069 (1.75); 3.0395 (3.22); 3.0107 (1.79); 2.6747 (0.58); 2.6698 (0.79); 2.6653 (0.61); 2.5399 (1.12); 2.5231 (3.4); 2.5097 (46.79);

2.5054 (87.29); 2.5009 (114.05); 2.4964 (78.33); 2.492 (37.06); 2.3321 (0.54);

2.3276 (0.75); 2.323 (0.54); 2.1176 (2.11); 2.1113 (2.21); 2.0853 (2.5); 2.0695 (1.41); 1,987 (16); 1.7247 (0.81); 1.6959 (1.94); 1.672 (1.78); 1.6433 (0.65); 1.2364 (0.33); 1.193 (4.38); 1.1752 (8.84); 1.1574 (4.29); -0,0002 (6.48)

Ex. I-36, solvent: DMSO-d6

8.0211 (14.29); 7.6895 (14.84); 7.6694 (16); 7.3078 (2.43); 7.1745 (5.6); 7.159 (2.78); 7.0833 (4.26); 7.0632 (7.34); 7.0429 (5.5); 7.023 (6.31); 6.8999 (5.83);

6.8872 (3.33); 5.7459 (3.42); 5.4534 (1.14); 5.4112 (4.22); 5.3671 (4.27); 5.3238 (1.2); 5.1462 (0.63); 5.1345 (1.07); 5.1272 (1.1); 5.1169 (1.71); 5.1081 (1.49);

5.0895 (1.2); 5.0766 (0.69); 4.3628 (1.36); 4.3301 (1.43); 4.1512 (0.86); 4.138 (1);

4.1256 (4.85); 4.1777 (5.51); 4.1229 (5.75); 4.1073 (5.12); 4.0924 (1.09); 4.0816 (0.73); 4.057 (1.23); 4.0392 (3.43); 4.0214 (3.48); 4.0036 (1.51); 3.9852 (1.37);

3.9537 (1.5); 3.6571 (1.44); 3.6296 (1.58); 3.6137 (3.66); 3.5866 (3.2); 3.5622 (3.44); 3.5431 (3.52); 3.5188 (1.71); 3.5 (1.59); 3.4646 (0.66); 3.418 (2.01); 3.409 (1.93); 3.3892 (3.81); 3.3792 (3.55); 3,3147 (1485.38); 3.2912 (22.56); 3.2443 (2.32); 3.1601 (0.45); 3.1453 (0.42); 2.8755 (1.09); 2.848 (1.81); 2.8175 (1.05);

2.6743 (1.35); 2.6699 (1.71); 2.6653 (1.31); 2.5399 (3.31); 2.5096 (94.11); 2.5053 (168.4); 2.5009 (215.71); 2.4965 (152.9); 2.4923 (75.9); 2.3322 (1.07); 2.3277 (1.4);

2.323 (1.04); 2.139 (1.31); 2.1054 (2.61); 2.0692 (3.56); 1.9869 (14.45); 1.8389 (0.59); 1.812 (1.17); 1.7877 (1.11); 1.7596 (0.47); 1.613 (0.6); 1.5822 (1.16); 1.5606 (1.06); 1.5311 (0.44); 1.3979 (0.48); 1.236 (0.46); 1.1929 (4.05); 1.1751 (7.85);

Petition 870190021920, of 03/07/2019, p. 132/172

129/160

1.1573 (3.89); -0,0002 (13.93)

Ex. I-37, solvent: DMSO-de

8.0162 (8.27); 7.312 (2.54); 7.2927 (3.86); 7.29 (3.1); 7.2796 (0.88); 7.2719 (3.15);

7.2658 (0.52); 6.9667 (6.29); 6.96 (1.97); 6.9501 (4.98); 6.9455 (4.13); 6.9434 (3.76); 6.9342 (1.24); 6.9319 (1.3); 6.4927 (4.15); 5.3443 (0.77); 5.3024 (2.57);

5.2514 (2.5); 5.2088 (0.76); 5.0797 (0.37); 5.066 (0.64); 5.0611 (0.6); 5.0506 (0.81); 5.0475 (0.82); 5.0387 (0.89); 5.0276 (0.59); 5.0203 (0.62); 5.0091 (0.4); 4.3876 (0.76); 4.3545 (0.83); 4.139 (0.45); 4.1223 (4.36); 4.1225 (3.11); 4.1075 (2.97);

4.0805 (0.35); 4.0569 (0.65); 4.0391 (1.88); 4.0213 (1.93); 4.0035 (1.04); 3.9932 (0.76); 3.9591 (0.8); 3.607 (1.2); 3.5796 (1.36); 3.5638 (1.81); 3.5365 (1.54); 3.4224 (0.48); 3.4135 (0.76); 3.4039 (0.68); 3.3941 (1); 3.3848 (1.56); 3.3752 (1.23); 3.3556 (1.66); 3.3445 (3.4); 3.3055 (567.39); 3.283 (5.2); 3.2447 (1.14); 2.8751 (0.59);

2.8459 (0.99); 2.8177 (0.57); 2.6738 (0.65); 2.6691 (0.82); 2.6647 (0.63); 2.5652 (0.48); 2.5391 (1.68); 2.5088 (48.27); 2.5045 (89); 2.5001 (115.88); 2.4957 (82.88);

2.4914 (41.54); 2.3314 (0.65); 2.3267 (0.84); 2.3222 (0.64); 2.2111 (16); 2.1409 (0.78); 2.1095 (1.55); 2.0692 (3.01); 1.9867 (8.01); 1.8189 (0.67); 1.7966 (0.63);

1.7898 (0.58); 1.5912 (0.62); 1.5815 (0.68); 1.5595 (0.63); 1.5521 (0.61); 1.1927 (2.22); 1.1749 (4.3); 1.1571 (2.15); -0,0002 (5.27)

Ex. I-38, solvent: DMSO-d6

8.0073 (5.72); 7.6232 (2.48); 7.4841 (2.04); 7.4794 (2.02); 7.3099 (1.76); 7.2906 (2.58); 7.2876 (2.17); 7.2768 (0.67); 7.2697 (2.19); 6.9653 (4.89); 6.9481 (3.7);

6.9444 (3.07); 6.9318 (0.79); 6.9296 (0.87); 6.8769 (1.74); 6.8562 (3.1); 6.8102 (1.43); 6.8065 (1.39); 6.7897 (0.81); 6.7859 (0.78); 5.7473 (9.49); 5.0623 (0.45);

5.0575 (0.41); 5.0483 (0.56); 5.0347 (0.62); 5.0234 (0.4); 5.0165 (0.42); 4.1316 (1.51); 4.12 (3.7); 4.1095 (2.91); 4.1048 (3.07); 4.0787 (0.33); 4.039 (0.5); 4.0212 (0.48); 3.7702 (16); 3.6067 (0.83); 3.5793 (0.96); 3.5635 (1.25); 3.5362 (1.07);

3.3439 (1.76); 3.325 (2.53); 3.2992 (241.38); 3.2828 (3.48); 3.026 (0.93); 2.9969 (1.65); 2.9687 (0.94); 2.6732 (0.42); 2.6686 (0.58); 2.6641 (0.41); 2.5387 (1.03);

2.5217 (2.92); 2.5083 (34.75); 2.50 (63.51); 2.4996 (82.11); 2.4952 (58.08); 2.4909 (28.57); 2,331 (0.49); 2.3264 (0.6); 2.322 (0.43); 2.2104 (11.48); 2.0865 (1.13);

2.0693 (1.15); 2.0593 (1.3); 1.9866 (2.15); 1.7156 (0.41); 1.7058 (0.49); 1.6851 (0.98); 1.6758 (1.1); 1.6541 (1); 1.6457 (0.93); 1.6234 (0.4); 1.6139 (0.34); 1.1926 (0.6); 1.1748 (1.18); 1.1569 (0.59); 0.0079 (0.53); -0,0002 (9.86); -0.0085 (0.44)

Petition 870190021920, of 03/07/2019, p. 133/172

130/160

Ex. I-39, solvent: DMSO-de

9.0412 (3.68); 8.0083 (8.33); 7.9969 (2.15); 7.514 (0.56); 7.4966 (1.13); 7.4813 (1.65); 7.461 (7.35); 7.4436 (4.79); 7.4243 (2.32); 7.4155 (1.71); 7.4109 (1.91);

7.3941 (1.64); 7.385 (0.54); 7.3816 (0.51); 7.3774 (0.53); 7.0899 (2.67); 7.0706 (3.43); 6.9581 (2.44); 6.9394 (1.84); 6.8638 (3.7); 5.8557 (1.31); 5.8458 (1.31);

5.7377 (1.28); 5.7279 (1.34); 5.7034 (0.33); 5.6888 (0.34); 5.5705 (0.35); 5.1724 (0.43); 5.1621 (0.46); 5.1534 (0.54); 5.1438 (0.83); 5.1346 (0.51); 5.1209 (0.63);

5.1153 (0.61); 5.111 (0.54); 5.102 (0.51); 5.0928 (0.75); 5.083 (0.44); 5.0741 (0.41); 5.0639 (0.36); 4.7968 (1.98); 4.7634 (2.08); 4.057 (0.46); 4.0391 (1.3); 4.0213 (1.3);

4.0033 (0.46); 3.7093 (0.34); 3.6957 (0.45); 3.6814 (0.43); 3.5678 (1.83); 3.5041 (0.99); 3.4873 (0.52); 3.4759 (1.43); 3.4602 (2.63); 3.4478 (1.15); 3.4319 (2.9);

3.4188 (1.59); 3.4113 (1.74); 3.3994 (3.61); 3.3804 (3.8); 3.3255 (1192.66); 3.6778 (4.37); 3.2383 (2.29); 3.1799 (0.57); 3.158 (0.73); 3.1386 (0.68); 3.1228 (0.38);

3.115 (0.53); 3.0958 (0.5); 2.6955 (0.54); 2.6744 (0.66); 2.6701 (0.87); 2.6658 (0.68); 2.5402 (2.51); 2.5098 (48.63); 2.5055 (88.38); 2.5011 (113.49); 2.4968 (79.56); 2.4926 (39.42); 2.3324 (0.72); 2.328 (0.9); 2.3233 (0.7); 2.2891 (0.44);

2.254 (16); 2.1141 (15.33); 2.0784 (2.2); 2.0685 (2.11); 2.0493 (0.36); 1.9867 (5.81); 1.7528 (0.85); 1.7248 (1.79); 1.6965 (1.6); 1.6689 (0.61); 1.2363 (0.37); 1.1928 (1.62); 1,175 (3.2); 1.1687 (0.35); 1.1571 (1.61); -0,0002 (2.74)

Ex. I-40, solvent: DMSO-d6

7.9577 (6.52); 7.6189 (0.43); 7.6129 (2.11); 7.6085 (2.73); 7.6024 (1.49); 7.5957 (2.16); 7.5894 (2.7); 7.4269 (0.83); 7.4161 (4.09); 7.408 (1.93); 7.3985 (2.27);

7.3852 (0.64); 7.304 (1.14); 7.1707 (2.48); 7.1581 (1.2); 7.0375 (1.19); 7.022 (2.76); 6.8981 (2.35); 6,886 (1.4); 5.7464 (3.91); 5.4747 (0.55); 5.4058 (1.77); 5.3612 (1.79); 5.319 (0.5); 4.3589 (0.59); 4.3256 (0.69); 4.2788 (1.13); 4.2505 (1.41);

4.2402 (1.49); 4.2115 (1.32); 3.9722 (0.59); 3.9431 (0.68); 3.6199 (0.39); 3.6051 (1.2); 3.5764 (1.32); 3.5642 (1.48); 3.5352 (1.32); 3.5043 (0.46); 3.4753 (0.56);

3.3986 (1.3); 3.3617 (3.06); 3.3065 (1733.11); 3.2839 (13.31); 3.2321 (0.55); 3.2289 (0.59); 3.1531 (1.14); 3.1335 (1.56); 3.0733 (0.9); 2.8591 (0.44); 2.829 (0.71); 2,796 (0.5); 2.6738 (1.65); 2.6691 (2.21); 2.6644 (1.61); 2.6605 (0.85); 2.5978 (0.5);

2.5391 (3.22); 2.5223 (9.32); 2.50 (123.76); 2.5046 (230.23); 2.5001 (300.24); 2.4957 (206.16); 2.4912 (97.47); 2.3358 (0.68); 2.3314 (1.44); 2.3267 (1.98); 2.3222 (1.35); 2.1919 (0.53); 2.0856 (1.01); 2.069 (1.42); 2.0495 (0.58); 1.7963 (0.44);

1.7736 (0.43); 1.7666 (0.42); 1.5648 (0.46); 1.5339 (0.43); 1.2357 (1); 0.3859 (16);

Petition 870190021920, of 03/07/2019, p. 134/172

131/160

0.3712 (15.91); 0.008 (1.1); -0,0002 (26.36); -0.0086 (1.02)

Ex. I-41, solvent: DMSO-de

8,008 (10.37); 7.9952 (3.98); 7.3121 (2.96); 7.3055 (0.93); 7.2928 (4.12); 7.2898 (3.66); 7.2788 (1.09); 7.2719 (3.78); 7.2657 (0.57); 7.0476 (2.67); 7.0284 (3.22);

7.0023 (3.63); 6.9676 (8.54); 6.9504 (6.29); 6.9468 (5.32); 6.9444 (4.44); 6.9342 (1.37); 6.9318 (1.55); 6.8591 (2.06); 6.8401 (1.72); 5.7458 (6.58); 5.0799 (0.4);

5.0662 (0.73); 5.0611 (0.67); 5.0508 (0.92); 5.0473 (0.96); 5.0386 (1.01); 5.0278 (0.68); 5.02 (0.69); 5.009 (0.44); 4.1742 (2.12); 4.1403 (2.7); 4.1233 (5.05); 4.1334 (3.64); 4.108 (3.43); 4.0952 (0.43); 4.0811 (0.41); 4.0569 (0.88); 4.0391 (2.53);

4.0213 (2.55); 4.0035 (0.88); 3.6095 (1.36); 3.5821 (1.54); 3.5664 (2.09); 3.539 (1.74); 3.3469 (4.33); 3.3131 (646.13); 3.2851 (4.56); 3.0142 (1.52); 2.9847 (2.7);

2.9562 (1.52); 2.6739 (0.49); 2.6693 (0.64); 2.6649 (0.48); 2.5394 (1.13); 2.5225 (2.97); 2.5091 (36.21); 2.5048 (67.26); 2.5003 (88.12); 2.4959 (62.47); 2.4915 (30.87); 2.3316 (0.55); 2.327 (0.69); 2.3225 (0.52); 2.234 (15.8); 2.2049 (0.46);

2.1224 (16); 2.0887 (1.92); 2.0823 (1.95); 2.0687 (1.51); 2.0562 (2.13); 1.9866 (11.26); 1.9079 (0.66); 1.7076 (0.65); 1.6984 (0.8); 1.6766 (1.61); 1.6682 (1.75);

1.6463 (1.64); 1.6381 (1.52); 1.6168 (0.66); 1.607 (0.53); 1.1927 (3.17); 1.1749 (6.3); 1.1571 (3.08); 0.0079 (0.86); -0,0002 (16.78); -0.0085 (0.74)

Ex. I-42, solvent: DMSO-de

8.142 (16); 8.1312 (1.56); 7.7334 (0.58); 7.7175 (1.39); 7.7124 (1.39); 7.6966 (2.54); 7.6806 (1.52); 7.6757 (1.52); 7.6605 (0.67); 7.3354 (2.73); 7.3166 (4.35); 7.2925 (5.53); 7.27 (3.53); 7.2023 (5.92); 7.1746 (0.89); 7.1595 (3.33); 7.0693 (2.98); 7.041 (0.46); 7.0235 (7.73); 7.0138 (0.57); 6.8985 (6.67); 6.8877 (4.29); 5.7458 (5.34);

5.6063 (0.48); 5.5611 (9.69); 5.5156 (0.56); 5.4275 (0.5); 5.4083 (1.44); 5.3868 (1.18); 5.3638 (1.36); 5.3496 (0.87); 5.335 (0.95); 5.3206 (2.01); 5.2862 (1.63);

4.4709 (1.44); 4.4369 (1.56); 4.0572 (0.81); 4.0394 (2.42); 4.0216 (2.42); 4.0038 (0.86); 3.8169 (2.05); 3.7999 (0.53); 3.7883 (2.19); 3.7722 (3.11); 3.7436 (2.7);

3.7099 (0.43); 3.7057 (0.46); 3.6964 (0.55); 3.6818 (0.71); 3.6723 (0.43); 3.6686 (0.52); 3.6016 (4.12); 3.5872 (4.22); 3.5646 (3.46); 3.557 (5.3); 3.543 (3.38); 3.5288 (2.21); 3.5047 (0.58); 3.493 (0.61); 3.4753 (0.68); 3.4644 (0.66); 3.4481 (0.49);

3.3952 (2.2); 3.3636 (4.5); 3.3158 (1509.35); 3.2172 (0.62); 2.6794 (0.61); 2.6746 (1.12); 2.6702 (1.5); 2.6655 (1.13); 2.6609 (0.58); 2.5401 (2.32); 2.5232 (6.05);

2.5099 (83.72); 2.5056 (157.06); 2.5011 (205.87); 2.4967 (142.94); 2.4922 (68.63);

2.3367 (0.59); 2.3323 (1.07); 2.3278 (1.45); 2.3233 (1.07); 2.3188 (0.55); 2.2997

Petition 870190021920, of 03/07/2019, p. 135/172

132/160 (0.55); 2.2171 (2.57); 2.1857 (2.9); 2.085 (1.01); 2.0692 (0.78); 2.0439 (0.33); 1,987 (10.45); 1.9489 (0.58); 1.9411 (0.69); 1.9114 (1.67); 1.8865 (1.28); 1.8814 (1.2);

1.8577 (0.54); 1.8486 (0.46); 1.7865 (0.62); 1.7775 (0.68); 1.756 (1.26); 1.7474 (1.35); 1.7242 (1.29); 1.7174 (1.19); 1.6949 (0.53); 1.6847 (0.42); 1.4048 (0.43);

1.2368 (1.27); 1.1929 (2.92); 1.1752 (5.71); 1.1574 (2.83); 0.9293 (0.39); 0.9127 (0.37); -0,0002 (3.79)

Ex. I-43, solvent: CDCI3

7.6396 (8.29) 7.2653 (16.83) 7.0027 (0.41) 6.9929 (1.02) 6.9898 (0.57) 6.9874 (0.63) 6, 9832 (0.48) 6.9792 (1.3) 6.9784 (1.38) 6.9745 (2.16) 6.9705 (0.63) 6.9679 (0.7) 6.9649 ( 1.5) 6.9552 (0.72) 6.9185 (0.45) 6.9094 (2.89) 6.905 (0.38) 6.8965 (4.09) 6.8957 (3.91) 6.8874 (0.6) 6.8825 (5.04) 6.7908 (1.56) 6.7631 (4.12) 6.6715 (3.94) 6.5801 (1.88) 5, 3029 (16) 5.191 (0.37) 5.1638 (3.38) 5.153 (3.41) 5.1258 (0.37) 5.1017 (0.37) 5.0929 (0.62) 5, 0885 (0.5) 5.0847 (0.73) 5.0797 (0.78) 5.0759 (0.73) 5.0715 (0.81) 5.0678 (0.45) 5.0631 ( 0.64) 5.0545 (0.39) 4.5865 (0.6) 4.5641 (0.61) 4.3094 (0.95) 4.3014 (0.98) 4.2919 (1, 85) 4.2839 (1.77) 4.2562 (1.6) 4.247 (1.58) 4.2387 (0.88) 4.2929 (0.85) 4.2778 (0.77) 4, 1159 (0.78) 3.9317 (0.59) 3.9088 (0.63) 3.707 (0.49) 3.6131 (0.43) 3.5845 (2.98) 3.5756 (2, 95) 3.5677 (2.99) 3.5624 (3.16) 3.547 (0.47) 3.3676 (0.64) 3.3606 (0.68) 3.3554 (1.14) 3.349 ( 1.37) 3.3423 (0.92) 3.3366 (1.18) 3.3307 (1.04) 3.3239 (0.4) 3.317 (0.49) 3.3124 (0.43) 2.9546 (0.39) 2.9499 (0 , 45) 2.9309 (0.77) 2.9124 (0.45) 2.9078 (0.41) 2.2934 (0.51) 2.2732 (0.58) 2.2117 (0.52 ) 2.1922 (0.57) 2.1895 (0.56) 2.048 (3.74) 1.9882 (0.47) 1.8918 (0.53) 1.8762 (0.5) 1.8701 (0.46) 1.8257 (0.51) 1.819 (0.56) 1.8037 (0.52) 1.7994 (0.42) 1.797 (0.46) 1.6249 (9.86) 1 , 4274 (2.17) 1.372 (0.35) 1.286 (0.65) 1.2847 (0.56) 1.2725 (1.19) 1.2605 (2.4) 1.2532 (1.74 ) 1.2487 (1.3) 0.0708 (0.55) -0.0002 (6.49)

Petition 870190021920, of 03/07/2019, p. 136/172

133/160

Ex. I-44, solvent: DMSO-d6

8.2506 (9.12); 7.3553 (2.18); 7.3500 (0.80); 7.3433 (0.36); 7.3370 (2.91); 7.3334 (3.30); 7.3276 (0.58); 7.3206 (1.89); 7.3150 (3.01); 7.3089 (0.41); 7.1879 (2.67);

7.1763 (1.30); 7.0919 (0.51); 7.0882 (2.73); 7.0856 (3.94); 7.0803 (1.12); 7.0687 (1.58); 7.0661 (3.12); 7.0638 (2.82); 7.0549 (1.42); 7.0403 (3.19); 7.0249 (5.74);

7.0183 (1.47); 7.0159 (0.85); 7,0000 (2.22); 6.9841 (0.60); 6.9816 (1.05); 6.9791 (0.60); 6.9167 (2.40); 6.9045 (1.55); 5.4715 (0.61); 5.4287 (2.01); 5.3883 (2.00);

5.3574 (8.19); 4.3828 (0.55); 4.3496 (0.58); 4.0551 (1.13); 4.0373 (3.48); 4.0195 (3.55); 4.0017 (1.59); 3.9628 (0.56); 3.4498 (0.37); 3.4304 (0.44); 3.4211 (0.83);

3.4119 (0.45); 3.3922 (0.44); 3.3477 (139.08); 3.3241 (0.74); 3.3149 (0.61); 3.3084 (0.62); 3.2776 (0.79); 3.2491 (0.47); 3.2426 (0.39); 3.0369 (0.56); 2.8757 (0.40);

2.8490 (1.10); 2.8188 (0.41); 2.5259 (0.34); 2.5212 (0.52); 2.5124 (12.90); 2.5079 (28.77); 2.5033 (39.38); 2.4987 (28.36); 2.4942 (13.50); 2.1643 (0.49); 2.1499 (0.37); 2.1322 (1.01); 2.0977 (0.56); 2.0770 (0.65); 1.9902 (16.00); 1.8471 (0.45);

1.8388 (0.51); 1.8166 (0.47); 1.8080 (0.44); 1.6172 (0.46); 1.6076 (0.51); 1.5862 (0.47); 1.5770 (0.46); 1.1923 (4.51); 1.1745 (9.14); 1.1566 (4.44); -0,0002 (3.31) Ex. I-45, solvent: DMSO-d6

8.0308 (9.22); 7.5207 (8.55); 7,5003 (10.00); 7.2220 (2.91); 7.2021 (3.90); 7.1814 (2.31); 7.0058 (1.50); 6.8686 (3.70); 6.7316 (1.72); 6.2984 (3.60); 5.7621 (12.53);

5.2691 (0.87); 5.2263 (2.59); 5.1773 (2.53); 5.1348 (0.86); 5.1172 (0.36); 5.1045 (0.55); 5.0985 (0.54); 5.0941 (0.48); 5.0887 (0.81); 5.0858 (0.76); 5.0764 (0.89);

5.0673 (0.50); 5.0582 (0.55); 5.0479 (0.38); 4.3886 (0.72); 4.3560 (0.75); 4.1736 (0.34); 4.1636 (0.49); 4.1475 (2.77); 4.1420 (3.02); 4.1378 (2.93); 4.1291 (2.43);

4.1559 (0.40); 4.1029 (0.43); 4.0550 (0.41); 4.0371 (1.22); 4.0193 (1.56); 4.0097 (0.69); 4.0016 (0.87); 3.9759 (0.73); 3.6430 (0.94); 3.6153 (1.08); 3.5998 (1.83);

3.5722 (1.52); 3.4991 (1.66); 3.4803 (1.67); 3.4558 (1.04); 3.4372 (1.03); 3.4096 (0.61); 3.4006 (0.52); 3.3911 (0.75); 3.3812 (1.33); 3.3724 (0.92); 3.3435 (254.94);

3.3200 (2.51); 3.2900 (0.62); 3.2592 (1.00); 3.2304 (0.54); 2.8557 (0.51); 2.8258 (0.91); 2.7979 (0.52); 2.6768 (0.42); 2.6721 (0.59); 2.6675 (0.43); 2.5423 (0.34);

2.5255 (0.97); 2.5207 (1.49); 2.5120 (31.41); 2.5076 (67.88); 2.5030 (91.55); 2.4985 (65.53); 2.4940 (31.35); 2.3343 (0.44); 2.3299 (0.61); 2.3251 (0.45); 2.1866 (16.00);

2.1275 (0.65); 2,1000 (1.36); 2.0769 (0.96); 2.0665 (0.75); 1.9901 (5.50); 1.7958 (0.57); 1.7872 (0.64); 1.7650 (0.57); 1.7562 (0.54); 1.5697 (0.55); 1.5601 (0.61);

1.5382 (0.56); 1.5289 (0.55); 1.1921 (1.45); 1.1743 (2.87); 1.1565 (1.41); 0.0080

Petition 870190021920, of 03/07/2019, p. 137/172

134/160 (0.36); -0,0002 (12.89); -0.0084 (0.48)

Ex. I-46, solvent: DMSO-d6

8.7850 (0.39); 8.0073 (7.23); 7.3306 (2.51); 7.3112 (2.48); 7.3033 (1.15); 7.2991 (0.91); 7.2818 (1.30); 7.2780 (0.97); 7.1838 (1.24); 7.1699 (1.32); 7.1635 (1.35);

7.1493 (1.77); 7.1426 (0.76); 7.1286 (0.73); 6.4991 (4.56); 6.4895 (0.63); 5.7541 (0.33); 5.3538 (0.84); 5.3107 (2.49); 5.2568 (2.58); 5.2143 (0.90); 5.1956 (1.18);

5.0458 (0.46); 5.0404 (0.53); 5.0317 (0.76); 5.0265 (0.63); 5.0179 (0.81); 5.0108 (0.57); 5.0044 (0.45); 4.9993 (0.42); 4.9904 (0.35); 4.3757 (0.75); 4.3526 (0.78);

4.2880 (0.80); 4.2792 (0.83); 4.2600 (1.48); 4.2521 (1.41); 4.2045 (1.45); 4.1909 (1.46); 4.1775 (0.88); 4.1643 (0.79); 4.0561 (1.12); 4.0382 (3.43); 4.0205 (3.45);

4.0027 (1.46); 3.9903 (0.72); 3.9564 (0.76); 3.6150 (1.07); 3.5873 (1.11); 3.5718 (1.70); 3.5441 (1.48); 3.4415 (1.74); 3.4225 (1.96); 3.4097 (0.88); 3.3982 (1.68);

3.3892 (1.29); 3.3794 (2.72); 3.3535 (98.01); 3.3412 (164.99); 3.3374 (156.80);

3.2697 (0.96); 3.2413 (0.50); 3.3246 (0.43); 3.0434 (2.58); 2.8695 (0.53); 2.8553 (2.41); 2.8437 (0.91); 2.8404 (0.89); 2.8134 (0.50); 2.6720 (0.40); 2.5069 (49.52);

2.5030 (64.43); 2.4993 (45.67); 2.3290 (0.38); 2.2094 (16.00); 2.1928 (2.49); 2.1350 (0.63); 2.1054 (1.39); 2.0734 (0.92); 1.9888 (14.55); 1.8195 (0.61); 1.8119 (0.63);

1.7884 (0.57); 1.7842 (0.55); 1.5824 (0.56); 1.5720 (0.62); 1.5512 (0.58); 1.5417 (0.57); 1.3975 (0.41); 1.1927 (3.78); 1.1749 (7.52); 1.1571 (3.69); 0.0080 (0.62); 0.0002 (17.03); -0.0085 (0.52)

Ex. I-47, solvent: DMSO-d6

8.8013 (0.51); 7.9795 (3.46); 7.9764 (4.63); 7.3988 (0.41); 7.3951 (0.43); 7.3887 (0.56); 7.3850 (0.81); 7.3790 (0.72); 7.3752 (0.93); 7.3710 (0.72); 7.3652 (0.96);

7.3552 (0.54); 7.3516 (0.53); 7.2736 (0.90); 7.2697 (0.86); 7.1851 (1.96); 7.1810 (1.86); 7.1304 (1.31); 7.0966 (0.98); 7.0925 (0.95); 7.0786 (1.19); 7.0642 (1.69);

7.0611 (1.97); 7.0589 (1.94); 7.0405 (4.57); 7.0272 (1.33); 6.9497 (1.40); 6.9150 (4.06); 5.5819 (2.74); 5.5547 (2.96); 5.4558 (0.91); 5.4538 (0.79); 5.4303 (1.87);

5.4253 (1.61); 5.4151 (0.39); 5.3763 (2.08); 5.3478 (1.02); 5.3205 (0.59); 5.1530 (0.65); 5.1393 (0.84); 5.1352 (0.80); 5.1212 (0.70); 5.0697 (0.50); 5.0567 (0.66);

5.0528 (0.60); 5.0397 (0.51); 4.6528 (0.41); 4.3566 (0.88); 4.3396 (0.93); 4.0455 (1.27); 4.0337 (3.82); 4.0218 (3.84); 4.0100 (1.31); 3.9696 (0.88); 3.9511 (0.95);

3.7180 (0.71); 3.7085 (0.69); 3.6747 (0.68); 3,6678 (0.44); 3.6652 (0.72); 3.5054 (0.44); 3.4974 (0.57); 3.4888 (0.35); 3.4676 (0.70); 3.4590 (0.67); 3.4492 (0.67);

3.4303 (0.64); 3.4204 (1.15); 3.4021 (1.35); 3.3955 (0.91); 3.3752 (3.31); 3.3547

Petition 870190021920, of 03/07/2019, p. 138/172

135/160 (484.69); 3.3313 (4.54); 3.2758 (0.66); 3.2548 (1.13); 3.2328 (0.61); 3.0365 (1.18);

2.8481 (1.47); 2.8213 (1.15); 2.8003 (0.61); 2.6181 (0.81); 2.6154 (1.05); 2.5064 (126.96); 2.5037 (163.63); 2.5011 (127.17); 2.3906 (0.80); 2.3879 (1.04); 2.3853 (0.81); 2.1145 (0.84); 2.0962 (1.12); 2.0872 (1.14); 2.0788 (1.44); 2.0600 (0.93);

1.9909 (16.00); 1.8226 (0.37); 1.8025 (0.86); 1.7967 (0.64); 1.7823 (0.80); 1.6326 (4.49); 1.5836 (0.49); 1.5614 (0.71); 1.5541 (0.75); 1.5477 (0.72); 1.5256 (5.75);

1.2342 (0.61); 1.1861 (4.16); 1.1741 (8.40); 1.1624 (4.15); -0,0002 (32.59)

Ex. I-48, solvent: DMSO-d6

8.0015 (7.99); 7.1638 (0.39); 7.1585 (1.21); 7.1530 (5.26); 7.1466 (1.75); 7.1416 (1.97); 7.1363 (3.15); 7.1279 (4.52); 7.1205 (0.98); 7.1136 (0.40); 6.9998 (1.59);

6.8626 (3.72); 6.7255 (1.75); 6.2950 (3.61); 5.7551 (9.05); 5.2619 (0.78); 5.2193 (2.56); 5.1714 (2.58); 5.1293 (0.79); 5.0210 (0.36); 5.0151 (0.45); 5.0099 (0.56);

5.0018 (0.81); 4.9953 (0.70); 4.9875 (0.86); 4.9798 (0.59); 4.9742 (0.48); 4.9683 (0.45); 4.9600 (0.36); 4.3860 (0.72); 4.3526 (0.77); 4.3051 (0.85); 4.2970 (0.90);

4.2774 (1.67); 4.2691 (1.63); 4.2259 (1.59); 4.2116 (1.58); 4.1982 (0.91); 4.1839 (0.87); 4.0378 (0.32); 4.0200 (0.59); 4.0082 (0.68); 4.0026 (0.66); 3.9743 (0.74);

3.5941 (1.09); 3.5664 (1.26); 3.5510 (1.76); 3.5233 (1.48); 3.4068 (0.56); 3.3974 (0.42); 3.3875 (0.64); 3.3780 (1.25); 3.3690 (2.60); 3.3403 (73.45); 3.3361 (102.61);

3.3269 (95.68); 3.3066 (3.37); 3.2600 (1.17); 3.2314 (0.68); 3.2263 (0.63); 2.8580 (0.54); 2.8280 (0.93); 2.8008 (0.53); 2.6709 (0.38); 2.5242 (0.60); 2.5109 (18.55);

2.5064 (39.19); 2.5018 (54.10); 2.4972 (40.78); 2.4927 (20.90); 2.3285 (0.41);

2.1876 (16.00); 2.1320 (0.72); 2.0957 (1.45); 2.0733 (0.86); 1.9885 (1.37); 1.7948 (0.60); 1.7870 (0.65); 1.7650 (0.60); 1.7568 (0.57); 1.5715 (0.58); 1.5616 (0.64);

1.5398 (0.60); 1.5315 (0.58); 1.1923 (0.39); 1.1746 (0.76); 1.1568 (0.38); -0,0002 (7.60); -0.0085 (0.33)

Ex. I-49, solvent: DMSO-d6

7.9731 (5.66); 7.9682 (9.39); 7.6879 (2.90); 7.6697 (3.42); 7.6311 (2.22); 7.6129 (2.85); 7.4823 (0.80); 7.4777 (1.17); 7.4733 (0.60); 7.4610 (3.28); 7.4419 (2.65);

7.4310 (2.65); 7.4270 (2.42); 7.4205 (1.11); 7.4103 (4.50); 7.3912 (3.84); 7.3827 (2.69); 7.3792 (1.57); 7.3726 (0.79); 7.3656 (1.77); 7.3562 (0.34); 7.3507 (0.34);

7.3475 (0.48); 7.3066 (1.54); 7.2972 (1.26); 7.1733 (3.60); 7.1640 (4.67); 7.1360 (7.05); 7.0402 (1.78); 7.0281 (4.71); 7.0243 (3.74); 6.9395 (5.75); 6.9030 (4.95);

6.8923 (2.59); 6.8886 (1.93); 5.7548 (8.18); 5.6411 (0.96); 5.6181 (1.28); 5.6135 (1.23); 5.5903 (1.00); 5.4667 (1.28); 5.4432 (2.56); 5.4400 (2.27); 5.4155 (1.80);

Petition 870190021920, of 03/07/2019, p. 139/172

136/160

5.4080 (2.94); 5.3999 (2.41); 5.3653 (2.72); 5.3544 (2.15); 5.3222 (0.88); 5.3125 (1.08); 4.6342 (0.45); 4.6214 (1.01); 4.6080 (0.54); 4.3441 (1.10); 4.3157 (1.20);

4.0558 (1.16); 4.0380 (3.59); 4.0202 (3.65); 4.0024 (1.24); 3.9561 (0.93); 3.9273 (1.06); 3.7291 (0.50); 3.7244 (0.67); 3.7180 (0.73); 3.7133 (1.72); 3.7092 (1.36);

3.7014 (1.93); 3.6994 (2.31); 3.6805 (2.15); 3,6784 (2.09); 3.6706 (1.38); 3.6665 (1.79); 3.6619 (0.79); 3.6554 (0.69); 3.6507 (0.53); 3.5971 (0.77); 3.5683 (1.02);

3.5532 (1.37); 3.5258 (1.39); 3.5137 (0.58); 3.5105 (0.87); 3.5084 (0.86); 3.4970 (1.51); 3.4852 (1.06); 3.4737 (2.16); 3.4772 (0.57); 3.4619 (2.02); 3.4506 (0.67);

3.4459 (0.45); 3.4077 (1.06); 3.3844 (1.44); 3.3777 (1.28); 3.3641 (1.73); 3.3323 (241.93); 3.3294 (281.54); 3.2904 (1.63); 3.2742 (1.12); 3.2609 (1.64); 3.2452 (2.23); 3.2284 (1.22); 3.2175 (1.64); 3.1998 (0.68); 3.0367 (1.07); 2.9750 (1.00);

2.9520 (1.00); 2.9319 (0.84); 2.9090 (0.82); 2.8490 (1.24); 2.8414 (0.64); 2.8105 (1.09); 2.7986 (0.91); 2.7846 (0.71); 2.7688 (0.51); 2.6753 (0.41); 2.6707 (0.60);

2.6662 (0.43); 2.5241 (0.96); 2.5107 (30.74); 2.5062 (65.08); 2.5016 (89.61); 2.4970 (67.57); 2.4926 (34.57); 2.3328 (0.48); 2.3283 (0.67); 2.3237 (0.52); 2.0731 (2.29);

2.0604 (2.01); 1.9884 (16.00); 1.9088 (0.41); 1.8062 (0.46); 1.7764 (1.14); 1.7457 (1.06); 1.7159 (0.40); 1.5564 (0.37); 1.5354 (0.90); 1.5136 (0.86); 1.5051 (0.89);

1.4845 (0.52); 1.3975 (1.71); 1.2351 (0.66); 1.1923 (4.38); 1.1745 (8.74); 1.1567 (4.34); 0.0080 (0.70); -0,0002 (24.51); -0.0084 (1.06)

Petition 870190021920, of 03/07/2019, p. 140/172

137/160

Ex. I-50, solvent: DMSO-d6

8.7784 (0.43); 8.1552 (3.52); 8.0174 (0.67); 7.9948 (7.98); 7.7484 (0.40); 7.3284 (3.30); 7.3228 (3.56); 7.2037 (2.27); 7.1833 (3.23); 7.1635 (0.46); 7.1521 (5.05);

7.1361 (2.72); 7.1273 (4.48); 7.0891 (2.34); 7.0832 (2.38); 7.0689 (1.63); 7.0632 (1.64); 5.0213 (0.41); 5.0017 (0.69); 4.9948 (0.65); 4.9883 (0.79); 4.9812 (0.58);

4.9744 (0.44); 4.9602 (0.35); 4.3074 (0.81); 4.2992 (0.82); 4.2789 (1.55); 4.2708 (1.43); 4.2250 (1.54); 4.2110 (1.46); 4.1970 (0.91); 4.1828 (1.47); 4.1707 (1.70);

4.1382 (1.74); 4.0562 (0.63); 4.0384 (2.03); 4.0206 (2.02); 4.0028 (0.68); 3.5963 (1.06); 3.5685 (1.29); 3.5531 (1.72); 3.5254 (1.44); 3.4554 (0.37); 3.4304 (0.60);

3.3618 (1939.47); 3.3287 (3.96); 3.3093 (2.10); 3.2994 (1.03); 3.2899 (0.66); 3.0393 (1.17); 3.0083 (2.10); 2.9803 (1.16); 2.6777 (0.57); 2.6732 (0.71); 2.5425 (0.37);

2.5082 (86.24); 2.5041 (113.87); 2.5002 (80.49); 2.3303 (0.67); 2.1553 (16.00); 2.0914 (1.37); 2.0722 (2.01); 2.0656 (1.57); 1.9888 (8.43); 1.7017 (0.55); 1.6809 (1.23); 1.6730 (1.37); 1.6490 (1.24); 1.6424 (1.17); 1.6199 (0.48); 1.6142 (0.40);

1.4223 (1.53); 1.4056 (1.53); 1.3977 (0.86); 1.2884 (4.96); 1.2355 (0.46); 1.1928 (2.14); 1.1750 (4.39); 1.1573 (2.16); -0,0002 (6.48)

Ex. I-51, solvent: DMSO-d6

8.1730 (3.55); 8.0112 (8.21); 7.3362 (1.06); 7.3338 (1.84); 7.3316 (1.48); 7.3264 (3.89); 7.3226 (4.53); 7.3184 (1.90); 7.3133 (1.57); 7.3095 (1.21); 7.3069 (0.95);

7.2953 (1.19); 7.2929 (0.97); 7.2007 (2.24); 7.1871 (2.80); 7.1777 (1.25); 7.1684 (1.23); 7.1640 (1.62); 7.1547 (1.77); 7.1502 (0.83); 7.1409 (0.76); 7.0883 (2.07);

7.0846 (1.98); 7.0748 (1.65); 7.0710 (1.60); 5.7635 (3.03); 5.0473 (0.34); 5.0415 (0.38); 5.0382 (0.44); 5.0347 (0.52); 5.0291 (0.76); 5.0259 (0.58); 5.0233 (0.54);

5.0200 (0.78); 5.0146 (0.51); 5.0109 (0.43); 5.0074 (0.40); 5.0017 (0.34); 4.2798 (0.93); 4.2744 (0.93); 4.2617 (1.38); 4.2563 (1.32); 4.1950 (1.37); 4.1859 (1.41);

4.1764 (1.36); 4.6777 (2.49); 4.1451 (1.64); 4.0457 (1.01); 4.0339 (3.06); 4.0221 (3.09); 4.0102 (1.02); 3.6031 (1.08); 3.5846 (1.26); 3.5745 (1.64); 3.5560 (1.38);

3.4351 (1.58); 3.4226 (1.62); 3.4064 (1.31); 3.3940 (1.35); 3.3787 (0.41); 3.3820 (0.61); 3.3549 (293.74); 3.3313 (1.71); 3.3227 (0.73); 3.3162 (0.46); 3.3098 (0.62);

3.3034 (0.32); 3.0293 (0.93); 3.0259 (1.06); 3.0063 (2.02); 2.9871 (1.08); 2.9839 (0.94); 2.9260 (0.80); 2.6185 (0.33); 2.6155 (0.45); 2.6126 (0.33); 2.5248 (0.75);

2.5217 (1.00); 2.5186 (1.18); 2.5097 (24.42); 2.5068 (51.37); 2.5037 (69.81); 2.5007 (51.03); 2.4979 (23.55); 2.3909 (0.33); 2.3879 (0.45); 2.3849 (0.32); 2.1545 (16.00);

2.0841 (1.34); 2.0780 (1.07); 2.0668 (1.44); 1.9905 (13.23); 1.6876 (0.45); 1.6681

Petition 870190021920, of 03/07/2019, p. 141/172

138/160 (1.17); 1.6488 (1.13); 1.6325 (0.37); 1.6296 (0.40); 1.3967 (1.03); 1.1862 (3.56);

1.1744 (7.06); 1.1626 (3.50); -0,0002 (7.18)

Ex. I-52, solvent: DMSO-d6

8.7996 (0.61); 7.9754 (5.31); 7.9534 (2.31); 7.3985 (0.44); 7.3948 (0.47); 7.3884 (0.61); 7.3848 (0.88); 7.3789 (0.81); 7.3749 (1.02); 7.3708 (0.80); 7.3651 (1.09);

7.3550 (0.62); 7.3514 (0.62); 7.0776 (1.25); 7.0589 (2.33); 7.0442 (2.29); 7.0407 (2.22); 7.0266 (1.42); 6.7571 (0.43); 6.5917 (1.38); 6.5685 (4.73); 5.7655 (10.34);

5.5818 (2.72); 5.5552 (3.11); 5.3656 (1.10); 5.3372 (2.03); 5.3333 (1.81); 5.3191 (0.37); 5.2673 (1.91); 5.2624 (1.61); 5.2390 (1.08); 5.2340 (0.90); 5.1544 (0.75);

5.1406 (0.95); 5.1367 (0.92); 5.1227 (0.79); 5.0713 (0.56); 5.0578 (0.80); 5.0541 (0.82); 5.0425 (1.54); 4.3765 (0.92); 4.3595 (1.06); 4.0456 (0.63); 4.0338 (1.91);

4.0220 (1.99); 4.0100 (1.29); 4.0015 (0.92); 3.9827 (1.03); 3.4494 (0.54); 3.4308 (0.66); 3.4207 (1.24); 3.4025 (1.26); 3.3888 (1.13); 3.3766 (3.60); 3.3562 (74.44);

3.3346 (2.75); 3.2758 (0.70); 3.2693 (0.62); 3.2553 (1.19); 3.2376 (0.69); 3.2328 (0.69); 2.9877 (0.36); 2.9461 (0.38); 2.9409 (0.44); 2.9349 (0.94); 2.9297 (0.99);

2.9236 (1.36); 2.9185 (1.28); 2.9123 (1.20); 2.9072 (1.04); 2.9009 (0.79); 2.8906 (14.64); 2.8498 (0.34); 2.8352 (0.69); 2.8142 (1.21); 2.7975 (0.60); 2.7929 (0.63);

2.7310 (12.45); 2.6154 (0.41); 2.5215 (1.21); 2.5066 (44.94); 2.5038 (59.07); 2.5011 (46.12); 2.3881 (0.38); 2.0849 (1.67); 2.0788 (2.06); 2.0633 (1.06); 1.9909 (7.93);

1.9104 (0.68); 1.8291 (0.39); 1.8093 (0.84); 1.8017 (0.66); 1.7965 (0.65); 1.7887 (0.77); 1.6339 (4.89); 1.5845 (0.35); 1.5791 (0.33); 1.5715 (0.38); 1.5581 (0.54);

1.5508 (0.78); 1.5265 (6.77); 1.2339 (0.51); 1.2080 (1.85); 1.1964 (2.53); 1.1944 (2.49); 1.1887 (6.87); 1.1838 (14.88); 1.1788 (14.72); 1.1727 (16.00); 1.1679 (10.90); 1.1626 (4.01); -0,0002 (7.66)

Petition 870190021920, of 03/07/2019, p. 142/172

139/160

Ex. I-53, solvent: DMSO-d6

8.6310 (7.22); 7.9902 (16.00); 7.7039 (3.91); 7.6837 (4.64); 7.5270 (6.00); 7.4870 (3.66); 7.4669 (3.02); 7.3731 (0.63); 7.3531 (3.40); 7.3436 (11.09); 7.3362 (9.49);

7.3294 (4.43); 7.3245 (1.31); 7.3090 (0.54); 7.2501 (0.36); 7.2381 (2.45); 7.2299 (2.17); 7.2227 (3.61); 7.2132 (2.69); 7.2099 (2.63); 7.2029 (2.62); 7.1926 (2.04);

7.1888 (1.78); 7.1786 (1.68); 7.0852 (5.99); 7.0717 (5.07); 6.9461 (2.92); 6.9339 (2.51); 5.7538 (8.66); 5.5873 (2.42); 5.5685 (2.81); 5.5587 (2.68); 5.5399 (2.45);

4.1755 (3.21); 4.1417 (3.48); 4.0564 (0.70); 4.0386 (2.11); 4.0208 (2.14); 4.0031 (0.71); 3.7266 (0.55); 3.7237 (0.60); 3.4715 (2.00); 3.4430 (2.35); 3.4273 (3.02);

3.3987 (2.94); 3.3577 (111.79); 3.3554 (117.89); 3.3539 (114.39); 3.3518 (120.56);

3.3434 (213.50); 3.3414 (232.75); 3.3200 (4.35); 3.3010 (1.08); 3.2915 (1.38);

3.2823 (0.76); 3.1794 (2.48); 3.1608 (2.48); 3.1352 (1.94); 3.1163 (1.91); 3.0522 (2.29); 3.0221 (4.23); 2.9932 (2.32); 2.6770 (0.40); 2.6724 (0.56); 2.6681 (0.37);

2.5257 (0.91); 2.5076 (63.89); 2.5034 (85.75); 2.4994 (59.51); 2.3348 (0.42); 2.3297 (0.60); 2.3257 (0.52); 2.0948 (2.79); 2.0691 (3.17); 1.9890 (9.26); 1.7089 (1.07);

1.7012 (0.84); 1.6794 (2.63); 1.6495 (2.53); 1.6278 (0.80); 1.6193 (0.99); 1.5833 (13.30); 1.5749 (13.50); 1.5053 (12.86); 1.4943 (12.96); 1.3969 (2.16); 1.1929 (2.42); 1.1751 (4.84); 1.1573 (2.41); -0,0002 (0.96)

Ex. I-54, solvent: DMSO-d6

8.0036 (8.63); 7.1583 (1.23); 7.1527 (5.15); 7.1361 (2.98); 7.1278 (4.58); 6.4985 (4.34); 5.7556 (8.75); 5.3546 (0.85); 5.3114 (2.62); 5.2582 (2.54); 5.2157 (0.87);

5.0297 (0.33); 5.0208 (0.37); 5.0143 (0.44); 5.0081 (0.53); 5.0020 (0.75); 4.9954 (0.67); 4.9878 (0.79); 4.9823 (0.55); 4.9690 (0.41); 4.9604 (0.35); 4.3880 (0.72);

4.3540 (0.73); 4.3053 (0.82); 4.2973 (0.82); 4.2776 (1.57); 4.2694 (1.48); 4.2666 (1.54); 4.2125 (1.56); 4.1989 (0.89); 4.1847 (0.87); 4.0203 (0.37); 3.9896 (0.67);

3.9556 (0.71); 3.5947 (1.05); 3.5669 (1.16); 3.5514 (1.65); 3.5237 (1.42); 3.4103 (0.53); 3.4014 (0.39); 3.3903 (0.61); 3.3809 (1.14); 3.3700 (2.09); 3.3619 (0.70);

3.3506 (2.36); 3.3310 (62.48); 3.3225 (91.78); 3.3073 (2.09); 3.2688 (0.93); 3.2379 (0.51); 2.8681 (0.53); 2.8418 (0.88); 2.8115 (0.54); 2.6707 (0.49); 2.6660 (0.36);

2.5236 (0.88); 2.5056 (59.33); 2.5015 (79.02); 2.4975 (55.59); 2.3327 (0.37); 2.3284 (0.46); 2.2091 (16.00); 2.1359 (0.60); 2.1060 (1.29); 2.0737 (1.09); 1.9885 (1.50);

1.8212 (0.57); 1.8137 (0.61); 1.7912 (0.56); 1.7835 (0.50); 1.7647 (0.60); 1.7310 (0.48); 1.5728 (0.61); 1.5505 (0.54); 1.5420 (0.53); 1.4070 (0.69); 1.2371 (1.12);

1.1924 (0.42); 1.1744 (0.77); 1.1567 (0.40); 0.8545 (0.40); -0,0002 (4.58)

Petition 870190021920, of 03/07/2019, p. 143/172

140/160

Ex. I-55, solvent: DMSO-d6

8.1423 (0.33); 7.9992 (11.73); 7.5639 (1.57); 7.5483 (2.81); 7.5447 (3.12); 7.5253 (1.71); 7.3378 (0.67); 7.3139 (2.74); 7.3031 (2.46); 7.2890 (1.38); 7.2856 (1.42); 7.2754 (0.35); 7.2622 (2.57); 7.2371 (2.97); 7.2292 (2.76); 7.2194 (1.53); 7.2163 (1.64); 7.2100 (3.38); 7.1917 (1.57); 7.1881 (1.75); 7.1802 (4.86); 7.1673 (2.45); 7.0467 (2.32); 7.0316 (5.37); 6.9082 (5.58); 6.8957 (2.67); 5.4602 (1.22); 5.4175 (4.19); 5.3742 (4.04); 5.3320 (1.21); 4.8689 (0.53); 4.8529 (1.36); 4.8356 (1.57); 4.8270 (1.64); 4.8106 (1.46); 4.7941 (0.56); 4.3643 (1.29); 4.3299 (1.34); 4.0556 (1.18); 4.0380 (3.72); 4.0203 (3.88); 4.0026 (1.44); 3.9811 (1.12); 3.9460 (1.28); 3.5919 (1.99); 3.5660 (2.09); 3.5489 (2.70); 3.5228 (2.23); 3.5020 (0.33); 3.4779 (0.33); 3.4467 (0.41); 3.4080 (1.32); 3.3809 (3.06); 3.3371 (1390.17); 3.3180 (7.04); 3,3004 (4.23); 3.2856 (3.67); 3.2712 (5.01); 3.2569 (2.72); 3.2499 (3.58); 3.2345 (3.81); 3.2158 (1.56); 3.1999 (1.34); 3.0354 (0.40); 2.8663 (0.88); 2.8380 (1.67);

2.8113 (0.89); 2.6711 (1.39); 2.5702 (0.35); 2.5412 (0.65); 2.5064 (158.56); 2.5023 (216.00); 2.4984 (157.74); 2.4624 (0.68); 2.3287 (1.19); 2.1227 (1.11); 2.0926 (2.23); 2.0732 (2.98); 1.9885 (16.00); 1.9082 (0.41); 1.8336 (0.56); 1.8053 (1.05);

1.7816 (0.92); 1.7431 (0.46); 1.5982 (0.53); 1.5797 (1.02); 1.5698 (1.07); 1.5491 (1.05); 1.5390 (0.99); 1.5178 (0.42); 1.2347 (0.70); 1.1925 (4.22); 1.1747 (8.38);

1.1568 (4.15); -0,0002 (5.83); -0.0082 (0.32); -2.2464 (0.34)

Ex. I-56, solvent: DMSO-d6

8.7825 (0.32); 8.0179 (12.91); 7.5159 (9.57); 7.4956 (11.37); 7.2193 (3.37); 7.1995 (3.87); 7.1787 (2.66); 7.0487 (2.28); 7.0293 (2.77); 6.9971 (3.02); 6.8599 (1.76);

6.8371 (1.41); 5.7554 (16.00); 5.1162 (0.37); 5.1031 (0.56); 5.0977 (0.57); 5.0876 (0.79); 5.0754 (0.95); 5.0568 (0.57); 5.0459 (0.33); 4.1743 (1.74); 4.1664 (1.58);

4.1498 (3.73); 4.1448 (4.47); 4.1400 (4.59); 4.1319 (3.70); 4.1887 (0.63); 4.1060 (0.48); 4.0557 (0.45); 4.0378 (1.11); 4.0201 (1.09); 4.0025 (0.39); 3.6444 (1.03);

3.6170 (1.08); 3.6010 (1.92); 3.5736 (1.65); 3.5046 (1.74); 3.4863 (1.74); 3.4613 (1.12); 3.4425 (1.07); 3.3482 (1.28); 3.3233 (534.95); 3.2999 (2.64); 3.2820 (0.54);

3.0093 (1.07); 2.9810 (2.09); 2.9507 (1.19); 2.6751 (0.66); 2.6704 (0.87); 2.6655 (0.66); 2.5404 (0.52); 2.5237 (1.72); 2.5054 (98.12); 2.5013 (132.06); 2.3327 (0.64); 2.3282 (0.93); 2.3233 (0.69); 2.3189 (0.34); 2.2333 (13.61); 2.1105 (13.49); 2.0735 (2.40); 2.0466 (1.58); 1.9884 (4.83); 1.6922 (0.52); 1.6603 (1.27); 1.6355 (1.14);

1.6046 (0.43); 1.3972 (0.37); 1.2341 (0.39); 1.1923 (1.35); 1.1745 (2.64); 1.1567 (1.36); -0,0002 (11.99)

Petition 870190021920, of 03/07/2019, p. 144/172

141/160

Ex. I-57, solvent: DMSO-d6

8.1108 (6.85); 7.8454 (1.79); 7.8433 (1.83); 7.8371 (1.83); 7.8350 (1.78); 7.5308 (1.04); 7.5295 (1.06); 7.5250 (1.12); 7.2707 (0.83); 7.1990 (0.68); 7.1910 (1.04);

7.1822 (2.32); 7.1291 (0.89); 7.0936 (0.95); 7.0387 (2.35); 6.9484 (1.05); 6.9143 (2.04); 5.4995 (0.34); 5.48853 (0.36); 5.4777 (0.40); 5.4667 (0.39); 5.4534 (0.74);

5.4249 (1.54); 5.3746 (1.54); 5.3462 (0.71); 5.2298 (0.59); 4.3579 (0.45); 4.3357 (0.46); 4.0459 (1.13); 4.0340 (3.50); 4.0222 (3.52); 4.0103 (1.16); 3.9727 (0.43);

3.9497 (0.45); 3.7824 (0.78); 3.7632 (0.91); 3.7528 (1.06); 3.7336 (0.89); 3.5681 (12.73); 3.5063 (0.38); 3.4852 (1.05); 3.4747 (1.07); 3.4556 (0.95); 3.4451 (0.93);

3.3959 (0.39); 3.3829 (0.50); 3.3767 (0.90); 3.3702 (0.79); 3.3553 (58.34); 3.2743 (0.36); 3.2545 (0.62); 3.2354 (0.35); 2.8419 (0.33); 2.8243 (0.56); 2.8213 (0.57);

2.8040 (0.33); 2.5215 (0.33); 2.5184 (0.33); 2.5095 (9.34); 2.5065 (20.80); 2.5035 (28.96); 2.5004 (21.04); 2.4974 (9.45); 2.1189 (0.38); 2.0961 (0.53); 2.0849 (0.40);

2.0779 (0.54); 2.0603 (0.42); 1.9905 (16.00); 1.9102 (1.14); 1.8047 (0.55); 1.7982 (0.42); 1.7936 (0.39); 1.7829 (0.46); 1.7780 (0.37); 1.5616 (0.37); 1.5551 (0.40);

1.5412 (0.38); 1.5348 (0.37); 1.1861 (4.34); 1.1743 (9.14); 1.1625 (4.26); -0,0002 (1.66)

Petition 870190021920, of 03/07/2019, p. 145/172

142/160

Ex. I-58, solvent: DMSO-d6

7.9741 (10.68); 7.5994 (12.59); 7.5798 (16.00); 7.4404 (5.22); 7.4195 (7.27); 7.4002 (3.41); 7.3117 (2.70); 7.1783 (5.82); 7.1650 (3.06); 7.0449 (2.97); 7.0290 (6.28);

6.9129 (11.18); 6.8931 (3.04); 5.7463 (4.14); 5.7446 (4.22); 5.4557 (2.15); 5.4145 (6.34); 5.3688 (6.00); 5.3266 (2.21); 4.7793 (1.03); 4.7640 (2.75); 4.7471 (3.57);

4.7381 (3.22); 4.7211 (3.04); 4.7058 (1.23); 4.3599 (2.48); 4.3275 (2.69); 4.2864 (0.33); 4.0558 (0.74); 4.0393 (2.36); 4.0216 (2.43); 4.0041 (1.09); 3.9804 (2.39);

3.9467 (2.65); 3.9172 (0.35); 3.8185 (0.38); 3.8029 (0.34); 3.7661 (0.35); 3.7518 (0.41); 3.7184 (0.45); 3.7090 (0.48); 3.6884 (0.52); 3.6814 (0.56); 3.6175 (0.91);

3.5851 (3.66); 3.5699 (1.85); 3.5591 (4.03); 3.5414 (5.91); 3.5146 (7.54); 3.4567 (792.13); 3.4525 (775.96); 3.4490 (764.64); 3.4443 (811.54); 3.4411 (832.24);

3.4384 (891.58); 3.4332 (929.12); 3.4312 (921.69); 3.4272 (1171.48); 3.4247 (1194.84); 3.3798 (7.07); 3.3670 (8.02); 3.3492 (7.18); 3.3236 (3.90); 3.3057 (4.79);

3.2717 (3.51); 3.2423 (1.95); 3.2088 (0.77); 3.1925 (12.78); 3.7776 (12.81); 3.1418 (0.41); 3.0375 (0.62); 2.8724 (1.76); 2.8434 (3.28); 2.8137 (1.78); 2.6785 (1.25);

2.6740 (1.07); 2.5485 (0.55); 2.5131 (156.15); 2.5091 (213.73); 2.5054 (165.44); 2.3357 (1.32); 2.1272 (2.23); 2.0948 (4.63); 2.0600 (2.63); 1.9895 (9.39); 1.8285 (0.91); 1.8131 (0.82); 1.7981 (2.09); 1.7663 (1.89); 1.7441 (0.82); 1.5957 (0.85);

1.5654 (2.06); 1.5428 (1.88); 1.5150 (0.82); 1.3979 (0.49); 1.2349 (0.98); 1.1939 (2.47); 1.1760 (4.98); 1.1583 (2.39); -0,0002 (3.98)

Ex. I-59, solvent: DMSO-d6

8.1517 (3.48); 8.0632 (0.35); 8.0190 (9.83); 7.5153 (9.19); 7.4950 (10.82); 7.3290 (3.34); 7.3233 (3.63); 7.2191 (3.13); 7.1995 (4.81); 7.1788 (3.89); 7.0877 (2.50);

7.0822 (2.36); 7.0675 (1.78); 7.0616 (1.68); 5.7545 (12.77); 5.1157 (0.36); 5.1035 (0.56); 5.0845 (0.77); 5.0756 (0.91); 5.0659 (0.52); 5.0578 (0.53); 5.0470 (0.40);

4.1721 (1.69); 4.1665 (1.57); 4.1496 (3.51); 4.1437 (4.36); 4.1401 (4.50); 4.1309 (3.51); 4.1779 (0.61); 4.1049 (0.53); 4.0559 (0.51); 4.0381 (1.45); 4.0203 (1.44);

4.0023 (0.50); 3.6435 (1.07); 3.6159 (1.10); 3.6004 (1.85); 3.5730 (1.60); 3.5043 (1.77); 3.4857 (1.78); 3.4771 (0.34); 3.4613 (1.16); 3.4423 (1.11); 3.3922 (0.43);

3.3785 (0.76); 3.3333 (811.15); 3.2917 (0.78); 3.2680 (0.33); 3.0390 (1.13); 3.0087 (2.01); 2.9805 (1.06); 2.6755 (0.60); 2.6711 (0.96); 2.6664 (0.64); 2.5412 (0.56);

2.5244 (1.75); 2.5063 (94.58); 2.5022 (126.35); 2.3331 (0.62); 2.3290 (0.81); 2.3241 (0.65); 2.1553 (16.00); 2.1413 (0.68); 2.0903 (1.30); 2.0734 (1.93); 2.0642 (1.54);

1.9886 (6.59); 1.7011 (0.49); 1.6791 (1.19); 1.6480 (1.16); 1.6222 (0.40); 1.2355

Petition 870190021920, of 03/07/2019, p. 146/172

143/160 (0.34); 1.1925 (1.75); 1.1747 (3.55); 1.1569 (1.68); -0,0002 (5.54)

Ex. I-60, solvent: DMSO-d6

8.1901 (4.01); 8.0230 (6.21); 7.6537 (1.35); 7.6496 (1.44); 7.6344 (1.46); 7.6302 (1.46); 7.4190 (0.75); 7.4147 (0.75); 7.4005 (1.02); 7.3977 (1.23); 7.3938 (1.02);

7.3797 (0.96); 7.3753 (0.91); 7.3126 (1.06); 7.1793 (2.49); 7.1659 (1.20); 7.1110 (1.83); 7.0911 (1.53); 7.0461 (1.21); 7.0299 (2.80); 7.0040 (1.01); 6.9852 (1.74); 6.9664 (0.88); 6.9085 (2.41); 6.8941 (1.34); 5.7526 (6.22); 5.4642 (0.55); 5.4214 (1.72); 5.3735 (1.77); 5.3308 (0.57); 5.1104 (0.40); 5.1059 (0.42); 5.0944 (0.63); 5.0859 (0.60); 5.0787 (0.39); 5.0745 (0.42); 5.0699 (0.38); 5.0669 (0.36); 4.3670 (0.54); 4.3327 (0.57); 4.2371 (0.68); 4.2487 (0.71); 4.2103 (1.30); 4.2021 (1.25);

4.1644 (1.18); 4.1522 (1.19); 4.1378 (0.69); 4.255 (0.64); 4.0383 (0.73); 4.0206 (0.76); 4.0026 (0.41); 3.9883 (0.59); 3.9545 (0.56); 3.8560 (0.55); 3.8111 (16.00);

3.6233 (0.78); 3.5957 (0.91); 3.5802 (1.23); 3.5527 (1.04); 3.4191 (0.87); 3.4040 (2.24); 3.3875 (4.18); 3.3624 (92.37); 3.3512 (129.28); 3.2771 (0.82); 3.2479 (0.45);

3.2423 (0.41); 2.8799 (0.36); 2.8492 (0.66); 2.8223 (0.39); 2.5666 (1.05); 2.5258 (0.61); 2.5126 (12.13); 2.5081 (24.39); 2.5035 (32.41); 2.4989 (23.34); 2.4944 (11.24); 2.1417 (0.46); 2.1079 (0.98); 2.0727 (0.86); 1.9888 (3.23); 1.8254 (0.44);

1.8169 (0.45); 1.7951 (0.41); 1.7874 (0.39); 1.5915 (0.42); 1.5827 (0.45); 1.5617 (0.43); 1.5523 (0.41); 1.1927 (0.88); 1.1749 (1.77); 1.1571 (0.86); -0,0002 (0.46)

Ex. I-61, solvent: DMSO-d6

8.0158 (16.00); 7.5246 (3.28); 7.5214 (3.50); 7.5046 (4.32); 7.5014 (4.32); 7.4864 (3.95); 7.4835 (4.05); 7.4667 (4.60); 7.4636 (4.60); 7.3719 (2.11); 7.3686 (2.08);

7.3530 (3.98); 7.3337 (2.32); 7.3304 (2.15); 7.3139 (2.76); 7.2433 (2.61); 7.2397 (2.56); 7.2238 (3.87); 7.2050 (1.78); 7,2017 (1.63); 7.1808 (6.06); 7.1678 (2.93);

7.0475 (3.03); 7.0319 (6.74); 6.9085 (6.43); 6.8961 (3.27); 5.7543 (5.95); 5.4614 (1.47); 5.4187 (4.83); 5.3754 (4.83); 5.3328 (1.47); 4.9400 (0.56); 4.9241 (1.73);

4.9075 (1.90); 4.8980 (1.85); 4.8818 (1.67); 4.8658 (0.67); 4.4445 (0.81); 4.4336 (0.65); 4.3655 (1.43); 4.3319 (1.49); 4.0558 (1.04); 4.0381 (3.31); 4.0203 (3.44);

4.0022 (1.32); 3.9825 (1.30); 3.9499 (1.48); 3.6217 (2.16); 3.5952 (2.35); 3.5781 (3.24); 3.5523 (2.72); 3.4128 (1.24); 3.3951 (2.88); 3.3812 (3.57); 3.3749 (2.46);

3.3482 (155.97); 3.3446 (161.44); 3.3368 (336.82); 3.3341 (282.93); 3.3179 (6.96); 3.3019 (7.36); 3.2840 (4.29); 3.2683 (3.50); 3.2388 (1.03); 2.8722 (0.94); 2.8688 (1.05); 2.8388 (1.79); 2.8123 (0.99); 2.6713 (0.69); 2.5414 (0.49); 2.5063 (91.38);

2.5024 (118.78); 2.4986 (83.75); 2.3291 (0.76); 2.3249 (0.55); 2.1308 (1.20); 2.0997

Petition 870190021920, of 03/07/2019, p. 147/172

144/160 (2.55); 2.0728 (1.37); 2.0618 (1.43); 1.9886 (14.20); 1.8497 (0.45); 1.8380 (0.56); 1.8175 (1.16); 1.8084 (1.30); 1.7874 (1.40); 1.7789 (1.32); 1.7607 (0.75); 1.6448 (0.36); 1.6369 (0.36); 1.6127 (0.83); 1.6036 (0.74); 1.5819 (1.15); 1.5713 (1.19); 1.5507 (1.30); 1.5409 (1.30); 1.5209 (0.62); 1.5097 (0.59); 1.2343 (0.86); 1.2004 (0.50); 1.1925 (3.84); 1.1748 (7.58); 1.1677 (0.61); 1.1570 (3.75); 0.8691 (3.74); 0.8528 (3.48); 0.7939 (0.32); 0.7646 (0.56); 0.7353 (0.54); 0.7228 (0.36); 0.7136 (0.33); 0.6917 (0.36); 0.0078 (1.27); -0,0002 (34.68); -0.0085 (1.01)

Ex. I-62, solvent: DMSO-d6

7.9843 (7.69); 7.4082 (0.36); 7.3929 (0.85); 7.3873 (0.78); 7.3722 (1.61); 7.3665 (0.65); 7.3568 (0.72); 7.3514 (0.93); 7.3368 (0.46); 7.0958 (2.66); 7.0751 (2.26);

7.0669 (2.74); 7.0461 (2.22); 6.4963 (4.35); 5.7538 (3.14); 5.3460 (0.85); 5.3037 (2.46); 5.2488 (2.35); 5.2046 (1.83); 5.1859 (1.32); 5.1754 (1.18); 5.1573 (1.09);

4.6257 (0.41); 4.3851 (0.71); 4.3527 (0.77); 4.0557 (0.53); 4.0380 (1.53); 4.0203 (1.63); 4.0021 (0.59); 3.9823 (0.71); 3.9469 (0.74); 3.9434 (0.70); 3.7127 (0.51);

3.7093 (0.42); 3.6994 (0.79); 3,6784 (0.77); 3.6706 (0.46); 3.6665 (0.60); 3.5679 (0.38); 3.5098 (0.46); 3.4967 (0.69); 3.4848 (0.57); 3.4735 (1.08); 3.4669 (1.33);

3.4620 (1.02); 3.4500 (0.47); 3.4385 (1.15); 3.4231 (1.57); 3.3942 (2.01); 3.3524 (251.72); 3.3488 (278.34); 3.3401 (691.55); 3.3184 (4.36); 3.2838 (0.76); 3.2491 (1.00); 3.2223 (0.53); 3.1764 (1.14); 3.1573 (1.10); 3.1324 (0.85); 3.1338 (0.77);

2.8909 (0.49); 2.8457 (0.47); 2.8139 (0.90); 2.7879 (0.57); 2.7313 (0.40); 2.6761 (0.78); 2.6718 (1.03); 2.6670 (0.78); 2.5418 (0.55); 2.5248 (1.82); 2.5068 (116.17);

2.5026 (156.51); 2.3336 (0.72); 2.3295 (1.01); 2.3249 (0.81); 2.2041 (16.00); 2.1931 (1.02); 2.1216 (0.64); 2.0888 (1.27); 2.0730 (2.10); 2.0523 (0.74); 1.9885 (6.66);

1.9089 (1.17); 1.7996 (0.56); 1.7707 (0.56); 1.5581 (0.59); 1.5530 (0.59); 1.5281 (0.58); 1.4917 (0.39); 1.4631 (6.84); 1.3924 (3.59); 1.3848 (6.31); 1.3778 (3.61);

1.2358 (0.41); 1.1925 (1.83); 1.1747 (3.61); 1.1569 (1.71); -0,0002 (4.58)

Ex. I-63, solvent: CDCI3

7.6098 (7.85); 7.5909 (2.40); 7.5889 (2.40); 7.5777 (2.52); 7.5756 (2.47); 7.4195 (1.95); 7.4171 (2.02); 7.4063 (2.51); 7.4040 (2.47); 7.3148 (1.36); 7.3127 (1.35);

7.3021 (2.28); 7.3004 (2.25); 7.2895 (1.26); 7.2874 (1.20); 7.2637 (43.73); 7.1104 (1.34); 7.1079 (1.36); 7.0974 (2.07); 7.0954 (2.07); 7.0849 (1.15); 7.0824 (1.10);

6.9749 (1.55); 6.8831 (3.28); 6.7914 (1.68); 6.7670 (4.29); 6.6735 (3.77); 6.5822 (1.83); 5.3038 (16.00); 5.1920 (0.48); 5.1648 (3.98); 5.1539 (4.02); 5.1267 (0.48); 5.0974 (0.40); 4.9503 (0.42); 4.9429 (0.49); 4.9393 (0.55); 4.9325 (0.89); 4.9246

Petition 870190021920, of 03/07/2019, p. 148/172

145/160 (0.83); 4.9176 (0.89); 4.9108 (0.54); 4.9071 (0.50); 4.8998 (0.43); 4.5937 (0.80); 4.5712 (0.82); 4.1286 (0.49); 4.1668 (0.50); 3.9299 (0.75); 3.9072 (0.80); 3.5917 (1.29); 3.5745 (1.35); 3.5630 (1.94); 3.5458 (1.80); 3.4942 (0.52); 3.4332 (2.09);

3.4218 (2.74); 3.4132 (1.78); 3.4044 (1.58); 3.3982 (2.03); 3.3934 (1.89); 3.3910 (2.04); 3.3689 (0.40); 3.3624 (0.80); 3.3538 (0.90); 3.3505 (1.02); 3.3438 (1.54);

3.3373 (1.54); 3.3253 (0.86); 3.3158 (0.69); 3.3113 (0.55); 3.0978 (0.43); 3.0384 (1.85); 3.0233 (1.87); 3.0161 (1.73); 3.0060 (0.44); 3.0010 (1.67); 2.9467 (0.52);

2.9423 (0.58); 2.9234 (1.01); 2.9046 (0.57); 2.9003 (0.51); 2.2913 (0.69); 2.2707 (0.77); 2.2095 (0.70); 2.1874 (0.76); 2.0496 (2.20); 1.8875 (0.68); 1.8681 (0.68);

1.8393 (0.38); 1.8320 (0.38); 1.8186 (0.68); 1.8125 (0.74); 1.7973 (0.71); 1.7918 (0.67); 1.7781 (0.37); 1.7714 (0.36); 1.6383 (0.68); 1.2733 (0.66); 1.2615 (1.27);

1.2496 (0.77); 0.0052 (0.84); -0,0002 (26.19); -0.0057 (0.85)

Petition 870190021920, of 03/07/2019, p. 149/172

146/160

Ex. I-64, solvent: DMSO-d6

11.1389 (6.68); 10.2551 (0.65); 10.2533 (0.65); 8.1882 (4.93); 8.0408 (1.31); 8.0320 (7.82); 8.0274 (1.54); 7.6855 (0.40); 7.6765 (1.51); 7.6722 (1.64); 7.6657 (0.61);

7.6573 (1.67); 7.6530 (1.59); 7.3772 (0.78); 7.3728 (0.80); 7.3587 (1.10); 7.3549 (1.33); 7.3520 (1.19); 7.3379 (1.28); 7.3336 (1.13); 7.3221 (0.38); 7.3124 (1.56);

7.1791 (3.44); 7.1668 (1.79); 7.0953 (2.10); 7.0757 (1.69); 7.0459 (1.72); 7.0307 (4.22); 7.0118 (0.35); 6.9921 (1.10); 6.9734 (1.99); 6.9545 (1.24); 6.9070 (3.50);

6.8949 (2.01); 5.7547 (16.00); 5.4595 (0.67); 5.4167 (2.24); 5.3938 (0.33); 5.3760 (2.34); 5.3330 (0.72); 5.3255 (1.01); 5.1267 (0.32); 5.1136 (0.54); 5.1095 (0.50);

5.1043 (0.55); 5.0996 (0.71); 5.0868 (0.77); 5.0773 (0.56); 5.0693 (0.49); 5.0604 (0.37); 4.3595 (0.70); 4.3230 (0.86); 4.3028 (0.32); 4.2179 (0.61); 4.2091 (0.71);

4.1913 (1.49); 4.1826 (1.54); 4.1662 (1.45); 4.1531 (1.37); 4.1395 (0.66); 4.1263 (0.68); 4.0557 (0.53); 4.0380 (1.61); 4.0202 (1.64); 4.0023 (0.63); 3.9819 (0.68);

3.9485 (0.75); 3.6327 (0.79); 3.6051 (1.16); 3.5895 (1.28); 3.5677 (0.44); 3.5620 (1.03); 3.4196 (0.63); 3.4128 (0.56); 3.3860 (2.38); 3.3765 (1.19); 3.3686 (1.96);

3.3328 (509.45); 3.2708 (1.30); 3.2501 (0.53); 3.2407 (0.70); 3.2181 (0.34); 3.1622 (3.57); 3.1537 (0.71); 3.0588 (2.55); 3.0414 (0.38); 2.8746 (0.54); 2.8434 (0.96);

2.8169 (0.56); 2.6756 (0.38); 2.6710 (0.53); 2.6664 (0.38); 2.5243 (1.46); 2.5110 (30.40); 2.5065 (61.38); 2.5019 (82.11); 2.4973 (59.35); 2.4927 (28.92); 2.3333 (0.43); 2.3287 (0.57); 2.3240 (0.43); 2.3663 (0.60); 2.1018 (1.30); 2.0733 (2.32);

1.9885 (7.32); 1.8256 (0.55); 1.8189 (0.61); 1.7976 (0.59); 1.7882 (0.54); 1.5894 (0.55); 1.5797 (0.65); 1.5589 (0.58); 1.5502 (0.61); 1.1924 (2.11); 1.1746 (4.16);

1.1568 (2.08); 0.0080 (0.34); -0,0002 (9.00); -0.0085 (0.34)

Ex. I-65, solvent: DMSO-d6

8.0235 (6.08); 7.5161 (6.69); 7.4958 (7.72); 7.2197 (2.12); 7.1995 (3.43); 7.1790 (1.64); 6.4994 (4.54); 5.7532 (5.60); 5.3529 (0.85); 5.3098 (2.42); 5.2560 (2.39);

5.2132 (0.82); 5.1175 (0.32); 5.1037 (0.57); 5.0972 (0.53); 5.0872 (0.84); 5.0758 (0.94); 5.0691 (0.59); 5.0600 (0.56); 5.0475 (0.36); 5.0357 (0.62); 4.3876 (0.77);

4.3546 (0.83); 4.1760 (0.39); 4.1659 (0.46); 4.1500 (2.75); 4.1449 (3.00); 4.1410 (2.73); 4.3221 (2.31); 4.1994 (0.37); 4.1070 (0.38); 4.0381 (0.73); 4.0203 (0.67);

3.9913 (0.72); 3.9583 (0.81); 3.6427 (0.87); 3.6147 (1.02); 3.5990 (1.75); 3.5713 (1.60); 3.5002 (1.71); 3.4816 (1.73); 3.4567 (1.21); 3.4387 (1.26); 3.4099 (1.51);

3.3647 (154.46); 3.3613 (151.04); 3.3506 (146.41); 3.3460 (167.37); 3.3384 (190.97); 3.2700 (1.29); 3.2409 (0.71); 3.0429 (0.41); 2.8687 (0.49); 2.8556 (0.59);

Petition 870190021920, of 03/07/2019, p. 150/172

147/160

2.8396 (0.93); 2.8126 (0.54); 2.6715 (0.76); 2.5411 (0.36); 2.5029 (117.60); 2.3294 (0.69); 2.3248 (0.58); 2.2518 (1.14); 2.2090 (16.00); 2.1942 (0.76); 2.3333 (0.68);

2.1044 (1.41); 2.0750 (0.82); 1.9886 (2.71); 1.8122 (0.62); 1.7891 (0.61); 1.7812 (0.56); 1.5730 (0.62); 1.5523 (0.62); 1.2357 (0.41); 1.1927 (0.72); 1.1750 (1.38);

1.1567 (0.70); -0,0002 (5.76)

Ex. I-66, solvent: DMSO-d6

7.9863 (5.17); 7.3935 (0.44); 7.3878 (0.40); 7.3726 (0.86); 7.3673 (0.34); 7.3574 (0.43); 7.3519 (0.52); 7.3083 (0.80); 7.1751 (1.79); 7.1651 (0.90); 7.0963 (1.41);

7.0755 (1.23); 7.0674 (1.49); 7.0542 (0.60); 7.0466 (1.27); 7.0421 (1.11); 7.0291 (2.11); 6.9051 (1.72); 6.8932 (1.00); 5.7543 (16.00); 5.4555 (0.38); 5.4126 (1.29);

5.3679 (1.24); 5.3250 (0.38); 5.3030 (0.69); 5.2057 (0.55); 5.1871 (0.65); 5.1774 (0.63); 5.1586 (0.57); 4.3630 (0.36); 4.3313 (0.39); 3.9762 (0.32); 3.9424 (0.37);

3.7010 (0.35); 3.6974 (0.46); 3.6883 (0.44); 3.6734 (0.62); 3.6635 (0.40); 3.6592 (0.41); 3.5681 (0.67); 3.4680 (0.44); 3.4393 (0.51); 3.4234 (0.68); 3.3947 (0.84);

3.3733 (0.42); 3.3641 (0.72); 3.3340 (192.46); 3.2813 (0.32); 3.2511 (0.48); 3.7774 (0.57); 3.1587 (0.55); 3.3336 (0.42); 3.1552 (0.41); 2.8495 (0.35); 2.8163 (0.44);

2.5199 (0.47); 2.5066 (21.11); 2.5024 (28.41); 2.4990 (19.28); 2.0860 (1.38); 2.0736 (0.57); 2.0489 (0.36); 1.9887 (0.35); 1.9092 (0.46); 1.4646 (3.61); 1.3933 (1.82);

1.3861 (3.35); 1.3792 (1.95); -0,0002 (0.87)

Petition 870190021920, of 03/07/2019, p. 151/172

148/160

Ex. I-67, solvent: DMSO-d6

7.9996 (6.17); 7.3639 (1.45); 7.3546 (4.84); 7.3472 (4.14); 7.3406 (2.05); 7.2496 (0.98); 7.2408 (0.84); 7.2334 (0.71); 7.2243 (0.87); 7.2141 (1.05); 7.2037 (0.81);

7.1998 (0.87); 7.1899 (0.65); 6.5076 (4.49); 5.5954 (1.09); 5.5779 (1.32); 5.5676 (1.27); 5.5489 (1.21); 5.3553 (0.89); 5.3132 (2.38); 5.2587 (2.26); 5.2158 (0.85);

4.3949 (0.73); 4.3639 (0.82); 4.0665 (0.50); 4.0488 (1.32); 4.0310 (1.33); 4.0133 (0.52); 3.9936 (0.65); 3.9611 (0.78); 3.4960 (0.48); 3.4786 (1.23); 3.4498 (1.59);

3.4340 (2.17); 3.3808 (422.45); 3.3742 (862.74); 3.3717 (915.50); 3.2940 (0.97);

3.2616 (1.06); 3.2334 (0.78); 3.1819 (1.21); 3.1641 (1.21); 3.1383 (0.94); 3,1201 (0.95); 2.9019 (0.59); 2.8594 (0.53); 2.8281 (0.90); 2.8013 (0.57); 2.7426 (0.46);

2.6882 (0.63); 2.6835 (0.94); 2.6792 (0.72); 2.5533 (0.44); 2.5371 (1.50); 2.5189 (104.35); 2.5147 (142.57); 2.5106 (100.47); 2.3505 (0.33); 2.3457 (0.70); 2.3410 (0.88); 2.3372 (0.66); 2.2153 (16.00); 2.1305 (0.68); 2.1268 (0.61); 2.0978 (1.37);

2.0827 (0.87); 2.0682 (0.79); 1.9993 (5.76); 1.9198 (0.58); 1.8119 (0.59); 1.7846 (0.52); 1.5908 (6.34); 1.5825 (6.37); 1.5408 (0.67); 1.5129 (6.00); 1.5018 (6.11);

1.2457 (0.44); 1.2034 (1.56); 1.1856 (2.96); 1.1680 (1.52)

Ex. I-68, solvent: DMSO-d6

8.6287 (8.28); 7.9844 (14.62); 7.7299 (0.34); 7.7026 (4.24); 7.6822 (5.10); 7.5250 (6.60); 7.4978 (0.46); 7.4859 (4.04); 7.4659 (3.35); 7.4247 (0.51); 7.4076 (0.72);

7.3928 (1.78); 7.3878 (1.70); 7.3723 (3.25); 7.3562 (1.74); 7.3516 (2.06); 7.3360 (1.02); 7.2243 (2.65); 7.2076 (2.37); 7.0954 (5.58); 7.0847 (6.64); 7.0674 (8.64);

7.0458 (4.65); 6.9458 (2.81); 6.9329 (2.39); 5.8615 (0.33); 5.7541 (14.73); 5.6743 (0.34); 5.2049 (2.46); 5.1867 (2.82); 5.1767 (2.70); 5.1581 (2.53); 4.1729 (3.66);

4.1392 (3.96); 4.0559 (0.69); 4.0383 (2.08); 4.0204 (2.19); 4.0030 (0.88); 3.7222 (0.48); 3.5682 (1.52); 3.4697 (2.10); 3.4412 (2.39); 3.4254 (3.25); 3.3971 (3.40);

3.3402 (1408.83); 3.3179 (7.32); 3.2890 (1.69); 3.2433 (0.39); 3.2143 (0.40); 3.1824 (2.47); 3.1664 (2.51); 3.1393 (2.06); 3.1205 (1.95); 3.0504 (2.60); 3.0201 (4.88);

2.9910 (2.61); 2.6715 (1.54); 2.5417 (0.63); 2.5066 (179.46); 2.5026 (243.49);

2.3289 (1.58); 2.3254 (1.32); 2.2121 (0.51); 2.0994 (3.03); 2.0918 (3.21); 2.0730 (3.38); 2.0654 (3.74); 1.9887 (8.88); 1.7063 (1.21); 1.6764 (2.86); 1.6468 (2.87);

1.6152 (1.13); 1.4655 (16.00); 1.4358 (0.43); 1.3877 (14.92); 1.2345 (0.61); 1.1926 (2.38); 1.1748 (4.75); 1.1570 (2.38); -0,0002 (3.15); -2.6302 (0.34)

Petition 870190021920, of 03/07/2019, p. 152/172

149/160

Ex. I-69, solvent: DMSO-d6

9.6020 (0.42); 7.9924 (11.69); 7.3735 (0.34); 7.3537 (2.03); 7.3442 (6.69); 7.3369 (5.57); 7.3300 (2.80); 7.3253 (0.89); 7.3088 (1.99); 7.2398 (1.39); 7.2317 (1.14); 7.2236 (1.07); 7.2151 (1.32); 7.2044 (1.47); 7.1941 (1.25); 7.1906 (1.24); 7.1799 (1.47); 7.1754 (4.30); 7.1655 (2.05); 7.0422 (2.03); 7.0294 (4.76); 6.9056 (4.03);

6.8936 (2.31); 5.7544 (16.00); 5.5862 (1.37); 5.5674 (1.63); 5.5579 (1.56); 5.5388 (1.45); 5.4555 (0.89); 5.4128 (3.04); 5.3983 (0.68); 5.3685 (2.96); 5.3262 (0.93); 4.3651 (0.87); 4.3314 (0.93); 4.0383 (0.76); 4.0204 (0.73); 3.9777 (0.78); 3.9430 (0.87); 3.6970 (0.91); 3.5680 (0.38); 3.4688 (1.18); 3.4396 (1.31); 3.4241 (1.67);

3.3957 (2.11); 3.3755 (1.00); 3.3661 (1.65); 3.3569 (1.61); 3.3348 (500.06); 3.2834 (0.79); 3.2522 (1.18); 3.2240 (0.67); 3.1729 (1.42); 3.1541 (1.44); 3.1285 (1.09);

3.1099 (1.10); 2.8498 (0.68); 2.8216 (1.06); 2.7926 (0.63); 2.6761 (0.33); 2.6715 (0.45); 2.6671 (0.33); 2.5245 (0.72); 2.5066 (52.78); 2.5026 (69.97); 2.3292 (0.48);

2.3246 (0.35); 2.1213 (0.80); 2.0875 (1.54); 2.0739 (1.22); 2.0538 (0.86); 1.9887 (3.27); 1.9094 (0.54); 1.8010 (0.65); 1.7693 (0.65); 1.7434 (0.34); 1.5818 (7.86);

1.5735 (8.33); 1.5319 (0.79); 1.5031 (7.64); 1.4920 (7.64); 1.2346 (0.32); 1.1926 (0.83); 1.1748 (1.74); 1.1571 (0.86); -0,0002 (1.53)

Ex. I-70, solvent: DMSO-d6

8.0094 (9.59); 7.4134 (1.85); 7.4122 (1.87); 7.4004 (2.20); 7.2742 (1.24); 7.2293 (1.56); 7.2171 (2.76); 7.2063 (1.86); 7.1934 (1.13); 7.1919 (0.99); 7.1856 (2.98);

7.1442 (1.48); 7.1424 (1.50); 7.1303 (3.35); 7.1196 (0.87); 7.1178 (0.82); 7.0971 (1.42); 7.0400 (3.48); 6.9497 (1.57); 6.9161 (3.14); 5.7632 (7.74); 5.4588 (1.14); 5.4304 (2.43); 5.3775 (2.40); 5.3491 (1.13); 4.8549 (0.35); 4.8439 (0.91); 4.8374 (0.49); 4.8337 (0.94); 4.8267 (0.93); 4.8229 (0.50); 4.8164 (0.88); 4.8054 (0.37); 4.3611 (0.73); 4.3390 (0.75); 3.9770 (0.68); 3.9542 (0.72); 3.5839 (1.24); 3.5665 (1.47); 3.5553 (1.70); 3.5380 (1.41); 3.4073 (0.35); 3.4011 (0.63); 3.3944 (0.49); 3.3883 (0.96); 3.3821 (1.40); 3.3756 (1.72); 3.3555 (379.88); 3.3320 (1.56); 3.3082 (1.78); 3.2964 (2.72); 3.2862 (1.81); 3.2896 (1.75); 3.2734 (2.25); 3.2680 (2.31); 3.2638 (2.89); 3.2448 (0.59); 3.2408 (0.50); 3.2079 (1.79); 3.1969 (1.83); 3.1854 (1.23); 3.1744 (1.19); 2.8570 (0.45); 2.8529 (0.53); 2.8352 (0.91); 2.8323 (0.93); 2.8150 (0.54); 2.8110 (0.45); 2.6184 (0.35); 2.6153 (0.48); 2.6123 (0.33); 2.5246 (0.98); 2.5215 (1.29); 2.5184 (1.48); 2.5096 (26.12); 2.5066 (55.05); 2.5036 (74.81); 2.5005 (54.16); 2.4976 (24.50); 2.3907 (0.36); 2.3878 (0.48); 2.3847 (0.36); 2.3048 (16.00); 2.1224 (0.63); 2.1028 (0.76); 2.0835 (0.72); 2.0776 (4.16); 2.0641 (0.70);

Petition 870190021920, of 03/07/2019, p. 153/172

150/160

1.9904 (0.71); 1.8085 (0.59); 1.8025 (0.65); 1.7878 (0.62); 1.7821 (0.58); 1.5685 (0.60); 1.5621 (0.65); 1.5481 (0.63); 1.5419 (0.59); 1.2337 (0.33); 1.1743 (0.41);

0.0053 (0.46); -0,0002 (13.65); -0.0057 (0.41)

Ex. I-71, solvent: DMSO-d6

9.9015 (0.55); 8.6461 (0.49); 8.0101 (16.00); 7.4198 (3.98); 7.4159 (4.30); 7.4001 (4.46); 7.3962 (4.50); 7.3217 (1.97); 7.3177 (1.97); 7.3090 (3.29); 7.3010 (3.77);

7.2826 (2.96); 7.2785 (2.72); 7.2738 (0.91); 7.1906 (4.81); 7.1873 (5.06); 7.1756 (7.08); 7.1699 (4.28); 7.1665 (3.76); 7.1592 (3.36); 7.1404 (0.40); 7.0424 (3.25);

7.0362 (1.07); 7.0231 (7.12); 6.9906 (2.62); 6.9872 (2.61); 6.9716 (4.10); 6.9684 (3.99); 6.9524 (2.30); 6.9490 (2.11); 6,9008 (6.67); 6.8872 (3.58); 5.7453 (13.54);

5.4561 (1.33); 5.4129 (4.75); 5.3684 (4.65); 5.3258 (1.31); 5.1117 (0.74); 5.0899 (1.87); 5.0851 (2.12); 5.0807 (1.61); 5.0711 (1.88); 5.0623 (1.17); 5.0576 (1.05);

5.0532 (1.01); 5.0440 (0.72); 4.3620 (1.52); 4.3307 (1.61); 4.2639 (1.74); 4.2550 (1.80); 4.2369 (3.94); 4.2280 (3.71); 4.2047 (3.83); 4.1911 (3.77); 4.7777 (1.85);

4.1641 (1.72); 4.0571 (0.37); 4.0393 (0.89); 4.0216 (0.90); 4.0041 (0.62); 3.9847 (1.48); 3.9510 (1.56); 3.6204 (2.35); 3.5929 (2.62); 3.5774 (3.65); 3.5681 (0.82);

3.5501 (3.18); 3.5101 (0.52); 3.4749 (0.71); 3.4183 (2.62); 3.4092 (5.43); 3.3998 (3.60); 3.3909 (7.47); 3.3812 (4.39); 3.3657 (7.73); 3.3212 (555.51); 3.2467 (1.87);

2.8779 (1.03); 2.8506 (1.89); 2.8207 (1.00); 2.6753 (0.46); 2.6705 (0.59); 2.6660 (0.49); 2.5401 (0.96); 2.5100 (35.91); 2.5057 (65.72); 2.5013 (84.54); 2.4969 (58.55); 2.4926 (28.03); 2.3327 (0.37); 2.3280 (0.52); 2.3233 (0.37); 2.1994 (1.35);

2.1044 (2.69); 2.0690 (1.65); 1.9870 (3.13); 1.8441 (0.58); 1.8220 (1.16); 1.8140 (1.22); 1.7916 (1.10); 1.7853 (1.05); 1.7609 (0.45); 1.6114 (0.68); 1.5895 (1.16);

1.5819 (1.27); 1.5604 (1.11); 1.5530 (1.07); 1.5310 (0.45); 1.5219 (0.36); 1.2372 (0.57); 1.1929 (0.94); 1.1752 (1.78); 1.1573 (0.88); 0.0078 (0.38); -0,0002 (7.13)

Ex. I-72, solvent: DMSO-d6

10.3781 (4.04); 10.3763 (4.00); 8.0115 (6.15); 7.4096 (1.22); 7.4055 (1.34); 7.3896 (1.53); 7.3855 (1.59); 7.3118 (1.00); 7.2981 (1.16); 7.2939 (1.32); 7.2785 (2.40);

7.2743 (1.99); 7.2396 (1.42); 7.2379 (1.42); 7.2198 (1.83); 7.2181 (1.86); 7.2001 (0.74); 7.1983 (0.79); 7.1785 (2.29); 7.1667 (1.12); 7.0453 (1.13); 7.0307 (2.60);

6.9065 (2.24); 6.8949 (1.29); 5.7551 (10.32); 5.4558 (0.50); 5.4159 (1.69); 5.3731 (1.72); 5.3306 (0.50); 5.0836 (0.34); 5.0797 (0.38); 5.0706 (0.56); 5.0650 (0.48);

5.0559 (0.62); 5.0466 (0.38); 5.0374 (0.32); 4.3625 (0.52); 4.3297 (0.55); 4.3011 (0.47); 4.2919 (0.54); 4.2736 (1.56); 4.2643 (1.58); 4.2582 (1.60); 4.2434 (1.42);

Petition 870190021920, of 03/07/2019, p. 154/172

151/160

4.2306 (0.49); 4.2158 (0.49); 4.0379 (0.34); 4.0201 (0.33); 3.9833 (0.49); 3.9483 (0.53); 3.8683 (16.00); 3.8339 (0.70); 3.5966 (0.71); 3.5689 (0.90); 3.5534 (1.20); 3.5259 (0.96); 3.4139 (0.62); 3.4005 (1.49); 3.3939 (0.89); 3.3821 (1.82); 3.3749 (1.23); 3.3563 (2.86); 3.3306 (450.97); 3.3073 (2.93); 3.2938 (0.97); 3.2701 (0.73); 3.2386 (0.40); 3.2310 (0.36); 2.8690 (0.35); 2.8409 (0.63); 2.8112 (0.35); 2.6755 (0.42); 2.6708 (0.59); 2.6663 (0.41); 2.5410 (0.40); 2.5240 (1.66); 2.5108 (33.29); 2.5063 (66.94); 2.5017 (89.03); 2.4972 (64.16); 2.4926 (31.01); 2.3330 (0.41);

2.3286 (0.58); 2.3240 (0.41); 2.1345 (0.44); 2.001 (0.91); 2.0735 (1.54); 2.0645 (0.53); 1.9885 (1.39); 1.8152 (0.40); 1.8074 (0.43); 1.7844 (0.40); 1.7771 (0.37);

1.5826 (0.40); 1.5735 (0.43); 1.5516 (0.40); 1.5427 (0.37); 1.1924 (0.40); 1.1745 (0.79); 1.1567 (0.40); 0.0080 (0.33); -0,0002 (8.61)

Ex. I-73, solvent: DMSO-d6

10.2509 (8.57); 8.0336 (13.13); 7.6869 (2.35); 7.6841 (3.68); 7.6793 (2.30); 7.6742 (2.59); 7.6714 (3.91); 7.6670 (2.76); 7.6655 (2.61); 7.6625 (1.79); 7.6533 (2.07);

7.6502 (1.55); 7.2722 (2.19); 7.2667 (4.06); 7.2528 (3.78); 7.1836 (4.45); 7.1273 (2.04); 7.1112 (2.20); 7.0988 (4.10); 7.0953 (2.48); 7.0864 (2.06); 7.0369 (5.02);

6.9465 (2.32); 6.9139 (5.17); 5.7604 (16.00); 5.4571 (1.70); 5.4286 (3.70); 5.3769 (3.63); 5.3485 (1.69); 5.1617 (0.56); 5.1537 (0.81); 5.1507 (0.84); 5.1478 (0.76);

5.1431 (1.28); 5.1367 (1.25); 5.1324 (0.76); 5.1295 (0.81); 5.1264 (0.76); 5.1244 (0.76); 5.1183 (0.55); 4.3608 (1.13); 4.3407 (2.45); 4.3351 (2.29); 4.3230 (3.02); 4.3173 (2.75); 4.2973 (2.82); 4.2890 (2.86); 4.2795 (1.51); 4.2713 (1.38); 4.0461 (0.67); 4.0343 (2.07); 4.0224 (2.06); 4.0106 (0.70); 3.9803 (1.06); 3.9575 (1.14); 3.3665 (1.68); 3.6181 (1.96); 3.6078 (2.55); 3.5895 (2.13); 3.4563 (2.40); 3.4451 (2.48); 3.4276 (2.06); 3.4164 (2.45); 3.4075 (1.05); 3.4010 (1.60); 3.3948 (2.58);

3.3870 (2.47); 3.3605 (693.55); 3.3372 (7.93); 3.3168 (0.37); 3.2911 (0.90); 3.2713 (1.54); 3.2522 (0.88); 2.8621 (0.82); 2.8418 (1.49); 2.8244 (0.87); 2.6188 (0.41);

2.6158 (0.56); 2.6129 (0.40); 2.5658 (1.65); 2.5250 (0.92); 2.5219 (1.20); 2.5187 (1.51); 2.5099 (31.29); 2.5070 (65.04); 2.5040 (88.14); 2.5010 (63.51); 2.4981 (29.07); 2.3913 (0.39); 2.3882 (0.55); 2.3852 (0.37); 2.1353 (0.97); 2.1252 (1.17); 2.0955 (1.12); 2.0765 (4.57); 1.9901 (8.99); 1.8413 (0.36); 1.8347 (0.44); 1.8211 (0.89); 1.8149 (0.98); 1.8008 (0.92); 1.7947 (0.87); 1.7805 (0.39); 1.6049 (0.39);

1.5981 (0.46); 1.5844 (0.91); 1.5780 (1.01); 1.5639 (0.98); 1.5577 (0.93); 1.5440 (0.41); 1.5372 (0.35); 1.1864 (2.37); 1.1745 (4.71); 1.1627 (2.35); -0,0002 (1.38)

Ex. I-74, solvent: DMSO-d6

Petition 870190021920, of 03/07/2019, p. 155/172

152/160

7.9998 (16.00); 7.3340 (2.20); 7.3303 (3.55); 7.3265 (3.65); 7.3209 (1.78); 7.3137 (2.97); 7.3073 (6.46); 7.3031 (4.55); 7.2976 (2.42); 7.2936 (1.93); 7.2763 (2.71); 7.2724 (2.08); 7.1813 (3.15); 7.1745 (6.21); 7.1673 (3.40); 7.1594 (4.91); 7.1467 (3.48); 7.1399 (1.63); 7.1259 (1.43); 7.0415 (2.90); 7.0229 (6.59); 6,9002 (5.66); 6.8870 (3.22); 5.7459 (14.51); 5.4534 (1.22); 5.4109 (4.33); 5.3665 (4.18); 5.3244 (1.21); 5.0584 (0.67); 5.0446 (0.95); 5.0303 (1.48); 5.0255 (1.25); 5.0167 (1.58); 5.0025 (0.92); 4.9896 (0.71); 4.3622 (1.36); 4.3290 (1.46); 4.2876 (1.66); 4.2788 (1.64); 4.2600 (2.92); 4.2523 (2.73); 4.2076 (2.80); 4.1934 (2.82); 4.1796 (1.65); 4.1669 (1.56); 4.0390 (0.39); 4.0211 (0.45); 3.9842 (1.35); 3.9492 (1.39); 3.6751 (0.34); 3.6494 (0.44); 3.6353 (0.44); 3.6138 (2.25); 3.5860 (2.48); 3.5707 (3.70); 3.5431 (3.28); 3.5300 (0.75); 3.5133 (0.76); 3.4407 (4.22); 3.4217 (4.90); 3.3972 (5.11); 3.3860 (4.90); 3.3783 (6.05); 3.3152 (2722.35); 3.2720 (4.76); 3.2435 (1.69); 3.2236 (0.75); 2.8810 (0.88); 2.8753 (0.94); 2.8441 (1.63); 2.8172 (0.97); 2.6745 (0.99); 2.6700 (1.51); 2.6654 (1.10); 2.5398 (1.99); 2.5096 (85.73); 2.5053 (161.11); 2.5008 (211.76); 2.4964 (147.17); 2.4919 (70.94); 2.3322 (1.04); 2.3275 (1.50); 2.3227 (0.99); 2.3668 (1.17); 2.1045 (2.42); 2.0690 (5.38); 1.9867 (1.44); 1.8375 (0.50); 1.8088 (1.08); 1.7850 (1.02); 1.7582 (0.39); 1.6188 (0.46); 1.6072 (0.54); 1.5873 (1.09); 1.5785 (1.18); 1.5568 (1.02); 1.5250 (0.44); 1.5173 (0.44); 1.3521 (1.60); 1.2986 (0.48); 1.2590 (0.70); 1.2362 (1.76); 1.2305 (1.74); 1.1926 (0.42); 1.1750 (0.84); 1.1572 (0.40); 0.0079 (0.88); -0,0002 (21.43); -0.0085 (1.03)

Petition 870190021920, of 03/07/2019, p. 156/172

153/160

Ex. I-75, solvent: DMSO-d6

8.0148 (14.18); 7.5454 (3.29); 7.5394 (3.42); 7.5182 (3.28); 7.5122 (3.46); 7.3537 (1.82); 7.3496 (2.18); 7.3444 (1.69); 7.3316 (2.48); 7.3277 (2.93); 7.3222 (2.33);

7.3087 (2.53); 7.2102 (3.28); 7.1877 (5.48); 7.1754 (5.80); 7.1654 (2.98); 7.1596 (2.94); 7.0421 (2.71); 7.0234 (6.08); 6.9000 (5.45); 6.8875 (3.13); 5.7469 (7.15);

5.4528 (1.11); 5.4111 (4.13); 5.3688 (4.11); 5.3262 (1.11); 5.0919 (0.58); 5.0774 (0.97); 5.0740 (0.94); 5.0644 (1.47); 5.0592 (1.25); 5.0551 (1.08); 5.0500 (1.61);

5.0404 (1.01); 5.0323 (0.85); 5.0223 (0.66); 4.3640 (1.29); 4.3313 (1.36); 4.2484 (0.86); 4.2387 (1.12); 4.2211 (4.00); 4.2106 (6.55); 4.1953 (3.63); 4.1829 (1.04);

4.1684 (0.99); 4.0568 (1.22); 4.0390 (3.71); 4.0213 (3.78); 4.0034 (1.50); 3.9847 (1.28); 3.9495 (1.33); 3.6105 (1.88); 3.5831 (2.15); 3.5673 (2.88); 3.5400 (2.37);

3.4158 (1.24); 3.4058 (1.06); 3.3964 (1.59); 3.3872 (2.49); 3.3778 (1.88); 3.3777 (1.83); 3.3584 (2.56); 3.3409 (5.73); 3.3040 (1216.35); 3.2802 (16.23); 3.2429 (2.24); 3.1765 (0.60); 3.1632 (0.48); 2.8739 (0.96); 2.8447 (1.67); 2.8168 (0.95);

2.6737 (0.95); 2.6691 (1.25); 2.6645 (0.94); 2.5391 (1.66); 2.5087 (68.90); 2.5044 (127.36); 2.5000 (165.63); 2.4956 (117.33); 2.4913 (58.43); 2.3312 (0.98); 2.3267 (1.27); 2.3221 (0.96); 2.3779 (1.23); 2.1042 (2.51); 2.0693 (4.98); 1.9867 (16.00);

1.9076 (0.33); 1.8510 (0.47); 1.8414 (0.57); 1.8199 (1.08); 1.8128 (1.13); 1.7892 (1.08); 1.7824 (1.01); 1.7607 (0.50); 1.6198 (0.48); 1.6103 (0.59); 1.5873 (1.08);

I, 5797 (1.13); 1.5589 (1.06); 1.5493 (1.03); 1.5292 (0.49); 1.4089 (0.88); 1.2363 (0.91); 1.1927 (4.44); 1.1749 (8.68); 1.1571 (4.30); 0.0079 (1.04); -0,0002 (19.61); 0.0084 (0.98)

NMR data from intermediaries

XVIII-1, solvent: DMSO-d6

II, 3471; (1.52); 8,172; (1.42); 7,9592; (1.36); 7.8249; (0.34); 4.3287; (0.42); 3.8907; (0.38); 3.4588; (0.32); 3.4461; (0.33); 3.4413; (0.34); 3.4286; (0.32); 3.3175; (28.88); 2.5112; (1.77); 2.5069; (3.23); 2.5024; (4.14); 2,498; (2.82); 2.4937; (1.34); 2.1258; (0.65); 2,1156; (0.51); 2.08; (0.61); 2.0703; (0.43); 1.4232; (15); 1.0757; (0.76); 1.0582; (1.49); 1.0408; (0.73); -0,0001; (0.44)

Petition 870190021920, of 03/07/2019, p. 157/172

154/160

XVIIa-1, solvent: DMSO-de

8,1017; (1.85); 7.4021; (1.98); 7.3911; (3.22); 4.3294; (0.68); 4.3132; (0.65); 3.3029; (160.66); 3.2892; (0.64); 3.2322; (0.4); 3.2048; (0.39); 3.1655; (5.27); 3.0649; (0.35); 3.0441; (0.33); 2.5224; (0.6); 2.5177; (0.89); 2,509; (11.67); 2.5046; (22.95); 2.5001; (31.05); 2.4956; (21.24); 2.4911; (9.97); 2,1179; (0.36); 2.1066; (0.54); 2.0963; (0.44); 2.0694; (0.39); 2.0619; (0.39); 1.4187; (16); 1.4084; (2.51); 1.3985; (0.52); -0,0001; (2.86)

XIII-1, solvent: DMSO-de

8.7012; (0.41); 8.6788; (0.46); 8.2106; (0.39); 7.8892; (0.36); 7.8851; (0.71); 7.3969; (0.55); 7.3945; (0.46); 3.5678; (16); 3.3917; (0.44); 3,3857; (0.5); 3,352; (32.76); 3.2112; (1.19); 3.1689; (1.13); 2.5241; (0.36); 2.5194; (0.51); 2.5107; (4.97); 2.5063; (9.71); 2.5017; (13.23); 2.4973; (9.21); 2.4928; (4.44); -0,0001; (0.55)

XIX-1, solvent: DMSO-d6

8.0704 (2.17) 8.0602 (0.91) 8.0576 (1.02) 8.0398 (1.13) 8.0364 (0.91) 7.7159 (0.59) 7, 6974 (0.42) 7.6169 (0.8) 7.5972 (1.14) 7.5786 (0.53) 6.2127 (0.4) 6.1939 (0.44) 6.1859 ( 0.55) 6.167 (0.41) 4.0405 (0.93) 4.0227 (1.12) 4.0048 (0.54) 3.9945 (0.4) 3.7686 (0.75) 3.7607 (0.71) 3.7499 (0.66) 3.7338 (0.66) 3.3119 (20.55) 3.2882 (0.36) 3.2489 (0.36) 2, 5113 (1.65) 2,507 (2.94) 2.5026 (3.72) 2.4892 (2.58) 2.494 (1.25) 2.0498 (0.41) 2.0447 (0.43) 2.0183 (0.47) 1.9881 (3.35) 1.5754 (0.38) 1.5657 (0.46) 1.5447 (0.37) 1.5355 (0.35) 1, 4071 (16) 1.1939 (0.94) 1.1761 (1.85) 1.1583 (0.91)

XVIIa-2, solvent: DMSO-d6

8.047; (2.03); 7.6197; (0.48); 7.6157; (0.57); 7.6024; (0.75); 7.5963; (0.84); 7.5539; (0.36); 7.5423; (1.46); 7.5258; (0.64); 4.0577; (0.47); 4.0399; (1.41);

4.0221; (1.66); 4.0044; (0.66); 3.9887; (0.37); 3.6486; (0.44); 3.6199; (0.38);

3.4795; (0.42); 3.4634; (0.42); 3.3124; (43.45); 3.2894; (0.33); 3.2336; (0.34); 2.5103; (2.76); 2.5061; (4.94); 2.5016; (6.28); 2.4973; (4.35); 2,493; (2.1);

2.0378; (0.39); 2.0326; (0.39); 2.0056; (0.48); 1.995; (0.53); 1.9873; (5.79);

1.5619; (0.41); 1.5512; (0.39); 1.5299; (0.37); 1,521; (0.33); 1.4071; (16); 1.1933;

(1.6); 1.1755; (3.14); 1.1577; (1.55)

Petition 870190021920, of 03/07/2019, p. 158/172

155/160

XIII-2, solvent: DMSO-de

8.0948 (1.15) 7.6043 (0.41) 7.5982 (0.46) 7.5462 (0.81) 7.5295 (0.35) 3.7555 (4.16) 3, 7,106 (0.32) 3.7027 (0.34) 3.568 (16) 2.5115 (2.77) 2.5072 (4.96) 2.5028 (6.33) 2.4984 (4.4) 2.4941 (2.13)

XVIIa-3, solvent: DMSO-de

7,9965; (1.95); 7.3093; (0.61); 7.29; (0.89); 7.2874; (0.69); 7.2691; (0.73);

6.9635; (1.28); 6.9566; (0.44); 6.9478; (1.02); 6.9422; (0.92); 6.94; (0.86); 4.1772; (1); 4,1073; (0.72); 4.1023; (0.68); 4.022; (0.38); 3.9952; (0.37); 3.5547; (0.42); 3.5274; (0.36); 3.3355; (0.7); 3.3131; (24.98); 3.2925; (0.59); 3.2736; (0.45); 3.2505; (0.35); 2.5097; (3); 2.5054; (5.43); 2.5009; (6.96); 2.4965; (4.84); 2.4922; (2.32); 2.0521; (0.41); 2.0467; (0.42); 2.0204; (0.47); 1.5784; (0.37); 1.5699; (0.43); 1.5484; (0.38); 1.5402; (0.36); 1.4092; (16); 1.398; (2.76)

XX-1, solvent: DMSO-de

7,9956; (1.6); 4.0236; (0.34); 3,9917; (0.35); 3.7017; (0.71); 3,697; (0.71);

3.6886; (0.72); 3.6843; (0.68); 3.5531; (0.4); 3.5262; (0.35); 3.3051; (109.24);

3.2639; (0.68); 3,253; (0.35); 3.2465; (0.58); 3.2203; (0.38); 3.203; (0.34); 2.5393; (0.34); 2,509; (10.79); 2.5046; (19.36); 2.5002; (24.75); 2.4958; (17.13); 2.4914; (8.19); 2.0463; (0.39); 2.0141; (0.44); 1.5714; (0.38); 1.5621; (0.42); 1.5401; (0.37); 1.5313; (0.34); 1.4276; (0.48); 1.4085; (16); 1.3932; (0.48); 0.0002; (3.27)

VII-1, solvent: DMSO-de

9.9015; (0.41); 8.7771; (0.43); 8.6466; (0.37); 8.4922; (1,2); 8.0162; (16); 7.3089; (3.15); 7.1757; (7.16); 7.1598; (3.62); 7.0423; (3.54); 7.0239; (7.95); 6,9004;

(7.3); 6,888; (4.36); 5.7464; (9.68); 5,454; (1.5); 5.4111; (5.43); 5.3686; (5.57); 5.3259; (1.5); 5.3071; (0.57); 5.2908; (0.33); 5.0077; (0.76); 4,9949; (1.71); 4.9906; (1.21); 4,981; (1.79); 4.9778; (2.27); 4,968; (2.21); 4,955; (1.25); 4.9508; (1.82); 4.9381; (0.82); 4.7915; (0.65); 4.7778; (0.7); 4.3649; (1.66); 4.3327; (1.77); 4.0571; (0.76); 4.0392; (2.28); 4.0213; (2.36); 4.0035; (1.07); 3.9843;

(1.6); 3.9502; (1.76); 3.7346; (0.64); 3.7215; (0.79); 3.708; (6.91); 3.7035; (7.1); 3.6949; (7.19); 3.6909; (6.95); 3.6768; (0.91); 3.6643; (0.62); 3.6075; (2.66); 3.5805; (2.87); 3.5639; (3.72); 3.5369; (3.21); 3.4118; (1.38); 3.4015; (1.19); 3.3924; (1.88); 3.3832; (2.9); 3.3737; (2); 3.3637; (1.89); 3,354; (2.74); 3.3079; (1047.19); 3.2847; (11.75); 3.2757; (9.27); 3.2584; (6.42); 3,232; (4.78); 3.2147; (3.72); 3.1537; (0.53); 3.1047; (0.36); 3.0888; (0.33); 3.0369; (1.23); 2.8709;

Petition 870190021920, of 03/07/2019, p. 159/172

156/160 (1.21); 2,849; (2.15); 2.8415; (2.17); 2.8137; (1.21); 2.6738; (0.91); 2.6693;

(1.25); 2.6649; (0.95); 2.5393; (2.24); 2,509; (74.52); 2.5047; (135.64); 2.5003; (174.36); 2,496; (122.78); 2.4917; (60.93); 2.3314; (1.08); 2.3271; (1.38); 2.3225; (1.07); 2.1336; (1.71); 2.0999; (3.31); 2.0691; (3.17); 2.0389; (0.35); 1.9868; (10.09); 1.9079; (0.39); 1.8398; (0.79); 1.819; (1.48); 1.81; (1.51); 1.7884; (1.43); 1.7789; (1.3); 1.7589; (0.64); 1.6063; (0.77); 1.5765; (1.53); 1.5548; (1,4);

1.5467; (1.34); 1.526; (0.6); 1.3986; (0.46); 1.2746; (0.44); 1.2375; (0.57);

1.1927; (2.82); 1.1749; (5.44); 1.1571; (2.73); -0,0002; (8.76); -0.0084; (0.49) [00376] The intensity of acute signals correlates with the height of the signals in a printed example of an NMR spectrum in cm and shows the true ratios of the signal strengths. In the case of wide signals, several peaks or the middle of the signal and their relative intensities can be shown compared to the most intense signal in the spectrum.

[00377] The 1H-NMR peak lists are similar to conventional 1HRMN impressions and thus usually contain all the peaks listed in conventional NMR interpretations.

[00378] Furthermore, like conventional 1H-NMR impressions, they may show solvent signals, stereoisomeric signals from the target compounds, which are similarly part of the subject of the invention, and / or impurity peaks.

[00379] In reporting compound signals in the solvent and / or water delta range, the present 1H-NMR peak lists show the usual solvent peaks, for example, DMSO peaks in DMSO-d6 and the water peak , which usually have a high intensity on average.

[00380] The stereoisomers peaks of the target compounds and / or impurity peaks usually have a lower intensity on average than the peaks of the target compounds (for example, with a purity of> 90%).

[00381] Such stereoisomers and / or impurities can be typical of the particular preparation process. Its peaks can thus help to identify the reproduction of the present preparation process “with reference to by-product fingerprints”.

[00382] An expert calculating the peaks of the target compounds by known methods (MestreC, ACD simulation, but also with empirically evaluated expected values) can, if required, isolate the peaks of the target compounds, optionally using additional intensity filters. This one

Petition 870190021920, of 03/07/2019, p. 160/172

157/160 isolation would be similar to the relevant peak choice of the conventional 1H-NMR interpretation.

[00383] The table lists all NMR data, both for the final compounds and for the intermediates.

Usage examples

Example A

Fitophora (tomato) / protector test [00384] Solvent: 49 parts by weight of N, N-dimethylformamide [00385] Emulsifier: 1 part by weight of alkylaryl polyglycol ether [00386] To produce a suitable active ingredient formulation, 1 part by weight of active ingredient it is mixed with the specified amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.

[00387] To test for protective efficacy, young tomato plants are sprayed with the active ingredient formulation at the indicated application rate. 1 day after treatment, the plants are inoculated with a spore suspension of Fitoftora infestans and then remain at 100% relative humidity and 22 ° C for 24 h. Subsequently, the plants are placed in an air-conditioned chamber at approximately 96% relative humidity and a temperature of approximately 20 ° C.

[00388] The evaluation continues for 7 days after inoculation. 0% means an efficacy that corresponds to that of the control, while a 100% efficacy means that no infection is observed.

[00389] In this test, the following inventive compounds show, at an active ingredient concentration of 100

Petition 870190021920, of 03/07/2019, p. 161/172

158/160

Ex. % of ef. l-l JÜO 1-2 100 1-3 wo M 100 1-5 100 1-6 100 1-7 100 1-8 100 1-9 100 1-10 100 1-11 95 M2 10Õ 1-13 100 M4 95 1-15 95

M6 100 1-17 95 1-18 95 1-19 100 1-20 95 1-21 95 1-22 95 1-23 95 1-24 100 1-25 100 1-26 100 1-27 90 1-28 100 1-29 100 1-30 95 1-31 100

1-32 94 1-33 100 1-34 100 1-35 95 1-36 100 1-37 100 1-38 100 1-39 100 1-40 100 1-41 100 1-42 95 1-43 95 1-44 95 1-45 93 146 95 1-47 93

149 97 1-50 92 1-51 95 Ϊ-52 95 [-53 91 [-54 100 1-55 94 1-56 94 1-57 95 [-58 94 1-59 94 1-60 94 T-61 91 1-62 91 T-63 91 1-64 95

1-65 84 1-66 94 1-67 94 1-68 94 1-69 94 1-70 95 1-71 100 1-72 95 1-73 90 1-74 100

Example B

Plasmopara (vine) / protector test [00390] Solvent: 24.5 parts by weight of acetone

24.5 parts by weight of dimethylacetamide [00391] Emulsifier: 1 part by weight of alkylaryl polyglycol ether [00392] To produce a suitable active ingredient formulation, 1 part by weight of active ingredient is mixed with the specified amounts of solvent and emulsifier , and the concentrate is diluted with water to the desired concentration.

[00393] To test for protective efficacy, young plants are sprayed with the active ingredient formulation at the indicated application rate. After the spray coating has dried, the plants are inoculated with a

Petition 870190021920, of 03/07/2019, p. 162/172

159/160 aqueous spore suspension of Plasmopara viticola and then remain in an incubation cabin at approximately 20 ° C and 100% relative humidity for 1 day. Subsequently, the plants are placed in a greenhouse at approximately 21 ° C and approximately 90% humidity for 4 days. The plants are then moistened and placed in an incubation cabin for 1 day.

[00394] The evaluation continues for 6 days after inoculation. 0% means an efficacy that corresponds to that of the control, while a 100% efficacy means that no infection is observed.

[00395] In this test, the following inventive compounds show, at an active ingredient concentration of 10 ppm, an efficiency of 70% or more:

Εκ. % of et. 1-1 100 1-2 97 1-3 100 1-4 97 1-5 100 1-6 96 1-7 96 1-8 93 1-9 100 1-10 93 1-12 70 1-16 87 1-17 100 1-18 100 1-19 94 1-20 93 1-21 85 1-22 100 1-23 89 1-24 94 1-25 94 1-26 96 1-27 92 1-28 98 Γ-29 78 1-30 100 1-31 85 1-32 78 1-34 96 1-35 100 1-36 100 1-37 97 1-39 78

1-50 97 1-51 93 1-54 97 1-55 100 1-56 1O0 1-57 100 1-58 100 1-59 too 1-61 93 1-62 96 1-63 96 1-64 73 1-65 100 1-66 100 1-67 100 1-68 96 1-69 95 1-71 100 1-72 81 1-74 100 1-75 98

I 1-40 ’92 ί [1-4! 94 | j 1-42: 100

1-43 100 1-44 100 1-45 100 1-46 98 1-47 95 MB 96

Petition 870190021920, of 03/07/2019, p. 163/172

160/160

Example C

Peronospora test (rapeseed) / seed treatment [00396] The test was conducted under greenhouse conditions.

[00397] Rapeseed seeds treated with an inventive active compound or a combination of inventive active compounds dissolved in N-methyl-2-pyrrolidone and diluted with water at the desired dose was sown in 6 * 6 cm containers. The containers contain 4 cm of a 1: 1 mixture of field soil treated with steam and sand. The plants were grown at 10 ° C.

[00398] The 14-day plants were inoculated with an aqueous spore suspension of Peronospora brassicae. The containers containing the plants were incubated in a greenhouse at a temperature of 15 ° C and a relative humidity of 100% for 7 days.

[00399] The test evaluation included the evaluation of the infected leaf area per plant. 0% means an efficiency corresponding to that of the control, while an efficiency of 100% means that no disease is observed.

[00400] In this test, the following compounds exhibited an efficiency of% or greater than a dose of 50 g / dt of the inventive active compound.

Ex. % of ef. 1-2 95 1-3 98 1-9 97 1-36 78 1-43 98

Claims (12)

1. Compounds characterized by the fact that they have the formula (I) where the radicals are defined, each, as follows: A is phenyl which can contain up to two substituents, where the substituents are selected, each independently from the following list: fluorine, bromine, iodine, chlorine, methyl, ethyl, propyl, chlorofluoromethyl, dichloromethyl, dichlorofluoromethyl, difluoromethyl, trichloromethyl, trifluoromethyl, or A is a heteroaromatic radical selected from the following group: pyrazol1-yl, pyrazol-3-yl, pyrazol-4-yl, which can contain up to two substituents, where the substituents are the same or different and are each selected independently from the following list: substituents on carbon: fluorine, chlorine, bromine, iodine, cyano, nitro, methyl, ethyl, propyl, chlorofluoromethyl, dichloromethyl, dichlorofluoromethyl, difluoromethyl, trichloromethyl, trifluoromethyl, L ¹ is NH or CH2, Y is sulfur or oxygen, G is where the bond identified by "v" is directly linked to the piperidine ring and where the bond identified by "w" is directly linked to Q, Q is or Petition 870190058786, of 06/25/2019, p. 21/26 2/6 where the link identified by * is linked directly to G and, at the same time, the link identified by # is linked directly to L ² , or where the link identified by * is linked directly to L ² and, at the same time , the link identified by # is linked directly to G, L ² is L ² -6 = where the link identified by i is linked directly to Q, and where the link identified by j is linked directly to R ¹ , m is 0 or 2, n is 0 or 2, R ²⁴ is the same or different and is independently hydrogen, C1-C4-aquyl or C1-C4-haloaquila, R ²⁷ is the same or different and is independently hydrogen, C1-C4-aquyl or C1-C4-alkoxy, R ¹ is unsubstituted or substituted phenyl, where the substituents are selected, each independently from Z ^1-2 , Z ^1-2 are the same or different and are each independently halogen, cyan, hydroxyl, uncle, nitro, -C (= O) H, -COOH, -C (= O) NR3R ⁴ , -NR3R ⁴ , C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C8-cycloalkenyl, C3-C8-halocycloalkenyl, C1 -C6-alkoxy-C1 -C6-alkyl, C1 -C6-alkylcarbonyl, C1 -C6-haloalkylcarbonyl, C3-C8-cycloalkylcarbonyl, C1-C6-alkoxycarbonyl, C3-C8-cycloalkoxycarbonyl, C3-C8-cycloalkylaminocarbonyl, Ci3 C6-alkoxy, C1 -C6-haloalkoxy, C3-C8-cycloalkoxy, C3-C8-halocycloalkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C4-alkoxyC1-C4-alkoxy, C1-C6-alkylcarbonyloxy, C1-C6-haloalkylcarbonyloxy, C3-C8-cycloalkylcarbonyloxy, C1-C6-alkylcarbonyl-C1-C4-alkoxy, C1-C6-alkylthio, C1-C6-haloalkylthio, C3-C6-cycloalkylthio, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, C3-C8-cycloalkylsulfonyl, C1-C6-alkylsulfonyloxy, C1C6-haloalkylsulfonyloxy, phenylsulfonyloxy, C1-C6-alkylsulfonylamino, C1-C6-haloalkylsulfonylamino, tri (C1-C4) alkylsilyl, tri (C1-C4) alkylsilyloxy or Petition 870190058786, of 06/25/2019, p. 22/26 3/6 C (= N-OR ⁷ ) R ⁸ , R ³ and R ⁴ are the same or different and are independently, each, methyl, ethyl, propyl, 1-methylethyl, butyl or 1,1-dimethylethyl, R ⁷ is hydrogen, methyl or ethyl, R ⁸ is hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl-C1-C4-alkyl, C3-C8-cycloalkyl, C1-C4-alkyl-C3-C8-cycloalkyl, C1-C4-haloalkyl-C3-C8cycloalkyl or C1-C4-alkoxy-C1-C4-alkyl, and salts, metal complexes and N-oxides of the compounds of formula (I). 2. Compounds of formula (I), according to claim 1, characterized by the fact that the symbols are defined, each, as follows: A is pyrazol-1-yl which can contain up to two substituents, where the substituents are selected, each independently from the following list: methyl, ethyl, chlorine, bromine, fluorine, difluoromethyl and trifluoromethyl, or A is phenyl which can contain up to two substituents, where the substituents are selected, each independently from the following list: methyl, ethyl, iodine, chlorine, bromine, fluorine, methoxy, ethoxy, difluoromethyl and trifluoromethyl, L ¹ is CH2, X R ² is oxygen, it is carbon, it is hydrogen or fluorine it is 0 R ^G1 is hydrogen Q is Q ²⁴ -1> 5 _Q 24 _-2 y \ '' R _Q the _Q 24 _-3 Petition 870190058786, of 06/25/2019, p. 23/26 4/6 Q ¹¹ -1 = or Q ¹¹ -2 = where the link identified by x is linked directly to G, and where the link identified by y is linked directly to L ² , R5 is hydrogen, cyano, methyl, trifluoromethyl, difluoromethyl or methoxymethyl, m is 0, n is 0, R ²⁴ is hydrogen R ²⁷ is hydrogen R ¹ is phenyl which can contain up to three substituents, where the substituents are selected, each, independently from the following list: fluorine, chlorine, bromine, iodine, cyan, nitro, hydroxyl, amino, uncle, - (C = O ) H, methyl, ethyl, propyl, 1-methylethyl, butyl, 1,1-dimethylethyl, 1,2-dimethylethyl, ethylene, ethynyl, trifluoromethyl, difluoromethyl, trichloromethyl, dichloromethyl, cyclopropyl, methoxy, ethoxy, propoxy, 1-methylethoxy , 1,1-dimethylethoxy, metilcarbonila, etilcarbonila, trifluorometilcarbonila, metoxicarbonila, etoxicarbonila, propoxicarbonila, 1metiletoxicarbonila, 1,1-dimetiletoxicarbonila, 1-ethenyloxy, 2-propenyloxy, 2propiniloxi, methylcarbonyloxy, trifluoroalquilcarboniloxi, clorometilcarboniloxi, methylcarbonylamino, trifluoroalquilcarbonilamino, clorometilcarbonilamino, methylthio , ethylthio, methylsulfinyl, methylsulfonyl, methylsulfonyloxy, trifluorosulfonyloxy, methylsulfonylamino, trifluoromethylsulfonylamino, -C (= N-OH) H, -C (= N-OCH3) H, C (= N-OCH2CH3) H, -C (= N- OH) CH3, -C (= N-OCH3) CH3, -C (= N-OCH2CH3) CH3 or trimethylsilyloxy, or salts, metal complexes and N-oxides of the compounds of formula (I). 3. Method for controlling harmful phytopathogenic fungi, characterized by the fact that the compounds of formula (I), as defined in claim 1 or 2, are applied to harmful phytopathogenic fungi and / or their habitat. 4. Composition to control harmful phytopathogenic fungi, characterized by the fact that the content of at least one compound of the formula (I), as defined in claim 1 or 2, in addition to extension agents and / or surfactants. 5. Use of at least one compound of formula (I), as defined in claim 1 or 2, or a composition, as defined in claim 4, Petition 870190058786, of 06/25/2019, p. 24/26 5/6 characterized by the fact that it is to control harmful phytopathogenic fungi. 6. Process for producing compositions to control harmful phytopathogenic fungi, as defined in claim 4, characterized in that the compounds of formula (I), as defined in claim 1 or 2, are mixed with extension agents and / or surfactants. 7. Use of compounds of formula (I), as defined in claim 1 or 2, characterized by the fact that it is for seed treatment. 8. Use of compounds of formula (I), as defined in claim 1 or 2, characterized by the fact that it is for the treatment of transgenic plants. 9. Use of compounds of formula (I), as defined in claim 1 or 2, characterized by the fact that it is for the treatment of transgenic seeds. 10. Compounds characterized by the fact that they have a formula (XVIIa) (XVIIa) in which W ⁶ is acetyl, C1-C4 alkoxycarbonyl, benzyl or benzyloxycarbonyl, and wherein the symbols G, L ² and R ¹ are each, as defined in claim 1 or 2, and salts, metal complexes and N-oxides of themselves. 11. Compounds characterized by the fact that they have a formula (XXXIII) (XXXIII) where W ¹⁴ represents aldehydes, ketones, esters, carboxylic acids, amides, thioamides, nitriles, alcohols, thiols, hydrazines, oximes, amidines, amide oximes, olefins, acetylenes, halides, alkyl halides, methanesulfonates, trifluoromethanesulfonates, boric acid, boron acids and wherein the symbols L ² , R ¹ , Q and G are each as defined in claim 1 or 2, Petition 870190058786, of 06/25/2019, p. 25/26 6/6 and salts, metal complexes and N-oxides thereof. 12. Compounds characterized by the fact that they have formula (XlIIa) wherein the symbols L ² , G and R ¹ are each as defined in the claim 1 or 2, and salts, metal complexes and N-oxides thereof.